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ABSTRACT 
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THE EFFECT OF MATERNAL NUTRITION ON THE EPIGENETIC REGULATION 
BY DNA METHYLATION OF HEPATIC GENES INVOLVED IN GLUCOSE AND 
FAT METABOLISM IN THE OFFSPRING 
By Samuel Peter Hoile 
 
Altered  maternal  nutrition  during  pregnancy  induces  persistent  phenotypic  changes  in  offspring, 
which can be transmitted between generations and are associated with differences in disease risk.  
Epigenetic processes have been shown to underlie the effects  of the early  life environment on 
phenotype.  It is not known if epigenetic marks are transferred directly  between generations or 
established de novo in each generation.  The extent to which induced changes in phenotype and 
epigenotype are affected by different nutrients and the timing of nutritional change, and the stability 
of  such  effects  during  the  life  course  are  also  not  known.    This  thesis  describes  a  series  of 
experiments to address these issues. 
  To investigate the mechanism by which induced phenotypic and epigenetic traits are transmitted 
between  generations,  dietary  energy  was  increased  25%  at  conception  in  F0  female  rats  and 
maintained  at  this  level  to  the  F3  generation.  Body  weight,  energy  intake,  glucose  and  lipid 
homeostasis and the expression of specific hepatic genes in the pregnant dams differed between 
generations.  In offspring, fasting glucose and fatty acid homeostasis was dysregulated in the F1 
generation,  but  showed  progressively  improved  metabolic  control  in  subsequent  generations 
despite continued exposure to the high energy diet. The effects on plasma glucose concentration 
were associated with altered mRNA expression and promoter methylation of phosphoenolpyruvate 
carboxykinase (PEPCK).  Altered DNA methylation was associated with changes in the epigenetic 
regulation of DNA methyltransferase (DNMT) 3a2. Protein restriction of the maternal diet modified 
the trajectory of changes in maternal and offspring phenotype, gene expression and epigenome 
between generations. These findings suggest that the changes in signals from mother to the fetus, 
induced  by  differences  in  the  interaction  between  maternal  phenotype  and  nutrition  in  each 
generation, provided a stimulus for modification of the phenotype of the offspring.  Such effects 
appeared to produce beneficial adjustments in metabolic control via altered epigenetic control of 
specific genes.  
  The  effects  of  different  maternal  nutritional  exposures  on  the  epigenetic  regulation  of  specific 
genes was investigated by comparing differences in gene regulation following feeding of a protein 
restricted, 7 and 21% safflower oil and fish oil diets during pregnancy. No offspring showed altered 
methylation of the PEPCK promoter, whereas feeding altered fat diets lead to significant changes in 
the promoter methylation of fads2. This suggests that alterations in the epigenetic regulation of 
transcription of specific genes are related to the nature of the nutritional challenge.  
  In  order  to  determine  whether  induced  changes  in  the  epigenetic  regulation  of  genes  are 
influenced by the timing of the nutritional challenge during the life course, folic acid supplementation 
was  provided  during  pregnancy  or  to  the  offspring  during  their  juvenile-pubertal  (JP)  period. 
Compared to prenatal folic acid supplementation, JP supplementation led to increased PEPCK and 
DNMT3a2 mRNA expression, and altered promoter methylation contingent on sex. This may be 
due to specific windows of plasticity in the epigenome. Differences in methylation of PEPCK and 
DNMT3a2 induced during development were found to change with increasing age. This suggests 
continued plasticity of the epigenome beyond the immediate developmental period. 
  Overall, the findings of these studies show that the nature of induced phenotypes involves signals 
produced by the interaction of the mother and her environment, and the timing and nature of the 
nutritional challenge acting via the epigenome.  Such induced traits may confer harm or benefit both 
within and between generations according to the nature of the nutritional exposure.   
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1. Introduction 
 
1.1 The cardio-metabolic disease pandemic 
There is a worldwide pandemic of heart disease, predominantly coronary 
heart  disease  and  stroke,  and  a  group  of  related  conditions  including  type  2 
diabetes mellitus and hypertension known collectively as the metabolic syndrome. 
These  diseases  are  caused  primarily  by  an  increase  in  levels  of  obesity  and 
represent a major health burden in terms of mortality, morbidity, and financial cost.  
In Westernised nations, the main factor driving the increasing prevalence of cardio-
metabolic disease is the ready availability of cheap, energy-dense foods, together 
with  an  increasingly  sedentary  life  style.  In  developing  nations,  increased 
prevalence of cardio-metabolic disease is primarily a feature of migration from rural 
subsistence  culture  to  an  urban  Westernised  life  style.    However,  developing 
countries suffer the double health burden of increasing cardio-metabolic disease 
together with continuing malnutrition and infectious disease in rural communities.  
In this context, it is of concern that nations with the highest predicted increase in 
the prevalence of cardio-metabolic disease are those which can least afford it.  For 
example, a meta-analysis of over 30 studies world-wide showed that although the 
world-wide prevalence of diabetes incidence is predicted to increase from 2.8% to 
4.4% from 2000 to 2030, the increase in India alone is predicted to be 151%
[1]. A 
similar pattern is also seen in Zimbabwe, where in 1994, 17.4% of 25-49 year olds 
were classified as obese
[2].  
In the United Kingdom, one in three deaths are caused by cardiovascular 
disease (CVD), accounting for around 191,000 deaths per year. The most common 
causes of death from CVD are coronary heart disease (CHD) and stroke, which 
account  for  46%  and  23%  of  CVD  deaths,  respectively
[3].  CVD  costs  the  UK 
economy around £30.7 billion per year, this constitutes approximately 47% health 
care costs, 27% loss of production and 26% spent on informal care of people with 
CVD
[3]. 
Type  2  diabetes  mellitus  and  obesity  are  traditionally  thought  of  as 
conditions which occur in adults. For example, a study in Micronesia determined Samuel Peter Hoile   
3 
 
that diabetes becomes prevalent at 45-55 years old in females and 55-65 years old 
in males, and obesity presents itself in 15-25 year olds
[4].  However, there is an 
increasing concern that children are becoming overweight. It has been estimated 
that 10% of the world’s school children are overweight and one quarter of these 
are obese
[5]. In the UK, 29% of girls and 31% of boys aged 2 to 15 years old are 
classified as over-weight or obese
[6].  An implication of these findings is that the 
burden  of  cardio-metabolic  disease  in  the  next  generation  will  be  substantially 
greater than in the current adult population, possibly accompanied by shorter life 
expectancy and a greater burden on the health care systems 
 
1.1.2 Factors which predispose to cardio-metabolic disease 
The risk factors for cardio-metabolic disease are well established, where it is 
influenced  by  both  genetics  and  environment.  The  medical  risk  factors  for  the 
disease are well understood. Increased blood pressure, both systolic and diastolic, 
are related to an increased risk developing the disease. 45% of heart attacks in 
Western Europe are due to abnormal blood lipids. As well as being independent 
risk  factors for  CVD,  being  overweight  or  obese  leads  to  an  increase  in  blood 
pressure,  blood  cholesterol  and  impaired  glucose  tolerance.  Men  with  type  2 
diabetes have a 2-4 fold risk of CVD, whereas for women this is increased to a 3-5 
fold  risk
[3].  Alternative  explanations  for  differences  between  people,  in  risk  of 
cardio-metabolic disease are, poor diet, in particular salt intake, smoking, alcohol 
consumption  and  physical  inactivity.  Preventions  are  in place  at  the  nationwide 
scale  to  reduce  environmental  risk  factors  for  CVD,  for  example  campaigns  to 
reduce salt and energy intake in the population. The benefits of understanding the 
interactive role of the environment on alterations in gene regulation, in terms of 
disease risk are clear. However, the factors which predispose an individual cause 
of cardio-metabolic disease are complex.   
 
1.1.3 Genetic factors in cardio-metabolic disease  
The role of gene polymorphisms in the cardio-metabolic disease has been 
studied extensively. Samuel Peter Hoile   
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1.1.3.1 Evidence from candidate gene studies 
Lusis  and  Arnett  provide  a  detailed  list  of  risk  factors  for  coronary  heart 
disease, which have significant genetic factors, with the main genes highlighted 
having roles in determining plasma cholesterol and triglyceride concentrations
[7,8]. 
The role of polymorphisms in CVD risk is dependent on environmental factors. This 
is shown clearly in the epsilon 3 allele of apolipoprotein E, where a two–fold risk of 
CVD is seen in smokers, compared with non-smokers
[9]. Hyperhomocysteinemia 
has  been  linked  to  an  increased  prevalence  of  cardiovascular  disease.  The 
677CT  mutation  of  the  methyltetrahydrofolate  reductase  (MTHFR)  gene  was 
found to be present in 15% of cardiovascular disease patients and around 5% of 
control  patients
[10].  The  mutation  was  associated  with  a  three-fold  increase  in 
prevalence of cardiovascular disease. In a large meta-analysis, polymorphisms of 
nitric oxide synthase (NOS3) were tested for links with CVD
[11]. The study found 
two  polymorphisms, Glu298Asp  and 786 TC,  where both  were  independently 
associated with cardiovascular disease (odds ratio 1.17 for both). 
 
1.1.3.2 Evidence from genome wide association studies 
Genome  wide  association  studies  have  shown  significant  correlations 
between cardiovascular disease risk and specific genes
[12,13]. In a study of 8,090 
African Americans from  5-population based cohorts 6 regions were significantly 
associated with cardiovascular disease risk, CDKN2A/CDKN2B, HDL-C, FADS1-3, 
PLTP, LPL and ABCA1
[12]. All measured regions had previously been shown to be 
significant in Caucasians also
[12]. Further advances in genome wide association 
studies have looked to determine if loci predicted trait levels at all ages. Using 
participants  from  the  longitudinal  Bogalusa  Heart  Study,  Smith  et  al  showed 
significant effects of CETP with plasma HDL levels and apolipoprotein E with LDL 
levels
[13]. Single nucleotide polymorphisms (SNPs) at specific loci were found to 
have significant age effects for 12 measured phenotypes, such as ESRRB/VASH1 
and CDH5/TK5, which were significantly associated with diastolic blood pressure 
and glucose homeostasis, risk factors for cardiovascular disease, respectively.  Samuel Peter Hoile   
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Cardiovascular  disease  represents  a  major  issue  in  terms  of  morbidity 
world-wide.  Although  progress  has  been  made  in  understanding  the  role  of 
genetics and contributing risk factors in the increased risk of the disease, it is not 
known why individuals with the same genotype and external environment display 
different disease risk. Risk factors for cardiovascular disease, such as obesity, are 
now presenting in children, as well as in adulthood. It is important, now more than 
ever, to understand the link between the early life environment and altered disease 
risk. 
 
1.1.4  Epidemiology 
Although numerous confounding factors are present, human observations 
have shown clear examples of early life origins of specific diseases. The following 
collection of studies aims to give an insight into the data obtained from human 
observations. The retrospective studies have looked at differences in growth during 
early life within a population and the prospective studies have looked at outcomes 
of individuals who differ in certain factors, within a sample cohort.     
 
1.1.4.1 Retrospective observations   
  By  looking  at  a  large  number  of  subjects,  studies  have  confirmed  the 
relationship  between  low  birth  weight  and  an  increased  risk  of  disease  in  later 
life
[14,15,16,17,18,19].  Good  record  keeping  in  the  early  20
th  century  allowed 
investigation into the relationship between mother’s pelvic size, fetal growth and 
death from stroke in a sample of 13,249 men in Hertfordshire and Sheffield born 
between 1907 and 1930. Mortality from cardiovascular disease was found to be 
associated with a small head circumference, thinness or shortness at birth and an 
altered ratio of placental weight to birth weight
[17,19].  Measurements of maternal 
placental  weight,  birth  weight  and  blood  pressure  in  adults  born  in  Preston 
between  1935  and  1943  have  shown  a  strong  relationship  between  placental 
weight and birth weight and systolic and diastolic blood pressure. An increase in 
birth  weight  was  associated  with  an  increase  in  mean  blood  pressure.  The 
relationships between placental weight and blood pressure, and birth weight and Samuel Peter Hoile   
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blood  pressure  were  independent  of  each  other,  meaning  a  baby  with  a  large 
placental  weight  and  small  birth  weight  was  found  to  have  the  highest  blood 
pressure  at  age  45-54
[14]. When  considering  the  similar  results  shown  in  these 
studies it is encouraging to know that all the results use the same guidelines for 
low birth weight (< 5.5 lb). Studies such as these are limited by the number of 
confounding  variables  present,  meaning  causal  relationships  cannot  be 
established. They fail to provide potential mechanisms for the relationships seen 
and due to the numerous environmental differences between each study group it is 
unwise to generalise to the whole population. The main limiting factor in human 
studies is that due to ethical reasons they must remain observations, meaning we 
cannot tell what will occur under more severe circumstances. 
  During the winter of 1944-1945, the Western Netherlands suffered from a 
severe reduction in food supplies as a result of Germany’s actions in the Second 
World War. During this period, known as the Dutch hunger winter, calorific intake, 
which was adequate before the war, fell to below 1000 kcal/day by November 26
th 
1944 and by April 1945 was as low as 500 kcal/day. Following liberation on May 5
th 
1945 food supplies were returned to normal levels. Children’s rations were well 
protected throughout the famine, never falling below 1000 kcal/day
[15,16,20,18]. The 
effects of the famine on birth weight and disease risk in later life have been well 
characterised in numerous studies, each paying close attention to the timing of the 
famine in regards to the stage of pregnancy (early, mid or late-gestation). A decline 
in mean birth weight of 300g and an increase in rate of perinatal death was seen in 
offspring,  following  famine  exposure  during  late  gestation
[15,16].  Coronary  heart 
disease was measured in 296 adults born during the famine, it was found that an 
increase  in  coronary  heart  disease  was  only  seen  in  those  exposed  to  famine 
during early gestation compared to a control group (non-exposed). Those exposed 
during early gestation tended to have smaller head circumferences and lower birth 
weights,  when  compared  to  the  control  group
[21].  At  age  50,  men  and  women 
exposed to famine during early gestation were the only group who had significantly 
increased BMI, low density lipoprotein (LDL) -high density lipoprotein (HDL) ratio 
and plasma apolipoprotein B concentrations and significantly reduced plasma HDL Samuel Peter Hoile   
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and apolipoprotein A concentrations when compared to non-exposed adults
[22,23,24]. 
This  resulted  in  a  more  atherogenic  lipid  profile,  giving  an  increased  risk  of 
coronary heart disease in these individuals. The Dutch hunger winter highlights the 
importance of timing of exposure to altered nutrition. It clearly indicates that it is 
during early development when  lifelong alterations in phenotype can be set up. 
This is useful in two ways, firstly the fact that cardiovascular disease is increased 
in offspring in mothers exposed to famine during the first trimester tells us those 
systems  which  were  developing  during  famine  exposure  are  those  at  risk  of 
alterations. Secondly it shows that once each stage of development is complete it 
is no  longer at  risk  of  environmentally  induced  alterations.  Although  it  must  be 
mentioned that more recent findings from Burdge et al, have shown that dietary 
modification  during  the  juvenile  period  of  rats  has  the  potential  to  reverse  the 
effects  of  the  maternal  diet,  indicating  the  changes  caused  during  early 
development  are  sensitive  to  change
[25].  Transgenerational  transmission  of 
phenotypes following the Dutch Winter Famine will be discussed later. 
Human studies in Norway, India and Finland have shown similar results to the UK 
and Netherlands, in terms of development, disease risk and the role of catch up 
growth
[26,27,28,29].  Catch-up  growth  has  been  shown  to  be  a  risk  factor  for  the 
development of heart disease, stroke, type II diabetes, and hypertension. Studies 
agree  that  slow  infant  growth  followed  by  catch  up  growth  which  leads  to  an 
average  or  above  average  BMI  at  aged  7  leads  to  the  highest  death  rate  in 
Helsinki, Finland
[27,28]. Although it is clear that different countries will have different 
nutritional intakes, as well as different environmental exposures, the similar results 
present  in  the  different  populations  suggest  the  mechanisms  responsible  for 
altered phenotype are not a result of specific adaptations following migration. 
 
1.1.4.2 Prospective studies 
A  number  of  non-communicable  diseases,  such  as  cancer,  osteoporosis 
and diabetes have been linked to a poor early life environment. A focus of the 
research in the field of DOHaD has been metabolic syndrome. Emerging evidence 
has shown that lower birth weight and altered placental growth are risk factors for Samuel Peter Hoile   
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cardiovascular disease, type 2 diabetes, high blood pressure, high cholesterol and 
abnormal  glucose  and  insulin  metabolism  in  adulthood
[30,31,32].  Maternal  weight 
gain during pregnancy, maternal metabolism and signalling across the placenta 
have also been shown to be factors in metabolic syndrome, with emphasis on the 
restriction of fetal growth due to the size of the mother
[33]. 
As shown in figure 1.1 disease risk is associated with both low birth weight 
and  high  birth  weight.  High  birth  weight  (defined  as  ≥  4,500  g) is  linked  to  an 
increase risk of cancer, in particular breast cancer, hepatoblastoma and childhood 
myeloid leukaemia
[34]. Like other predictive adaptive responses leading to stable 
alterations  in  genes,  these  phenotypes  are  only  seen  if  the  disease-inducing 
environmental cues are encountered later in life. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  1.1  Diagram  showing  the  association  between  birth  weight  and  later  life  risk  of 
disease. In the absence of disease inducing environmental cues, both high and low birth weight 
will  result  in  a  healthy  phenotype.  In  the  presence  of  disease  inducing  environmental  cues 
throughout life, a low birth weight will result in an increased risk of CVD and metabolic syndrome. 
In the presence of disease inducing environmental cues throughout life, a high birth weight will 
result in an increased risk of cancer. An optimal birth weight does not increase the risk of disease. Samuel Peter Hoile   
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Infant  weight  gain  and  catch-up  growth  play  a  vital  role  in  phenotype 
induction, particularly in development of disease. This is due to the small window 
of plasticity present in early infancy. Lucas et al have shown that in terms of lung 
function in adulthood, a combination of both low fetal growth and high infant growth 
lead  to  the  least  beneficial  lung  development.  This  sub-optimal  development 
resulted in diminished lung function and an increased risk of chronic obstructive 
airway disease. Interestingly these findings were not related to birth weight, only 
growth
[35]. A review of studies has found that following low birth weight, a high level 
of catch-up growth in infancy leads to increased blood pressure in adulthood
[32]. 
This review looked at a large number of studies encompassing both males and 
females  of  all  ages  and  races.  Although  these  studies  seem  to  show  the 
deleterious effects of catch-up growth, a more recent review of similar literature on 
weight gain in general by Adair et al indicates that any period of weight gain during 
life is related to an elevated adult blood pressure
[36]. The review shows that catch-
up growth in infancy and young childhood displayed no greater risk compared to 
other  periods  of  weight  gain
[36].  When  considering  the  evidence  it  is  not  clear 
whether the data on catch-up growth are a result of weight gain alone, or if the 
window  of  plasticity  in  infancy  is  responsible.  In  order  to  confirm  this  further 
experiments must be carried out, which distinguish catch-up growth in infancy from 
growth following excess calorific intake in later life. It is clear however that the 
concept  of  weight  gain,  as  a  period  of  change  in  nutritional  intake,  provide 
evidence for the negative result of a predictive adaptive response (PAR) mismatch 
following birth. Studies into timing of compensatory growth will inevitably lead to 
benefits on human health, where optimum periods of growth, in terms of reduced 
detrimental outcomes, will be identified. 
    Cohort studies have been invaluable in showing the developmental origins 
of adult disease. The next collection of studies that will be discussed are cohort 
studies from different areas in the United Kingdom, followed by those worldwide. 
The  Southampton  Women’s  Survey  was  established  to  measure  the  pre-
pregnancy  characteristics  of  women  aged  20-34  years  old  living  in  the  city  of 
Southampton.  The  study  followed  up  the  women  who  became  pregnant  and Samuel Peter Hoile   
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focused on fetal development, post-natal growth and the way in which these are 
associated  with  risk  of  chronic  disease  later  in  life.  Early  data  has  shown  a 
decrease in maternal liver blood flow at 36 weeks gestation in women who were 
slim before pregnancy, compared to those who were not
[37]. Similar to previous 
findings, babies who were smaller at birth or who had high post-natal weight gain 
showed  a  poorer  lung  function
[37].  The  Nurses’  Health  study,  set  up  in  1976, 
provides one of the most significant insights into the health of woman. Although not 
intended as a cohort to investigate development, the 121,700 participant study has 
found that a birth weight of over 4.54 kg is associated with a two fold increase in 
adult onset rheumatoid arthritis in later life
[38]. A further cohort prospective study 
which  provided  links  between  body  size  at  birth  and  later  health  is  the  Avon 
Longitudinal Study of Parents and Children (ALSPAC). The study found that an 
increase in birth weight was associated with an 18% reduction in risk of definite 
psychosis-like symptoms at age 12
[39]. The study also looked at the relationship 
between childhood growth and the same symptoms, and found no association
[39]. 
This  shows  that  the  direction  of  phenotype  established  during  prenatal 
development cannot be changed by patterns of growth in childhood. These cohort 
studies  have  used  prospective  methods  to  follow  the  emerging  changes  in 
phenotype following different maternal nutrition. As well as the timing of nutritional 
exposure, it is apparent that the magnitude and duration of the altered phenotype 
is also dependent on the extent of the nutritional alteration. 
  Although useful in allowing large populations to be measured and providing 
relationships between the in utero environments and onset of disease in later life, 
human  observations  do  not  provide  the  opportunity  to  explore  mechanisms  of 
phenotype induction. As in most observations there are too many variables, such 
as socio economic status, lifestyle and maternal and paternal background, to allow 
true  causality  of  results  to  be  determined.  Human  data  is  based  either  on 
retrospective  analysis  of  past  pregnancies  or  prospective  studies  covering  pre-
pregnancy  and  post-natal  life.  In  retrospective  studies,  desired  data  may  be 
lacking. Prospective studies are highly useful in allowing collection of many desired Samuel Peter Hoile   
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measurements at various time points, however they require a considerable amount 
of time to complete, in most cases a lifetime.  
Animal  studies  in  controlled  environments,  whereby  interfering  variables 
may  be  eliminated,  must  therefore  be  used  in  order  to  establish  patterns  of 
developmental origins of adult disease. Due to the shorter lifespan of animals used 
in  these  studies,  they  provide  an  invaluable  method  to  asses  phenotype  and 
genotype  in  offspring  in  an  appropriate  time  scale.  Transmission  of  these 
phenotypes  and  mechanisms  underlying  these  phenotypes  must  also  be 
determined. 
 
1.1.4.3 Animal studies 
  The most common animal models used in the field of the developmental 
origins of health and disease are those in rodents, specifically rats. In order to 
appreciate the benefits of rat models, in terms of understanding human disease 
development,  it  is  also  important  to  understand  their  limitations.  Although  the 
physiology  of  the  rat  is  very  similar  to  that  of  the  human,  as  both  have  four-
chambered hearts and an identical respiratory system, key differences are present. 
For  example,  humans  have  a  gall  bladder,  whereas  rats  have  a  bile  duct, and 
where humans have an appendix, rats do not. One key difference in development 
between  humans  and  rat  is  seen  in  the  formation  of  the  brain.  In  humans, 
development of the brain occurs in utero, whereas in rats, brain development is 
post-natal. A study by Romijn showed that the rat brain at postnatal day 12-13 is 
equivalent, to a human baby at term, in terms of development
[40]. 
   
1.1.4.3.1 Low protein rat model 
The low protein model has been used extensively in rodents to show how a 
change in protein intake during pregnancy leads to alterations in metabolism and 
phenotype in the offspring. The following section aims to give an introduction to the 
model and summarise some of the key findings. The first use of the low protein 
model, from which all further uses of the model are based, was by Langley-Evans 
et  al
[41].  The  study  showed  that  a  maternal  low  protein  diet  before  and  during Samuel Peter Hoile   
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pregnancy  led  to  hypertension  in  4  week  old  rat  offspring.  The  finding  was 
independent of sex and was not seen in adult rats fed a low protein diet for a 14 
day period, showing the importance of the in utero exposure to the low protein 
diet
[41]. Langley-Evans et al went on to show how a low protein diet leads to altered 
programming by maternally-derived glucocorticoids due to the decrease in 11 β-
hydroxysteroid  dehydrogenase  2  (11βHSD2),  a  glucocorticoid  inactivating 
placental enzyme. Overexposure to maternally derived glucocorticoids in the low-
protein  model  resulted  in  altered  physiology  and  endocrine  functions  in  the 
offspring  and  as  a  result  disease,  caused  by  loss  of  homeostatic  control
[42,43]. 
Experiments by Langley-Evans have used variants of the low protein diet, where 
protein levels of the diet have stayed constant at 9% casein, but nutrient levels 
have varied and control diets used have been either 22% or 18% casein. These 
slight  variations  in  macro  and  micronutrient  intake  have  led  Langley-Evans  to 
describe  their  critical  importance  when  designing  diet  protocols
[44].  Similar  to 
Langley-Evans,  a  study  by  Bertram  et  al  also  looked  at  altered  glucocorticoid 
receptor and 11βHSD1 and 11βHSD2 expression in offspring of low-protein diet 
fed  mothers.  They  found  that  fetal  and  neonatal  offspring  displayed  a 
glucocorticoid dependent rise in systolic blood pressure and a two fold increase in 
mRNA expression of the glucocorticoid receptor in kidney, liver and brain tissue, 
compared to control offspring. This increase in gene expression  was three fold 
higher in juvenile and adult rats
[45]. Similar variants of the low-protein rat model 
have been used to investigate the developmental origins of disease. These studies 
have found that the model resulted in a reduced cell number in embryos signifying 
a  slower  rate  of  cellular  proliferation
[46],  smaller  birth  size  of  offspring,  rapid 
deterioration of  glucose  tolerance,  increased  hepatic PEPCK  mRNA  expression 
and  decreased  glucokinase  activity  in  adulthood,  leading  to  altered  metabolism 
and capacity to deal with glucose
[47,48]. Ozanne et al, used a perfusion method to 
asses  hepatic  glucose  output,  following  a  maternal  protein  restriction
[49].  The 
results showed an increased capacity for gluconeogenesis, larger liver lobule size 
and  insulin  and  glucagon  resistance  in  the  reduced  protein  offspring,  when 
compared to control offspring. As well as changes in liver metabolism caused by Samuel Peter Hoile   
13 
 
the low protein diet, skeletal muscle and adipose tissue also showed changes in 
glucose  uptake  and  insulin  response
[49].  As  discussed  earlier  in  humans,  the 
relationship between high birth weight and increased cancer incidence has been 
shown. In rats however, although a relationship between birth weight and cancer 
risk is present, it appears to be the inverse relationship to that seen in humans. 
Low birth weight achieved by feeding a low-protein diet (8% casein) was found to 
correlate to an increased risk of breast cancer, when induced via injection with 
carcinogen, N-Nitroso-N-methylurea (NMU). High birth weight however, was linked 
to an increased risk of breast cancer, hyperglycaemia and insulin resistance. When 
compensatory  growth  was  followed  maternal  protein  restriction  levels  of  early 
mammary  tumour  incidence  was  doubled  when  compared  the  control  group
[50]. 
The  forms  of  cancer investigated  in  the  human  and  rat  studies  differ,  meaning 
direct species comparisons cannot be made. The studies do however show the 
importance  of  using  animal  models  to  look  at  potential  mechanisms  present  in 
humans, rather than for direct comparisons. 
To further understand mechanisms behind phenotype induction in the low 
protein rat model, numerous studies have fortified the low-protein diet with extra 
nutrients, such as folic acid or specific amino acids. In a study where a maternal 
low-protein  diet  led  to  comprised  maternal  cardiovascular  adaptations,  folate 
supplementation  improved  maternal  vascular  function  and  restored  offspring 
cardiovascular  function
[51].  Another  study  used  fortification  of  a  9%  casein  low-
protein diet with 3% glycine, 3% alanine or 3% urea. The study found that the 
maternal low-protein diet led to significantly higher blood pressure, when compared 
to an 18% casein control group
[52]. The difference was not seen in the low-protein 
plus  glycine  group,  whereas  it  was  in  the  other  dietary  groups.  Body  weight 
however  was  significantly  reduced  in  all  low-protein  groups  compared  to  the 
control group, except for the low-protein plus urea group. This study confirms the 
importance of glycine in normal cardiovascular development
[52].  
The  low  protein  rat  model  provides  a  working  example  of  phenotypic 
changes caused by altered nutritional intake during pregnancy. The low protein 
model  can  be  used  experimentally  to  identify  possible  mechanisms  behind  the Samuel Peter Hoile   
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phenotypic changes seen. By looking closer at systems affected, it will be possible 
to understand how these differences are brought about, how they are maintained 
and potentially how they can be avoided. 
 
1.1.4.3.2 Intra uterine growth restriction 
  A number of studies have used the intrauterine growth restriction (IUGR) 
model to investigate the mechanisms behind the developmental origins of disease. 
The  study  objective  is  to  cause  restriction  of  growth  in  the  fetus.  The  most 
abundant variant of this method involves decreasing maternal nutrition; another 
cause  of  growth  restriction  involves  bilateral  ligation  of  the  uterine  artery. 
Symptoms of metabolic syndrome have been induced in rats via the IUGR model. 
These  experiments  used  bilateral  ligation  of  the  uterine  artery  at  day  17  of 
gestation, which led to placental insufficiency and resulted in growth restriction of 
the offspring. These experiments have found that IUGR leads to obesity, type 2 
diabetes and metabolic syndrome
[27,53].  
Studies using the IUGR model, in rat, have shown an increase in development of 
hypertension  in  offspring.  IUGR  achieved  by  reduced  uterine  perfusion  in  late 
gestation resulted in low birth weight in offspring. At 4 weeks of age, mean arterial 
pressure  was  significantly  increased  in  IUGR  offspring,  compared  to  control 
offspring
[54]. At 8 weeks of age the elevations in arterial pressure were associated 
with sex-specific decreases in body weight in male and female offspring, versus 
control rats. IUGR as a result of chronic maternal under nutrition also led to signs 
of hypertension in offspring. When dams were fed a 30% ad libidum diet during 
pregnancy, offspring were significantly smaller from term, until postnatal week 12, 
compared to offspring of ad libidum fed dams
[55]. Blood pressure, measured by tail 
cuff plethysmography, showed an elevated systolic blood pressure at postnatal 30, 
40 and 56 weeks in IUGR offspring. Two studies which used 50% ad libidum diet 
to induce IUGR in offspring, showed significantly altered β -cell development and 
risk  of  obesity  in  offspring
[56,57].  Feeding  a 50%  ad  libidum  diet from day  15 of 
pregnancy led to a significantly decreased body weight and β-cell mass, compared 
to control offspring, at postnatal day 1
[57]. Following 21 days of ad libidum feeding Samuel Peter Hoile   
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there were no significant differences between IUGR and control offspring, in terms 
of body weight, however a 40% decrease in β-cell mass was retained. The result 
suggests that IUGR did not result in persistent changes in postnatal growth, but did 
result in impaired β-cell development. When 50% ad libidum was fed to pregnant 
dams from day 10 of pregnancy, offspring showed a decreased plasma leptin and 
increased ghrelin concentration
[56].  The decrease in programming of orexigenic 
hormones led to an increase in incidence of offspring obesity. The model of intra 
uterine growth restriction used by Vickers et al involves maternal under nutrition 
(30% of an ad libidum diet) during gestation, followed by a post-weaning control or 
high fat diet (30% fat). The hyper caloric postnatal diet exacerbated decreased 
locomotor activities present following the period of under nutrition, which is part of 
the  fetal  origin  of  hyperphagia,  obesity  and  hypertension  seen  in  these 
animals
[58,59]. One major problem associated with studies such as these described 
is the fact that such dramatic nutritional alterations are used to cause a different 
phenotype. In terms of the Dutch Winter Famine, it could be argued that the 70% 
reduction in food intake used for the under nutrition group is directly relevant, when 
using calorific intakes stated for the period in Ravelli 1999
[23]. However the fact the 
Dutch  Winter  famine  occurred  over  50  years  ago  in  one  town  in  one  country 
implies a lack of relevance to the population in general. These flaws present in 
animal models reduce the relevance of the findings when considering humans.  
A study by Battista et al has shown how a small nutritional change during 
pregnancy can lead to fetal growth restriction. By feeding a low-sodium diet during 
the last week of gestation in rats (equivalent in time to the last trimester of human 
gestation),  growth  restriction  was  achieved
[60].  High  blood  pressure,  elevated 
plasma urea concentration, decreased urinary sodium and renal dysfunction was 
seen in adulthood of the IUGR offspring, and creatinine levels were augmented in 
females only. Although an unlikely comparison to human gestation the study gives 
a  good  insight  into  the  consequences  of  short  time  nutritional  deficiencies  and 
highlights the importance of sex in IUGR rats
[60]. 
IUGR  in  offspring  is  not  caused  by  altered  nutrition  alone.  Decreased  oxygen 
supply  to  dams  during  pregnancy  (hypoxia),  has  been  used  experimentally  to Samuel Peter Hoile   
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induce reduced growth in offspring. In a study by Xu et al, IUGR was caused by 
hypoxia (12% O2) or nutrient restriction (40% ad libidum), in Sprague-Dawley rats. 
In 4-month old offspring, maternal hypoxia resulted in increased collagen I and III 
mRNA expression, increased left and right ventricular weight/ body weight ratio, 
decreased  MMP-2  activity  and  decreased  functional  recovery  after 
ischemia/reperfusion,  compared  to  both  control  and  nutrient  restriction  induced 
IUGR  offspring  groups.  There  were  no  differences  between  nutrient  restriction 
IUGR and control offspring. At 7 months, however, IUGR offspring, regardless of 
the  method  of  restriction,  showed  increased  left  ventricular  weight/birth  weight 
ratio, increased collagen I and III mRNA expression, decreased MMP-2 activity 
and  decreased  cardiac  recovery,  compared  to  control  offspring
[61].  The  results 
suggest  that  IUGR  caused  by  hypoxia  leads  to  earlier  incidence  of  altered 
phenotype  in  offspring,  however  by  7  months,  the  method  of  IUGR  had  no 
significant  effect  on  phenotype.  Williams  et  al  showed  that  IGUR,  caused  by 
hypoxia, led to altered adult vascular function in offspring
[62]. Using L-NAME, NO 
synthase inhibition, in small mesenteric arteries, it was shown that IUGR offspring 
at 4-months, but not 7-months, had reduced methacholine-induced endothelium 
dependent relaxation
[62]. 
Although the previous studies do provide insight into the way in which these 
systems work, they fail to show the minimal level of alteration in nutrition required 
to bring about these changes. It would be interesting to see if the differences in 
specific nutrient intake seen across different population groups in humans were 
sufficient to bring across evident changes in phenotype in experimental animals, if 
equivalent nutrition was given. 
 
1.1.4.3.3 Maternal high fat feeding 
  In the past 50 years the type and amount of fat intake in the Western World 
has changed dramatically
[63]. One example of this is the introduction of margarine, 
which led to an increase in the dietary intake of trans 18:2n-6.  
  The effects of feeding a high fat diet have been shown experimentally in 
rodents
[64,65,66,67,68,69,70,71,72],  where  the  most  common  dietary  alteration  used  is Samuel Peter Hoile   
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increased supply of saturated fatty acids to dams. Feeding rats a diet containing 
20%  dietary  lard  during  both  pregnancy  and  lactation  led  to  a  defect  in 
endothelium-dependent relaxation in 180 day old offspring, compared to control 
animals
[71].  In  offspring  of  Sprague-Dawley  rats  fed  a  lard-rich  diet  during 
pregnancy  and  suckling,  followed  by  a  control  diet  fed  post-weaning,  aortic 
stiffness  was  increased  and  endothelium-dependent  relaxation  was  decreased, 
compared to control offspring
[65]. These two studies show a clear effect of maternal 
fat  intake  on  offspring  vascular  function.  Glucose  homeostasis  is  significantly 
altered  in  offspring  of  high  fat fed  dams.  Increased  risk  of  type-2-diabetes  and 
obesity was shown in male offspring of high fat-fed dams
[64]. These effects were 
independent of maternal obesity, birth weight and post-natal macronutrient intake. 
In  a  study  by  Cerf  et  al,  feeding  dams  a  high  fat  diet  during  pregnancy  and 
lactation  or  throughout  lactation  alone,  led  to  a  greater  fasting  glucose 
concentration 30 minutes following a meal, which was normalised at 60 minutes
[67]. 
Although a high fat diet fed during pregnancy alone did lead to glucose intolerance, 
this  was  significantly  milder  compared  to  pregnancy  and  lactation  or  lactation 
alone.  A  further  study  by  the  group  concluded  that  ‘high  fat  programming’  is 
induced  by  maternal  saturated  fat  intake  during  periods  of  gestation  and/or 
lactation and programs the physiology and metabolism of the offspring in early life, 
through failure of pancreatic β cell development and function
[66].   
Feeding a high fat diet to dams leads to altered regulation of food intake and body 
weight  in  offspring.  In  a  multigenerational  mouse  study,  three  generations  of 
C57BL/6 dams were fed a chow or high fat diet. The study found that high fat 
offspring weighed less at weaning, but gained more during the first 8 weeks of life, 
to achieve a significantly higher body weight at adulthood, compared to control 
offspring
[68].  In  humans,  energy  balance,  metabolism  and  behaviour  are 
significantly altered in offspring following a maternal high fat diet
[70]. The effects, 
thought to involve altered programming of neural pathways, led to an increased 
risk of development of mental health disorders, such as anxiety. In rats, altered 
responses to fat-enriched foods were shown in offspring of high-fat fed dams
[69]. Samuel Peter Hoile   
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The  effect  was  associated  with  altered  dopamine  transmission  in  the  nucleus 
accumbens, and was also related to altered stimulant drug response. 
Increased dietary fat intake in rats during the 6 weeks before mating, pregnancy 
and  lactation  led  to  an  increase  in  PPARα,  and  a  decrease  in  PPARγ  mRNA 
expression  in  new-born  offspring.  This  suggests  an  increase  in  fatty  acid  β-
oxidation  and  a  decrease  in  adipose  formation  in  the  offspring.  The  mRNA 
expression  level  of  PPARα  was  negatively  correlated  (r  =  -0.743,  p<0.05)  with 
serum  triglyceride  concentration
[72].  The  previous  studies  have  all  shown  that 
consumption  of  a  high-fat  diet  during  pregnancy  and/or  lactation,  leads  to 
significant changes in the offspring with effects on vascular function, energy intake 
and body weight and glucose and lipid homeostasis. 
  Despite the majority of studies into the effects of dietary fat focusing on the 
detrimental effects of increased saturated fat, as is prevalent in Western society, a 
number of studies have investigated effects of other forms of fat on phenotypic 
outcomes.  In  Sprague-Dawley  rats,  an  n-3  polyunsaturated  fatty  acid  (PUFA) 
deficient diet during the perinatal period led to an increase in blood pressure in 
later  life
[73].  The  persistence  of  the  effect  was  confirmed  as  the  effect  was  still 
significant, albeit to a lesser extent, following repletion of the fatty acids. 
C57BL/6 mice were fed diets identical to Western diets, in terms of cis- and trans- 
isomers of C18:1, in order to determine whether the maternal transfer of trans-fatty 
acids,  through  breast  milk,  alters  offspring  body  composition  and  glucose 
metabolism
[74]. The study showed that high trans fatty acid feeding led to growth 
retardation,  decreased  adiposity  and  higher  fasting  glucose  levels  in  offspring, 
which were not related to insulin  insensitivity. Again, these studies have shown 
effects of maternal fat intake on body weight and glucose homeostasis in offspring. 
It  is clear that the  effects  of fat  are determined  by  the  type  and  amount of fat 
altered, however mechanisms may be preserved between fat types. 
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1.1.4.3.4 Catch up growth   
Catch  up  growth  in  humans  was  discussed  previously.  An  experiment  in 
mice using cross fostering has shown the role catch up growth plays in both health 
and  in  longevity.  In  terms  of  the  gestational  diet  low-protein  diet  pups  died 
significantly younger than control diet offspring. Limiting catch up growth was found 
to  be  significantly  beneficial  in  terms  of  lifespan  by  decreasing  the  risk  of  life 
threatening disease. The biggest increase in life span was seen when comparing 
postnatal growth restricted mice to catch up mice fed an obesity inducing diet
[75]. 
Studies  into  catch  up  growth  show  the  importance  of  matching  the  diet  during 
embryonic development and early life development. However, they also disagree 
with the PAR hypothesis, in that the most beneficial diet during life is not always 
one that mimics the maternal diet during development. 
 
1.1.4.3.5 Maternal overfeeding 
  Maternal overfeeding leads to an altered phenotype in offspring similar to 
under  nutrition  during  pregnancy.  Experiments  by  Kirk  et  al  have  shown  that 
offspring of obese rats have an amplified and prolonged neonatal leptin surge
[76]. 
This  resulted  in  altered  regulation  of food  intake  in the  offspring,  and  therefore 
obesity  risk  was  increased.  In  an  experiment  by  Plagemann  et  al,  overfeeding 
neonatal rats led to rapid early weight gain and an overall metabolic syndrome 
phenotype.  The  overfeeding  resulted  in  a  higher  level  of  methylation  at  the 
promoter  of  the  anorexiogenic  gene,  proopiomelanocortin  (POMC)
[77].  These 
studies involving over nutrition during early development have used high fat and 
high energy diets to result in offspring with increased disease risk. Interestingly the 
previously discussed studies have shown how severe under and over nutrition can 
result  in  phenotypes  with  similar  disease  risks,  though  likely  by  different 
mechanisms. 
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1.1.4.3.6 Endocrine disruptor exposure 
  The effect of an altered developmental environment on offspring phenotype 
in adult life is not limited to dietary modifications or oxygen supply to dams. In rats, 
exposure  of  dams  to  certain  phytalate  esters  led  to  reproductive  toxicity  in 
males
[78].  Exposure  of  pregnant  dams  to  endocrine  disruptors  vinclozin  or 
methoxycholor  induced  decreased  spermatogenic  capacity  and  increased 
incidence of male infertility in male offspring
[79]. These studies show that through 
the  maternal  circulation,  all  aspects  of  the  external  environment  are  subject  to 
transmission  to  the  developing  offspring,  and  must  therefore  be  considered,  in 
terms of potential altered disease risk in adulthood. 
 
1.1.4.3.7 Summary of findings from animal models 
  Dietary animal models have been vital in widening the understanding of the 
developmental  origins  of  adult  disease,  as  they  allow  controlled  dietary 
manipulations and in depth measurements to be taken. These studies have used 
changes in the maternal nutrition during pregnancy to lead to a phenotypic change 
in  the  offspring,  in  order to  increase  our understanding.  Changes  in  phenotype 
must be a result of altered protein synthesis, as a result of altered levels of gene 
transcription. The next step is to investigate the effect of timing of the nutritional 
variation and to understand what is happening at the genome level. It is important 
to find out if it is only during the pregnancy when changes in phenotype can be 
brought  about.  It  is  not  known  if  differences  are  only  seen  following  extreme 
nutritional alterations, or if subtle changes in phenotype result from subtle changes 
in  nutritional  alterations.  Although  movement  of  nutrients  across  the  placenta 
clearly  plays  a  role  in  the  developing  embryo  not  much  is  known  about  other 
factors,  such  as  hormones,  stress  and  temperature.  The  limits  of  these 
adjustments  in  developmental  trajectory  are  not  fully  understood.  Whatever 
mechanisms are responsible for changes in phenotype displayed by the described 
papers, it is clear that they must be passed during cell division. 
It  is evident  that  the maternal effect  is vital in  transmission  of  signals from the 
external  environment  to  the  developing  offspring,  yet  no  studies  to  date  have Samuel Peter Hoile   
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investigated the metabolism and phenotype of the dams exposed to the altered 
nutrition during pregnancy. An altered metabolism in dams will lead to an altered 
capability  to  accurately  represent  the  external  environment  to  the  developing 
offspring. An understanding of changes in maternal metabolism associated with 
pregnancy  will  help  us  to  better  understand  changes  caused  by  nutritional 
exposures, such as those seen in the previously described studies. 
 
1.1.5 Models of the early life origins of disease 
  The  findings  of  the  studies  described  above  have  formed  the  basis  of 
models to explain the association between the early life environment and later risk 
of disease. 
 
1.1.5.1 The thrifty gene hypothesis  
  The hypothesis has arisen to explain why diabetes, a disease with a strong 
genetic basis
[80], is prevalent when natural selection aims to ensure only genes 
with a reproductive advantage are transmitted. The theory states that for 99% of 
man’s history  we  have  survived  with  a  ‘feast  or famine’ lifestyle,  meaning  man 
utilises all nutrients when nutrition is available, in preparation for the famine which 
may  be  ahead
[81].  Although  a  great  advantage  in  times  of  food  scarcity,  Neel 
argues that as a result of natural selection modern day man to favour expression of 
‘thrifty  genes’,  which  result  in  fat  accumulation  during  times  of  abundant 
nutrition
[80]. However, in the current age it seems our metabolism is programmed to 
store energy, in the form of triglyceride in adipose tissue, for a famine which, due 
to the current availability of nutrition, never arrives. Over a lifetime, this is leading 
to an increase in fat accumulation. This has been shown to have links with an 
increase  in  obesity  and  diabetes  in  our  current  population
[81].  However,  this 
hypothesis  was  proposed  in  1962  and  to  date  no  ‘thrifty  genes’  have  been 
identified.  
 
 Samuel Peter Hoile   
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1.1.5.2  Fetal  programming  or  the  developmental  origins  of  health  and 
disease (DOHaD) hypothesis  
The  developmental  origins  of  health  and  disease  (DOHaD)  hypothesis 
suggests  that  disease  risk  in  later  life  is  influenced  by  the  developmental 
environment.  The  hypothesis,  which  provides  a  link  between  genetics  and 
environment,  is  a  progression  of  Barker’s  fetal  programming  hypothesis,  which 
suggests that a malnourished fetus makes adaptations during development that 
may prove to be detrimental in later life
[82]. The fetal programming hypothesis was 
suggested after investigation of the link between ischaemic heart disease and both 
neonatal and postnatal mortality rates in England and Wales
[82,83]. Following this 
finding, Barker further investigated the link between early life and disease risk in 
adulthood
[82,84,14,85,86,87,88]. Using samples from the Helsinki cohort, Barker showed 
that the relationship between development and disease was not restricted to the 
UK
[87]. In a study of 3,676 men born between 1934 and 1944 in Helsinki, Finland, 
hospital admission for or death from coronary heart disease was increased if men 
were from a low social class, low household income, had a low education, had 
accelerated weight gain in infancy or were thin at birth. These observations led 
Barker  to  conclude  that  those  that  grow  slow  in  utero  maintain  an  altered 
metabolism  throughout  life
[87].  A  key  finding  of  Barker’s  work  has  been  the 
introduction  of  the  role  of  nutrition  in  the  hypothesis  of  the  early  life  origins  of 
disease
[83]. 
Barker  formulated  the  DOHaD  hypothesis,  a  more  general  theory  that 
encompasses not only under nutrition, but an altered developmental environment 
in general, which alters the body’s setting of metabolism and hormones as well as 
the  number  of  cells  in  key  organs
[83].  Barker  concluded  that  signals  from  the 
external  environment  pass  from  the  mother  to  the  fetus  and  lead  to  constant 
changes in the phenotype of the fetus. 
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1.1.5.3  Predictive-adaptive  response  and  the  mismatch  hypothesis  of  the 
early life origins of cardio-metabolic disease 
There  is  evidence  from  natural  history  that  parents  pass  ‘developmental 
cues’ to their developing offspring which induce phenotypic changes that predict 
the environment to which the offspring will be involved.  Fetal adaptations during 
development can be seen in nature. Meadow vole pup (Microtus pennsylvanious) 
development is affected by hours of light in a day, leading to altered maturation 
and  preparedness  for  winter,  through  increased  coat  thickness
[89].  Adult  desert 
locust  (Scistocera  gregaria)  show  density-dependent  polymorphisms
[90].  With 
obvious  survival  advantages,  overcrowding  leads  to  production  of  migratory, 
gregarious  offspring,  whereas  a  low  population  density  leads  to  production  of 
sedentary, isolated locusts
[90]. Presence of a predator during pregnancy leads to 
offspring helmet and neck-pedestal formation in Daphnia cucullata and Daphnia 
pulex, respectively
[90]. In Taeniopygia gutta (Zebra Finch), male attractiveness can 
cause mothers to influence the attractiveness of offspring phenotype
[91]. In a non-
genomic mechanism, the size of early stage F2 eggs was significantly greater in 
response  to  an  experimentally  manipulated  father’s  attractiveness  (red  leg  ring 
compared to pale green leg ring). Gilbert suggests that attractiveness of the father 
led to a shift in the allocation of resources of the mother, leading to larger eggs. As 
the  effects  of  paternal  attractiveness  were  present  in  the  F2  generation,  the 
paternal effect may have implications in terms of evolution of the species. 
Again,  the  aim  of  these  adaptations  is  for  offspring  to  survive  to  the 
reproductive age.  Based on these observations, Gluckman et al. hypothesised 
that the embryo adapts to environmental cues in a way which predict the future 
environment
[92,93]. If this prediction is correct and the later environment matches 
that  on  which  the  maternal  signals  were  based,  this  will  confer  a  survival 
advantage. If however, the environment later in life is significantly different to that 
predicted then the resulting mismatch may confer a disadvantage.  For example, in 
humans if the signals from the mother predict an energy poor future environment, 
possibly as a result of placental insufficiency, which would be reflected in lower 
birth weight, the fetus may develop a phenotype which tends to conserve nutrients.  Samuel Peter Hoile   
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However, if the infant is born into an energy rich environment then it would tend to 
store energy to a greater extent than an infant whose phenotype predicted the 
energy  dense  environment.  Gluckman  et  al  suggest  that  such 
metabolic/environmental  mismatch  may  underlie  the  increased  risk  of  cardio-
metabolic disease in infants born at the lower end of the normal birth weight range.  
 
In a study by Cleal et al, pre and post-natal under nutrition led to greater 
weight gain by  weaning in offspring, compared to offspring of control chow fed 
dams
[94].  Postnatal  under  nutrition  alone  led  to  altered  growth  cardiovascular 
function  and  basal  hypothalamo-pituitary-adrenal  axis  activity  in  offspring  in 
adulthood. Offspring that were fed an adequate postnatal diet following prenatal 
under nutrition exhibited cardia-hypertrophy and altered cardiovascular function in 
adulthood. The experiment provides evidence for the PAR hypothesis, where the 
least detrimental outcomes were seen in pre and post-natal under nutrition and 
adequate  maternal  and  offspring  groups,  compared  to  the  mismatch  offspring 
groups. 
However, the predictive adaptive response hypothesis does not appear to 
apply in all cases. One example of this has been shown by Bruce et al
[95]. Female 
mice were fed either a control (21% kcal fat) or high fat diet (45% kcal fat) before 
and during gestation. Following birth, offspring were fed either the control or high 
fat diet. At 15 weeks, offspring of dams fed the high fat diet control diet, which were 
fed the control diet after weaning, had fatty liver disease.  However, the severity of 
disease was increased if both the mother and offspring were fed a high fat diet
[95]. 
According to the PAR hypothesis, the offspring of dams fed the high fat diet should 
have adapted to the increased fat exposure and have a smaller response to the 
post-weaning high fat diet than offspring of dams fed the control diet 
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1.1.5.4 The accelerator hypothesis  
  It has been suggested that risk of both type I and type II diabetes mellitus is 
more dependent on postnatal weight gain than the developmental environment
[96]. 
According to the hypothesis weight gain is necessary to cause an accelerated loss 
of  β-cells  through  apoptosis
[96].  Although multiple  investigations  have  shown  an 
inverse  relationship  between  age  of  onset  of  diabetes  and  body  mass  index 
standard  deviation  score,  it  is  not  the  case  in  all  studies
[97].  Although  a  useful 
theory  in  terms  of  diabetes  susceptibly  and  prevention,  it  is  limited  to  the 
prevalence of a single disease, so is unlikely to benefit the understanding of the 
link between environment and disease risk. 
 
1.2 Maternal adaptations during pregnancy 
  Pregnancy  and  lactation  represent  a  major  metabolic  demand  on  the 
mother, both from the developing fetus and from the need to support the functional 
changes  in  reproductive  organs.  In  order  to  meet  these  demands  there  are  a 
number of well-characterised adaptations to maternal nutrient metabolism and to 
cardiovascular function.  Thus the interaction between the diet of the mother, her 
physiological  (for  example  insulin  sensitivity)  and  physical  status  (for  example 
relative  fat  and  muscle  mass)  before  conception,  and  the  adaptations  to  her 
physiology  during  pregnancy  and  lactation,  together  with  the  activity  of  the 
placenta, provide the ‘developmental environment’ from which the fetus may derive 
cues that lead to physiological changes that determine future disease risk.     
 
1.2.1 Adaptations to maternal cardiovascular function during pregnancy 
  In humans, cardiac output is increased by the fifth week of pregnancy
[98]. 
This increase continues up to 24 weeks, where it is 45% above the level seen in 
non-pregnant  women.  The  increase  in  cardiac  output  is  brought  about  by  an 
increase in heart rate, which occurs from five weeks of gestation and continues 
until 32 weeks. Following the increase in heart rate, stroke volume is increased at 
8 weeks, where it reaches its maximum around 20 weeks
[98]. By the end of the 
second trimester, cardiac output is at its maximum; following pregnancy however, it Samuel Peter Hoile   
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is reduced by 43%
[99,98].  The increase in cardiac output is associated with a 40% 
increase in blood volume
[98], which is brought about by both production of several 
hormones by the fetus and placenta and utero placental circulation acting as an 
arteriovenous  shunt
[100].  In  effect,  the  increased  plasma  volume  is  due  to  the 
reabsorption  of  Na
+  and  water  retention,  as  a  result  of  increased  aldosterone 
production. This in turn is a result of placental oestrogen production
[100]. By acting 
as a low-resistance circuit, the utero-placental circulation leads to an increase in 
maternal blood flow, increasing cardiac output and nutrient delivery for further fetal 
growth
[100].  The increase in cardiovascular function is dependent on the type of 
pregnancy, where twin pregnancies show a 15% higher cardiac output compared 
to  singleton  pregnancies
[98].  This  further  increase  is  due  to  an  exaggerated 
increase in heart rate present in twin pregnancies, and an increased left arterial 
diameter. 
 
1.2.1.2  Adaptations  to  maternal  fat  and  carbohydrate  metabolism  during 
pregnancy and lactation 
Metabolic adaptations in the mother during pregnancy ensure the adequate 
growth  and  development  of  the  fetus,  provide  the  fetus  with  adequate  energy 
substrate that are needed following birth, meet the altered needs of the mother for 
the increased physiological demands of pregnancy and provide the mother with 
sufficient energy stores and substrate to cope with the demands of pregnancy as 
well  as  those  of  labour  and  lactation
[101].  Changes  in  the  metabolic  function  of 
maternal organs facilitate to meet the nutritional demands of the mother and fetus, 
this involves substantial changes throughout pregnancy from an anabolic state at 
the start of pregnancy to a catabolic state during late pregnancy
[102,102]. 
 
  During pregnancy, nutrients are transported from the maternal circulation to 
the  developing  fetus  via  the  placenta.  Regulation  of  nutrient  partitioning  during 
pregnancy  involves  coordinated  control  in  metabolism  between  tissues 
(homeorhetic  control)
[103].  Compared  to  non-pregnant  women,  during  early 
pregnancy women are in an anabolic condition, where storage of energy substrate Samuel Peter Hoile   
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is  a  primary  goal.  In  early  pregnancy,  due  to  the  increased  plasma  volume, 
compared  to  non-pregnant  women,  there  is  an  apparent  decrease  in  maternal 
plasma glucose and amino acid concentration, although the total amount remains 
unaltered. Glucose is the most abundant nutrient crossing the placenta. Despite an 
increase in gluconeogenesis during early pregnancy, this leads to hypoglycaemia 
in  mothers.  In  early  pregnancy  plasma  fatty  acids  become  the  main  energy 
source
[101]. Hepatic conversion of glucose to triacylglyceride, for storage in adipose 
tissue,  is increased  two-fold,  combined  with  a  diminished  release  of fatty  acids 
from adipose. Combined with hyperphagia
[104], the enhanced lipogenesis leads to 
an increase in storage of energy in the form of triacylglyceride (TAG) in adipose 
tissue
[105]. 
In  late  pregnancy,  when  fetal  growth  is  increased,  the  effectiveness  of  insulin 
decreases, compared to early pregnancy (i.e. insulin resistance). As the glucose 
utilisation  rate  by  maternal  tissue  is  decreased,  this  indicates  that  the  mother 
supplies glucose to the developing fetus at the expense of herself
[106]. According to 
Catalano, insulin sensitivity is decreased by 56% at 34-36 weeks gestation
[107]. The 
reduction  in  sensitivity  of  maternal  tissue  to  insulin  is  ameliorated  shortly  after 
delivery
[108].  Compared  to  early  pregnancy,  late  pregnancy  is  associated  with 
decreased TAG storage in adipose and mobilisation of fat stores as non-esterified 
fatty acids
[105], as well as an increase in levels of fasting gluconeogenesis when 
compared  to  early  pregnancy
[109].  This  facilitated  anabolism  ensures  sufficient 
supply  of  glucose,  amino  acids  and  fatty  acids  to  the  fetus
[101].  Further  to 
adaptations in storage and mobilisation of energy substrate during pregnancy, the 
maternal metabolism is also adapted to provide nutrients to the developing fetus 
during times of fasting, these will be discussed in the following section. 
  
1.2.1.3 Metabolic adaptations to fasting during pregnancy   
The developing fetus requires oxidisable energy substrate, in the form of 
fatty acids and glucose. Ketone bodies produced from the β-oxidation of fatty acids 
provide  the  primary  source
[104].  When  maternal  supply  of  glucose  is  low,  the 
maternal  metabolism  must  ensure  sufficient  transport  of  glucose  across  the Samuel Peter Hoile   
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placenta. It is therefore essential that adaptations in the mother during pregnancy 
maintain  glucose  homeostasis  in  times  of  fasting,  through  the  process  of 
gluconeogenesis.  
During fasting, glucose is taken up by tissues that are not sensitive to insulin 
control, for example the brain and is transported across the placenta to provide 
energy substrate for the developing fetus. It is essential that in pregnancy, glucose 
uptake  is  precisely  matched  by  the  rate  of  endogenous  glucose  production, 
primarily by the liver
[101]. As in non-pregnant animals, in pregnancy the primary 
source of glucose is from the breakdown of glycogen. However, these stores are 
finite, with the average 65kg person storing around 450g glycogen, enough to fuel 
the brain for 18 hours
[110]. Therefore glycogen stores do not provide a long term 
solution for fasting glucose homeostasis. Pregnant animals have a more rapid and 
exaggerated  response  to  fasting  compared  to  non-pregnant  mammals,  termed 
‘accelerated starvation’
[111]. Fasting in pregnancy is also with ‘facilitated anabolism’, 
a  maternal  adaptation  which  ensures  an  adequate  supply  of  nutrients  to  the 
fetus
[104].  Facilitated  anabolism  involves  a  more  prolonged  increase  in  plasma 
glucose,  greater  increase  in  very  low  density  lipoprotein  and  a  greater  fall  in 
plasma glucagon, in the fed state
[112]. Plasma glucose and the β-hydroxybutyrate, 
the breakdown product of fatty acid β-oxidation, concentrations are increased in 
the third trimester of pregnancy, when compared to non-pregnant woman (Figure 
1.2). 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Fasting plasma glucose and β-hydroxybutyrate concentrations in pregnant 
and non-pregnant women, during the third trimester of pregnancy, from 12 hours to 18 
hours following a meal. Adapted from Hadden (2009) Seminars in Fetal and Neonatal Medicine Samuel Peter Hoile   
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1.2.2   Evidence of maternal effects on offspring phenotype 
  In order to understand the relevance of changes in maternal physiology it is 
important to consider the role of the mother in determining offspring development. 
The maternal effect of physical size, on growth of offspring was first shown when 
cross-breeding Shire horses and Shetland ponies
[113]. The experiment was the first 
to cross different breeds within the same species, to show the maternal effect. It 
was shown that the size of the mother determined the size of the offspring, such 
that a foal born from a Shetland sire and Shire dam was larger than a foal born of a 
Shire sire and Shetland dam. In both large and small breeds, the fetus at birth was 
approximately proportional to the size of the mother. The study showed that the 
nutrient supply from the mother plays a role in the size of the fetus, and this in turn 
may  be  a  function  of  the  size  of  the  mother.  Short  stature  in  women  leads  to 
altered development of offspring. In a study of 1,180 mothers and 1,511 children 
(<10  years  old)  living  in  the  semi-arid  region  of  Alagoes,  Brazil,  low  maternal 
stature  was  independently  associated  with  low  birth  weight,  obesity,  abnormal 
adiposity, high systolic blood pressure in offspring
[114].  Compared to children born 
of women of normal stature, the offspring showed a higher prevalence of chronic 
degenerative diseases. In South-central Asia and Sub-Saharan Africa, maternal 
under nutrition led to short stature and a lower BMI in 10% and 2% of women of 
reproductive  age,  respectively
[115].  In both demographics maternal height  was  a 
strong predictor of birth size, independent of pre-pregnancy BMI and weight gain 
during pregnancy. Maternal smoking, height, weight and education have significant 
implications  in  terms  of  offspring  development.  Data  from  the  1980  National 
Natality Survey shows that women with less than 12 years education are more 
likely  to  give  birth  to  offspring  with  a  low  birth  weight  (odds  ratio  1.59);  this  is 
mainly due to the reluctance to give up smoking in this group, compared to those 
with a greater education
[116]. The total effect of smoking was such that every 5 
cigarettes smoked a day increased the odds of low birth weight by 26%
[116]. 
Maternal  constraint  can  be  defined  as  either  supply  limited,  such  as 
maternal size, or demand-driven, such as twinning
[33,92]. It has been shown that 
maternal constraint is greater in pregnancies where there is small maternal size, Samuel Peter Hoile   
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young maternal age and multiple pregnancies
[33,92]. By affecting nutrient availability 
and the metabolic hormonal drive to grow, maternal constraint has the potential to 
affect  growth  of  the  fetus,  leading  to  long-term  alterations  in  phenotype  and 
therefore increased disease susceptibility of the offspring
[92]. 
As  a  common  disease  in  the  developed  world,  numerous  studies  have 
investigated the effect of maternal diabetes on alterations in offspring phenotype, 
in both humans and animal models. A study found that 58% of offspring aged 15-
19 years from mothers who had gestational diabetes, weighed 140% or more of 
their  desirable  weight,  compared  with  17%  of  offspring  from  the  control 
offspring
[117]. The study further confirms that maternal diabetes starts the offspring 
on an altered trajectory of growth in terms of weight gain. However, in a study by 
Whitaker et al, there was no increase in risk of obesity in offspring of mothers with 
gestational diabetes
[118]. Although in this study, the severity of gestational diabetes 
was mild, and was diet-treated. As well as influencing risk of obesity in offspring, 
plasma β-hydroxybutyrate concentration during the third trimester of pregnancy in 
mothers was positively associated with offspring mental development index scores 
at age 2 years and Stanford-Binet intelligence scale at ages 3, 4 and 5 years
[119]. 
In the rat, streptozotocin induced diabetes during the last half of pregnancy, led to 
an  increase  in  birth  weight,  pancreatic  insulin  content,  plasma  insulin  and  C-
peptide  concentration  in  offspring,  compared  to  control  pups
[120].  Following  oral 
glucose  challenge  at  10  weeks  of  age,  higher  plasma  insulin  and  glucose 
concentrations were seen, compared to control offspring
[120]. The results suggest 
an  accelerated  growth  and  abnormal  glucose  tolerance  in  offspring  of  diabetic 
dams. 
The increase in offspring weight, following maternal diabetes, was confirmed in a 
study  by  Plagemann  et  al
[77].  The  offspring  were  hyperinsulineamic,  had  an 
increased  risk  of  obesity  and  developing  diabetes  mellitus  throughout  life.  In 
contrast, lower postnatal body weight gain was seen in offspring of diabetic dams, 
compared  to  control  offspring,  in  the  rat
[121].  Gestational  diabetes  in  pregnancy 
appears to predispose offspring to becoming overweight and developing diabetes 
throughout life, in both human and animal studies. Although not all results are in Samuel Peter Hoile   
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agreement in the direction in change in growth compared to control offspring, in 
terms  of  diabetes,  there  is  a  clear  effect  of  maternal  metabolism  on  offspring 
phenotype.  There  are  clear  examples  of  the  maternal  effect  seen  in  Gambian 
women. In a longitudinal study ranging from birth to postnatal 18 months, it was 
shown that offspring growth was significantly associated with maternal parity
[122]. 
For a firstborn child, birth weight was significantly lower, but catch-up growth was 
complete by postnatal 3 months. However, if children were born to mothers of high 
parity (10 or more) then birth weight was higher than average, but early postnatal 
growth was poor. The study shows that alterations in physiology, as a result of 
multiple  pregnancy  leads  to  significant  differences  in  the  in  utero  environment, 
which  have  clear  effects  on  early  offspring  growth.  Although  there  were  clear 
maternal effects seen in this study set, the maternal effect is not seen in terms of 
every  metabolite.  Maternal  plasma  25-hydroxyvitamin  D  concentration  during 
pregnancy had no effect on fetal and infant growth or bone mineral accrual
[123]. 
However, one potential reason for the absence of a maternal effect is that due to 
the population studied (women from the rural area of The Gambia, West Africa), all 
participants  had  a  high  vitamin  D  status,  due  to  the  sun  exposure.  Perhaps  a 
maternal effect of vitamin D status is only seen across a wider range? 
In Pomacentrus amboinensis (Coral reef fish) the proportion of maternal energy 
allocated to the offspring was tested by manipulations in food availability. Although 
there  was  no  significant  effect  of  maternal  condition  on  number  of  embryos 
hatching, or number of hatchlings surviving to a set time, maternal environment 
influenced  the  relationship  between  offspring  characteristics  and  survival,  via 
increased  yolk-sac  and  oil  globule  size,  compared  to  non-supplemented 
mothers
[124]. Avian eggs contain a substantial amount of maternal hormones, such 
as androgens, which affect behaviour, growth, morphology, immune function and 
survival of offspring
[125]. Maternal androgen deposition provides a mechanism for 
mothers  to  favour  specific  offspring  for  survival,  allowing  them  to  adjust  their 
developmental trajectory to the environmental conditions. This was confirmed in a 
study comparing addition of testosterone to avian eggs to a control egg, where oil 
was  used.  Offspring  of  the  androgen  supplemented  eggs  showed  increased Samuel Peter Hoile   
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survival, which was significant up to postnatal day 23. Following the initial 23 days, 
the effects of maternal androgen were no longer significantly different to control 
offspring
[125].  Duggleby  and  Jackson  showed  evidence  for  altered  maternal 
metabolism  on  offspring  phenotype
[126].  During  late  pregnancy,  mothers  whose 
amino  acid  oxidation  decreased  the  most  gave  birth  to  heavier  infants
[126]. 
Following adjustment for length of gestation and sex of infant, it was calculated that 
maternal amino acid oxidation during pregnancy accounted for 34% of the variation 
in birth weight. 
 
1.2.3 Regulation of gluconeogenesis 
In  the  fasting  state,  gluconeogenesis  provides  glucose  from  non-
carbohydrate  precursors,  including  lactate,  glycerol  and  gluconeogenic  amino 
acids, such as glycine, serine and valine. The process occurs primarily in the liver. 
Phosphoenolpyruvate  carboxykinase  (PEPCK)  and  glucose-6-phosphatase  are 
key enzymes involved in the pathway. As such, altered regulation of the enzymes 
will impact plasma glucose levels during fasting. PEPCK converts oxaloacetate to 
phosphoenolpyruvate (PEP) and carbon dioxide (Figure 1.3). Along with pyruvate 
carboxylase,  PEPCK  catalyses  the  irreversible  conversion  of  PEP  to  pyruvate 
which occurs in the glycolytic pathway, by the enzyme pyruvate kinase. As the 
rate-limiting  step  of  gluconeogenesis,  down  regulation  in  PEPCK  will  result  in 
decreased glucose production. 
 
 
 
 
 
 
 
The  final  step  of  gluconeogenesis  is  the  conversion  of  glucose-6-phosphate  to 
glucose by glucose-6-phosphatase. The reaction is a key determinant of plasma 
glucose levels during the fasting response (Figure 1.4). In terms of hepatic glucose 
Figure 1.3 Conversion of oxaloacetate to phosphoenolpyruvate by the enzyme PEPCK. The 
reaction requires a phosphate group, provided by GTP. Samuel Peter Hoile   
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production, glucose-6-phosphatase provides the distal step, whereas glucokinase 
accounts for the proximal step
[127]. Following this step, glucose enters the blood 
stream, via the facilitated glucose transporter GLUT2. 
 
 
 
 
 
 
 
The  bi-functional  enzyme  phosphofructokinase-2/fructose-2,6-bisphosphatase 
(PFK-2/F-2,6-BPase)  works  to  determine  the  direction  of  glucose  metabolism, 
depending on the metabolic state
[128]. Following a meal, insulin levels are elevated 
resulting in an increase in PFK-2 activity. This leads to the conversion of fructose-
6-phosphate  to  fructose-2,6-bisphosphate  (Figure  1.5  (A)).  Fructose-2,6-
bisphosphate acts as an allosteric activator of phosphofructokinase-1 (PFK-1) and 
inhibitor of fructose-1,6,bisphosphatase  (F-1,6-BPase). This increases  glycolysis 
and decreases gluconeogenesis. During fasting, glucagon activates F-2,6-BPase, 
thus  reducing  fructose-2,6-bisphosphate  concentration,  and  so  inhibits  PFK-1 
(figure 1.5 (B)). Glucagon also up-regulates fructose-1,6-bisphospatase. Overall, 
this  decreases  glycolysis  and  increases  gluconeogenesis.  The  bi-functional 
enzyme  phosphofructokinase-2/fructose-2,6-bisphosphatase  provides  the  main 
stage for hormonal regulation of the glycolytic and gluconeogenic pathways. 
The three major modes of regulation of the pathways are allosteric, covalent 
and gene regulation. The allosteric regulation by hormones works mainly through 
adenylate cyclase and cyclic adenylate monophosphate (cAMP), which leads to 
phosphorylation  of  phosphofructokinase-2/fructose-2,6-bisphosphatase  by  cyclic-
AMP-dependent protein kinase when glucagon is high and dephosphorylation of by 
protein phosphatase-2A when insulin is high
[129]. Adenine nucleotides (ATP, ADP 
and AMP) regulate several steps of the pathways when the ATP/ADP ratio is low 
(when  the  energy  state  is  low),  leading  to  an  increase  in  glycolysis
[130].  Other 
Figure  1.4  Conversion  of  glucose-6-phosphate  to  glucose  by  the  enzyme  glucose-6-
phosphatase. The reaction results in phosphate release. Samuel Peter Hoile   
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molecules  which  regulate  the  glycolytic  and  gluconeogenic  pathways  include 
citrate, which inhibits PFK and adrenaline and noradrenaline, which play equivalent 
roles  to  glucagon  and  insulin,  raising  cAMP  concentrations  via  β-adrenergic 
receptors
[131]. 
 As a result of lower plasma glucose levels in fasting, insulin secretion is 
reduced and glucagon secretion increased, from the β and α-cells of the pancreatic 
Islets of Langerhans, respectively. When plasma glucose is low, glucagon acts to 
maintain blood glucose levels, via interactions with the glucagon receptor in target 
tissues, such as the liver and muscle. Binding of glucagon to the α-subunit of the 
glucagon receptor, a G-protein coupled receptor in the plasma membrane, leads to 
a  conformation  change  in  the  receptor  which  leads  to  activation  of  adenylate 
cyclase
[132]. In turn, adenylate cyclase leads to an increase in intracellular cAMP. 
The points of interaction of glucagon in gluconeogenesis are through increasing 
levels  of  PEPCK,  FBPase-2  and  pyruvate  kinase,  with  the  net  effect  being  an 
increase  in  fasting  glucose  levels
[132].  In  the  early  stages  of  fasting  glucagon 
activates  protein  kinase  A,  which  in  turn  leads  to  activation  of  glycogen 
phosphorylase  kinase.  This  enzyme  phosphorylates  serine  14  residues  on 
glycogen phosphorylase leading to its activation. The result of this is breakdown of 
glycogen to release glucose-6-phosphate, which is converted to glucose by the 
enzyme glucose-6-phosphatase. 
The  21-carbon  steroid  hormone  corticosterone  is  the  main  glucocorticoid 
present in rodents. Secretion from the cortex of the adrenal glands is increased in 
situations of stress and fasting. Further to its roles in immune reactions and the 
stress response, the actions of corticosterone include increased gluconeogenesis, 
particularly  in  the  liver,  mobilization  of  amino  acids  from  muscle  for  use  as 
substrate  in  gluconeogenesis,  inhibition  of  glucose  uptake  in  non-glucose 
dependent tissue and stimulation of fat breakdown in adipose through lipolysis. In 
male Wistar rats, administration of the synthetic glucocorticoid, dexamethasone, 
led  to  a  decrease  of  insulin  binding  to  the  insulin  receptor,  in  adipoctyes
[133], 
providing a mechanism for the inhibition of glucose uptake. In a similar mechanism 
to glucagon, corticosterone leads to increased gluconeogenesis through increased Samuel Peter Hoile   
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expression  of  the  PEPCK  gene,  via  increased  expression  of  the  glucocorticoid 
receptor
[134,135]. Upon activation, the transcription factor, the glucocorticoid receptor 
(GR)  leads  to  increased  expression  of  genes  involved  in  immunology  and 
metabolism. In terms of fasting, GR has been shown to regulate expression of both 
PEPCK
[136]  and  PPARα
[137]. GR  exon110, has  been  shown  to be  the  exon  most 
expressed in liver
[138].  
 
The  peptide  hormone  leptin,  secreted  mainly  from  white  adipose  tissue, 
plays a role in regulation of energy intake, through binding to the leptin receptor in 
the mediobasal hypothalamus in the brain. This is through three mechanisms, by 
counteracting the effects of feeding stimulants neuropeptide Y and anandamide 
and  by  promoting  synthesis  of  α-MSH,  an  appetite  suppressant
[139].  In  the 
metabolic  state  of  fasting,  the  feeling  of  satiety  is  low  and  therefore  levels  of 
plasma leptin are low. 
Hormonal  regulation  of  energy  metabolism  involves  multiple  hormones 
acting at both similar and different points to achieve an overall effect. For example 
both glucagon and corticosterone lead to an increase in gluconeogenesis, through 
increased expression of PEPCK. However the hormone insulin, which is secreted 
when plasma glucose is elevated, binds to the insulin receptor to cause a decrease 
in gluconeogenesis by causing opposite effects to glucagon at the same points of 
the  pathway.  One  example  of  this  is  seen  in  pyruvate  kinase,  where  insulin 
maintains the enzyme activity, and therefore levels of glycolysis, by preventing its 
inhibitory phosphorylation through glucagon and cAMP-dependant kinase
[140]. 
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Figure 1.5 The role of the bi functional enzyme PFK-2/F-2,6-BPase in glucose metabolism 
in the fed (A) and fasted (B) state. Through the hormonal regulation of insulin and glucagon. Samuel Peter Hoile   
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1.2.4 Regulation of fatty acid β-oxidation 
  β-oxidation  of  fatty  acids  and  ketone  body  production  is  an  essential 
mechanism  to  provide  energy  substrate  in  the  fasted  state.  β-oxidation  and 
ketogenesis are hormonally induced, where the pancreatic hormones insulin and 
glucagon  play  dominant  roles.  The  importance  of  insulin  and  glucagon  were 
determined through investigations using anti-insulin serum and glucagon exposure 
and measuring plasma free fatty acid and ketone body levels over a three hour 
period, with both leading to a ketogenic profile
[141]. Although the concentrations of 
the individual hormones play their roles, it is the glucagon:insulin ratio which has 
the greater effect
[142]. The main role of insulin is to control the delivery of free fatty 
acid substrate to the liver, whereas the main action of glucagon is to enhance the 
ketogenic machinery  of  the  liver
[141].  The  rate  limiting  step  of β-oxidation  is the 
transport  of  fatty  acids  into  the  mitochondria,  the  site  of  β-oxidation,  through 
carnitine-O-palmitoyltransferase-1  (CPT-1)
[110].  In  the  fed  state  an  increased 
plasma  insulin  concentration  leads  to  a  higher  level  of  malonyl-CoA,  a  potent 
inhibitor  of  CPT-1,  thereby  decreasing  the  level  of  β-oxidation.  As  well  as 
mitochondrial  β-oxidation,  peroxisomal  β-oxidation  accounts  for  5-30%  of  the 
hepatic fatty acid oxidation. The end products of β-oxidation and ketogenesis are 
the ketone bodies acetoacetate and β-hydroxybutyrate, which are released into the 
circulation. 
  The Peroxisome Proliferator Activated Receptor α (PPARα) is a transducer 
protein, which plays a vital role in lipid metabolism
[143]. Due to their conserved DNA 
and  ligand-binding  domains,  PPARs  are  classed  as  members  of  the  steroid 
nuclear hormone family
[144].  PPARα is activated by natural fatty acids
[143]. PPARα 
is  activated  by  long  to  medium  (C10-C22)  unsaturated  fatty  acids  with 
unmetabolisable  parent  molecules being  more  effective  activators,  the  two  best 
fatty acid activators are linoleic acid (LA) and docosahexaenoic acid (DHA)
[145,146]. 
PPARα  activation  in  the  liver  leads  to  activation  of  fatty  acids  to  acyl-CoA, 
peroxisomal β oxidation, mitochondrial β oxidation and activation of ketogenesis, 
through  the  enzymes  acyl-CoA  synthetase,  acyl-CoA  oxidase  (AOX),  CPT-1, 
medium chain acyl-CoA synthase and hydroxymethyl glutamyl-CoA synthase
[145]. Samuel Peter Hoile   
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As mentioned previously, CPT-1 is a mitochondrial membrane bound transporter, 
which transports long chain fatty acids into the mitochondria, for β-oxidation. 
 
1.2.5 Polyunsaturated fatty acid metabolism and fetal development 
  Mammals lack the ʔ12 and ʔ15 desaturase enzymes, which are present in 
plants. These enzymes are required for the synthesis of the polyunsaturated fatty 
acids  α-linolenic  acid  (18:3n-3)  and  linoleic  acid  (18:2n-6),  thorough  the 
introduction of double bonds
[147].  As a result these fatty acids are termed essential; 
therefore they must be consumed in the diet. Linoleic acid is found in vegetable 
oils, products from vegetable oils (such as margarines) and foodstuffs into which 
vegetable  oils  or  margarine  are  incorporated  (such  as  cakes  and  biscuits).  α-
linolenic acid is found within green plants, vegetable oils, such as rapeseed oil and 
soybean, certain nuts, and linseed. 
One of the major roles of the essential fatty acids is to provide substrate for the 
synthesis  of  long-chain  PUFA,  such  as  arachidonic  acid  (AA)  (20:4n-6),  DHA 
(22:6n-3)  and  eicosapentanoic  acid  (EPA)  (22:5n-3),  through  the  desaturation-
elongation  pathway.  DHA  and  EPA  can  be  found  in  oily  fish,  where  mackerel 
contains  3g  n-3  PUFA/140g,  however  according  to  the  SACN  advice  on  fish 
consumption, 74% of people in the UK consume no oily fish. As a result synthesis 
of long chain n-3 PUFA, through the desaturation-elongation pathway, is essential. 
The desaturation-elongation pathway occurs within the endoplasmic reticulum of 
hepatocytes, with the last step occurring in the peroxisome
[147] (Figure 1.6). The 
pathway begins with the addition of a double bond, by the enzyme ʔ6 desaturase, 
followed by the addition of two  carbons to the hydrocarbon chain by elongase. 
Following this ʔ5 desaturase adds a further double bond to the fatty acid, and it is 
subject to two further elongation reactions. The enzyme ʔ6 desaturase then adds 
a final double bond to the chain. The membrane bound ʔ5 and ʔ6 desaturase 
enzymes  share  around  75%  homology
[148]  and  activity  of  both  enzymes  is 
increased by low PUFA status
[149]. 
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The  fetal  liver  has  limited  capacity  to  carry  out  the  desaturation-elongation 
pathway
[150];  therefore  the  maternal  circulation  is  responsible  for  providing  n-3 
PUFA for the developing fetus. In pregnant women, plasma phosphatidylcholine 
(PC) DHA content increases from 170μmol/l at 16 weeks to 230μmol/l at 40 weeks 
gestation
[150]. Numerous studies have investigated the role of n-3 PUFA in fetal 
development,  with  focus  on  visual  and  cognitive  effects.  The  central  nervous 
system  (CNS)  appears  to  be  protected  from  n-3  fatty  acid  deficiency
[151], 
suggesting it is a priority during development. The most abundant PUFAs found in 
the brain are DHA and AA
[152]. Incorporation of PUFA into phospholipids, leads to 
more  fluid  cell  membranes,  ensuring  the  successful  conformational  changes  of 
proteins and molecules in the cell membrane and passing of signals from one the 
external space to within the cytoplasm. 
α-Linolenic Acid 
18:3n-3
18:4n-3
20:4n-3
EPA
20:5n-3
DPA
22:5n-3
24:5n-3
24:6n-3
DHA
22:6n-3
Δ6-Desaturase
Elongase
Δ5-Desaturase
Δ6-Desaturase
Elongase
Elongase
Linoleic Acid 
18:2n-6
18:3n-6
20:3n-6
AA
20:4n-6
22:4n-6
24:4n-6
24:5n-6
22:5n-6
Β-Oxidation
Figure 1.6 The fatty acid desaturation-elongation pathway for both n-3 and n-6 fatty acids, 
where the enzymes for each step are shown in the middle of the pathways.  Samuel Peter Hoile   
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The optimal DHA content of the retina is 19% of total fatty acids
[153]. One rat study 
used an electroretinogram to assess the physiological response evoked from the 
retina by brief flashes of light and showed that a poorer response was present 
when  n-3  deficiency  was  present
[154].  In  rat,  DHA  levels  in  whole  brain 
phospholipids  were  reduced  by  80-90%,  in  offspring  of  dams  fed  safflower  oil 
based diets during pregnancy, compared to soybean oil fed dams. Reflexes and 
motor abilities  were  unaltered,  and  success  on  the maze  task  was  60%  in  the 
safflower group offspring, compared to 90% in the soybean oil offspring group
[155]. 
Maze learning tasks, which involved discrimination between black and white stimuli 
were  performed  poorly,  although  this  could  be  a  combination  of  altered 
phospholipid composition in the brain and retina. As the rate limiting step in the 
synthesis of long chain PUFA, the expression and activity of the ʔ6 desaturase 
gene,  specifically  in  female  offspring  (future  mothers),  following  an  altered 
maternal  diet,  is  important  in  terms  of  cognitive  and  visual  function  in  future 
offspring. 
 
1.2.6  Evidence  for  effects  of  altered  maternal  metabolism  on  offspring 
phenotype between generations 
  There are few studies which has specifically studied the effect of altered 
maternal  metabolism  on  the  phenotype  of  the  offspring  between  generations. 
Alterations  in  development  of  the  endocrine  pancreas,  glucose  intolerance  and 
insulin resistance in later life have been shown, following an increase in stress 
situations in the mother
[156,157,158]. According to Aerts et al, the additional metabolic 
stress  of  diabetes  during  pregnancy  and  lactation  can  lead  to  a  diabetogenic 
tendency in the offspring, potentially leading to gestational diabetes in the offspring 
in later life
[159]. If this occurs the cycle will continue and lead to increased risk of 
gestational diabetes in the subsequent generation. As well as risk of gestational 
diabetes being passed between generations through altered maternal metabolism 
during  pregnancy,  a  similar  pattern  has  been  shown  in  terms  of  obesity
[160]. 
Following maternal obesity, offspring are 2-3 times more likely to develop obesity, 
and this will lead to both an increase in disease risk in later life of the mother and Samuel Peter Hoile   
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offspring, as well as continuing the prevalence of obesity between generations. 
However, whether this effect is purely metabolic, or reflects transition in nutrition in 
the Western world, is unknown. 
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1.3 Transgenerational transmission of phenotype 
 
“Non-genomic  processes  of  transmitting 
environmental  information  between  generations 
evolved  to  assist  our  evolution  as  we  moved 
across changing environments”’ 
Gluckman 2007 
Heritable non-communicable diseases such as type II diabetes, metabolic 
syndrome,  obesity  and  cardiovascular  disease  are  transmitted  between 
generation,  in  a  manner  that  does  not  involve  alterations  in  DNA 
sequence
[161,162,163].  Gluckman  argues  that  disease  risk  has  arisen  as  a 
‘maladaptive  consequence  of  an  ancestral  mechanism  of  developmental 
plasticity.
[164] It is for this reason that the mechanisms behind the transgenerational 
transmission of phenotype must be understood. 
 
As discussed by Skinner, true transgenerational transmission requires the 
effect of environmental exposure to be prevalent in the F3 generation
[165]. Skinner 
argues that as the F2 oocyte germ line is developing in the F1 fetus, an altered 
external environment in the F0 generation pregnancy will directly affect the F0, F1 
and F2 generations. As a result, in order for an effect to be truly transgenerational 
it must be seen in the F3 generation, the first generation not to be directly exposed. 
This  concept  is  described  in  Figure  1.7.  It  is  stated  that  true  transgenerational 
transmission can be seen in the F2 generation if the F0 exposure is postnatal or 
during  adulthood
[165]. Although  not  regarded  as  true  transmission  of  phenotype, 
alterations in phenotype present in the F2 generation show the magnitude of effect 
a stimulus in the F0 pregnancy can have. The first selection of studies have shown 
phenotype transmission to the F2 generation, whereas the second section shows 
transmission to F3 generation. 
 Samuel Peter Hoile   
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1.3.1 Transmission of an altered phenotype to the F2 generation 
By following up periods of altered environment in subsequent generations it 
has  been  shown  that  the  changes  in  phenotype,  such  as  those  discussed 
previously,  are  transmitted  during  further  reproduction.  A  recent  review  by 
Jablonka  provides  an  in  depth  view  into  the  developments  in  the  study  of 
transgenerational transmission of phenotype
[166]. The paper highlights the different 
ways in which altered phenotypes may be passed on to later generations, such as 
direct, parallel and somatic induction, as well as parallel induction with non-parallel 
effects
[166]. These different mechanisms include the environmental stimulus leading 
to transmittable changes in the somatic cell line, germ cell line, or both, and the 
interactions  which  may  be  present  between  them.
[166]  The  different  methods  of 
induction take into account the fact that an alteration in the somatic cell line has the 
potential to lead to alterations in phenotype in later generations, by affecting the 
somatic or germ cell lines in later generations. This seems logical, as an altered F1 
phenotype, caused by an environmental stimulus in the F0 pregnancy, may lead to 
an altered F1 pregnancy. This could be a minimal alteration, which goes unnoticed 
in the F2 generation, or a greater alteration, such as a difference in metabolism of 
nutrients, which would be as important as altered diet during the F1 pregnancy. 
The  following  studies  provide  evidence  of  transgenerational  transmission  in 
humans and rats. In humans, Kaati et al have shown that an increased risk of 
Figure 1.7 Diagram showing the indirect effect of the F0 generation and direct effect of the 
F1 generation on the F2 generation phenotype as the F1 fetus and F2 germ cell are present at 
the time of an altered environmental exposure to the F0 generation. Samuel Peter Hoile   
44 
 
cardiovascular  disease  and  diabetes  in  adulthood  is associated with  overeating 
during  the  slow  growth  period  in  the  grandparents,  during  childhood
[162]. 
Administration  of  dexamethasone  to  pregnant  rats,  leads  to  alterations  in 
phenotype of offspring which are transmitted to subsequent generations. Exposure 
of  the  fetus  to  an  excess  of  glucocorticoids,  in  the  form  of  the  synthetic 
glucocorticoid  dexamethasone,  resulted  in  low  birth  weight  leading  to  later  life 
hyperinsulinaemia and hyperglycaemia. These differences, which are seen in both 
the  F1  and  F2  generation  are  associated  with  increased  activity  of  hepatic 
PEPCK.
[167]  The  change  in  phenotype  however  was  not  present  in  the  F3 
generation. A high fat mouse model used by Dunn et al, showed transmission of 
an altered phenotype to the second generation
[168]. Feeding a high fat diet to dams 
from 4 weeks preconception up to the end of lactation, led to both a significant 
body length increase and increased insulin resistance in both the first and second 
generation. Another study which has shown an increased insulin response in the 
F2  generation  following  an  altered  F0  pregnancy  is  provided  by  Martin  et  al. 
Undernourishment of the developing fetus, provided by feeding dams a low protein 
diet, followed by a high fat post weaning diet in the F1 offspring was shown to 
induce an increased insulin response at 30 minutes and 120 minutes following a 
glucose challenge
[169]. The findings of this study highlight the susceptibility of the 
insulin system to transgenerational alteration in phenotype. In the Overkalix cohort 
study,  the  slow  growth  period  in  young  boys  and  girls  was  well  characterised. 
Pembrey et al used this data from the Swedish study to see if the slow growth 
period  in  children  was  associated  with  mortality  risk  in  their  grandchildren. The 
study showed that if their paternal grandfather had experienced a good food supply 
during their slow growth period then men had an increased mortality risk. Similarly 
if  their  maternal grandmother had a  good food  supply  during  their  slow  growth 
period  then  women  also  had an  increased mortality  risk.  If  the food availability 
during  this  period  was  poor  then  an  opposite  effect  was  seen
[163].  The  study 
showed the importance of sex in transmission of disease risk in humans, although 
the mechanisms are not fully understood. It is likely that it is the role of the X and Y 
chromosomes which have an effect, rather than gametes; due to the differences in Samuel Peter Hoile   
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oocytes  and  sperm  production  (oogenesis  occurs  during  fetal  life,  whereas 
spermatogenesis is continual following puberty.) 
 
  It has been shown by Benyshek et al that in Native Americans levels of type 
II diabetes in adulthood is associated with fetal malnutrition
[161]. When considering 
further generations, the risk of the disease was seen to be propagated through 
perturbations  in  the  intra  uterine  environment
[161].  In  1971  the  use  of 
diethylstilbestrol (DES) as a preventative for miscarriages in pregnant women was 
banned, due to the discovery of its action as a teratogenic agent. In mothers, DES 
has been shown to lead to almost a two-fold increase in risk of breast cancer
[170]. In 
a single case study of a 15 year old girl who developed ovarian carcinoma, the fact 
that  her  grandmother  had  taken  DES  before  giving  birth  to  the  girl’s  mother 
highlights  the  potential  of  DES  as  an  agent  capable  of  transgenerational 
effects
[171]. Although this single case is not enough to confirm the role of DES in 
this cancer development, further investigation into later generations of DES treated 
women may confirm it. 
 
The  following  studies  have  used  the  low  protein  rat  model  to  show 
transgenerational transmission of phenotype up to the F2 generation. As shown by 
Pinheiro et al, feeding a low protein diet throughout pregnancy and/or lactation led 
to transgenerational effects in both the F1 and F2 offspring. In the F0 pregnancy 
dams were fed either a control (C) or protein restriction (PR) diet during pregnancy 
and lactation. This led to 4 dietary groups; C-C, C-PR, PR-PR and PR-C, where 
the first diet represents pregnancy and the second lactation. In the F1 offspring, 
the PR-C group were shown to have a lower birth weight, which following catch up 
growth  matched  the  C-C  in  later  life.  The  group  also  showed  an  increased 
glycaemia. Both groups exposed to a PR diet during pregnancy showed impaired 
growth. Results showed that a PR diet during gestation had beneficial effects on 
weight at birth, fat mass and growth rates in the F1 generation, but led to insulin 
resistance  in  adulthood  in  both  the  F1  and  F2  generation.  A  PR  diet  during 
lactation also led to insulin resistance, but only in the F2  generation
[172]. These Samuel Peter Hoile   
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results again highlight the consequences of a mismatch between the in utero and 
post  natal  environment.  The  study  does  show  that  some  consequences  of  a 
protein restricted diet during pregnancy can be beneficial to health in the offspring, 
even if a mismatched environment is encountered following birth. It may be that 
while  an  altered  environment  during  pregnancy  may  lead  to  an  increased 
susceptibility of certain diseases, risk of other diseases may be reduced. It has 
been hypothesised that feeding of the PR diet during development led to altered 
control of the leptin and glucose pathways, which are crucial in setting up energy 
balance circuits during development and maintaining energy balance throughout 
life
[172]. 
Zambrano et  al have  shown  that feeding  a  protein  restricted diet  to  rats 
during  pregnancy  and/or  lactation  led  to  altered  body  weights,  food  intake  and 
insulin sensitivity in F1 and F2 offspring. When compared to control animals, male 
F2 animals, whose mothers were fed a protein restricted diet during lactation alone 
and female F2 animals, whose mothers were fed a protein restricted diet during 
pregnancy alone were found to be insulin resistant
[173]. These results identify the 
importance of sex in transmission of phenotype in resistance to insulin in terms of 
the  developmental  window  whereby  modifications  to  the  epigenome  can  take 
place. 
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1.3.2 Transmission of altered phenotype to the F3 generation 
  As discussed previously, an altered phenotype must be transmitted to the 
F3 generation in order to be termed ‘true transmission’. The following studies have 
all shown ‘true transgenerational transmission’ in animal models. Although it could 
be argued that true transmission of phenotype should entail cross fostering of the 
offspring, in order to be independent from the effects of the maternal physiology, it 
is widely accepted that studies which cover transmission to the F3 generation are 
sufficient to display transgenerational transmission of phenotype. 
  A study by Benyshek et al involved feeding female rats either a control or an 
isoenergetic protein restricted diet throughout pregnancy and lactation. The F1, F2 
and F3 adult offspring were harvested following an overnight hour fast and glucose 
tolerance test. The study shows that 30 minute plasma glucose levels, following a 
glucose  challenge,  were  significantly  lower  in  males  in  the  protein  restricted 
offspring, when compared to the control lineage males. As well as this, the male F3 
protein restricted offspring also showed significantly higher plasma insulin levels, 
compared  to  the  control  equivalent
[174].  Although  the  study  clearly  shows 
transmission to F3, it is worth mentioning that the magnitude of result in the F3 
generation was less than that of the F2 generation, suggesting that the phenotype 
may be returning to that of the control animals. 
By exposing the developing embryo to the endocrine disruptor vinclozin, at 
the point of gonadal sex development, a transmittable reprogramming of the male 
and female germ-lines is created
[175]. After three generations it was found that in 
males 92 genes in the hippocampus and 276 genes in the amygdala were altered, 
and in females 1,301 genes in the hippocampus and 172 genes in the amygdala 
were  altered.  These  differences  were  associated  with  a  decreased  anxiety-like 
behaviour in males and an increased anxiety-like behaviour in females
[175]. These 
reproducible changes in anxiety behaviour highlight the importance of sex in both 
the  magnitude  and  direction  of  transgenerational  phenotype  induction.  The 
mechanisms behind these sex differences are still unclear. These studies prove 
that environmental exposures can lead to transmittable alterations in phenotype. 
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1.3.3 The role of transgenerational transmission of phenotype in evolutionary 
adaptation 
  The previous studies have shown that a novel stimulus in the F0 generation 
can  lead  to  an  altered  phenotype  in  the  offspring  in  subsequent  generations. 
Although  the  animal  studies  have  used  a  severe  dietary  change  to  produce  a 
‘wrong’ or unhealthy phenotype in order to understand the consequences of an 
altered developmental environment, studies of this nature have led to the formation 
of a novel evolutionary hypothesis. In the alternative adaptation hypothesis, West-
Eberhard stated that ‘novel traits originate and become stable phenotypes within a 
species, prior to reproductive isolation and speciation’ 
[176]. This concept shows that 
the phenotype, not the genotype is the object of selection
[176]. As shown in the 
transgenerational  studies  described  in  the  previous  sections,  provided  there  is 
significant  environmental  variation,  an  altered  phenotype  can  be  present  for 
numerous generations, without genetic variations
[177]. According to the concept of 
phenotypic  accommodation,  a  novel  input,  for  example  migration  resulting  in 
altered nutritional intake, can lead to a novel phenotype. Following this, there will 
be  an  initial  spread  of  the  phenotype  into  the  community  and  as  a  result  of 
‘epigenetic opportunity’, genetic accommodation will take place
[178]. This involves 
changes  in  gene frequency.  The  possible epigenetic  processes involved  in  this 
accommodation will be discussed in the next section. In a more recent review, 
Fembery  similarly  hypothesises  that  stochastic  variation  can  result  from  ‘soft 
inheritance’, whereby useful traits are passed through generations, which do not 
require changes in the genome
[179]. 
By  investigating  the  transmission  of  phenotype  through  generations,  our 
understanding of the mechanism involved in evolution of species will be increased. 
Whilst transient exposure to an environmental stimulus may result in an altered 
phenotype in a number of generations, constant exposure to a new stimulus has 
the potential to result in a new species, without the need for mutation. 
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1.3.4  Transgenerational  transmission  of  an  altered  phenotype  following 
exposure to a constant environmental stimulus 
When considering the data in Section 1.1, it appears that the magnitude of 
difference in phenotype in the organism is associated with the both strength and 
duration of the environmental stimulus. 
Nutritional transition, such as that seen in migration is associated with an 
altered risk of disease, leading to an altered survival of the species in the novel 
environment. Nutritional transition onto a Western diet in China in the 90s, led to 
an  increase  intake  of  fat  and  complex  carbohydrates.  There  was  a  causal  link 
between this nutritional transition and increased risk of obesity
[180]. Due to a lack of 
studies, the mechanism behind altered disease risk following nutritional transitional 
is unknown. Past studies have focused on single F0 dietary exposures, rather than 
effects of sustained alteration.  
Due to the expense and time required to undertake, there are few constant 
exposure  studies.  Two  studies  in  Drosophila,  however  do  show  long  lasting 
changes in gene regulation following a constant exposure to an altered nutrition, 
throughout the life course
[181,182]. Both studies compared Drosophila grown in either 
a  starch  or  maltose  based  medium.  The  first  study,  carried  out  by  Powell  and 
Andjelkovic,  showed  how  selective  changes  were  present  in  the  amylase  gene 
(Amy) in Drosophila fed starch, although it must be mentioned that no differences 
in amylase activity  were associated with the changes
[182]. The second study by 
Dodd,  also  showed  changes  in  Amy  in  the  Drosophila  fed  starch,  where  an 
increase  in  activity  was  also  present
[168].  This  second  study  also  showed  an 
increased  adaptation  to  the  medium  in  subsequent  generations.  These  studies 
show  that  constant  exposure  to  altered  nutrition  results  in  constant  changes  in 
gene regulation. It would be beneficial to see if these findings are limited to this 
particular gene, or if the mechanism is present in different genes. These studies 
have provided evidence for transgenerational adaptation of phenotype following a 
constant,  altered  nutrition,  which  supports  the  phenotypic  accommodation 
hypothesis.  It  is  now  important  to  investigate  the  mechanisms  responsible  for Samuel Peter Hoile   
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adaptation following  migration  to  a new  environment.  As  stated  in  the  previous 
statement it is the phenotype which is responsible for the fitness of the organism, 
not  the  genotype.  How  phenotype  can  be  altered  to  accommodate  a  novel 
environment, without changes in genotype, is the key to alternative adaptation. 
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1.4 Epigenetic processes   
It  is  clear  that  altered  phenotypes  can  arise  following  a  change  in 
environment. This requires long term, stable alterations to the genome. Changes in 
the expression of genes have been shown to be involved in the induction of an 
altered phenotype. As these changes have been shown to be transmitted through 
generations, the mechanism responsible must also be hereditary. The following 
section will provide background on processes which can alter expression of genes, 
without changes in nucleotide sequence. Processes which result in a change of 
gene  expression  without  altering  DNA  sequence  are  termed  epigenetic.  In  the 
following selection the epigenetic processes; DNA methylation (Section 1.41) and 
histone modifications (Section 1.4.2) will be discussed. 
   
1.4.1 DNA methylation 
Both  X-chromosome  inactivation  and  long  term  silencing  of  non-coding 
DNA,  such  as  introns,  repetitive  elements  and  potentially  active  transposable 
elements,  occur  through  DNA  methylation,  by  the  enzymes  DNA 
methyltransferases (DNMTs)
[183]. DNMTs transfer methyl groups from S-adenosyl 
methionine (SAM) to carbon 5 of cytosines in CpG dinucleotides, this chemical 
modification  results  in  altered  DNA-protein  interactions
[183].  In  humans  5-
methylcytosine represent 1% of all nucleotides in the genome, with 70-80% found 
within  CpG  dinucleotides
[184].  There  is  a  high  density  of  CpG  dinucleotides  in 
promoter regions of around 30,000 genes in humans, as well as within introns and 
exons
[184].  A  200  base  pair  section  of  DNA,  with  a  high  GC  content  and  an 
observed ratio of CpGs greater than 0.6 is termed a CpG island
[185]. CpG islands 
are typically unmethylated. CpGs are typically methylated in non-promoter regions 
and unmethylated in promoter regions, indicating that an absence of methylation is 
required for expression
[185]. Although it must be stated that within a population of 
one  cell  type,  the  methylation  status  at  one  particular  loci  will  have  a  level  of 
variability, meaning when measuring DNA methylation it is the overall population 
that is measured, not single cells. Samuel Peter Hoile   
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Methylation of cytosines in a promoter region can result in silencing of gene 
expression  through  direct  or  indirect  blocking  of  transcription.  Methylation  of 
cytosines can physically prevent binding of transcriptional machinery, such as RNA 
Pol II, or indirectly bock transcription through the recruitment of methyl cytosine 
binding proteins. Methyl binding proteins, such as methyl CpG binding protein 2 
(MeCP2), can lead to an inhibition of transcription through recruitment of further 
proteins,  such  as  histone  deacetylases  (HDAC)  and  histone  methyltransferase 
(HMT)
[186]. The silencing of genes via DNA methylation can be seen in Figure 1.8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There are three main types of  DNMTs; DNMT1, DNMT2 and DNMT3. The two 
DNMT3  subtypes,  DNMT3a  and  DNMT3b  are  responsible  for  the  de  novo 
methylation of the embryo genome, following the extensive demethylation seen in 
the  maternal  and  paternal  genomes  following  fertilization
[187].  In  somatic  cells 
methylation patterns are maintained by DNMT1 in the S-phase of the cell cycle 
Figure 1.8 Diagram showing epigenetic silencing of transcription through the recruitment of 
MeCP2, HMT and HDAC to methylated cytosine residues within the promoter regions of genes. 
This  creates  a  physical  blocking  of  transcription  factor  and  RNA  Polymerase  II  (RNA  Pol  II) 
binding, to achieve silencing of genes.  Samuel Peter Hoile   
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during mitosis. Genomes of mature gametes in mammals are highly methylated 
compared to somatic cells, this is achieved by specific DNMTs, DNMT1o (oocytes) 
and DNMT1p (sperm)
[184]. Following the first cell division after fusion of gametes 
DNMT1s (somatic) maintains methylation status in cells
[184,188]. DNMT1
-/- knock out 
(k/o) mice experiments have shown a loss of both imprinting and x-linked gene 
expression  and  embryonic  lethality  when  the  enzyme  is  absent
[189].  Syzf  has 
hypothesized  that  the  epigenome  is  a  dynamic  equilibrium  of  methylation  and 
demethylation, which is responsive to physiological and environmental signals
[190]. 
This hypothesis is founded on the knowledge that genes such as PEPCK show a 
loss  of  methylation  during  development  and  that  post-mitotic  cells,  such  as 
neurons  show  a  presence  of  the  DNMT1.  Although  this  is  supported  well  by 
findings,  it  is  still  not  understood  how  much  of  the  epigenome  is  subject  to 
demethylation throughout the life course. If methylation status is determined upon 
cell division, there would be no need for DNMT1 expression in post-mitotic cells. 
This  methylation  equilibrium  provides  a  possible  platform  for  gene-environment 
interactions
[190].  
Cellular  senescence  is  associated  with  a  decrease  in  levels  of  global 
methylation. In liver and visceral adipose tissue, the rat genome showed significant 
differences  in  DNA  methylation  with  age  at  >5%  of  analysed  sites
[191].  Using 
luminometric methylation analysis to determine global methylation levels and HpaII 
tiny fragment enrichment to define patterns of CpG methylation, it was shown that 
the most distinct regions where DNA methylation was decreased with age, was at 
intergenic  sequences  and  conserved  non-coding  elements
[191].  The  changes  in 
methylation  were  consistently  found  near  genes  with  metabolic  function, 
suggesting  a  link  to  pathogenesis  of  age-related  diseases.  The  study  failed  to 
show data on transcription factor binding at sites where methylation was lost, total 
protein  levels  and  activity.  Without  these,  the  overall  effect  of  the  findings  is 
unclear. The loss in DNA methylation seen with senescence may be due to the 
decreased  activity  of  DNMT1  with  age
[192].  As  stated  earlier,  this  could  have 
implications  on  disease  risk,  such  as  progression  of  cancer,  when  tumour 
suppressor genes are considered. Samuel Peter Hoile   
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This may result in an increase in disease risks associated with aging such 
as  cancer,  through  improper  methylation  of  tumour  suppressor  genes  and 
oncogenes. DNA methylation offers a potential long term, heritable mechanism for 
silencing  of  genes.  Evidence  into  the  role  of  DNA  methylation  in  alterations  of 
phenotype will be discussed later. 
 
1.4.1.1 Promoter methylation and gene expression 
  DNA methylation provides a mechanism by which expression of genes can 
be  modified  following  an  altered  environment.  The  stability  of  the  genome  is 
decreased  during  embryogenesis,  therefore,  this  window  of  plasticity  allows 
alterations in DNA methylation to occur. Studies have shown direct associations 
between promoter methylation and mRNA expression of specific genes. 
CpG methylation of the insulin gene promoter was measured in both human (INS) 
and mouse (Ins2) pancreatic β cells
[193].  As a ubiquitously expressed gene, it is 
unsurprisingly that in both species the insulin gene promoter was hypomethylated. 
Using  ChIP  assays  it  was  shown  that  methylation  of  the  promoter  suppressed 
insulin-reporter gene activity by almost 90%, through inhibition of binding at the 
cAMP response element (CRE)
[193]. It was further shown in mouse stem cells, that 
loss  of  methylation  at  the  Ins2  promoter  is  associated  with  differentiation  into 
insulin-expressing cells. In colorectal cells, methylation of the hMLH1 promoter is 
associated  with  loss  of  expression
[194].  Treatment  with  methylation  inhibitor  5’-
azacytidine lead the cells to re-express the gene. In humans, methylation analysis 
of the POMC promoter in blood mononuclear cells, showed that methylation of a 
single CpG in the E2F binding site was inversely correlated to expression, however 
the result was not significant (P=0.557)
[195]. However methylation of other CpGs 
along the promoter may have a greater role in POMC regulation. 
Previous studies have presented methylation data as average DNA methylation 
across  the  promoter
[196,197,198,187,199,200,201].  Methylation  of  gene  promoters  can 
regulate  mRNA  expression  through  recruitment  of  methyl  CpG  binding  proteins 
and  by  physically  blocking  recruitment  of  transcriptional machinery.  In  terms  of 
physically blocking binding, it is not mean methylation across the whole promoter Samuel Peter Hoile   
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that is important, but methylation of specific CpGs. For example methylation of the 
CG dinucleotide in the CRE (5’-TGACGTCA-3’), results in a loss of transcription 
factor binding, as well as loss of transcriptional activity of the human glycoprotein 
hormone  α-subunit  in  vitro  and  in  vivo
[202].  The  methylation  across  the  whole 
promoter is therefore irrelevant, in terms of this regulation at this element. The 
same study however, found that methylation of the CpG situated in the Sp1 binding 
site had no effect on transcription factor binding
[202]. CREs are often associated 
with promoters of cell-type specific genes, whereas Sp1 is mainly associated with 
regulation of house-keeping genes, this provides a mechanism through which DNA 
methylation plays a role in cell differentiation. CpG specific methylation also plays 
a role in transcriptional activity of the Epstein-Barr virus through CBF2 binding
[203] 
and expression of the XAF1 gene in human gastric and colon cancers
[204]. In both 
examples  methylation  led  to  a  reduction  in  mRNA  expression.  It  is  therefore 
essential, when considering promoter methylation to use a sequencing technique 
to  measure  methylation  of  specific  CpGs,  not  average  methylation  across  the 
promoter.  
 
1.4.1.2 Changes in DNA methylation in aging 
  There are few studies, to date, that have investigated methylation across 
the life course
[205,206]. In two cohorts in Iceland and Utah, both males and females 
showed changes in levels of global DNA methylation over time. The average age 
of  individuals  was  74.6  years  at  the  time  of  the  first  sample,  with  the  second 
sample  taken  11  years  later,  on  average.  29%  of  an  Icelandic  cohort  of  111 
individuals showed significant differences of over 10% methylation change in blood 
cell DNA methylation, between 1991 and 2002-2005
[205]. In the Utah cohort, where 
samples were collected 16 years apart, samples were grouped into families, and 
those  that  showed  the  greatest  global  methylation  loss  also  demonstrated  the 
greatest  loss  of  gene-specific  methylation
[205].  This  suggests  that  loss  of 
methylation in specific genes may have a genetic component. Differences in DNA 
methylation between monozygotic twins show variability in methylation across the 
life course. During early life monozygotic twins are epigenetically indistinguishable, Samuel Peter Hoile   
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however during adult life remarkable differences are present in the overall content 
and  genomic  distribution  of  5-methylcytosine  DNA  and  histone  acetylation
[207]. 
Using  capillary  electrophoresis,  relative  5-methylcytosine  DNA  content  was 
measured in 80 pairs of monozygotic twins, with an average age of 30.6 years. A 
third  of  twins  had  epigenetic  differences  in  both  DNA  methylation  and  histone 
modifications, affecting repeat sequences of DNA and single copy genes, which 
had impacts on gene expression. The differences were more distinct in the older 
twins, suggesting the role of time, however due to the nature of the study changes 
in environment could play a part. The study confirms variability in DNA methylation 
with age. A study by Wong et al, investigated epigenetic variation in twins between 
the ages of 5 and 10 years old
[208]. In both monozygotic and dizygotic twins, DNA 
methylation  of  the  dopamine  receptor  4,  serotonin  transporter  and  X-linked 
monoamine  oxidase  A  (MAOA)  genes  were  measured  using  a  sequencing 
technique. Although differences in variation in DNA methylation were seen in all 
genes, the extent to which levels changed with time was gene specific. The biggest 
variation in average methylation was seen in the MAOA promoter, where 74% of 
children showed at least a 10% change in methylation and 32% of children showed 
at least a 20% change in methylation. As well as differences in methylation seen 
between twins, there was a low inter-individual stability over time seen methylation 
of the MAOA promoter, however this was not significant. 
One potential mechanism for the decrease in DNA methylation in age is a 
decrease  in  activity  of  DNMT1
[192].  In  WI-38  fibroblasts  activity  of  DNMT1 
decreased  steadily  with  cellular  senescence.  Over  the  course  of  41  days, 
maintenance methyltransferase activity of DNMT1 decreased by 69% and de novo 
methyltransferase activity decreased by 83.7%. In immortalised WI-39 fibroblasts 
however, methyltransferase activity of DNMT1 was elevated. Perhaps variation in 
promoter methylation with age is a consequence of deceased DNMT1 activity. 
One  apparent  consequence  of  varied  levels  of  methylation  with  age  is 
hypermethylation of tumour suppressor genes and hypomethylation of oncogenes, 
leading to an increased risk of cancer
[209]. The most widely studied are tumour 
suppressor genes. Tumour suppressor genes have functions including cell cycle Samuel Peter Hoile   
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regulation,  DNA  repair,  apoptosis  and  drug  resistance,  inactivation.  Increased 
methylation of the promoter of the breast cancer antigen 1 (BRCA1) gene, which 
plays a role in DNA repair, is associated with sporadic breast cancer
[210]. In 2 out of 
7  sporadic  breast  carcinomas,  a  southern  blotting  technique  revealed 
hypermethylation of the BRCA1 promoter. 
As the methylation status of the genome has been shown to change with time it is 
important  to  determine  how  this  global  change  in  methylation  affects  specific 
genes. 
 
1.4.1.3 Expression and regulation of DNMT3a2 
  All  promoters  of  DNMT3a  and  DNMT3b  lack  typical  TATA  sequences 
adjacent to their transcription start sites
[211]. In these promoters Specificity protein-1 
(Sp1) binding sites, play a major role in regulation. Using reporter plasmids, over 
expression of both Sp1 and Sp3 led to up regulation of promoter activity in both 
DNMT3a and DNMT3b, the effect was confirmed using gel shift assays to confirm 
Sp1 and Sp3 binding to the promoters
[211]. DNMT3a2 is a smaller form of DNMT3a, 
the  transcript  encoding  DNMT3a2  is initiated  from  a  2kb  promoter upstream  of 
exon 7 of the DNMT3a gene
[212]. In adult liver, DNMT3a2 accounts for around 50% 
of DNMT3a expression and is the predominant form found in developing tissue. In 
comparison  to  DNMT3a,  DNMT3a2  lacks  the  223  N-terminal  amino  acids  in 
humans,  and  219  N-terminal  amino  acids  in  mouse
[212].  DNMT3a2  is  the 
predominant form found in both embryonic stem cells and embryonic carcinoma 
cells,  and  can  be  detected  in  testis,  ovary,  thymus and  spleen  tissue,  where  it 
correlates  with  high  levels  of  de  novo  methylation
[212].  In  terms  of  functional 
differences, it appears that DNMT3a2 localises at chromatin, whereas DNMT3a is 
concentrated on heterochromatin
[212]. As well as regulation through Sp1 and Sp3, 
binding of retinoblastoma-like protein 2 (Rbl2) to the DNMT3a2 promoter has also 
been shown to regulate its expression
[213]. No evidence to date has shown altered 
methylation of the DNMT3a2 promoter. However, as the gene is not expressed at 
detectable levels following de novo methylation, it is likely that DNA methylation of Samuel Peter Hoile   
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the promoter plays a role. As a result altered methylation at the promoter has the 
potential to affect de novo methylation and DNA methylation in late life. 
 
1.4.3 Histone modifications 
Histones are proteins found within the cell nucleus. An octamer of 8 histone 
proteins, together with DNA forms one nucleosome. The main histone proteins are 
termed H1, H2A, H2B, H3 and H4. Present in the nucleosome is a H3-H4 tetramer, 
with  an  H2A-H2B  dimer  on  either  side.  A  chain  of  nucleosomes  is  known  as 
chromatin.  DNA  tightly  packed  around  chromatin  is  known  as  heterochromatin, 
DNA loosely packed around chromatin is known as euchromatin. Euchromatin is 
associated with a higher rate of expression of DNA, as the DNA is more accessible 
to transcriptional machinery
[214]. There are many forms of modification present in 
histones that result in making genes more or less accessible for expression, this 
occurs due to the altered charge associated with the added molecules (Figure 1.9). 
By chemically altering residues on the tails of histones, weaker forces are present 
between DNA and the histones; this alters the chromatin structure, allowing greater 
accessibility  for  transcriptional  machinery.  The  most  common  modifications  that 
result in activation of genes are acetylation of lysines 9 and 14 and methylation of 
lysine  4  on  H3;  these  are  achieved  by  histone  acetyltransferases  (HATs)  and 
HMTs,  respectively.  The  most  common  chemical  modifications  that  result  in  a 
silencing of expression are di- and trimethylation of lysine 9 of H3 by HMTs, G9a 
and  Suv39Hi
[214].  Methylation  of  histones  is  an  important  method  of  gene 
regulation. It is unclear if histone modifications play a role in transmission of altered 
phenotypes through generations. 
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1.4.4 Epigenetics and early life origins of disease 
The  mechanisms  behind  gene  regulation  have  been  discussed  with 
emphasis on those with potential epigenetic modifications. The following human 
observations and animal studies provide evidence behind epigenetic modifications 
and change of phenotype, particularly where disease risk results. 
 
As stated previously, the Dutch Winter Famine provides a novel observation 
into the effects of parental under nutrition and the later life development of disease. 
Following the recent identification of the role of DNA methylation as a potential 
mechanism for induction of phenotype, the methylation profiles of adult offspring of 
Figure  1.9  Diagram  showing  activation  and  repression  of  gene  activity  through 
covalent modifications of histone H3. Methylation (activating and repressing) is achieved 
by histone methyltransferases (HMTs). Phosphorylation is catalysed by protein kinases (PKs,) 
Acetylation is catalysed by histone acetyltransferases (HATs). Samuel Peter Hoile   
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famine parents has been investigated. Hejimans et al measured 5 CpG sites within 
the downstream methylated region for the Insulin-like growth factor 2 (IGF-2) gene, 
a  maternally  imprinted  gene  that  plays  a  key  role  in  human  growth  and 
development. When comparing adults who were subject to periconceptional famine 
exposure to those who had no famine exposure, it was found that methylation of all 
5  measured  CpGs  was  significantly  lower  in  the  periconceptually  exposed 
group
[215]. The result was found to be independent of sex. The group also looked at 
methylation of the same CpGs in adults exposed to famine during late gestation 
and found no significant differences to unexposed adults. Interestingly, age also 
played a factor in methylation status in these CpGs, with a 10 year increase in age 
significantly associated with a 3.6% reduction in methylation
[215]. In a similar study 
by  Tobi  et  al,  the  methylation  status  of  15  imprinted  and  non-imprinted  genes 
involved in growth and metabolic disease was characterised in adult Dutch Winter 
Famine individuals and their non-famine exposed same-sex siblings. In agreement 
with Hejimans et al, the study showed that periconceptual famine exposure led to 
decreased  methylation  in  the  gene  INSIGF,  when  compared  to  non-famine 
exposed  same-sex  siblings.  However  this  study  also  found  an  increase  in 
methylation in the genes IL10, LEP, ABCA1, GNASAS and MEG3
[201], suggesting 
that famine exposure lead to constant changes in DNA methylation, which is not 
limited to lower levels of methylation. The study also highlighted the importance of 
timing of famine exposure, where late-gestation exposure only led to a change in 
methylation in GNASAS, when measuring methylation of 4 non-imprinted and 4 
imprinted  genes.  Again  this  was  comparing  famine  exposed  to  non-famine 
exposed  same-sex  siblings
[201].  The  study  also  highlights  a  role  of  sex  in 
susceptibility of changes to methylation status in these measured genes, with sex 
differences in IGFR, LEP, IL10 and APOC1 shown
[201]. These two studies focus 
heavily  on  imprinted genes,  in  order to  show  the  true  consequences  of famine 
exposure during times of development, it would be more beneficial to focus on 
differences seen in non-imprinted genes. Although these studies show variation in 
DNA  methylation  between  groups,  it  must  be  stated  that  the  level  of  variation 
between  samples  in  the  methods  used  is  around  5%.  The  limitations  of  the Samuel Peter Hoile   
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techniques used are such that detection of methylation levels below 5-10% are 
below that of the stringent background levels of the software, but are subject to 
acceptance from users. As these findings are based on methylation differences of 
less than this, we cannot be confident of the results. 
Through animal experiments into DNA methylation status in embryos the 
consequences  of  In  Vitro  Fertilisation  and  Assisted  Reproductive  Technologies 
(ARTs) on the epigenome have been investigated. The following studies will give 
detail  into  the  methylation  status  of  embryos  and  how  implantation  results  in 
alterations.  The  effect  of  embryo  culture  and  embryo  transfer  on  genomic 
imprinting was investigated in mice by Rivera et al
[216]. The results showed that 
both  embryo  transfer  and  culturing  followed  by  transfer  resulted  in  irregular 
expression of one or more imprinted genes in both the yolk sac and placenta, with 
culture exacerbating the effects or increasing the number of genes affected
[216]. A 
study using the Agouti mouse model by Morgan has investigated 96 hour culturing 
of  zygotes  to  the  blastocyst  stage,  followed  by  transfer  to  a  pseudo-pregnant 
female. A pseudo-pregnant female is one which has received hormonal treatment 
to prepare the body to accept a blastocyst. Results show a significant increase in 
pups expressing the active epiallele leading to the yellow coat, showing a decrease 
in methylation of the A
vy allele in these mice. Again this result was validated by 
comparing  natural  pups  to  embryonic  transfer  alone  and  no  difference  was 
observed
[200].  Further  uses  of  the  Agouti  mouse  in  determining  epigenetic 
mechanisms  will be  explored  later in  this section. These  animal studies  clearly 
show how misexpression of imprinted genes can be caused by in vitro techniques. 
The following group of studies focus on retrospective observations of IVF rates in 
children  with  birth  defects  or  higher  risks  of  disease  in  later  life.  IVF  rates  in 
children with the overgrowth syndrome, Beckwith-Weidermann Syndrome (BWS), 
or those born with defects, are higher than those conceived naturally
[196,217]. In the 
United States of America the incidence of BWS is 0.8%, following IVF treatment 
this  increases  to  4.6%
[196].  This  increase  is  associated  with  specific  epigenetic 
alterations in LIT1 and H19 in more than 80% of cases
[196]. In Western Australia, 
Hansen  et  al  investigated  the  relationship  between  intracytoplasmic  sperm Samuel Peter Hoile   
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injection or IVF and risk of birth defects, when compared to naturally conceived 
births
[217].  The  group  obtained  a  high  sample  size  by  using  data  from  three 
registries  and  found  that  incidence  of  birth  defects  increased  from  4.2%  for 
naturally  conceived  births  to  8.6%  for  those  born  using  intracytoplasmic  sperm 
injection  and  to  9.0%  for  those  born  via  IVF
[217].  These  findings  have  been 
confirmed by experiments by Katari who showed IVF children had a greater risk of 
low-birth weight, birth defects of any variety and disorders resulting from imprinted 
genes
[197]. Methylation of 1,536 CpG sites in more than 700 genes in cord and 
placenta  were  measured,  and  although  a  high  level  of  variance  was  seen  in 
results,  a  lower  level  of  methylation  was  evident  in  both  imprinted  and  non-
imprinted  genes  in  these  tissues
[197].  These  three  studies  have  proved  the 
considerations which must be taken into account when using ARTs, as any altered 
exposure to the zygotes of developing embryo is likely to result in changes to the 
epigenome and therefore phenotype of the offspring.  
 
Experiments using the Agouti mouse have shown how fortifying the diet with 
factors that affect epigenetic machinery resulted in a change of phenotype and 
physiology of the animal. An experiment by Wolff et al looked at expression of the 
ectopic agouti gene, which codes for coat colour. In offspring of dams fed a diet 
fortified with folic acid, choline, betaine and vitamin B12, an increase in methylation 
at  the  agouti  retrotransposon  was  present.  This  correlated  with  a  reduced 
expression  in  the  ectopic Agouti  gene  (A
vy),  leading  to  synthesis of  eumelanin, 
which led to the black coated pseudoagouti phenotype
[218]. As well as change in 
coat  colour  it  was  observed  that  the  wild  yellow  coat  coloured  phenotype  are 
typically  larger,  more  obese,  hyperinsulinemic,  more  susceptible  to  cancer  and 
shorter lived when compared to the pseudoagouti phenotype
[218]. This experiment 
shows  how  folic  acid  can  lead  to  a  changed  phenotype  through  epigenetic 
modifications. However it is not the only nutritional alteration in the diet, so the 
results must be taken with caution. It would be beneficial to see the effects of folic 
acid alone in this model. 
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As  discussed  earlier  the  low  protein  diet  provides  a  distinct  change  in 
metabolism and phenotype in rats which can be utilised to determine mechanisms 
and pathways which have been altered. Work by Lillycrop et al has shown that 
feeding  a  PR  diet  (9%  casein  Vs  a  control  of  18%  casein)  to  dams  during 
pregnancy leads to changes in gene expression in the offspring which can in part 
be  explained  by  alterations  in  the  methylation  status  of  CpGs  found  within  the 
promoter  regions  of  the  genes.  In  6  day  old  PR  offspring  PPARα  and  GR 
expression was 10.5 fold and 2 fold higher than control offspring, respectively
[198]. 
This change was concurrent with a decrease in promoter methylation of 20.6% for 
PPARα and 22.8% for GR
[198]. In later experiments by the group, using the same 
model, similar patterns in expression and methylation of GR were shown in both 37 
and  80  day  old  offspring
[187,199].  Expression  of  the  maintenance  DNA 
methyltransferase, DNMT1 was 17% lower in the PR offspring, indicating the role 
of the enzyme in the changes in expression seen
[187]. The group also looked at 
methylation and acetylation of specific lysines in histones, which are associated 
with  an  increase  in  transcription.  In  the  same  group  of  animals  they  found  an 
increase histone modifications that increase levels of transcription, such as H3K9 
methylation, in the PR offspring compared to control, whilst modifications which 
lead to a suppression of transcription were decreased
[187]. In a further study by the 
same group, the methylation status of specific CpG dinucleotides was determined, 
when using the same animal model
[199]. In offspring of dams fed the PR during 
pregnancy  methylation  of  CpGs  2,  3,  4  and  16  of  the  PPARα  promoter  were 
significantly  lower  than  offspring  of  dams fed  the  control  diet,  giving  an  overall 
lower methylation of 26% at the promoter (p<0.05)
[199]. The study also showed that 
supplementing the PR diet with 5mg/kg folic acid (PRF) led to no differences in 
methylation at these sites, when comparing the PRF and control offspring. This 
provides  evidence  for  ‘rescuing’  the  offspring  of  mothers  fed  a  PR  diet,  by 
providing DNA methylation promoting diets. 
As  well  as  changes  in  the  epigenome  resulting  from  changes  in  nutritional 
exposure,  non-nutritional  phenotype  induction  has  been  shown.  Weaver  et  al 
showed that an increase in pup licking and grooming and arched backed nursing Samuel Peter Hoile   
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by dams altered the epigenome of the glucocorticoid promoter in the hippocampus 
of the offspring when compared to controls. These differences were seen in the 
first week of life and were reversed by cross fostering
[206]. Although the mechanism 
behind these alterations are unknown, it is likely via a change in plasma levels of 
specific chemicals, such as endorphins, caused by the grooming. These results 
show that maternal behaviour can alter the phenotype of the offspring independent 
of nutrition and that the window of plasticity in the offspring extends beyond birth. 
  In  nature  all  female  honeybees  are  genetic  clones  arising  from  identical 
larvae, however some become fertile queens and others sterile workers. It has 
been found that those who are fed with royal jelly, a chemically uncharacterised 
substance,  by  young  nurse  bees  become  queen  bees
[219].  Those  destined  to 
become worker bees are fed a less sophisticated diet. By injecting small interfering 
RNA, to target DNMT3 in larvae the majority of females (72%) went on to become 
queens,  with  fully  developed  ovaries
[219].  This  study  provides  evidence  that 
methylation is vital in nature, in the honeybee, in order to determine reproductive 
status. This provides insight into the role of natural methylation in other species 
including humans which must be explored. 
 
To  date  the  only  study  that  has  shown  a  role  of  epigenetic  processes  in 
transgenerational  transmission  of  phenotype  is  by  Burdge  et  al
[220].  The  study 
found that feeding rats a protein restricted diet during pregnancy led to significantly 
lower levels of methylation of the promoter regions of both PPARα and GR in the 
liver, which were passed to the F2 generation
[220]. It is not known if differences in 
epigenetics,  which  underlie  alterations  in  phenotype  between  generations  are 
passed between generations unaltered or if changes in the F0 pregnancy lead to 
variation in the offspring, which have the potential for adaptation. 
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1.4.5 Folate 
  The  B9  family  of  water-soluble  B-vitamins  are  known  as  the  folates. 
Physiologically they have roles in; cell division and repair, nucleotide biosynthesis, 
1  carbon  metabolism,  DNA  methylation,  phospholipid  biosynthesis  and 
homocysteine remethylation
[221]. Folates are comprised of a pteridine ring, p-amino 
benzoylglutamate group and polyglutamate tail, where 5 – 7 glutamate residues 
are  normally  present.  The  natural form,  which  contains the polyglutamte  tail,  is 
known as folate, it cannot be synthesised by the body, so is consumed in the diet. 
Synthetic folate, which only has one glutamate residue (monoglutamate) is known 
as folic acid.  
Folates  are  transported  into  cells  in  the  form  of  5-methyltetrahydrofolate,  this 
involves  the  hydrolysis  of  dietary  folate  polyglutamates  to  the  monoglutamate 
forms
[221]. 
Tetrahydrofolates  are  responsible  for  one  carbon  metabolism;  this  involves  the 
transport  of  methyl  groups  (CH3),  which  are  made  available  for  purine  and 
pyrimidine biosynthesis, amino acid metabolism (serine, glycine and methionine), 
phospholipid  biosynthesis  and  DNA  methylation.  The  one  carbon  metabolism 
pathway  takes  place  in  both  the  mitochondria  and  cytoplasm.  Phospholipid 
biosynthesis  is  important  in  growing  tissues  for  incorporation  into  the  cell 
membrane,  the  conversion  of  phosphatidyl  ethanolamine  (PE)  to  phosphatidyl 
choline  (PC)  by  phosphatidyl  ethanolamine  methyltransferase,  requires  the 
addition  of  a  methyl  group.  The  end  point  of  one  carbon  metabolism  provides 
methyl  groups  for  either  phospholipid  biosynthesis  or  DNA  methylation  S-
Adenosyl-Methionine  (SAM)  is  formed  from  the  methyl  groups  derived  from 
methionine in the one-carbon pathway
[222]. As a result of the transfer of a methyl 
group, SAM is converted to S-Adenosyl-Homocysteine (SAH); this methyl group is 
available for DNA methylation. 
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1.4.5.1 Modification of DNA methylation by folic acid 
The  result  of  supplementation  of  the  protein  restricted  diet  during 
pregnancy, in rats, has been discussed previously. Further experiments involving 
folic  acid  supplementation  in  both  rat  models  and  human  observations,  with 
particular reference to cancer, have been undertaken. 
 
1.4.5.2 Evidence from animal models 
Folic  acid  prevented  the  alterations  in  gene  specific  regulation  and 
cardiovascular adaptations, caused by protein restriction alone
[198,51]. To potentially 
reverse the effects of protein restriction during pregnancy, the juvenile-pubertal diet 
has  been  supplemented  with  folic  acid
[25].  When  feeding  offspring  of  protein 
restricted dams, additional folic acid for 28 days following weaning, the phenotype 
was not simply reversed. Offspring that received the folic acid supplemented diet, 
regardless of the protein content of the prenatal diet showed; increased weight 
gain,  lower  plasma  β-hydroxybutyrate  concentration  and  increased  hepatic  and 
plasma triglyceride concentrations, compared to offspring who received the folic 
acid adequate diet. The folic acid supplemented offspring also showed changes in 
the epigenome, where both PPARα and GR promoter methylation was increased 
in  liver  and  insulin  receptor  promoter  methylation  was  decreased  in  liver  and 
adipose tissue, compared to the folic acid adequate offspring
[25].  
 
1.4.5.3 Evidence in humans   
Initiation of cancer can be through altered regulation and expression of both 
tumour suppressor genes and proto-oncogenes, therefore supplementation of the 
diet with folic acid has been investigated. Although the majority of studies linking 
folic acid intake to cancer risk are inconclusive, the relationship between folic acid 
intake and colorectal cancer has been well investigated. In a controlled placebo 
trial  in  patients  with  a  history  of  colonic  dysplasia  or  neoplasma,  folic  acid 
supplementation in adults was shown to improve the DNA methylation status in 
both colonic mucosa
[223] and rectal mucosa
[224] and reduce colonic mucosal cell 
proliferation
[225]. A follow-up to the Nurse’s Health Study and Health Professionals Samuel Peter Hoile   
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study found a 30-40% decrease in risk of colorectal adenoma, when dietary folic 
acid intake was > 700μg/day, compared with lower intakes
[226]. Interestingly a more 
recent  study  has  shown  that  both  higher  and  lower  intakes  of  folic  acid  are 
associated with a moderate reduction in risk of colorectal cancer
[227]. 
Hyperhomocysteinaemia  is  a  condition  where  S-adenosyl  homocysteine  is 
increased,  as  a  competitive  inhibitor  for  S-adenosyl  methionine,  this  suggests 
unbalanced methylation
[228]. DNA methylation, via cytosine extension assay and 
southern blotting, showed that genome wide DNA hypomethylation was present in 
men with hyperhomocysteinaemia and uraemia
[228]. Folate treatment was given to 
those who were heterozygous for the H19 gene, where it decreased the level of 
DNA  hypomethylation.  This  clear  example  of  folate  restoring  DNA  methylation 
levels, however, was only investigated in those heterozygous for the H19 gene, 
which accounted for around 20% of those with the condition. The study did not 
comment on the remaining patients.  
 
1.5.1 PEPCK 
  The enzyme PEPCK is integral to provision of glucose during periods of 
fasting. An alteration in the regulation of transcription of the gene will therefore lead 
to a significant difference in the ability to provide glucose for dependent organs 
during  fasting. The following  sections  provide  a  review  on  the  current  literature 
detailing  the  epigenetic  regulation  of  the  PEPCK  promoter,  with  particular 
reference to DNA methylation.  
 
1.5.1.1 Epigenetic regulation of PEPCK 
  The  PEPCK  gene  is  expressed  in  high  levels  in  adult  liver  and  kidney. 
During fetal development PEPCK remains dormant in these gluconeogenic tissues 
until it is induced in response to changes in the insulin/glucagon ration around fetal 
day  15-18
[229,230].  PEPCK  gene  expression  is  positively  regulated  by 
glucagon
[231,232,233,234] and glucocorticoids
[167,235,232,236] and negatively regulated by 
insulin
[237]. Regulation by glucagon is via increased levels of cAMP, which leads to 
activation  of  PKA
[231].  cAMP  also  acts  to  stabilise  PEPCK  mRNA,  so  that  it  is Samuel Peter Hoile   
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degraded after 150 - 240 minutes, compared to its typical degradation time of 30 
minutes
[231]. Administration of the synthetic glucocorticoid, dexamethasone to rats 
in the last week of pregnancy led to a 60% increase in both expression and activity 
of  PEPCK
[236].  The  effect  however,  was  not  seen  following  dexamethasone 
administration during the first or second week of pregnancy, suggesting an inability 
of the gene to respond to altered environment during early development. 
The PEPCK promoter has been most extensively studied in the rat; however, there 
is a high level of homology in the PEPCK gene from -1500 bp to the start site of 
transcription in human, rat, mouse, cow and dog genomes
[238,136]. Despite studies 
providing  different  definitions  of  the  promoter,  there  is  much  agreement  into 
regulation of the promoter. Short et al, state that the region -2088 to + 69 bp of the 
PEPCK  gene  is  necessary  and  sufficient  to  direct  hepatocyte  specific 
developmental,  hormonal  and  dietary  regulation  of  the  gene
[230].  However, 
Chakravarty et al have shown the region -1500 to +73 bp of the PEPCK gene 
contains  all  of  the  regulatory  elements  required  for  transcription
[238].  The  initial 
study into binding at the PEPCK promoter identified 8 protein binding domains, 
using  DNase  I footprinting
[234,230]. The  study  identified  4  binding  sites for cAMP 
response element (CRE) binding proteins, with the most important functionally at -
147  to  -130  bp
[234,230].  Further  investigation  into  the  promoter  has  led  to  the 
promoter being divided into three regions, region 1, the closest to the transcription 
start site, contains one CRE binding site and an NF-1 site, region 2 contains a 
HNF-1 site, critical for transcription of PEPCK in kidney and region 3, the furthest 
from  the  transcription  start  site,  contains  the  cAMP  response  unit  (CRU)  and 
glucocorticoid response unit (GRU) of the promoter
[238]. Rather than containing one 
glucocorticoid  response  element  (GRE),  the  GRU  coordinates  the  hormonal 
response of PEPCK to insulin and glucocorticoids and interacts with the CRU to 
mediate cAMP control of PEPCK transcription
[238]. Table 1.1 shows a selection of 
transcription factors which bind at the PEPCK promoter and their role in regulation 
of the promoter. 
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Transcription factor  Function in PEPCK regulation 
C/EBPα 
Basal transcription, cAMP-induced gene 
expression, hepatic expression 
C/EBPβ 
Basal transcription, cAMP-induced gene 
expression, hepatic expression 
DBP 
(D-binding protein) 
Basal transcription 
NF-1 
(Nuclear factor-1) 
Inhibits cAMP induced gene expression 
HNF-1 
(Hepatic nuclear factor-1) 
Renal gene expression 
HNF-3  Glucocorticoid–induced gene expression 
CREB  cAMP-induced gene expression 
GR  Glucocorticoid-induced gene expression 
THY 
(Thyroid response element) 
Thyroid-induced gene expression 
PPARγ2  Adipose tissue specific expression 
 
 
 
 
The CAAT/enhancer binding protein (C/EBP) is a key regulator of PEPCK gene  
transcription
[238,231,239,230].  Deleting  the  gene  for  C/EBPα  in  mouse  completely 
repressed  the  expression  of  PEPCK  in  liver  at  birth  and  led  to  profound 
hyperglycaemia in 1-2 hour new-born
[230,136]. Along with a conformational change in 
chromatin around 19 days of fetal life, the transcription factor plays a vital role in 
the  initial  expression  of  PEPCK  in  mammals.  As  well  as  positive  regulation  of 
PEPCK  by  glucocorticoids,  through  the  GRU  and  glucagon,  through  the  CRU, 
PEPCK is also subject to negative regulation, through insulin. In human HepG2 
cells,  insulin  inhibits  binding  of  transcription  factors  to  regulatory  sites
[237,230], 
although the direct mechanism is unknown. In a study by Hall et al, ablation of the 
Table  1.1  Transcription  factors  involved  in  regulation  of  PEPCK  gene  expression 
modified from Nizielski 96. Samuel Peter Hoile   
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insulin-responsive  sequence  did  not  prevent  the  negative  regulation  by  insulin 
seen in the liver, suggesting the involvement of further elements
[240,230]. Due to its 
role in fasting energy metabolism, altered regulation at the PEPCK promoter has 
the  potential  to  have  adverse  consequences  on  health  during  times  of  poor 
nutrition. 
 
1.5.1.2 Methylation at the PEPCK promoter 
  There is some evidence that transcription of PEPCK is regulated via DNA 
methylation. Through use of the methylation inhibitor 5-azacytidine in rat fetuses, it 
was shown that demethylation of the PEPCK promoter in spleen and liver led to 
expression of the gene
[241,230]. Using the methyl sensitive enzymes HpaII and HhaI, 
it was shown that in tissues which do not express the PEPCK gene, adult spleen, 
heart muscle and fetal liver, the PEPCK promoter is methylated. However in fetal 
liver there is a loss of methylation between day 18 and 21 of fetal development, 
which correlates with expression of the gene
[229,230]. These changes in methylation 
are concurrent with changes in the metabolic phenotype of the developing fetus. 
During  in  utero  development,  the  maternal  circulation  provides  glucose  for  the 
fetus, via the placenta. Following birth and weaning, the offspring must provide 
their own glucose, from gluconeogenesis, when none is available from the diet. A 
loss  in  repressive  methylation  at the  late  stages  of fetal development  therefore 
appears  to  prepare  the  offspring  metabolism  for  the  external  environment. 
Although useful in understanding regulation of the gene, these studies do not cover 
all CG dinucleotides in the PEPCK promoter, only those covered by the methyl 
sensitive enzymes and the methods used are not as accurate as those currently 
available.  It  has  been  shown  that  methylation  of  specific  CpGs  is  sufficient  to 
significantly alter gene expression; therefore the use of a sequencing technique will 
allow a deeper understanding of regulation of transcription.  
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1.6 Summary of literature and research hypothesis 
  The  cardio-metabolic  disease  pandemic  is  an  increasing  issue  in  the 
present population, where although those in developing countries are seeing the 
greatest risk in the disease
[230,1], it is still a major burden on the economy in the UK, 
with  risk  factors  now  presenting  in  school  aged  children
[3].  Although  genetic 
components  are  evident  behind  risk  factors,  there  is  clear  link  between 
environment and genotype. 
  A plethora of studies have explored the association between the early life 
risk of disease, with particular focus on the transmission of disease risk between 
generations
[166].  In  animal  studies  the  mechanisms  and  extent  to  which  the 
environment, in particular nutrition of the mother during pregnancy has been fully 
explored
[242,243,220,244,48,57,41,245,246,247,42,198,187].  It  has  become  apparent,  when 
considering the altered phenotype of offspring that the duration and magnitude of 
the altered external plays a fundamental role. 
  The  fasting  response  requires  an  orchestrated  combination  of  hormonal 
effects, to ensure preservation of glucose and provision of energy substrates to 
key organs. In the state of pregnancy, this response is heightened to ensure the 
growth  of  the  fetus  as  well  as  the  survival  of  the  mother
[160,112,102].  Fatty  acid 
desaturation  and  elongation  is  essential  in  order  to  produce  long  chain  fatty 
acids
[147].  Physiologically,  this  is  important  for  use  in  membrane  structures,  to 
increase fluidity and transmission of signals through the bilayer. 
  The optimal functioning of both fasting glucose homeostasis and the fatty 
acid  desaturation-elongation  pathway  is  required  for  successful  survival  to 
reproductive  age  and  beyond.  Differences  in  metabolism  have  been  shown  to 
result from an altered early life environment
[47,244,74,32,70]. An understanding of the 
mechanisms  behind  the  changes  in  phenotype  in  postnatal  life  will  increase 
knowledge of this association and could potentially lead to strategies for minimising 
the deleterious effects of predictive adaptive responses. 
  Epigenetic  processes  have  been  implicated  as  a  potential  mechanism 
behind  the  early  life  origins  of  disease
[184,162,248,216].  Through  inhibition  of Samuel Peter Hoile   
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transcription  DNA  methylation  can  directly  or  indirectly  lead  to  alterations  in 
phenotype of an organism. 
To date no studies have investigated the transmission of DNA methylation 
marks of specific promoter regions between subsequent generations of  different 
dietary lines. 
In order to fully understand the potential for changes in methylation on gene 
expression  and  phenotype,  it  will  be  necessary  to  investigate  the  regulation  of 
gene expression in different dietary exposure groups, in animals of subsequent 
generations. This will identify if methylation levels of one promoter are subject to 
variation under different experimental conditions, in a CpG specific manner. 
The role of pregnancy in the developmental origins of health and disease is 
clear, as environmental markers are passed from the maternal circulation to the 
fetus
[156,157,158]. However, no studies to date have investigated changes in maternal 
physiology, gene expression and epigenotype during pregnancy, in a diet specific 
manner. 
 
The aim of this thesis is to address these unanswered research questions. It 
is hypothesised that; 
 
-In  the  rat,  increased  energy  content  throughout  life,  across  four 
generations, will lead to significant differences in weight gain, energy intake and 
fasting plasma metabolite levels across the generations, as the animals adjust to 
the high energy content of the diet. 
 
-The trajectory of adjustment towards the high energy diet across the four 
generations will be significantly altered by a reduced protein content of the F0 diet 
during pregnancy. 
 
 -Underlying  differences  in  gene expression  of  specific genes  involved  in 
fasting  carbohydrate  and  fat  metabolism  will  be  related  to  the  significant 
differences in fasting energy metabolites. Samuel Peter Hoile   
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-Differences in DNA methylation of the promoter regions of specific genes 
will be related to expression levels of the gene, in a CpG specific manner. 
 
-The additional stress of pregnancy will lead to significant differences in the 
phenotype, gene expression and DNA methylation levels of specific genes. 
 
-The nature of the nutritional exposure will led to gene specific differences in 
transcriptional regulation. 
 
-Regulation of specific genes will be significantly altered by the form and 
timing of the altered nutritional environment. 
 
-Where  altered  promoter  methylation  is  associated  with  significant 
differences in gene expression, differences in transcription factor binding will be 
present. 
 
-Mutation of specific CpGs, which show associations with gene expression, 
will  lead  to  significantly  different  levels  of  gene  transcription  under  basal  or 
activated conditions.  
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2. Materials and methods 
 
2.1 Materials   
 
Table 2.1 Reagents used in experiments 
 
Reagent/Chemical 
 
 
Supplier 
1 kb ladder 
17α ethinylestradiol 
2018S Teklad Global 18% Protein Diet 
2-mercaptoethanol 
3mm blotting paper 
40% Acrylamide 
5-bromo-4-chloro-3-indolyl-beta-D-
galactosyronoside (X-Gal) 
50 X Tris-acetate-EDTA (TAE) buffer 
Agarose 
AIN93-G diet 
AIN93-M diet 
Albumin bovine serum 
Amersham Hybond N+ nylon membrane 
Aminopropyl silica columns 
Ammonium persulfate (APS) 
Ampicillin 
Bromphenol blue 
Chloroform 
DNase I 
DNAse and RNAse free water 
Deoxynucleotide Trisphosphates (dNTPs) 
Dulbecco’s Modified Eagle Medium, low glucose 
Dual-luciferase reporter assay kit 
Ethanol 
Ethylenediaminotetraacetic  acid  disodium  salt 
(EDTA) 
EZ-DNA Methylation Gold Kit 
Ficoll 400 
fuGENE transfection reagent 
Glucagon DuoSet ELISA 
Glucagon DuoSet ELISA substrate solution 
Glycine 
Goat polyclonal antibody against fads2 sc-109272 
Goat polyclonal antibody to rabbit (HRP) ab97051 
HEPES 
Hydrochloric acid (HCl) 
Isopropanol 
Isoprpyl β-D-1 thiogalactopyranoside (IPTG) 
JM109 competent cells 
Leupeptin 
Light-Shift  chemiluminescent  electro  mobility  shift 
assay kit 
Luria broth 
Fermentas, York, UK 
Sigma-Aldrich, Dorset, UK 
Harlan, Bicester, UK 
Sigma-Aldrich, Dorset, UK 
Whatman, Maidstone, UK 
Fisher, Leicestershire, UK 
Fisher, Leicestershire, UK 
 
Fisher, Leicestershire, UK 
Melford Laboratories, Ipswich, UK 
TestDiet, Indiana, USA 
TestDiet, Indiana, USA 
Sigma-Aldrich, Dorset, UK 
GE Healthcare, Chalfront, UK 
Varian, California, USA 
Fisher, Leicestershire, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Fisher, Leicestershire, UK 
Sigma-Aldrich, Dorset, UK 
Fisher, Leicestershire, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Promega, Southampton, UK 
Fisher, Leicestershire, UK 
Sigma-Aldrich, Dorset, UK 
 
Cambridge Bioscience, Cambridge, UK 
Sigma-Aldrich, Dorset, UK 
Promega, Southampton, UK 
R&D Systems, Abingdon, UK 
R&D Systems, Abingdon, UK 
Sigma-Aldrich, Dorset, UK 
Santa-Cruz Biotechnologies, California, USA 
Abcam, Cambridge, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Fisher, Leicestershire, UK 
Fisher, Leicestershire, UK 
Promega, Southampton, UK 
Sigma-Aldrich, Dorset, UK 
Fisher, Leicestershire, UK 
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Marvel powdered milk 
Methanol 
Modified AIN93-G diet 
Molecular weight marker ab1746 
M-MLV reverse transcriptase 
NP-40 
Orange G 
Pierce BCA protein assay kit 
Phenylmethanesulfonylfluride (PMSF) 
Phosphate buffered saline (PBS) 
Phenol 
Pyrogold reagents 
Pyrosequencer annealing buffer 
Pyrosequencer binding buffer 
Pyrosequencer nucleotide tips 
Pyrosequencer reagent tips 
Pyrosequencer wash solution 
PCR primers – biotin labelled 
PCR primers 
pGEMT vector 
pGl3 vector 
Pfu proofreading polymerase 
Proteinase K 
QIAquick gel extraction kit 
QIAquick PCR clean up kit 
Rabbit polyclonal antibody against PEPCK ab28455 
Rabbit polyclonal antibody to goat (HRP) ab97100 
Random Nonamers 
Rat and Mouse No.1 Maintenance Diet 
Rat leptin ELISA kit 
Restriction enzymes 
        ApoI, BglII, Cla, DpnI, HindIII, Xba 
RNase A 
Reference dye for quantitative PCR 
SequalPrep long polymerase 
Sodium acetate (NaAc) 
Sodium chloride (NaCl) 
Sodium dodecyl sulphate (SDS) 
Sodium deoxycholate 
Streptavidin sepharose beads 
Sulfuric acid (H2SO4) 
SYBR GREEN Master Mix 
Taq DNA polymerase Hot start 
Tetramethylethylenediamine (TEMED) 
Tri reagent 
Tris 
Tris-acetate EDTA (TAE) 
Tris-borate EDTA (TBE) 
Triton X-100 
Tween
®20 
Sainsburys, Southampton, UK 
Fisher, Leicestershire, UK 
TestDiet, Indiana, USA 
Abcam, Cambridge, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Thermo-Fisher, Illinois, USA 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Fisher, Leicestershire, UK 
Qiagen, Crawley, UK 
Qiagen, Crawley, UK 
Qiagen, Crawley, UK 
Qiagen, Crawley, UK 
Qiagen, Crawley, UK 
Qiagen, Crawley, UK 
Biomers, Söflinger Straße, Germany 
Invitrogen, Paisley, UK 
Promega, Southampton, UK 
Promega, Southampton, UK 
Promega, Southampton, UK 
Promega, Southampton, UK 
Qiagen, Crawley, UK 
Qiagen, Crawley, UK 
Abcam, Cambridge, UK 
Abcam, Cambridge, UK 
Sigma-Aldrich, Dorset, UK 
SDS, Essex, UK 
Millipore, Missouri, USA 
Promega, Southampton, UK 
 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Invitrogen, Paisley, UK 
Sigma-Aldrich, Dorset, UK 
Fisher, Leicestershire, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
GE healthcare, Chalfont, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Qiagen, West Sussex, UK 
Sigma-Aldrich, Dorset, UK 
SDS, Essex, UK 
Fisher, Leicestershire, UK 
Fisher, Leicestershire, UK 
Fisher, Leicestershire, UK 
Fisher, Leicestershire, UK 
Sigma-Aldrich, Dorset, UK 
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2.2 Methods 
 
2.2.1 Study design 
 
2.2.1.1 Animal model 
All  animal procedures  were  conducted  in accordance  with  the  UK  Home 
Office  Animals  (Scientific  Procedure)  Act  (1986).  All  experimental  diets  were 
supplied  by  TestDiet,  Indiana,  USA.  The  composition  of  the  diets  is  shown  in 
Tables 2.2, 2.3 and 2.4. The energy content of the diets is shown in Figure 2.2.  
Before  arrival  to  the  animal house  F0 females  were  fed  the  standard  breeding 
colony diet (2018S, Teklad Global 18% Protein Rodent Diet, Harlan, Bicester, UK.) 
Upon arrival to the animal house, adult female virgin Wistar rats (F0) were fed the 
standard animal house diet (RM1, Rat and Mouse No.1 Maintenance diet, SDS, 
Essex, UK) during the 14 day acclimatisation period. Following this, adult females 
were mated and fed either; a protein sufficient diet (PS) containing 180 g/kg casein 
(w/w)  or  an  isoenergetic  protein  restricted  diet  (PR)  containing  90  g/kg  casein 
(w/w), throughout pregnancy (Table 2.2) the diets are based around those used by 
Burdge et al
[25]. For the short duration of mating, females were fed the standard 
animal house diet; this was to ensure all breeding males were not exposed to the 
altered  nutrition  of  the  experiment,  in  order  to  avoid  male  intergenerational 
effects
[167]. The experimental design is summarised in Figure 2.1.  Sixteen dams 
were randomly assigned to each diet. Pregnancy was determined by presence of 
the copulatory plug. On day 8.5 of pregnancy seven females per dietary group 
were  culled  for  tissue  collection.  The  remainder  were  allowed  to  deliver 
spontaneously  at  around  day  21.    Within  24  hours  of  birth,  F1  litters  were 
standardised to eight pups, in order to ensure even nutrition. In order to maximise 
breeding  stock,  litters were  maximised for females.    At  delivery,  all  dams  were 
transferred  to  the  AIN93-G  semi-purified  breeding  diet.  After  28  days,  three 
females from each litter were selected at random and weaned onto the AIN-93M, 
maintenance diet, and placed in group cages, with five rats being placed in each 
cage. Dams and remaining day 28 old offspring were culled and tissues collected. 
At 70 days old, one female from each litter was culled, and tissues were collected. 
The two remaining F1 females from each litter were mated with males who had Samuel Peter Hoile   
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received standard chow throughout life. All pregnant females were fed the PS diet 
throughout  pregnancy.  Following  pregnancy  the  experimental  set  up  for  the  F2 
offspring was identical to that of the F1 offspring. At 70 days of age F2 females 
were  either  killed  for sample  collection  or  mated  with  males  who  had  received 
standard  chow  throughout  life.  All  pregnant  females  were  fed  the  PS  diet 
throughout pregnancy. Following pregnancy the experimental diets used for the F3 
offspring were identical to that of the F2 offspring. 
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Figure 2.1 Diagram showing the experimental design of the animal model. The protein sufficient diet (PS) is shown in blue, the protein restricted 
diet (PR) is shown in red, the lactation diet is shown in yellow and the maintenance diet is shown in green. Pregnancy is shown by P, lactation by L and 
growth by G. F0 females were mated and fed either the PS or PR diet throughout pregnancy. Following birth all dams were fed the lactation diet. At 28 
days old F1 offspring were weaned onto the maintenance diet. Once 70 days old (adults), F1 females were mated and fed the PS diet throughout 
pregnancy. Once the F2 offspring were born, F1 dams were fed the lactation diet. At 28 days old F2 females were weaned onto the maintenance diet. 
Once 70 days old, F2 females were mated and fed the PS diet throughout pregnancy. Following birth all F2 dams were fed the lactation diet. At 28 
days old F3 offspring were weaned onto the maintenance diet, they continued on this diet until adulthood. Seven females per dietary group were 
sacrificed at day 8.5 of pregnancy, in each generation. Samuel Peter Hoile   
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  PS  PR  Lactation 
diet 
(AIN-93G) 
Maintenance 
diet 
(AIN-93M) 
Animal 
House 
diet 
(RM1) 
Breeding 
colony diet 
(2018S) 
g/kg 
Casein 
 
183  92  200  140  129  188 
Cornstarch 
 
420  482  397  466  450  450 
Sucrose 
 
213  243  100  100  40.5  50 
Choline 
 
2.8  2.8  2.5  2.5  1.1  1.1 
Methionine 
 
9.7  7.4  5.2  3.6  2.2  4.3 
Cellulose  (Crude 
Fiber) 
50  50  50  50  43.2  38 
Soybean oil 
 
100  100  70  40  27.1  60 
Total 
metabolizable 
energy, MJ/kg 
17.2  17.4  16.4  15.78  10.74  13.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2 Table showing the composition of the diets fed to animals during the study. All 
nutrients are given as g/jkg. Total metabolizable energy is given in MJ/kg. PS, PR, AIN-93G and 
AIN-93M diets were supplied from TestDiet, Indiana, USA. The animal house diet was supplied by 
SDS, Essex, England. The 2018S diet was supplied by Harlan, Bicester, England. Samuel Peter Hoile   
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  PS  PR  Lactation 
diet 
(AIN-93G) 
Maintenance 
diet 
(AIN-93M) 
Animal 
House 
diet 
Breeding 
colony diet 
(2018S) 
mg/kg 
Vitamin A  
 
0.6  0.6  1.2  1.2  2.5  9.21 
Vitamin  D3 
(Cholecalciferol) 
0.0125  0.0125  0.025  0.025  0.015  0.052 
Vitamin  E  (α-
Tocepherol) 
30.55  30.55  50.25  52.79  56.3  128 
Vitamin  K 
(Menadione) 
0.14  0.14  0.29  0.29  10.17  102 
Vitamin  B1 
(Thiamine) 
3.1  3  6  6  8.58  117.6 
Vitamin  B2 
(Riboflavin) 
3.6  3.3  6  6.5  4.33  27.2 
Vitamin B3 
(Niacin) 
15  15  30  30  61.32  87.3 
Vitamin  B5 
(Pantothenic Acid) 
8  8  15  16  20.17  141.6 
Vitamin  B6 
(Pyridoxine) 
2.9  2.9  5.8  5.8  4.81  26.8 
Vitamin B7 
(Biotin) 
0.1  0.1  0.2  0.1  0.27  0.8 
Vitamin  B12 
(Cyanocobalamine) 
0.016  0.014  0.025  0.028  0.0075  0.150 
Vitamin C 
(Ascorbic Acid) 
-  -  -  -  259  - 
Folic acid 
 
1.1  1.1  2  2.1  0.79  8.4* 
Choline Chloride 
 
1960  1960  1250  1250  1080  1120 
Inositol 
 
-  -  -  -  2300  1450 
ʒ-carotene 
 
-  -  -  -  0.16  2.5 
Table 2.3 Table showing the vitamin content of the diets fed to animals during the study. All 
values are given as mg/jkg. PS, PR, AIN-93G and AIN-93M diets were supplied from TestDiet, 
Indiana, USA. The animal house diet was supplied by SDS, Essex, England. The 2018S diet was 
supplied by Harlan, Bicester, England. * As dietary folate. Samuel Peter Hoile   
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  PS  PR  Lactation 
diet 
(AIN-93G) 
Maintenance 
diet 
(AIN-93M) 
Animal 
House 
diet 
Breeding 
colony diet 
(2018S) 
Calcium 
g/kg 
2.9  2.9  5  5  7.3  10 
Phosphorus 
(available), g/kg 
1.5  0.7  1.6  1.1  2.8  6.5 
Potassium 
g/kg 
2.1  2.1  3.6  3.6  6.7  6.8 
Magnesium 
g/kg 
0.3  0.3  0.5  0.5  2.3  2 
Sodium 
g/kg 
0.8  0.8  1  1.3  2.5  2.3 
Chloride 
g/kg 
1.9  1.9  1.6  2  3.8  4 
Fluorine 
mg/kg 
0.6  0.6  1  1  10.49  - 
Iron 
mg/kg 
21  20  41  36  159.3  225 
Zinc 
mg/kg 
22  19  35  35  35.8  77 
Manganese 
mg/kg 
6  6  11  11  72.4  118 
Copper 
mg/kg 
3.4  3.4  6  6  11.5  15 
Cobalt 
mg/kg 
-  -  -  -  0.63  0.6 
Iodine 
mg/kg 
0.12  0.12  0.21  0.21  1.2  12 
Chromium 
mg/kg 
0.6  0.6  1  1  -  0.5 
Molybdenum 
mg/kg 
0.08  0.08  0.14  0.14  -  - 
Selenium 
mg/kg 
0.1  0.1  -  0.17  0.29  0.2 
 
 
 
 
 
 
 
Table 2.4 Table showing the mineral content of the diets fed to animals during the study. All 
minerals are given as either g/jkg or mg/kg. PS, PR, AIN-93G and AIN-93M diets were supplied 
from TestDiet, Indiana, USA. The animal house diet was supplied by SDS, Essex, England. The 
2018S diet was supplied by Harlan, Bicester, England. Samuel Peter Hoile   
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Figure 2.2 Diagram showing the difference in total metabolizable energy/ MJ/kg between 
the breeding colony diet and the diets used in the study.  The total metabolizable energy for 
each diet is; 13.7 MJ/kg for the Breeding colony diet, 17.2 MJ/kg for the protein sufficient diet, 
17.4 MJ/kg for the protein restricted diet, 16.4 MJ/kg for the AIN-93G diet and 15.8 MJ/kg for the 
AIN-93M  diet.  Due  to  the  short  exposure  of  mating  females  to  the  animal  house  diet  during 
mating, it is not shown on the graph. Samuel Peter Hoile   
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2.2.1.2 Animal weight and food intake collection. 
Throughout the experiment animal weights and 24 hour food intakes were 
recorded every 7 days. The 24 hour food intake measurements were achieved by 
providing each cage a set amount of food (120 -150g for single cages, and 450-
550g for group cages), measuring the amount of food remaining 24 hours later and 
calculating the difference. 
   
2.2.1.3 Tissue collection 
  After being culled, liver, heart and blood were collected from each rat. Liver 
and hearts weights were measured, and tissues were snap frozen in liquid nitrogen 
upon collection. All tissue was stored at -80
oC long term.  
 
2.2.1.4 Plasma analysis  
Blood was collected by cardiac puncture and stored on ice at collection in 
heparinised  tubes,  to  prevent  coagulation.  Upon  arrival  in  the  lab,  blood  was 
centrifuged at 2,000 rpm for 10 minutes, in order to collect plasma. Plasma was 
stored long term at -80
oC.  Plasma  concentrations  of  β-hydroxybutryate,  glucose, 
corticosterone, glucagon and leptin were measured.  
For β-hydroxybutryate and glucose, aliquots of plasma were measured by Dr John 
Jackson (Institute of Human Nutrition, University of Southampton) using a Konelab 
20 autoanalyser. Enzyme-Linked Immunosorbent Assays (ELISAs) were used to 
measure  corticosterone,  glucagon  and  leptin  plasma  concentrations. 
Corticosterone concentration was measured by Dr Nicola Thomas. 
 
2.2.1.4.1 Enzyme linked immunosorbent assays (ELISAs) 
  Plasma  glucagon  and  leptin  was  measured  using  sandwich  ELISA  kits: 
Glucagon DuoSet ELISA (R & D Systems, Abingdon, UK) and Rat Leptin ELISA kit 
(Millipore,  Missouri,  USA).  Both  ELISAs  were  carried  out  according  to 
manufacturer’s instructions. All required reagents were supplied with the Rat Leptin 
ELISA kit. For the Glucagon DuoSet ELISA, substrate solution (R & D Systems, Samuel Peter Hoile   
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Abingdon, UK) was ordered separately and the following solutions were made in 
the laboratory; 
  Phosphate buffered saline – 1 PBS tablet/ 100ml deionized water 
  Wash buffer – 0.05% Tween
®20 in PBS, pH 7.2-7.4 
  Reagent diluent – 1% albumin bovine serum in PBS, pH 7.2-7.4 
  Stop solution – 2 N H2SO4 
 
2.3.1 Isolation of total RNA 
Tissues  were  crushed  under  liquid  nitrogen,  using  a  pestle  and  mortar. 
Tissue was not allowed to thaw during crushing. Approximately 500mg of each 
tissue  was  crushed  and  placed  into  each  of  three  1.5ml  eppendorfs.  Two 
eppendorfs  contained  100mg, and  were  reserved for DNA and RNA  extraction. 
The third eppendorf contained 200mg crushed liver, and was used as a reserve 
supply. Once crushed all tissue was returned to -80
oC, for long term storage. 
RNA from pulverised tissue was isolated using Trizol. In 1.5ml eppendorfs, 
1ml of Trizol was added to 100mg of crushed tissue. Samples were incubated at 
room temperature for 5 minutes before adding chloroform (200µl). Samples were 
shaken vigorously by hand for 15 minutes and then left at room temperature for 2-3 
minutes.  Following  centrifugation  at  12,000  rpm,  at  4
oC  for  15  minutes,  the 
colourless upper phase was collected and transferred to a fresh 1.5ml eppendorf. 
RNA was precipitated by addition of 500µl isopropyl alcohol. Samples were then 
incubated at room temperature for 10 minutes and centrifuged at 12,000 rpm at 
4
oC for 20 minutes. The supernatant was discarded and the RNA was then washed 
by addition of 1ml 75% ethanol, vortexing and centrifugation at 7,500rpm at 4
oC for 
5 minutes. Ethanol was removed and samples were left to dry at room temperature 
for 5-10 minutes. RNA was dissolved in 20µl DNase and RNase free water  by 
incubation for 10 minutes at 55-60
oC. Quality and quantity of RNA was checked 
using a NanoDrop1000 (Labtech, East Sussex, UK.) spectrophotometer.  All RNA 
had a 260/280 ratio of >1.8.  RNA was stored at -80
oC. 
 
 Samuel Peter Hoile   
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2.3.2 cDNA synthesis 
1µg RNA per sample was treated with DNase before synthesis of cDNA by 
reverse  transcription.  1µl  Amplification  grade  DNase  I  (1  unit/µl)  and  1µl  10x 
reaction buffer were added to the RNA and the samples were then incubated at 
room temperature for 15 minutes. 1µl Stop Solution (50mM EDTA) was then added 
to inactivate the DNase I. Samples were then incubated at 70
oC for 10 minutes to 
denature the DNase I. Stop solution and reaction buffer solutions were supplied 
with the Amplification Grade DNase I. 
Following DNase treatment, 1ug RNA was incubated with 1 µl 10mM dNTP 
mix and 1 µl 5µM random nanomers in a total volume of 10µl for 10 minutes at 
70
oC. Following incubation, samples were stored on ice before addition of 1µl M-
MLV  Reverse  Transcriptase  (200  units/µl)  and  2µl  10x  M-MLV  Reverse 
Transcriptase buffer. Samples were incubated at room temperature for 10 minutes, 
followed by incubation at 37
oC for 50 minutes. The reverse transcriptase was then 
denatured by incubation at 90
oC for 10 minutes. cDNA was diluted with DNase and 
RNase free water to a total volume of 200µl and stored at -80
oC. 
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2.3.3 Real time RT-PCR 
Primers for real time RT-PCR 
Real  Time  RT-PCR  primer  sequences  for  cyclophilin,  PPARα,  Acyl-CoA 
oxidase (AOX) and GR were taken from Lillycrop et al
[198]. Primer sequences for 
GR110  and  PEPCK  were  taken  from  Burdge  et  al
[220].  Primer  sequences  for 
carnitine-palmitoyltransferase I (CPT-1) and PPARα were designed and optimised 
as part of this project. Primers were supplied from Biomers (Söflinger, Germany). 
All primers were diluted to a concentration of 100µM upon arrival and stored at -
20
oC. Primer sequences are shown in Table 2.5. 
 
Real time RT-PCR 
cDNA  was  diluted  to  a  total  volume  of  200  µl.  For  each  sample,  12.5µl 
SYBR GREEN, 0.5 µl ROX, 5µl of cDNA, 1µl each of 10µM forward and reverse 
primers and 5.5µl DNAse and RNAse free water was used, giving a total volume of 
25µl. Each cDNA sample was analysed in duplicate. All samples were analysed in 
96 well plates using the Step One Plus PCR machine (Applied Bioscience, CA, 
USA) with two negative controls per plate, where the sample cDNA was replaced 
with 5µl DNAse and RNAse free water. 
Cycle condition were; holding stage of 95
oC for 10 minutes, 40 cycling stages of 
95
oC for 15 seconds, primer specific annealing temperature for 1 minute and 72
oC 
for 1 minute, a melting curve stage of 95
 oC for 15 seconds, 60
 oC for 1 minute and 
a gradual increase to 95
oC, which was held for 15 seconds once reached. 
For each gene of interest the comparative  ʔʔCt method was used to measure 
relative changes in gene expression
[249]. All genes were normalised to cyclophilin 
(CYC),  a  gene  which  is  ubiquitously  expressed  in  a  sample  groups  and  is 
unaffected by the treatments of the studies. 
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Table 2.5 Sequence and annealing temperatures of real time RT-PCR primers for 
analysis of mRNA expression 
 
 
Gene 
 
 
Forward Primer 
(5’  3’) 
 
Reverse Primer 
(3’  5’) 
 
Annealing 
temperature 
/ 
oC 
Cyclophilin 
PPAR α 
CPT-1 
GR110 
PEPCK 
Pfkf/Fru-
2,6-P2 
Glc-6-Pase 
DNMT3a2 
Fads2 
TTGGGTCGCGTCTGCTTCGA 
CGGGTCATACTCGCAGGAAAG 
ACCACTGGCCGAATGTCAAG 
TGACTTCCTTCTCCGTGACA 
AGCTGCATAATGGTCTGG 
QIAGEN Quantitect primer assay 
 
QIAGEN Quantitect primer assay 
QIAGEN Quantitect primer assay 
QIAGEN Quantitect primer assay 
GCCAGGACCTGTATGCTTCA 
TGGCAGCAGTGGAAGAATCG 
AGCGAGTAGCGCATGGTCAT 
GGAGCCTCCTCTGCTGCTTG 
GAACCTGGCGTTGAATGC 
Q T00185395 
 
QT00190610 
QT01783551 
QT00186739 
60 
60 
60 
60 
55 
60 
 
55 
55 
55 
 
 
2.3.3.1 Statistical analysis of real time RT-PCR 
The results of real time RT-PCR analysis were non-parametric and were 
log10 transformed before analysis.  Comparison between groups was by a general 
linear  model  with  generation  and  F0  maternal  diet  as  fixed  factors,  with 
Bonferroni’s post hoc test. 
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2.3.4 DNA extraction 
  DNA from pulverised tissue was extracted using a high salt method. 100mg 
of tissue was incubated overnight at 55
oC in 500µl TNES buffer (Table 2.6) and 
2.5μl  proteinase  K  (>600  mAU/ml).  Samples  were  mixed  by  inverting  the  tube 
several times. 
 
Table 2.6 The composition and concentrations of chemicals used to produce 50ml 
TNES buffer 
STOCK  Volume added  Final concentration 
1M Tris pH 7.5  2.5ml  50mM 
4M NaCl  5ml  400mM 
0.5M EDTA  10ml  100mM 
10% SDS  2.5ml  0.5% 
H2O  31ml   
 
Following  incubation,  500µl  of  3.6M  NaCl  was  added  and  the  samples  were 
shaken vigorously for 20 seconds. Samples were then centrifuged for 10 minutes 
at 13,000 rpm, at room temperature. Supernatant was then removed and placed 
into a new 2.2ml eppendorf. 1ml of cold 100% ethanol (kept at  -20
oC overnight) 
was then added to the samples. Following inversion, samples were stored at -20
oC 
for 10-30 minutes. DNA was visible in ethanol as a white precipitate. DNA was 
spooled from ethanol, using glass pipettes, which had been melted under a butane 
flame to form a hook at the end. Samples were then air dried prior to suspension in 
500μl sterile distilled water. 5μl RNase A (10mg/ml) was added to each sample 
and then incubated at 37
oC for 1-2 hours. 500μl phenol: chloroform 1:1 was then 
added and  the  samples  were  mixed  by  inversion.  Samples  were  centrifuged at 
13,000  rpm  for  15  minutes,  at  room  temperature.  The  aqueous  phase  was 
transferred  to  a  new  1.5ml  eppendorf  containing  1ml  cold  100%  ethanol.  50μl 
sodium acetate (3M, pH 6.8) was then added. Samples were incubated at -20
oC 
for 10 minutes and then DNA was collected by spooling using a glass hook and the 
DNA placed into new 1.5ml eppendorfs. Pellets were air dried and suspended in Samuel Peter Hoile   
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150μl sterile water. Samples were stored at -20
oC. Quality and quantity of DNA 
was  checked  using  a  NanoDrop1000  (Labtech,  East  Sussex,  UK.) 
spectrophotometer.  All DNA had a 260/280 ratio of >1.7. 500ng of each sample 
was run on an Agarose gel to visualise quality of the DNA. 
 
2.3.5 Agarose gel electrophoresis 
  DNA  and PCR  product  were  run  on  Agarose  gels to determine quantity. 
0.8% gels (0.8g Agarose in 100ml 1 X Tris-acetate-EDTA buffer (TAE)) were used 
for genomic DNA, whereas 1.5% gels (1.5g Agarose in 100ml 1 X TAE) were used 
for PCR product.  Agarose was dissolved in TAE by heating in a microwave and 
then cooled for 5 minutes before adding 5μl of 10mg/ml Ethidium Bromide. The gel 
was then poured into the mould, combs inserted, and left to set for 15 minutes. 1 X 
TAE was used as a running buffer. 3μl of Fermentas 1kb ladder was added to one 
well in each row used. Samples were mixed with loading dye (4g Ficol 400 and 
50mg Orange G in 20ml 1 X TAE) prior to loading onto the gel. All gels were run at 
120V until loading dye had reached a suitable distance.  
 
2.3.6 Bisulphite conversion of DNA for analysis by pyrosequencing 
  All DNA samples used for analysis of methylation were treated with sodium 
metabisulphite using the EZ-DNA Methylation Gold™ Kit (Cambridge Bioscience, 
Cambridge,  UK)  according  to  the  manufacturer’s  instructions.  The  kit  produced 
10μl bisulphite treated DNA for each sample. Bisulphite treated DNA was stored at 
-20
oC, and was used within 14 days. 
 
2.3.7 Pre-pyrosequencing PCR of bisulphite converted DNA  
Primers for pre-pyrosequencing PCR 
PCR primer sequences for PEPCK -691bp to -219bp and -215bp to +44bp, 
DNMT3a2 -428bp to -63bp and -315bp to -110bp and Fads2 -766bp to -473bp, -
499bp to -318bp and -139bp to +165bp , where 0bp refers to the transcription start 
site, can be found in table 2.7. Primer sequences were designed using PSQ Assay 
Design software (Biotage, Uppsala, Sweden.) Primers were supplied from Biomers Samuel Peter Hoile   
92 
 
(Söflinger, Germany). All primers were diluted to a concentration of 100µM upon 
arrival and stored at -20
oC. 
 
Pre-pyrosequencing PCR 
Bisulphite converted DNA was used as a template for amplification by the 
polymerase chain reaction (PCR.) For each sample, 0.25µl Taq DNA Polymerase 
Hot Start, 10µl Q solution, 1µl 10mM DNTP mix, 5µl 10 X reaction buffer, 1µl each 
of 10µM forward and reverse primers, 2µl bisulphite converted DNA and 29.75µl 
DNAse and RNAse free water was used, giving a total volume of 50µl for each 
reaction set up. All samples were measured in 0.5ml eppendorfs using the Thermo 
Scientific  Thermo  Hybaid  PCR  express  Thermal  Cycler  (Fisher  Scientific, 
Leicestershire,  UK).    Each  master  mix  preparation  including  a  negative  control 
where the sample DNA was replaced with 2µl DNAse and RNAse free water. 
Cycle  condition  were;  holding  stage  of  95
oC  for  15  minutes,  45  cycling 
stages of 94
oC for 30 seconds, an amplicon specific annealing temperature (shown 
in table 2.7) for 30 seconds and 72
oC for 1 minute, followed by a final stage of 
72
oC for 10 minutes. The amplicon specific annealing temperatures are shown in 
Table 2.7.All PCR products were run on a 1.5% Agarose gel to determine both 
quality and size of product. 
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Table  2.7  Sequences  and  annealing  temperatures  of  PCR  Primers  for 
amplification of PEPCK, DNMT3a2 and Fads2 promoter regions. 
 
 
Bases 
covered/bp 
 
 
Forward Primer 
(5’  3’) 
 
Reverse Primer 
(3’  5’) 
 
Annealing 
temperature 
/ 
oC 
PEPCK 
-658 to -405 
 
-417 to -56 
 
-373 to -44 
AGGGGTTAGTATGTATATAGAGT
GATT 
GTGGTGTTTTGATAATTAGTAGT
GATT 
GTTAGTAGTATATGAAGTTTAAG
A 
ATCAAAACACCACAACTATAAA
ATATC 
CCCCTCAACTAAACCTAAAAAC
TC 
CCCCTATTAACCAAAAATATAT
TCC 
51 
 
51 
 
49 
 
DNMT3a2 
-428 to -63 
 
-131 to +56 
TTGATGTTTTTTTTTGGTGTGTTT 
 
TGGTGAGTTGTTTGGGTTGTTA 
CAAAAACCTTCAACCCATCAAT
AA 
CCTAACTTTCCTCCACAACATT
CA 
50 
 
55 
Fads2 
-766 to -473 
 
-499 to -318 
 
-139 to +165 
 
TTGTGTATTTTTTGATGTGGTTAG
ATT 
TTTTAGGTGTTAGGGATTGAGT 
 
TTGTTATTGAGGAGTGGGAAGTT 
CCCAACTCAATCCCTAACACCT
A 
ACTCCTAAACTAAATATCCTTC
AATATACA 
CCCCTACCATCCAACCTCAT 
53 
 
51 
 
51 
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2.3.8 Pyrosequencing 
Primers for pyrosequencing 
PEPCK, DNMT3a2 and Fads2 primer sequences were designed using PSQ 
Assay Design software (Biotage, Uppsala, Sweden.) The location of the primers 
and the area that they cover is shown in Figure 2.8. The positioning of the primers 
is shown in Figures 2.3, 2.4 and 2.5 for PEPCK, DNMT3a2 and fads2, respectively. 
Primers were supplied from Biomers (Söflinger, Germany). All primers were diluted 
to a concentration of 100µM upon arrival and stored at -20
oC. 
 
Table 2.8 Sequences of PEPCK, DNMT3a2 and Fads2 sequencing primers for use in 
pyrosequencing of the PEPCK, DNMT3a2 and Fads2 promoter regions. 
 
Start 
location 
 
 
Sequencing Primer 
(5’  3’) 
 
CpGs covered 
 
Volume  of  PCR  product 
added  to  each 
pyrosequencing 
reaction/µl 
PEPCK 
-637 
-555 
-251 
-170 
GTGATTATTTTATATTAGGTATTG 
AGAGGATTTAGTAGATATTTAGTG 
TAAATATTAAAAAACCTCAAACCC 
TTATTATTTTTTTAAAGTTTATTG 
-606 
-508, -440 
-248, -218 
-129, -100, -90, -81 
10 
5 
5 
5 
DNMT3a2 
-228 
-22 
GGTTAGAGGATAGATATTGG 
CATCTTAACCCTCCC 
-207, -190 
-56, -39 
10 
10 
Fads2 
-748 
-646 
-421 
-112 
GGTTAGATTTGAGTGTG 
AAATGAAGTGTAATTTATGTTT 
TGAGTTTTATTTTTTTATTGATAAT 
ATTTGGTTTTTGAGTAGATA 
-722, -711, -678 
-623, -608, -585 
-394 
-84, -76, -65, -31 
5 
5 
10 
5 
 
Prior to pyrosequencing, both amplicons (-661bp to -219bp and -215 bp +44bp) of 
the PEPCK promoter were amplified using primers listed in table 2.7. The PCR and 
sequencing primer binding locations for PEPCK, DNMT3a2 and fads2 are shown in 
figure 2.3, figure 2.4 and figure 2.5, respectively. 
All solutions were removed from -4
oC storage, and left on the workbench in order 
to  reach  room  temperature.  Each  sequencing  primer  was  initially  optimised  to Samuel Peter Hoile   
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either 5µl or 10µl PCR product per reaction. The volumes of PCR product added 
are listed in table 2.8. The optimised volume of PCR product was added and made 
up to 40µl with water in a 96-well PCR plate. 2µl streptavidin sepharose beads and 
38µl binding buffer were added to each well, the plate sealed and shaken on a 
plate  shaker  for  5  minutes.  A  master  mix  containing  0.5µl  sequencing  primer 
(10µM) and 11.5µl annealing buffer / sample, was prepared. 12µl of the mix was 
added to each well of a PSQ HS 96 well plate. The plate was then placed in the 
holding  bay  of  the PyroMark  Q96  Vacuum Prep Workstation  (Qiagen,  Crawley, 
UK). The beads from the 96- well PCR well plate were captured onto the vacuum 
prep tool, ensuring all solution was removed. The vacuum prep tool was then used 
to wash the beads in 70% ethanol and then separate the strands in denaturation 
solution. The beads were then washed in wash solution (Qiagen, Crawley, UK), the 
vacuum  switched  off  and  the  beads  released  into  a  PSQ  HS  96  well  plate. 
Sequencing primers were then annealed to samples by placing the PSQ plate on a 
preheated heating plate and incubated at 80
oC for exactly 2 minutes. Following 
incubation, the plate was removed from the block and left to cool for at least 5 
minutes.  As  instructed  by  the  Pyrosequencer  software,  the  required  amount  of 
nucleotide, enzyme and substrate were added to each nucleotide dispensing tip 
(NDT) ensuring no bubbles were present in tips. Tips were inserted into the holder 
in the Biotage PyroMark MD Pyrosequencer (Biotage, AB, Kungsgatan, Sweden), 
and a tip test was performed to check the tips were in working condition.  If a tip 
failed  more  than  3  times,  it  was  not  used.  Once  all  tips  were  confirmed  to  be 
successful, the PSQ plate was inserted into the Pyrosequencer and the samples 
were then analysed. A quality control was included in the pyrosequencing assay to 
check 100% bisulphite conversion of DNA. 
 
2.3.8.1 Statistical analysis of methylation data 
Comparison between groups was by a general linear model, with generation 
and F0 maternal diet as fixed factors, with Bonferroni’s post hoc test. 
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GATATGTAATTTTTTTGGTTTTTATTAGTTAGTTGGATTTGTTTAGTATTTTTTTTGTTT -740 
 
 
TAGTTTTTTAGTTTGTATTTAGGGTTGTTATAGTTTTATTTTAGGTAGTAGTAATGAATG -680 
 
                GTGATTATTTTATATT 
AGTTGATATAAAATATTTAGAGTAGGGGTTAGTATGTATATAGAGTGATTATTTTATATT -620 
 
AGGTATTG     -606 
AGGTATTGTTTTTTYGGAATGAAGTTTATAATTATTTTTTTTTTTGTAGTTTATTTTGGG -560 
 
  AGAGGATTTAGTAGATATTTAGTG           -508 
GTGGTTAGAGGATTTAGTAGATATTTAGTGGGGTAATATATTTTAGTTAATTYGGTTGTT -500 
 
      -477 
GTAGATTTTGTTTAGAAGTTTTAYGTTTTAGAGTTGAATTTTTTTTTTATGATTTTTGGT -440 
 
-440 
YGTGGGAGTGATATTTTATAGTTGTGGTGTTTTGATAATTAGTAGTTATTGGTATATAAA -380 
 
           -347 -342      
ATGTGTAGTTAGTAGTATATGAAGTTTAAGAGGYGTTTYGGTTAGTTTTGTTTTTGATTT -320 
 
              -271 
TTATTTGATAATTAAGGTAAGAGTTTATAGTTTGTATTAGTAATAGTTAYGGTTAAAGTT -260 
 
       -248         -218GGGTTTGAGGTTTTT 
TAGTTAATTAAAYGTTGTGTAAGGATTTAATTATGGTTGATAYGGGGGTTTGAGGTTTTT -200  
 
TAATATTTA          TTATTATTTTTTTAAAGTTTATTG 
TAATATTTATTAATAATAGTAAGTTTAATTATTATTTTTTTAAAGTTTATTGTGTTAGGT -140 
 
      -129         -100      -90     -81 
TAGTTTTAAATYGTGTTGATTATGGTTATGATTTAAAGGTYGGTTTTTTAYGTTAGAGGY -80 
 
                      -22 
GAGTTTTTAGGTTTAGTTGAGGGGTAGGGTTGTTTTTTTTTTTGTATATTATTTAAAGYG -20 
 
           +2 
AGGAGGGTTAGTTATTAAGTAYGGTTGGTTTTTTTTTTGGGAATATATTTTTGGTTAATA +40 
 
    +50+53  +58 
GGGGAAATTYGGYGAGAYGTTTTGAGATTTTTGATTTAGATTTTTTAAAAGGAGGAAGAA +100 
 
 
AGGTAGGTAGGGTTATTTTATTTTTTTTTTTAAAAGTATTATTGAGGGGTTTATTTATAG +160 
 
 
TTTTTGTTTTGATAATTAAGGTTTTTTAGTTATGTGTAATTTATGTAAAGTTTATAGAAG +220 
Figure 2.3 Diagram showing the PEPCK promoter with primer and CpG locations.  Diagram 
shows -830bp to +220bp, where 0bp is the transcription start site. A red highlight represents the 
transcription  start  site,  a  yellow  highlight  represents  CpG  dinucleotides,  a  green  highlight 
represents  PCR  primers,  a  dark  green  highlight  represents  the  overlap  region  of  primer 
sequences and a blue highlight represents sequencing primers. Blue text represents the area 
covered by the sequencing primers and underlined text represents exon 1. Samuel Peter Hoile   
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Figure  2.4  Diagram  showing  the  DNMT3a2  promoter  with  primer  and  CpG  locations.  
Diagram  shows  -397bp  to  +88bp,  where  0bp  is  the  transcription  start  site.  A  red  highlight 
represents the transcription start site, a yellow highlight represents CpG dinucleotides, a green 
highlight represents PCR primers and a blue highlight represents sequencing primers. Blue text 
represents the area covered by the sequencing primers and underlined text represents exon 1. 
 
GATAGTTGTATTGTTTTTATTGTATAATTATAGTGTATTTATATATATAAAGTAAATTTT  -337 
                  -281 
AAAAAAAGAAAAGAAATAGAGGTAGGAGGATTGAGAGTTTAGGATTATTTTTAGYGATAT  -277 
             
                GGTTAGAGGATAGA 
AGTAAGTTTGAGATTAGTTTGGATTATGTGAGATTTGTTTTTTAAAGGTTAGAGGATAGA  -217 
 
TATTGG -207    -190 
TATTGGGTYGAGAGGGAGGTTTTTTYGGAGGTAGGAAGGAAAGTTGAGTAGGTTTTTTTT  -157 
      
TAGTTTTAGTTGTTTTTATTTATATGGTGAGTTGTTTGGGTTGTTAGAGTAAAGTTA  -97 
 
            -56             -39G 
TTTTTTTTAGATTATTGATGGGTTGAAGGTTTTTGAGTTTTAYGGAGTTTTGTTTATTTYG -37 
 
GGAGGGGTTAAGATG            
GGAGGGGTTAAGATGATTTTTGTTTTTATTTTTTTAGGTTGAGAAGAAAGTTAAGGTGA    +22 
 
TTGTAGTAATGAATGTTGTGGAGGAAAGTTAGGTTTTTGGGGAGTTTTAGAAGGTGGA    +88 
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Figure 2.5 Diagram showing the fads2 promoter with primer and CpG locations.  Diagram 
shows -800bp to +220bp, where 0bp is the transcription start site. A red highlight represents the 
transcription  start  site,  a  yellow  highlight  represents  CpG  dinucleotides,  a  green  highlight 
represents  PCR  primers,  a  dark  green  highlight  represents  the  overlap  region  of  primer 
sequences and a blue highlight represents sequencing primers. Blue  text represents the area 
covered by the sequencing primers and underlined text represents exon 1. 
                        GGTTAGAT 
TTTTATGTGGTGATTATTTATTTTTTTTATTTTTTTGTGTATTTTTTGATGTGGTTAGAT  -740 
 
TTGAGTGT    -722        -711 
TTGAGTGTGTTTTTGTTTYGTTTTTGGTAYGAGAGATATTAAAATGTAGAATATTATAGT  -680 
 
 -678           AAATGAAGTGTAATTTATGTTT-623 
AAYGTTAGGGAAAGTTTGTAAATTTATGAGAATAAAATGAAGTGTAATTTATGTTTTYGG  -620 
    -608        -585 
TATTAGTTTAATTTTYGAAATTTTGTGTTAGGTTTYGTAGGAATTTTTTTATATGATTTT  -560 
 
ATGTTATTTTTTTTGTTGTTGTTTTATGATATTTAAATATATTTTTTAGGTTGTAGTTAT  -500 
 
TTTTTAGGTGTTAGGGATTGAGTTGGGYGTTTTATATATGTTGGGTAAATATTTTTATTA  -440 
       
         TGAGTTTTATTTTTTTATTGATAAT -394 
TTGAGTTAAATTTTTTTTTTGAGTTTTATTTTTTTATTGATAATTTYGATTTTGTGGAAA  -380 
 
AGGATATTTTTGGAGTGGTGGGTGGTATAGTTTGTATATTGAAGGATATTTAGTTTAGGA  -320 
 
GTAGGTTAGGGGTGTTTTTTTTGAGTTTTGTGTTTATTTGTTTTTTTTGGAGATTTATTT  -260 
 
GTTTATAAATTTTTGATTAGTTTAGTAGGTTTGGTGTTAGTTTAGAGGTTTAGGATGGTT  -200 
 
ATGGTTTGTTATTAGAGTTTTGTATTGGGGATATGTTTTGTGGTGGAGTTTGGAGTAAGT  -140 
         
           ATTTGGTTTTTGAGTAGATA        -84 
ATTTGTTATTGAGGAGTGGGAAGTTTTATTTGGTTTTTGAGTAGATATTGGATTTGYGGT  -80 
   -76        -65          -31 
AAAAYGTTTTTTTTTYGAGAGTGGGAGGAGTTAGTATAGGTTTGGGGTTYGGTTTTAGTA  -20 
 
GTTTGTTTTTTTGTTTTTTAGGATGTTTTTYGTGTTTTTTATTTGGATTTGGATTTYGTG  +40 
 
GGTAAGTTTTTGAAGTTTTTGTTGATTGGTGAGTTGGTTTTAGAGGAGTTTAGTTTGGAT  +100 
 
YGGGGTAAAAGYGTGAGTGGGAYGTGTAATATTGATGGGGGTGGGATGAGGTTGGATGGT  +160 
 
AGGGGTGAGAGTATTTTTTTTTTAGAATTTTATTGTTAGGGTTGTGTTAGGAGAGTTTYG  +220 
 Samuel Peter Hoile   
99 
 
2.3.9 Promoter cloning 
 
2.3.9.1 Promoter amplification 
  Promoter regions of the PEPCK, DNMT3a2 and fads2 genes were amplified 
using RTPCR. Restriction sites for XhoI and HindII were added to the forward and 
reverse primers, respectively, in order to provide sticky ends for insertion into the 
pGl3 vector. The sequences of primers used for each of the amplicons are shown 
in table 2.9. Pfu Proof reading Taq polymerase was used to ensure minimal error 
when replication of the promoter regions. For each gene, a minimum of 1407bp 
upstream  and  a  section  of  the  first  exon  were  amplified.  Briefly,  0.5µl  Pfu  Taq 
polymerase 1µl 10mM DNTPs, 5µl 10 x buffer, 1µl each of 10mM forward and 
reverse primers, 40.5µl DNAse free water and 50ng template DNA was used per 
sample. Samples were run on a thermal cycler G-Storm PCR machine using the 
following  steps.  95
oC  for  2  minutes,  then  40  cycles  of  95
oC  for  1  minute,  an 
amplicon-specific  annealing  temperature  for  30  seconds  and  72
oC  for  1min/kb 
product. Quality and quantity of PCR product was assessed on an agarose gel. 
PCR product was gel extracted, to ensure purity, using a QIAquick gel extraction 
kit (Qiagen, Crawley, West Sussex, UK), according to manufacturer’s instructions. 
 
Table 2.9 Promoter PCR primer sequences 
Gene  Direction  Sequence  Annealing 
temperature 
PEPCK 
-2400bp  to 
+100bp 
Forward  ATCTCGAGGCGGCTTCACATTCATAAAC
A  58.9
oC 
Reverse  ATAAGCTTCTGCCTACCTTTCTTCCTC 
DNMT3a2 
-1407bp  to 
+172bp 
Forward  ATCTCGAGAACCCCCTCTCCCATCCC 
58.9
oC 
Reverse  ATAAGCTTCCCCAGCATCAGCCCCTA 
Fads2 
-1038bp  to 
+318bp 
Forward  ATCTCGAGCTCTGGTTCTTTTTCCTGGT
A  58.9
oC 
Reverse  ATAAGCTTAGAGGATGCTGCTAACTATC
ACCC 
 
 
 
 
 
 Samuel Peter Hoile   
100 
 
2.3.9.2 Tailing reaction 
  Tailing reactions are used to add a string of adenosine nucleotides to the 
end of Pfu Taq PCR product, in order to allow binding of the product to the string of 
thymines of the P-GEMT vector. The reaction set up is as follows. 8µl of 5 x buffer, 
0.4µl of 25 mM DNTPs, 0.5µl GoTaq DNA polymerase and 31.9µl of template DNA 
and  distilled  H2O  were  used  per  sample.  The  tube  was  heated  to  74
oC for  30 
minutes, and the product was then cleaned using the QIAquick PCR clean up kit 
(Qiagen, Crawley, West Sussex, UK). 
 
2.3.9.3 Ligation 
  pGEM-T or cut pGl3 vectors and PEPCK, DNMT3a2 and fads2 promoter 
PCR  products  were  ligated  using  1µl  T4  DNA  ligase  in  a  10µl  reaction.  The 
promoter DNA and vector were ligated overnight at 4
oC. 
   
2.3.9.4 Luria Broth and LB agar plates 
  Luria Broth (LB) solution was made by mixing 20g LB broth powder to 1 litre 
of double distilled H2O. The solution was autoclaved before use. LB agar plates 
were  made  by  adding  1.5g  agar  powder  to  100ml  LB  broth.  The  mixture  was 
sterilised using an autoclave, to sterilise the solution and dissolve the agar. Once 
cooled to around 30
oC, filter sterilised ampicillin was added at a final concentration 
of  100μg/ml,  using  a  sterile  technique.  If  the  vector  used  was  pGEM-T,  IPTG 
(isopropyl  β-D-1  thiogalactopyranoside),  which  induces  the  transcription  of  β-
galactosidase  and  X-Gal  (5-bromo-4-chloro-3-indolyl-  beta-D-galactopyranoside), 
an organic compound consisting of galactose linked to a substituted indole, which 
is broken down  by  β-galactosidase,  giving  an  insoluble blue-product,  were  also 
added to the LB agar, at final concentrations of 0.02% and 400μM, respectively, 
using a sterile technique. LB agar was poured into 9ml petri dishes, with 25ml used 
per dish, using a sterile technique and left to set on the work bench. LB agar plates 
were stored at 4
oC prior to use. 
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2.3.9.5 Transformation and screening 
  The amplified promoter regions were first cloned into the p-GEMT vector to 
increase the number of copies of the promoter. Once successfully cloned into the 
pGEMT vector, the promoter region was cut out and ligated into cut pGl3 vector. 
Diagrams  of  the  pGEMT  and  pGl3  vector  are  shown  in  Figures  2.6  and  2.7, 
respectively.  2µl  of  PCR  product  was  added  to  50µl  JM109  competent  cells 
(Promega, Southampton, UK) in pre-chilled eppendorf tubes and placed on ice for 
20 minutes. The DNA/cell mixture was then subjected to heat shock for 45 seconds 
at 42
oC, to allow the cells to take up the DNA. The cells were then placed on ice for 
2 minutes. 450µl sterile LB was then added to the cells and incubated at 37
oC for 
30-60  minutes  with  shaking.  Cells  were  then  centrifuged  for  5  minutes  at 
10,000rpm  and  400µl  of  supernatant  discarded.  The  remaining  100µl  and  cell 
pellet were then mixed by pipetting and spread onto an LB Agar plate, containing 
ampicillin, X-Gal and IPTG. The presence of ampicilin enables transformants to be 
distinguished from non-transformants, as these are the only cells to contain the 
Amp
r gene  Untransformed cells are unable to survive in the presence of ampicilin, 
suggesting all present colonies represent transformed cells. Plates were incubated 
at 37
oC overnight and then sealed and stored at 4
oC. 
  For  pGEMT  transformations,  presence  of  X-Gal  and  IPTG  allowed  blue-
white  screening  of  colonies.  The  pGEMT  vector  contains  the  α-peptide  coding 
region  of  the  enzyme  β-galactosidase.  Insertional  inactivation  of  the  α-peptide 
leads  to  a  decrease  in  the  breakdown  of β-galactosides  into  monosaccharides, 
leading to blue colonies on the LB agar plate. The pGl3 vector does not contain the 
β-galactosidase gene, so blue-white screening is not utilised, ampicillin screening 
however, is used. 
  The pGl3 basic vector contains a modified gene for firefly luciferase, without 
a functional prompter region. Presence of the Amp
r gene allows transformants to 
be identified. Firefly luciferase catalyses the conversion of luciferin to oxyluciferin 
which  generates  a  light  signal.  Insertion  of  the  PEPCK,  DNMT3a2  or  fads2 
regulatory DNA into the multiple cloning region of the pGl3 basic vector allows its 
transcriptional activity to be assessed. Samuel Peter Hoile   
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Figure 2.6 Diagram of the pGEMT vector map and sequence reference points taken from 
the Promega pGEMT protocol (Promega, Southampton, UK) 
Figure 2.7 Diagram of the pGl3 vector map and sequence reference points taken from 
the Promega pGEMT protocol (Promega, Southampton, UK) Samuel Peter Hoile   
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2.3.9.6 Restriction digests 
  Once sufficient quantity of the transformed pGEMT vector was obtained, the 
PEPCK,  DNMT3a2  and  fads2  promoters  were  cut  using  XhoI  and  HindIII 
(DNMT3a2 and fads2) or XhoI and BglII (PEPCK). The promoter regions were then 
transformed into pGl3 vectors, which were cut with the same respective restriction 
enzymes, in order to provide sticky ends for ligation. The vectors were cut using 
the following technique. 5µg of the transformed pGEMT or stock pGl3 basic vector 
was digested with 25 units of either XhoI and HindIII or XhoI and BglII in a total 
volume of 50µl for 60 minutes at 37
oC. Completion of the digest was confirmed by 
running digest product on an agarose gel. The band was cut from the gel and 
extracted using the QIAquick gel extraction kit (Qiagen, Crawley, West Sussex, 
UK).  Confirmation  of  transformation  was  following  restriction  mapping,  which 
involved  digesting  transformed  vectors  with  selected  restriction  enzymes  and 
clarifying promoter presence by size of products. The list of restriction enzymes 
used is shown in table 2.10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Samuel Peter Hoile   
104 
 
Table 2.10 Restriction enzymes used to confirm transfection clones 
Input  Restriction  Enzymes 
used 
Number  of  products 
expected 
PEPCK  XhoI + BglII  1 
PEPCK + pGEMT  Cla 
DraI 
XbaI 
0 
5 
1 
PEPCK + pGl3     
DNMT3a2  XhoI + HindIII  1 
DNMT3a2 + pGEMT  BglII 
SalI 
NcoI 
0 
1 
2 
DNMT3a2 + pGl3  NcoI 
ApoI 
2 
6 
Fads2  XhoI + HindIII  1 
Fads2 + pGEMT  SalI 
ApoI 
0 
5 
Fads2 + pGl3  ApoI  6 
 
 
2.3.9.7 Sequencing   
  Samples were sent for external sequencing to GATC biotech, London, UK. 
In  house  pGl3  primers shown  in  table  2.11  were  used for forward  and  reverse 
reads of sequences. 
 
Table 2.11 Primer sequences for pGl3 sequencing 
Direction  Sequence 
Forward  CTAGCAAAATTGTCCC 
Reverse  CTTTATGTTTCTTCCA 
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2.3.9.8 Single site mutagenesis of the PEPCK, DNMT3a2 and fads2 promoters 
  In order to understand the role of methylation at specific CpG sites in the 
PEPCK,  DNMT3a2  and  fads2  promoters,  cytosine  to  adenosine  single  point 
mutations were introduced into the cloned promoters. Only specific CpG sites were 
mutated, where significant differences in methylation were shown and the region 
has the potential for a role in transcriptional regulation. The quick-change single 
point  mutagenesis  primers  were  designed  using  online  software  from  Agilent 
technologies (Cheshire, UK). Cytosine to adenosine mutations were selected for 
each  primer  pair  as  these  were  the  most  energy  efficient.  The  sequences  of 
mutagenesis primers and the mutated cytosines are shown in Table 2.12. 
 
Table 2.11 Sequences of mutagenesis primers and CpGs targeted 
Gene  – 
CpG 
targeted 
Forward Sequence 5’ 3’  Reverse Sequence 5’  3’ 
PEPCK 
CpG -248 
GTCACGGTCAAAGTTTAGTCAATC
AAAAGTTGTGTAAGGACTC 
GAGTCCTTACACAACTTTTGATTGACT
AAACTTTGACCGTGAC 
PEPCK 
CpG -90 
GGCCGGCCCCTTAAGTCAGAGGC
GAG 
CTCGCCTCTGACTTAAGGGGCCGGCC 
DNMT3a2 
CpG -56 
TGAAGGTCCCTGAGTCTCAAGGAG
CCTTGC 
GCAAGGCTCCTTGAGACTCAGGGACC
TTCA 
DNMT3a2 
CpG -39 
GGAGCCTTGCTCATTCAGGGAGG
GGTCA 
TGACCCCTCCCTGAATGAGCAAGGCT
CC 
Fads2 
CpG -394 
TGAGTCTTATCTCTTCACTGATAAT
TTAGACCTTGTGGAAAAGG 
CCTTTTCCACAAGGTCTAAATTATCAG
TGAAGAGATAAGACTCA 
 
SequalPrep (Invitrogen, Paisley, UK) was used to amplify the mutated pGl3 vector 
containing the PEPCK, DNMT3a2 or fads2 promoter. In a 20μl reaction, 2μl of 10X 
reaction buffer. 0.4μl DMSO, 1μl SequelPrep 10X Enhancer A, 15μl distilled H2O, 
0.5μl  10mM  forward  and  reverse  primers  (each)  and  0.36μl  SequelPrep  Long 
Polymerase were used. The reaction condition were as follows, 94
oC for 2 minutes, 
12 cycles of 94
oC for 10 seconds, 55
oC for 30 seconds and 68
oC for 1 minute/kb, 
followed by 72
oC for 5 minutes. The quantity and quality of the PCR product was Samuel Peter Hoile   
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established  using  an  Agarose  gel.  Samples  were  incubated  with  the  restriction 
enzyme DpnI for 1 hour at 37
oC, in order to remove the non-mutated supercoiled, 
input  dsDNA. The  digested mutated  vectors were  then  transformed  into  JM109 
cells using the previously described technique, in order increase copy number. 
 
2.3.9.9 Transfection 
  Rat hepatocyte cells (CC-1) were transfected with the wild type or mutated 
forms of the fads2 promoter using fuGENE HD Transfection Reagent (Promega, 
Southampton, UK), according to manufacturer’s instructions. Briefly, 2μg of fads2 
in  pGl3  plasmid  DNA,  2μg  of  Renilla  luciferase  plasmid  DNA  and  12μl  of 
transfection reagent were made up in 300μl DMEM, containing 5% serum. After 
incubation at room temperature for 15 minutes, the media containing the plasmid 
DNA and transfection reagent was added to washed cells and cells were incubated 
at  37
oC,  5%  CO2  for  4  hours.  After  this  period  the  media  was  removed  and 
treatment media was added. The treatment groups used are 
-  0pM 17α-ethinylestradiol 
-  70pM 17α-ethinylestradiol 
-  700pM 17α-ethinylestradiol 
Cells were left in the treatment for 24 hours. 6 wells were used per treatment group 
per promoter type. 
17α-ethinylestradiol treatments were made using the following steps. 
10mls  of  7μM  17α-ethinylestradiol  was  made  up  by  dissolving  20.74mg  17α-
ethinylestradiol in 10ml ethanol. Using one in ten dilutions in upH2O the following 
concentrations of 17α-ethinylestradiol were made, 70nM and 7nM. 100μl of 70nM 
17α-ethinylestradiol was added to 9.9ml media (in dish) to get 10mls of 700pM 
17α-ethinylestradiol. 100μl of 70nM 17α-ethinylestradiol was added to 9.9ml media 
(in dish) to get 10mls of 70pM 17α-ethinylestradiol. 
2.3.9.10 Luminescence 
  Following incubation in the treatment media, media was removed from wells 
and  cells  were  washed  with  PBS.  The  Dual-Luciferase  Reporter  Assay  kit 
(Promega, Southampton, UK) was used to determine transcriptional activity. 1X 
Passive  Lysis  Buffer  (PLB)  was  made  by  diluting  2.5mls  of  5X  PLB  in  10mls Samuel Peter Hoile   
107 
 
upH2O. 250μl 1X PLB was added to each well and cells were lysed using a rubber 
policeman. To ensure successful lysis, cells in PLB were subjected to two rounds 
of freeze thawing using dry ice. 100μl of luciferase assay reagent (LAR II). The TD-
20/20  Turner  Designs  Luminometer  (Tuner  Designs,  CA,  USA)  was  then 
programmed for use. 20μl of lysed cells in PLB was then transferred to the 2.2ml 
eppendorf containing 100μl LAR II and mixed by pipetting, ensuring no bubbles 
were  created.  The  firefly  luciferase  activity  across  10  seconds,  following  a  2 
second delay, was then measured and recorded three times. Once all samples had 
been measured, 100μl of Stop and Glo Reagent was added to each sample and 
mixed by pipetting. The renilla luciferase activity was then measured and recorded 
in triplicate for each sample and the tube discarded. 
The  corrected  quantification  was  measured  by  dividing  the  mean  firefly 
luminometer  value  by  the  mean  renilla  luciferase  value,  for  each  sample 
separately. 
 
2.3.9.10.1 Statistical analysis of luminescence data 
The results of transformation luminescence analysis between groups was by a one 
way analysis of variance (ANOVA) with 17α-ethinylestradiol concentration as a 
fixed factor, with Bonferroni’s post hoc test. 
 
2.3.11.1 Preparation of a nuclear extract 
     Nuclear  extracts  were  prepared  from  CC-1  cells.  Composition  of  the  buffers 
used are shown in table 2.12. Cells were suspended in 800µl of buffer A, to which 
5µl PMSF (phenylmethanesulfonylfluoride, a serine protease inhibitor)  and 2.5µl 
LP (leupeptin, a cysteine, serine and threonine protease inhibitor) was added prior 
to use and incubated on ice for 10 minutes. 50µl of 10% (v/v) NP40 (Tergitol-type 
NP-40,  a  detergent  used  to  break  the  cytoplasmic  membrane)  was  added  and 
samples were vortexed for 10 seconds, centrifuged at 12,000rpm for 30 seconds 
and  the  supernatant  containing  the  cytoplasm  was  removed.  The  pellet  was 
resuspended in 30 -50µl of buffer C, to which 10µl PMSF was added prior to use. 
Samples were incubated on ice for 15 – 30 minutes, spun at 13,000 rpm at 4
oC for 
5 minutes. The supernatant, containing the nuclear extract was stored at -80
oC. Samuel Peter Hoile   
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The nuclear extract was quantified using a Pierce BCA Protein Assay Kit (Thermo 
Scientific, Illinois, USA). 
 
Table 2.12 Composition of nuclear extract buffers A and C 
Chemical added  Volume added  Final concentration 
Buffer A / 10 ml 
1M HEPES pH 7.9  100µl  10mM 
1M KCl  100µl  10mM 
0.5M EDTA  2µl  0.1mM 
1M DTT  10µl  1mM 
H2O  9,773µl   
Buffer C / 10ml 
1M HEPES pH 7.9  200µl  20mM 
4M NaCl  1ml  0.4M 
0.5M EDTA  20µl  1mM 
1M DTT  10µl  1mM 
 
 
2.3.11.2 Annealing oligonucleotides 
  Oligonucleotides  covering  selected  CpGs  were  designed  to  measure 
transcription factor binding across the promoter regions of the PEPCK, DNMT3a2 
and fads2 genes. Table 2.13 shows the sequences of primers used, and the CpGs 
which they cover. In order to measure the binding of transcription factors to cell 
extracts  from  a  rat  hepatic  cell  line,  CC-1  cells,  the  complementary 
oligonucleotides  were  first  annealed,  using  the  following  method.  Initial 
denaturation of the oligonucleotides ensured secondary structures were removed 
and allowed the complimentary oligonucleotides to hybridize. 
Oligonucleotides  were  mixed  at  a  molar  ratio  of  1:1,  in  1.5ml  eppendorfs.  The 
oligonucleotides mixture was diluted to a final concentration of 1pmol/µl with 10mM 
Tris, 1mM EDTA and 50mM NaCl. The samples were heated in a water bath for 5 
minutes at 95
oC. The water bath was then switched off and left to cool to room Samuel Peter Hoile   
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temperature overnight, allowing annealing of the oligonucleotides. The annealed 
oligonucleotides were stored at -20
oC. 
 
Table 2.13 Sequences of complimentary primers used in EMSAs. 
Gene/ CpG 
covered 
Forward  Reverse 
PEPCK / -248 
AGTCAATCAAACGTTGTGTAAGGAC
TCAACTA 
TAGTTGAGTCCTTACACAACGTTTGATT
GACT 
PEPCK / -90 
CCAAAGGCCGGCCCCTTACGTCAG
AGGCGAGC 
GCTCGCCTCTGACGTAAGGGGCCGGC
CTTTGG 
Fads2 / -394 
ATCTCTTCACTGATAATTTCGACCTT
GTGGAAA 
TTTCCACAAGGTCGAAATTATCAGTGAA
GAGAT 
 
2.3.11.3 Electromobility Shift Assays 
    Binding of nuclear extract to specific DNA sequences was measured using 
the LightShift Chemiluminescent Electro Mobility Shift Assay (EMSA) Kit (Fisher, 
Leicestershire, UK), according to manufacturer’s instructions. Gels for EMSA were 
made  using  3.125ml 40%  Acrylamide,  1.25ml  10x  TBE,  20.6ml ultra-pure  H2O, 
250µl  10%  ammonium  persulfate  (APS)  and  25µl  Tetramethylethylenediamine 
(TEMED). Gels were set in electrophoresis tanks and sealed prior to setting. Once 
set, the inside of the gel electrophoresis tank was filled with 0.5x TBE to cover the 
gel by a few millimetres and the outside of the gel tank was filled to a level above 
the bottom of the gel wells, in order to reduce heat during running of the gel. Prior 
to addition of sample, the wells were flushed and the gel was run at 100V for 30 – 
60  minutes.  The  composition  of  the  binding  reactions  are  shown  in  table  2.14. 
Components of the binding reactions were thawed and stored on ice prior to use. 
Following addition of extract the tubes were placed on ice for 5 minutes, then again 
for  20  minutes  following  addition  of  DNA  probes.  Before  addition  of  binding 
reactions to the gel, 5µl of the loading buffer was added to each tube and mixed via 
pipetting. 
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Table 2.14 Composition of binding reactions in EMSA experiments. 
  1  2  3  4  5 
upH2O  12  8.7  3.7  2  0 
10X Binding Buffer  2  2  2  2  2 
Poly dicc (1µg/µl)  1  1  1  1  1 
50% Glycerol  1  1  1  1  1 
100mM MgCl  1  1  1  1  1 
1% NP40  1  1  1  1  1 
Unlabelled DNA (1pmol.µl)  0  0  0  0  2 
Nuclear Extract (0.6µg/µl)  0  3.3  8.3  10  10 
Biotin labelled DNA (10fmol/µl)  2  2  2  2  2 
 
 
 
 
The gels were run at 100V for about 45 minutes (until the bromophenol blue dye 
had migrated ¾ down the length of the gel). 
In  order  to  transfer  binding  reactions  to  nylon  membrane,  sections  of  nylon 
membrane  were  soaked  for  at  least  10  minutes  in  0.5X  TBE.  The  gel  was 
sandwiched with the nylon membrane between 6 pieces of 3mm  blotting paper 
(Whatman,  Maidstone,  UK), ensuring  no air  bubbles  were  present. The binding 
reactions were transferred at 200mA for 60 minutes, using a Bio-Rad Trans-Blot 
Semi-Dry Transfer Cell (Bio-Rad Laboratories, Hertfordshire, UK). Following the 
transfer, the membrane was placed on a dry paper towel, with the bromophenol 
blue  side  up,  allowing  the  buffer  on  the  membrane  surface  to  absorb  into  the 
membrane. 
Transferred DNA was then crosslinked to membrane, at 120mJ/cm
2 for 1 minute, 
using a UVP CL-1000 Ultraviolet Crosslinker (UVP, Cambridge, UK). 
The  biotin-labelled  DNA  was  then  detected  by  chemiluminesence  using  a 
VersaDoc  Imaging  System  (Bio-Rad  Laboratories,  Hertfordshire,  UK),  using  the 
following procedure. 20ml warm blocking buffer was added to the membrane and 
Table 2.14 Composition of binding reactions in EMSA experiments where 1 contains 
Biotin DNA only, 2 contains nuclear extract and biotin DNA, 3 contains more nuclear extract 
and biotin DNA, 4 contains the largest quantity of nuclear extract and biotin DNA and 5 
contains the largest amount of nuclear extract, biotin DNA and unlabelled DNA, to check 
specificity of binding.  Samuel Peter Hoile   
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incubated for 15 minutes with gentle shaking. Blocking buffer was then removed 
from  the  membrane  and  conjugate  buffer/blocking  solution  was  added,  the 
membrane  was  then  incubated  for  15  minutes,  with  gentle  shaking.  Conjugate 
buffer/blocking  solution,  contained  66.7µl  stabilized  streptavidin-horseradish 
peroxidise  conjugate  and  20ml  blocking  buffer.  The  conjugate  buffer/blocking 
solution was then removed and the membrane was washed for 4 times with 20ml 
1x wash solution, for 5 minutes each time, with gentle shaking. Following washes, 
the membrane was dried by touching the edge to a dry paper towel and placed in a 
fresh container containing 12ml substrate working solution (6ml luminal/enhancer 
solution and 6ml stable peroxidise solution), the membrane was incubated for 5 
minutes, with gentle shaking. The solution was removed from the membrane, and 
the membrane dried by touching the edge of the membrane to a dry paper towel 
for 2-5 seconds. The membrane was then wrapped in plastic, avoiding bubbles and 
wrinkles  and  chemi-ultrasensitivity  was  measured  using  a  VersaDoc  (Bio-Rad 
Laboratories, Hertfordshire, UK). 
 
2.3.11.4 Western Blot analysis of protein levels 
  Total protein levels were measured using Western Blotting. Initially tissue 
was  lysed  in  order  to  release  all  protein  from  within  cells.  This  was  achieved 
through  a  two  hour  incubation  of  around  30mg  tissue  in  RIPA  lysis  buffer, 
containing 1mM PMSF and 2.5μl LP, at 4
oC, rotating. The composition of RIPA 
buffer is shown in Table 2.15. 
 
Table 2.15 The composition of RIPA buffer 
Chemical added  Final concentration 
NaCl  150mM 
Triton X-100  1% 
Sodium deoxycholate  0.5% 
Sodium dodecyl sulphate  0.1% 
Tris pH 8.0  50mM 
 Samuel Peter Hoile   
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Following incubation the mixture was spun for 20 minutes, at 4
oC at 12,000rpm 
and  supernatant,  containing  protein,  removed  and  placed  in  a  fresh  1.5ml 
eppendorf. Total protein concentration of samples was determined using a Pierce 
BCA Protein Assay Kit (Thermo Scientific, Illinois, USA), where BSA was used as a 
standard. 
Western blot gels were made by casting a three quarters sized resolving gel and 
topping up with a stacking gel and allowing setting. Water was used on top of the 
stacking gel to ensure a flat surface for the resolving gel. The composition of the 
gel mixtures is shown in Table 2.16. 
 
Table 2.16 Composition of stacking and resolving gels, for two gels 
 
Chemical added  Volume 
Staking Gel 
Stacking gel mix (2X)  2.5ml 
30% Acrylamide  0.835ml 
H2O  1.67ml 
10% Ammonium Persulfate  50μl 
TEMED  5μl 
 
 
Chemical added  Volume 
    Resolving Gel 
Resolving gel mix (4X)  2.5ml 
30% Acrylamide  3.3ml 
H2O  4.1ml 
10% Ammonium Persulfate  100μl 
TEMED  10μl 
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2X Stacking gel mix – 6.04g Tris. 180ml H2O, pH to 6.8 with concentrated HCl, 
add 8ml 10% SDS, make up to 200ml, with H2O 
 
4X Resolving gel mix – 29.04g Tris, 180ml H2O, pH to 8.8 with concentrated HCl, 
add 8ml 10% SDS, make up to 200ml with H2O 
 
Gels were pre-run for a minimum of 20 minute before use. 
20μg  of  protein  per  sample  was  mixed  with  an  equal  amount  of  2X  Laemmli 
loading  buffer  (4%  SDS,  10%  2-mercaptoethanol,  20%  glycerol,  0.004% 
bromphenol blue, 0.125M Tris-HCl) and incubated at 95
oC for 5 minutes, in order 
to dentaure proteins. A Molecular weight marker was used to determine size of 
detected protein (ab41746, Abcam, Cambridge, UK) Gels were run at 200V for 45 
minutes in running buffer (1 litre H2O, 3g Tris, 14.4g Glycine, 1g SDS), until the 
bromphenol blue dye front had moved to the end of the gel. 
Gels were transferred onto PVDF membranes, which were pre-soaked in methanol 
for one minute, sandwiched between 6 layers of 3mm blotting paper, which were 
pre-soaked in transfer buffer (10% 10X protein running buffer, 25% ethanol, 65% 
upH2O) for 10 minutes prior to transfer. Gels were transferred at 200mA for 60 
minutes,  using  a  Bio-Rad  Trans-Blot  Semi-Dry  Transfer  Cell  (Bio-Rad 
Laboratories, Hertfordshire, UK). 
The nylon membrane was blocked at 4
oC overnight, shaking, in PBS with 0.1% 
Tween-20  containing  5%  Marvel,  as  a  source  of  protein.  Following  blocking, 
membranes were washed three times for 5 minutes in PBS with 0.1% Tween-20. 
Membranes were placed in 50ml falcon tubes and incubated for 1 hour at room 
temperature, shaking, with 5ml blocking solution containing the appropriate amount 
of primary antibody. Following incubation with primary antibody, membranes were 
washed  again  three  times  for  5  minutes  in  PBS  with  Tween-20.  Following  the 
second  wash  membranes  were  incubated  in  5ml  blocking  buffer  containing  the 
appropriate amount of secondary antibody. Protein levels were detected by placing 
the  membrane  on  saran  wrap  and  incubating  in  1ml  West  DURA 
Chemiluminescent substrate Super-Signal (Pierce, Fisher, Leicsershire, UK), for 5 Samuel Peter Hoile   
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minutes.  Following  removal  of  Super-signal  solution,  chemi-ultrasensitivity  was 
measured  using  a  VersaDoc  (Bio-Rad  Laboratories,  Hertfordshire,  UK).  The 
specific primary and secondary antibodies and amounts/concentrations used are 
shown in Table 2.17. 
 
Table  2.17  Primary  and  secondary  antibody  used  for  Western  blot 
measurement of Fads2 and PEPCK protein levels. 
 
Protein  Primary 
antibody  (Ab) 
used 
Amount  of 
primary  Ab 
used 
Secondary 
Ab used 
Amount  of 
secondary Ab 
used 
Fads2  Goat  polyAb 
sc-109272 
(SantaCruz, 
CA, USA) 
1μg  Rabbit pAb to 
goat  (HRP) 
ab97100 
1/10000  – 
1/50000 
tested 
PEPCK  Rabbit 
polyAb 
ab28455 
(Abcam) 
0.5μg/ml  Goat  pAb  to 
rabbit  (HRP) 
ab97051 
0.1μg/ml 
(1/10000 
dilution) 
 
2.3.12 Measurement of fatty acid composition by gas chromatography 
Tissue fatty acid composition measurements were carried by Nicola Irvine, 
according  to  the  method  described  by  Burdge
[250].  Briefly,  liver  (approximately 
100mg)  was  powdered  under  liquid  nitrogen  and  total  lipids  extracted  with 
chloroform and methanol
[251].  Plasma (0.8ml) was extracted with chloroform and 
methanol
[251].  PC was isolated from total lipid extracts by solid phase extraction 
using 100mg aminopropyl silica cartridges
[250] and converted to fatty acid methyl 
esters (FAMEs) by incubation with methanol containing 2%(v/v) sulphuric acid
[250].  
FAMEs  were  recovered  by  extraction  with  hexane
[250].    The  proportions  of 
individual fatty acids were measured by gas chromatography using BPX70 fused 
silica  capillary  column  (30m  x  0.25mm  x  0.25μm)  on  an  Aglient  6890  gas Samuel Peter Hoile   
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chromatograph  equipped  with  flame  ionisation  detection
[250].    FAMES  were 
identified  by  their  retention  times  relative  to  standards  and  quantified  using 
Chemstation software.  
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Chapter 3 
 
The Effect of Dietary Energy and Protein 
Content on Maternal Phenotype and on 
the Expression of Genes Involved in 
Fasting Carbohydrate and Fat 
Metabolism During Pregnancy 
 
 
 
 Samuel Peter Hoile   
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3.1 Introduction 
Observations in humans and animal models have shown that poor nutrition during 
pregnancy leads to persistent alterations in the phenotype of the offspring which 
can  be  transmitted  to  subsequent 
generations
[161,174,171,167,168,170,252,166,169,163,172,175,173].  The  mechanism  for  such 
transmission however is unclear.  
  Despite substantial evidence that abnormal changes in the physiology of the 
mother,  for  example  gestational  diabetes  mellitus,  induce  changes  in  the 
phenotype of the offspring over one generation, there has been little investigation 
about the role of variations in the metabolic adaptations of the mother to pregnancy 
in the passage of altered phenotype between generations.  Therefore, the effect of 
differences  in  maternal  protein  intake  during  F0  pregnancy  and  of  a  persistent 
increase in energy intake from conception in F0 until the F3 generation on maternal 
physiology was investigated.  We used fasting during pregnancy as a physiological 
challenge to test the capacity of dams to adapt to pregnancy as the response to 
fasting is heightened during gestation and so may be vulnerable to the effects of 
altered nutrition.   
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3.1.2 Aims 
The effect of altered nutrition during pregnancy in the F0 generation on the 
metabolic response to fasting in pregnant dams was determined in F0, F1 and F2 
dams. Body weight and food intake during pregnancy were measured as markers 
of metabolic partitioning of energy substrates. Plasma glucose concentration was 
measured  as  a  marker  of  gluconeogenesis  and  plasma  β-hydroxybutyrate  was 
measured as a marker of fatty acid β-oxidation in dams on day 8.5 of pregnancy. 
The  role  of  hormonal  regulation  of  fasting  metabolism  was  determined  by 
measuring glucagon, corticosterone and leptin. 
Real time RT-PCR was used to test the hypothesis that alterations in the 
fasting phenotype in pregnancy are associated with changes in the expression of 
key  regulatory  genes  in  fasting  energy  metabolism:  GR,  PEPCK,  glucose-6-
phosphatase  (Glc-6-Pase),  phosphofructokinase-2/fructose-2-phosphatase  (PFK-
2), PPARα and carnitine palmitoyltransferase 1 (CPT-1).  
 
3.2 Experimental Design 
 
3.2.1 Animal model 
The experimental design is described in Section 2.2.1. The compositions of 
all the diets is shown in Tables 2.2, 2.3 and 2.4. The energy content of the diets is 
shown in Figure 2.2.   
   
3.2.2 Methods  
In order to standardise metabolism and provide a state of stress, all rats 
were fasted for 12 hours, approximately 20:00 to 08:00, prior to sample collection.  
 
3.2.2.1 Molecular biology procedures 
  Extraction of RNA and RT-PCR methods are described in section 2.3.5. 
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3.3 Results 
3.3.1 Does energy and protein content of the F0 diet during pregnancy alter 
weight gain and energy intake during pregnancy and lactation? 
  There  was  a  significant  effect  of  generation  and  a  significant  interactive 
effect of generation and F0 protein intake (both P<0.0001) on weight gain during 
pregnancy. There was no significant difference in weight gain at day 7, 14 or 28 of 
pregnancy, between generations or dietary groups (Figure 3.1). F0 dams gained 
significantly more weight compared to both F1 and F2 dams. At post-conception 
day  35,  F2  dams  had  a  significantly  higher weight  compared  F0  and  F1 dams 
irrespective of F0 protein intake (P<0.0001) (Figure 3.1). 
During pregnancy there was no effect of generation or F0 protein intake on 
energy intake over 24 hours (Figure 3.2). However, there was a significant effect of 
generation and age on maternal energy intake (interaction P=0.009). F1 PR-PS 
and F2 dams from both F0 dietary lines consumed more energy during lactation 
than  F1  PS-PS  and  F0  dams  (generation*time  interaction  P<0.0001).  From  42 
days  post  conception  onwards,  this  was  only  significantly  different  from  the  F0 
dams (Figure 3.2). There were significant interaction effects of F0 diet, generation 
and post-weaning age on litter weight gain (P<0.0001). At post-conception day 28, 
F2 PR-PS and F3 offspring had a significantly higher weight compared to F2 PS-
PS and F1 offspring, this difference remains significant at post-conception day 35. 
At  post-natal  day  40  there  is  no  significant  difference  between  litter  weights, 
between groups (Figure 3.3). 
Table 3.1 shows the interactive effects of generation and F0 diet on the measured 
phenotypes. 
 
 
Glucose  ʒ-hydroxybutyrate  Corticosterone  Glucagon  Leptin 
Generation  <0.0001  <0.0001  0.008  <0.0001  0.003 
F0 diet 
 
NS  NS  NS  0.023  NS 
Generation*F0 diet  NS  0.036  0.005  0.023  NS 
 
 
 
Table 3.1 A General Linear Model showing significant interactive effects of generation 
and F0 diet on measured phenotypes. 
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Figure 3.1 Change in weight from pre-pregnancy in F0, F1 and F2 generation pregnancies. 
Values  are  means  with  their  standard  deviations.  Where  ‘a’  is  significantly  different  from  ‘b’. 
Significant differences between diets and generation were determined by two-way ANOVA with 
Bonferroni’s post hoc test. P<0.05 Samuel Peter Hoile   
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Figure  3.2  Energy  intake  during  pregnancy  and  lactation  in  F0,  F1  and  F2  generation 
pregnancies. Values are means with their standard deviations. Where ‘a’ is significantly different 
from  ‘b’.  Significant  differences  between  diets  and  generation  were  determined  by  two-way 
ANOVA with Bonferroni’s post hoc test. P<0.05 Samuel Peter Hoile   
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Figure 3.3 F1, F2 and F3 generation litter weight gain, from delivery until weaning. Values 
are means with their standard deviations,  where  ‘a’ is significant to ‘b’. Significant differences 
between diets and generation were determined by two-way ANOVA with Bonferroni’s post hoc 
test. P<0.05 
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3.3.2 Does the protein content of the F0 diet during pregnancy alter length of 
gestation and litter size? 
  There were no significant effects of energy or protein content of the F0 diet 
during pregnancy or generation on length of gestation or litter size (Table 3.2). 
 
  Length of Gestation (days)  Litter size (n) 
F0 PS  22 ± 1  11 ± 3 
F0 PR  23 ± 1  12 ± 3 
F1 PS-PS  22 ± 1  12 ± 3 
F1 PR-PS  22 ± 1  12 ± 2 
F2 PS-PS-PS  22 ± 1  12 ± 3 
F2 PR-PS-PS  22 ± 1  12 ± 4 
Generation (P)  NS  NS 
F0 diet (P)  NS  NS 
Interaction (P)  NS  NS 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table  3.2  Length  of  gestation  and  Litter  size  in  F0,  F1  and  F2  generation 
pregnancies.  Values  are  means  with  their  standard  deviations.  Significant  differences 
between diets and generation were determined by two-way ANOVA with Bonferroni’s post 
hoc test. P<0.05 Samuel Peter Hoile   
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3.3.3 Does the energy content of the diet and the protein content of the F0 
diet  during  pregnancy  alter  plasma  glucose  and  β-hydroxybutyrate 
concentrations during pregnancy? 
  There was a significant effect of generation (P <0.0001) on fasting plasma 
glucose concentration (Table 3.1).  Both the PS and PR lineages showed lower 
plasma  glucose  levels  in  the  F2  pregnancy  compared  to  both  the  F0  and  F1 
generations  (Figure  3.4).  Fasting  β-hydroxybutyrate  plasma  concentrations  also 
showed a significant effect of generation (P <0.0001) irrespective of the protein 
content  of  the  F0  diet  during  pregnancy.  Both  PS  and  PR  lineages  showed  a 
higher β-hydroxybutyrate concentration in the F2 pregnancy compared to the F0 
and F1 generations (Figure 3.4).  
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 Samuel Peter Hoile   
126 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Plasma glucose and β-hydroxybutyrate concentrations in pregnancy day 8.5 in 
the F0, F1 and F2 generations. Values are means with their standard deviations. Where ‘a’ is 
significantly  different  from  ‘b’.  Significant  differences  between  diets  and  generation  were 
determined by two-way ANOVA with Bonferroni’s post hoc test. P=<0.005. Samuel Peter Hoile   
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3.3.4 Does the protein content of the F0 diet during pregnancy alter fasting 
hormonal  regulation  of  glucose  metabolism,  appetite  and  energy 
expenditure? 
Plasma glucagon showed no significant differences between groups (Table 
3.1; Figure 3.5). However, there was a significant interaction effect of generation 
and F0 diet (P=0.023) on plasma corticosterone concentration (Figure 3.5). Plasma 
corticosterone concentration was significantly higher in F2 dams of both the PS 
and PR lineage, as well as F1 PR-PS dams, compared to both F0 PS and PR 
dams.  Fasting  plasma  leptin  concentration  was  significantly  higher  in  the  F1 
generation (P=0.005), compared to both the F0 and F2 generations, irrespective of 
the protein content of the F0 diet during pregnancy (Figure 3.5). 
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Figure 3.5 Plasma glucagon, corticosterone and leptin concentrations in pregnancy 
day  8.5  in  the  F0,  F1  and  F2  generations.  Values  are  means  with  their  standard 
deviations,. Significant differences between diets and generation were determined by two-
way ANOVA with Bonferroni’s post hoc test.  Samuel Peter Hoile   
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3.3.5  Does  the  protein  content  of  the  F0  diet  affect  expression  of  hepatic 
genes involved in glucose metabolism in pregnancy? 
  There was a significant effect of generation and F0 diet on GR, Glc-6-Pase 
and PFK-2 (P=0.009). There was a significant effect of generation on all genes 
measured which are involved in glucose metabolism (PEPCK, P=0.001; GR, Glc-6-
Pase and PFK-2 all P<0.0001). There was a significant effect of F0 diet on mRNA 
expression of Glc-6-Pase (P=0.033) and PFK-2 (P<0.0001). Expression of GR and 
Glc-6-Pase was significantly higher in F1 PR-PS and F2 PS-PS dams compared to 
all other groups (Figure 3.6). Hepatic mRNA expression of both PEPCK and PFK-2 
was increased in the F1 PR-PS dams, compared to; F0 dams for PEPCK and all 
other groups for PFK-2 (Figure 3.6). 
 
Table  3.3  shows  the  interactive  effects  of  generation  and  F0  diet  on  mRNA 
expression. 
 
 
 
GR  PEPCK  G6Pase  PFK-2  PPARα  CPT-1 
Generation  <0.0001  0.001  <0.0001  <0.0001  <0.0001  <0.0001 
F0 diet 
 
NS  0.001  0.033  <0.0001  NS  NS 
Generation*F0 diet  0.001  0.009  <0.0001  <0.0001  <0.0001  <0.0001 
 
 
 
Linear regression analysis showed that the level of GR mRNA expression was not 
significantly associated to the plasma level of corticosterone (PS, r <0.0001, p = 
0.40,1 PR, r = 0.1007, p = 0.314). There was a significant association between 
mRNA expression of GR and its target genes PEPCK (PS r = 0.305, p = 0.02, PR, 
r = 0.8803, p <0.0001) PPARα (PS r = 0.733, p<0.0001, PR r = 0.512, p<0.0001) 
and CPT-1 (PS r = 0.793, p <0.0001, PR r = 0.805, p <0.0001). 
 
 
 
Table  3.3  A  General  Linear  Model  showing  significant  interactive  effects  of 
generation and F0 diet on mRNA expression.  Samuel Peter Hoile   
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Figure  3.6  Hepatic  GR110,  Glucose-6-Phosphatase,  PEPCK  and  PFK-2/F-2,6-BP 
mRNA expression in pregnancy day 8.5 in the F0, F1 and F2 generations. Values 
are means with their standard deviations, where ‘a’ is significantly different from ‘b’, and 
‘ab’ is not significantly different from either ‘a’ or ‘b’. Significant differences between 
diets and generation were determined by two-way ANOVA with Bonferroni’s post hoc 
test. P<0.05. Samuel Peter Hoile   
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3.3.6 Does the energy content of diet and F0 pregnancy diet protein content 
alter  expression  of  hepatic  genes  involved  in  fatty  acid  metabolism  in 
pregnancy? 
  There  was  a  significant  interaction  effect  of  generation  and  diet  on  both 
PPARα  and  CPT-1  mRNA  expression  (P<0.0001)  (Table  3.3).  Expression  of 
PPARα was significantly higher in both the F2 PS-PS-PS and F1 PR-PS groups, 
compared to all other groups (Figure 3.7). Expression of CPT-1 was significantly 
higher in both the F2 PS-PS-PS and F1 PR-PS groups, compared to all groups, 
except for the F2 PR-PS-PS group (Figure 3.7)  
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 Samuel Peter Hoile   
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Figure 3.7 Hepatic PPARα and CPT-1 mRNA expression in pregnancy day 8.5 in the 
F0, F1 and F2 generations. Values are means with their standard deviations, where ‘a’ is 
significantly  different  from  ‘b’,  and  ‘ab’  is  neither  significantly  different  from  ‘a’  or  ‘b’. 
Significant  differences  between  diets  and  generation  were  determined  by  two-way 
ANOVA with Bonferroni’s post hoc test. P<0.05 Samuel Peter Hoile   
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3.4 Discussion 
3.4.1 Maternal phenotype during pregnancy 
The first generation exposed to the high energy diet (both PS and PR F0 
dams)  gained  more  weight  during  pregnancy,  specifically  in  the  third  trimester 
(around 40g more than F1 and F2 dams). This not only indicates an effect of the 
dietary energy content as early as the F0 generation, but also provides possible 
evidence of adjustment to the high energy content in subsequent generations, as 
the  animals  did  not  gain  as  much  weight  during  pregnancy  after  the  initial 
generation. An increase in weight gain could represent a larger litter size, larger 
offspring weights or an increased storage of energy in the form of adipose. The 
results show that the litter weights and litter sizes did not account for the increased 
maternal weight gain during F0 pregnancy. Although F0 dams gained more weight 
than subsequent generations in pregnancy, F1 PR-PS dams and F2 dams from 
both F0 diet protein groups showed significantly increased energy intakes, relative 
to body weight. These findings indicate that although F1 PS-PS  and F2 dams 
were consuming more energy in pregnancy, they were gaining significantly less 
weight.  One  possible  explanation  is  that  F1  PS-PS  and  F2  dams  partitioned  a 
greater proportion of their diet into energy production compared to the F0 dams. 
In order to understand the metabolic phenotype of the dams, the fasting 
plasma concentrations of glucose and β-hydroxybutyrate were measured. Fasting 
glucose  concentration  is  increased  in  early  pregnancy  and  decreased  in  late 
pregnancy
[101]. Throughout pregnancy, plasma levels of non-esterified fatty acids 
and β-hydroxybutyrate are inversely related to plasma glucose concentration
[111].  
In both the F0 and F1 pregnant dams, glucose concentration was higher, 
compared to published concentrations seen in an adult female rat that received no 
dietary modification
[253,254,48,173], irrespective of the protein content of the F0 diet 
during pregnancy. In the glucose–fatty acid cycle
[255], increased plasma glucose 
concentration  increases  insulin  secretion.  Increased  insulin  increases  cellular 
malonyl CoA concentration, which in turn, will decrease fatty acid β-oxidation by 
inhibiting CPT-1 activity (Figure 3.8). This suggests F0 dams have lower levels of 
fatty acid β-oxidation than F1 and F2 dams, potentially leading to increased fat Samuel Peter Hoile   
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storage. The plasma glucose concentrations, of over 10mmol/l, in the F0 and F1 
dams suggest an exaggerated gluconeogenic response during fasting or impaired 
glucose uptake, as in the fasted state liver glycogen stores would be depleted. The 
high level of plasma glucose in the F0 and F1 dams was not associated with an 
increase in PEPCK, GR or G-6-Pase gene expression, or with increased glucagon 
concentration. This suggests that gluconeogenesis was not increased in F0 and F1 
dams.  However, one possible explanation for the increased glucose value in dams 
is a decreased placental glucose uptake. 
In  the  F2  generation,  there  was  a  significantly  higher  plasma  β-
hydroxybutyrate  concentration,  compared  to  both  the  F0  and  F1  generation, 
irrespective  of  F0  diet  protein  content.  The  F2  dams  showed  fasting  plasma 
glucose values are comparable to that for chow fed fasting dams
[253,254,48,173]. Thus 
despite the same nutrition, the fasting phenotype of F2 dams differed from that of 
F0 dams, irrespective of the protein content of the F0 diet during pregnancy. This 
suggests that after three generations on a diet containing around 16 MJ/kg energy, 
dams have adjusted and regained homeostatic control during fasting.  
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Figure 3.8 Interactions between glucose and fatty acid metabolism. Figure A shows how high 
plasma glucose leads to an increase in plasma β-hydroxybutyrate, where an increase in plasma 
glucose leads to an increase in insulin secretion. This in turn results in an increase in malonyl 
CoA, which results in an inhibition of CPT-1. The inability of CPT-1 to transport fatty acids across 
the  mitochondrial  membrane  results  in  a  decrease  in  β-oxidation  of  fatty  acids,  and  therefore 
plasma  levels  of  β-hydroxybutyrate.  Figure  B  shows  how  β-oxidation  of  fatty  acid  leads  to 
conservation of glucose by increasing levels of acetyl CoA. Through intermediates, Acetyl CoA 
leads  to  inhibition  of  the  glyoclytic  enzyme  phosphofructokinase  and  increases  the  level  of 
gluconeogenesis via inhibition of pyruvate dehydrogenase. Samuel Peter Hoile   
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There were no differences between generations in fasting plasma glucagon 
and  leptin  concentrations.  However,  plasma  corticosterone  concentrations  were 
lower  in  F0  compared  to  F2  generations.  Plasma  glucose  concentrations 
decreased from F0 to F2 generations. As plasma corticosterone concentration is 
increased when glucose levels are low
[101,256], these results are in agreement, as 
the decreased plasma glucose concentration in the F2 generation is concurrent 
with  an  increase  in  plasma  corticosterone  concentration.  Although  it  was  not 
possible  to  determine  whether  there  was  a  direct  causal  association  between 
plasma corticosterone and glucose concentrations from this experiment.   
     
3.4.2 Maternal phenotype during lactation 
  During lactation mothers must produce milk for the growing offspring. As a 
result, dams need to consume enough food to provide for both themselves and the 
growing pups. F0 dams had significantly higher weight gain during late pregnancy, 
which was not explained by litter number or weight. As the increased weight was 
not represented by the F1 offspring, we would have expected mothers to have a 
significantly higher postnatal body weight. Although it must be stated that dams 
were  weighed  up  to  7  days  following  pregnancy,  as  added  stress  following 
pregnancy can lead to dams consuming pups. F0 dams had a significantly lower 
body weight from day 35 to day 49 of lactation compared to the F2 dams, this 
suggests that the excess stored energy in the F0 dams was either incorporated 
into the milk, or oxidised. Both F1 and F2 dams showed a significantly greater 
energy  intake  during  the  period of  lactation,  compared  to  the  increased  energy 
intake seen in the F0 dams. For F1 dams there is an increased energy intake that 
is not concurrent with an increased weight gain.  For these dams, as energy is not 
being stored, it is either being oxidised, or it is partitioned into milk synthesis. F2 
dams showed a significantly greater weight gain from post conception day 28 to 
day 35, which remained significant until postnatal day 49. In terms of F2 dams, the 
increased weight gain can be explained by the increased energy intake, where 
excess energy is being stored as adipose.  Samuel Peter Hoile   
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F2  PR-PS  and  F3  offspring  from  both  protein  lineages  had  significantly 
higher weight gain during lactation compared to F2 PS-PS and F1 offspring, which 
is related to an increased energy intake in their respective mothers (F1 PR-PS and 
F2  dams).  Although  the  increased  energy  intake  during  lactation  in  F1  PS-PS 
dams is not related to an increased weight gain in F2 PS-PS offspring, all other 
groups that showed an increased energy intake in the dams, showed increased 
growth  in  the  offspring.  This  suggests  that  the  increased  energy  is  being 
incorporated in the milk. In terms of the F1 PS-PS dams, as the increased energy 
intake is not related to an increased dam weight or offspring weight, the additional 
energy  must  represent  a  higher  level  of  substrate  oxidation.  As  well  as  an 
increased offspring litter weight during lactation, increased energy intake in the F2 
dams  is  also  associated  with  an  increased  F2  dam  weight  during  lactation. 
Compared to the F1 PR-PS dams, which do not show an increased body weight, 
the  energy  intake  of  F2  dams  is  about  25%  greater.  It  seems  that  the  initial 
increase in energy, present in F1 and F2 dams is reflected in the offspring weight, 
whereas  the  additional  energy  consumed  by  just  the  F2  dams,  appears  to  be 
stored by the dams. 
 
3.4.3 mRNA expression of genes involved in fasting energy metabolism in 
day 8.5 dams 
  Both generation and protein content of the F0 diet during pregnancy had 
significant effects on genes involved in fasting glucose and fatty acid metabolism. 
All  genes  involved  in  glucose  metabolism  showed  a  significant  increase  in 
expression  in  the  F1  PR-PS  group,  with  GR  and  Glc-6-Pase  also  significantly 
increased in the F2 PS-PS-PS group. Interestingly, where fasting plasma glucose 
and β-hydroxybutyrate concentrations appear to return to expected levels by the 
F2 generation, the mRNA expression of all measured genes was increased in the 
F1  generation,  in  the  PR  group.  Although  this  pattern  is  not  present  in  the 
phenotype data, it does suggest an altered capacity for fasting energy homeostasis 
in the group. Samuel Peter Hoile   
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Glc-6-Pase  expression  is  increased  2-3  fold  in  the  state  of  fasting
[257]. 
Administration of the synthetic glucocorticoid dexamethasone to rats led to a 10-
fold increase in Glc-6-Pase mRNA expression
[257]. In the animals of this study the 
pattern of increase in corticosterone across generations and dietary groups directly 
matched the pattern of Glc-6-Pase expression. This suggests the increase in Glc-
6-Pase may be due to the increased level of plasma corticosterone acting through 
the  GR.  During  fasting,  the  bifunctional  enzyme  PFK2/F-2,6-BPase  acts  to 
increase  levels  of  gluconeogenesis.  Although  this  could  explain  the  increased 
fasting glucose levels in the F1 PR-PS, as increased levels were also seen in both 
the F0 and F1 dams, other forms of regulation are likely to be involved. 
There was an increase in mRNA expression of the genes PPARα and CPT-
1, in the F2 PS-PS-PS and F1 PR-PS groups, compared to all other groups. An 
increased expression of both PPARα and CPT-1 would lead to an increase in β-
oxidation  and  therefore  an  increase  in  circulating  ketone  bodies,  such  as  β-
hydroxybutyrate.  By  comparing  to  phenotype  data,  we  can  see  that  this  is  in 
agreement for all PS lineage dams and F0 PR dams. Although gene expression 
values do not directly match all of the differences seen in circulating glucose and β-
hydroxybutyrate in the fasted dams, these genes represent only a sub-set involved 
in  fasting  energy  metabolism  and  do  not  reflect  potential  changes  in  enzyme 
activity or total protein levels. 
Increased levels of plasma corticosterone will lead to increased expression 
of the transcription factor GR (Figure 3.9). In turn, increased GR levels lead to up 
regulation  of  PEPCK
[134,136]  and  PPARα
[137]  expression.  PPARα  expression  will 
lead to increased CPT-1 expression
[258]. Linear regression analysis showed that 
the level of  GR mRNA expression was not significantly associated  with plasma 
glucose  levels.  However,  there  was  a  significant  positive  association  between 
mRNA expression of GR and its target genes PEPCK. In order for mRNA of GR to 
have  an  effect  on  transcription  of  other  genes,  the  increased  expression  must 
represent increased levels of protein synthesis. These relationships suggest that 
increased gene expression of GR is related to increased protein synthesis of GR, 
and that the regulation of downstream genes by GR is present. Samuel Peter Hoile   
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Overall,  these  findings  suggest  that  despite  being  fed  a  diet  with  an 
increased energy content than that fed before conception in F0 dams, there was a 
progressive  adjustment  in  the  regulation  of  fasting  energy  metabolism  between 
generations.  The pattern of pregnancy and lactation-associated changes in weight 
and  food  intake,  and  in  glucose  and  β-hydroxybutyrate  concentration  between 
generations suggests progressive improvement in metabolic control.  Furthermore, 
these findings imply that the interaction between the phenotype of the dam and its 
environment, specifically diet, differed between generations.  This implies that any 
developmental  signals  from  the  dam  to  the  offspring  may  also  differ  between 
generations.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.9  The  role  of  corticosterone  in  energy  metabolism.  Increased  levels  of 
corticosterone lead to an increase in GR expression. In turn, GR leads to up regulation of 
both  the  gluconeogenic  enzyme  PEPCK  and  the  key  β-oxidation  regulatory  transcription 
factor PPARα. Samuel Peter Hoile   
140 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Samuel Peter Hoile   
141 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
 
Phenotypic Characterisation of the Non-
Pregnant Offspring in each Generation 
 
 
 
 Samuel Peter Hoile   
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4.1 Introduction 
  The findings presented in Chapter 3 showed that the fasting phenotype of 
dams  during  pregnancy  was  significantly  altered  over  three  generations  in  a 
manner which suggested progressive improvement in control of whole body energy 
balance in response to fasting.  The purpose of the experiments described in this 
chapter is to determine whether the inter-generational effects observed in the dams 
are also found in the non-pregnant female offspring and also whether there is any 
direct  relationship  between  the  metabolic  phenotype  of  the  dams  and  of  their 
offspring in generation.  The growth of female offspring and their food intake after 
weaning  was  used  to  assess  regulation  of  whole  body  energy  balance.    As  in 
Chapter 3, capacity to respond to fasting was used as a proxy measure of control 
of fat and carbohydrate metabolism.   
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4.2 Experimental Design 
 
4.2.1 Animal model 
The  experimental  design  is  described  in  detail  in  section  2.2.1  and  the 
composition of the diets is summarised in Tables 2.2, 2.3 and 2.4, and in Figure 
2.2  
 
4.2.2 Methods  
In order to standardise metabolism and provide a state of stress in offspring 
that may uncover changes in metabolism, all rats were fasted for 12 hours prior to 
sample collection.  
 
4.2.2.1 Molecular biology procedures 
  Extraction of RNA and RT-PCR methods are described in section 2.3.5. 
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4. Results 
4.3.1 Does energy content of diet and protein content of the F0 diet during 
pregnancy alter post-weaning weight gain and energy intake in non-pregnant 
F1, F2 and F3 offspring? 
  There was a significant effect of generation and protein content of the F0 
diet  during  pregnancy  on  offspring  post-weaning  weight  gain  (P=0.002).  At 
postnatal day 49, F1 PS offspring and all PR offspring, irrespective of generation, 
had  a  significantly  lower  weight  compared  to  F2  PS-PS  and  F3  PS-PS-PS 
(P<0.05).  On  post-natal days  56, 63 and  70,  all  generations of  the  PR lineage 
showed  a  significantly  lower  weight  gain  compared  to  those  of  the  PS  lineage 
(P=0.002)  (Figure  4.1).  There  were  significant  interaction  effects  of  F0  diet, 
generation and post-weaning age on offspring energy intake (P<0.0001). On post-
natal  day  28,  all  F1  and  F2  offspring  had  a  significantly  higher  energy  intake, 
regardless  of  F0  diet.  On post-natal days 35, 42 and  49  this increased  energy 
intake was only seen in the F2 groups. Following this there were no significant 
differences in energy intake between groups and generations at post-natal days 56 
and  63.    However,  on  postnatal  day  70,  the  F2  generation  offspring  had  a 
significantly higher energy intake compared to both the F1 and F3 offspring (Figure 
4.2). 
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Figure 4.1 F1, F2 and F3 generation post-weaning weight gain. Values are means 
with  their  standard  deviations,  where  ‘a’  is  significant  to  ‘b’.  Significant  differences 
between diets and generation were determined by two-way ANOVA with Bonferroni’s 
post hoc test. P<0.05 
 Samuel Peter Hoile   
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Figure 4.2 F1, F2 and F3 generation post-weaning energy intake. Values are means 
with  their  standard  deviations,  where  ‘a’  is  significant  to  ‘b’.  Significant  differences 
between diets and generation were determined by two-way ANOVA with Bonferroni’s post 
hoc test. P<0.05 
 Samuel Peter Hoile   
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4.3.2  Does  the  energy  content  of  diet  and  protein  content  of  the  F0  diet 
during  pregnancy  alter  fasting  plasma  glucose  and  β-hydroxybutyrate 
concentrations in non-pregnant offspring? 
  There  was  a  significant  interaction  effect  of  both  generation  and  diet  on 
plasma  glucose  concentration  (P<0.0001)  (Table  4.1).  Glucose  levels  were 
significantly lower in the F3 PR-PS-PS group, compared to all other groups, except 
for the F2 PR-PS group (Figure 4.3). There were no significant differences in β-
hydroxybutyrate concentration between groups (Figure 4.3). 
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Figure 4.3 Plasma glucose and β-hydroxybutyrate concentrations in adult females in 
the F0, F1 and F2 generations. Values are means with their standard deviations, where 
‘a’ is significantly different from ‘b’, and ‘ab’ is neither significantly different from ‘a’ or ‘b’. 
Significant differences between diets and generation were determined by two-way ANOVA 
with Bonferroni’s post hoc test. P<0.05 Samuel Peter Hoile   
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4.3.3 Does energy content of diet and protein content of the F0 diet during 
pregnancy alter fasting plasma concentrations of corticosterone, leptin and 
glucagon in non-pregnant adult offspring? 
In  order  to  investigate  whether  the  plasma  corticosterone,  leptin  and 
glucagon  concentrations  in  day  70,  non-pregnant  adult  female  offspring  were 
affected by increased energy content of diet throughout life and the protein content 
of the F0 pregnancy diet, the concentrations of these hormones were measured by 
ELISA (Section 2.2.1.4.1). Measurement of plasma corticosterone was carried out 
by Dr Nicola Thomas. 
There  were  significant  interaction  effects  for  plasma  corticosterone 
concentration  for  generation  and  F0  diet  (P<0.0001)  (Table  4.1).  Plasma 
corticosterone  concentration  was  significantly  higher  in  the  F3  generation, 
irrespective of diet, and the F2 PR-PS group, compared to all other groups (Figure 
4.4). Plasma glucagon concentrations showed no significant effect of generation or 
F0 diet (Figure 4.4). There was a significant effect of generation on plasma leptin 
concentration  in  day  70  non-pregnant females  (P<0.0001).  Plasma  leptin  levels 
were  significantly  lower  in  the  F2  and  F3  generation  compared  to  the  F1 
generation, regardless of F0 diet (P<0.0001) (Figure 4.4). 
Table 4.1 shows the interactive effects of generation and F0 diet on the measured 
phenotypes. 
 
 
 
Glucose  ʒ-
hydroxybutyrate 
Glucagon  Corticosterone   Leptin 
Generation  <0.0001  NS  NS  <0.0001  <0.0001 
F0 diet 
 
<0.0001  NS  NS  0.004  NS 
Generation*F0 
diet 
NS  NS  NS  NS  NS 
 
 
 
 
 
 
Table 4.1 The results of analysis of interactive effects between generation and F0 
diet  using  a  General  Linear  Model  on  fasting  concentrations  of  glucose,  β-
hydroxybutyrate, corticosterone and leptin. Samuel Peter Hoile   
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Figure  4.4  Plasma  corticosterone,  glucagon  and  leptin  concentrations  in  adult 
females  in  the  F0,  F1  and  F2  generations.  Values  are  means  with  their  standard 
deviations, where ‘a’ is significantly  different from ‘b’. Significant differences between 
diets and generation were determined by two-way ANOVA with Bonferroni’s post hoc 
test. P<0.05 Samuel Peter Hoile   
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4.3.4 Does energy content of diet and protein content of the F0 diet during 
pregnancy alter expression of genes involved in glucose metabolism in the 
liver of the adult offspring? 
  There  were  significant  interaction  effects  of  generation  and  diet  on 
expression  of  GR,  PEPCK,  CPT-1  and  PFK-2  in  adult  non-pregnant  female 
offspring  (P=0.001).  The  F1  PR  group  and  F3  adults  of  both  protein  lineages 
showed a significantly higher expression of GR compared to all other PS groups, 
which was not significantly associated with plasma corticosterone concentration (r
2 
= 0.0057, p=0.633) (Figure 4.5). PEPCK expression was significantly lower in the 
F2  PS-PS  group,  compared  to  all  other  groups  (P=0.001)  (Figure  4.5).  PFK-2 
expression was significantly higher in the F2 and F3 PR groups, compared to all 
other groups (P<0.05) (Figure 4.5). There were no significant differences between 
groups  for  Glc-6-Pase  expression  (Figure  4.5).  Table  4.2  shows  the  interactive 
effects of generation and F0 diet on the measured phenotypes. Linear regression 
analysis showed no effect of regulation of PEPCK by GR (PS, r
2 = 0.056, P = 0.22, 
PR r
2 = 0.042, P = 0.347).  
 
 
 
GR  PEPCK  G6Pase  PFK-2  PPARα  CPT-1 
Generation  <0.0001  0.001  NS  <0.0001  NS  <0.0001 
F0 diet 
 
NS  NS  NS  <0.0001  NS  NS 
Generation*F0 diet  0.001  NS  NS  <0.0001  NS  NS 
 
 
 
 
   
 
 
 
 
 
Table 4.2 A General Linear Model showing significant interactive effects of generation and 
F0 diet on mRNA expression. Samuel Peter Hoile   
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Figure  4.5  Hepatic  GR110,  Glucose-6-Phosphatase,  PEPCK  and  PFK-2/F-2,6-BP 
mRNA expression in adult females in the F1, F2 and F3 generations. Values are 
means with their standard deviations, where ‘a’ is significantly different from ‘b’, and 
‘ab’  is  not  significant  from  ‘a’  or  ‘b’.  Significant  differences  between  diets  and 
generation  were  determined  by  two-way  ANOVA  with  Bonferron’s  post  hoc  test. 
P<0.05 
 Samuel Peter Hoile   
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4.3.5 Does energy content of diet and protein content of the F0 diet during 
pregnancy alter expression of genes involved in fatty acid β-oxidation? 
  As shown in table 4.2, there were no significant effects of generation or F0 
diet on expression of PPARα in non-pregnant adult female offspring (Figure 4.6). 
There  was  a  significant  effect  of  generation  on  CPT-1  expression  (P<0.0001), 
where the F3 offspring had significantly higher CPT-1 expression, compared to all 
other  generations,  irrespective  of  diet  (Figure  4.6).  There  was  a  significant 
association between GR mRNA expression and mRNA levels of PPARα (PS r
2 = 
0.438, P = 0.002, PR r
2 =0.587, P <0.001) and CPT-1 (PS r
2 =0.239, p = 0.034, PR 
r
2 =0.2177, P = 0.025). 
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Figure 4.6 Hepatic PPARα and CPT-1 mRNA expression in adult females in the 
F1, F2 and F3 generations. Values are means with their standard deviations, where ‘a’ 
is significantly different from ‘b’. Significant differences between diets and generation 
were determined by two-way ANOVA with Bonferroni’s post hoc test. P<0.05 
 Samuel Peter Hoile   
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4.4 Discussion 
4.4.1 Non-pregnant offspring phenotype 
At every time point, all PR offspring had significantly lower body weights 
than PS offspring. This implies transmission of a persistent influence of the F0 over 
three  subsequent  generations.  This  may  be  due  to  either  decreased  somatic 
growth, lower partitioning of dietary energy into adipose tissue or greater physical 
activity. The metabolic response to fasting in female non-pregnant adult offspring 
was  determined  by  measuring  plasma  glucose  and  β-hydroxybutyrate 
concentrations.  In  an  adult  non-pregnant  female  rat  that  received  no  dietary 
modification,  the  fasting  plasma  glucose  concentration  is  between  4  and  6 
mmol/l
[253,254,48,173].  Total  energy  and  protein  content  of  the  F0  diet  during 
pregnancy  had  significant  effects  on  fasting  plasma  glucose  metabolism.  The 
values are higher than 4 – 6mmol/l
[254,259], the value seen in an adult female rat that 
received no dietary alteration, in all groups, except for the F3 PR-PS-PS group. 
There was no significant effect of energy or F0 pregnancy diet protein content on 
fasting plasma β-hydroxybutyrate concentration, although all offspring had plasma 
levels higher than that of a standard adult non pregnant female rat that received no 
dietary modification in any previous generation
[254,259].  These data suggest that 
there was an increased level of gluconeogenesis in all offspring, except for the F3 
PR-PS-PS  group,  accompanied  by  an  increase  in  ketogenesis.  One  possible 
explanation  for  the  high  fasting  glucose  concentration  is  that  the  constant  high 
energy diet induced an insulin resistant or diabetes-like phenotype. 
Circulating plasma levels of corticosterone were shown to be affected by the 
dietary  alterations.  F2  PR-PS  and  F3  dams  from  both  protein  lineages  had 
significantly higher plasma corticosterone levels. The F2 PS-PS and F1 groups had 
fasting plasma corticosterone levels comparable to that shown by Hanson et al
[231]. 
An increase in plasma corticosterone would lead to increased expression of GR, 
and therefore PEPCK. As a result gluconeogenic activity would be increased and 
plasma glucose levels would be increased. Although fasting plasma corticosterone 
levels  do  not  agree  with  plasma  glucose  levels  in  the  offspring,  the  role  of 
corticosterone  in  this  phenotype  cannot  be  ruled  out.  It  may  be  that  altered Samuel Peter Hoile   
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regulation  of  the  PEPCK  gene,  such  as  methylation  of  specific  CpG  sites,  is 
preventing an increase in PEPCK expression by corticosterone through inhibition 
of transcription factor binding. 
Generation,  but  not  diet,  had  a  significant  effect  on  plasma  leptin 
concentrations.  F1  offspring  had  significantly  increased  plasma  leptin  levels 
compared to both F2 and F3 offspring. The pattern of changes in plasma leptin 
concentration did not correspond with the offspring body weight or to food intake.  
This suggests that leptin secretion and possibly leptin action were dysregulated in 
all generations, although these changes did not appear to have any effect on the 
physiology of the offspring.   
In  summary,  the  first  two  generations  of  offspring  exposed  to  the  high 
energy  diet  have  an  increased  level of  gluconeogenesis and β-oxidation  during 
fasting. The F3 generation, showed a fasting phenotype similar to an animal that 
received no dietary alteration, suggesting adjustment to the high energy diet. In a 
similar pattern to the day 8.5 dams, the offspring’s adjustment to the high energy 
diet  seems  to  be  associated  with  an  increase  in  fasting  corticosterone 
concentration, possibly suggesting increased stress during fasting. 
 
4.4.2 mRNA expression of genes involved in fasting energy metabolism in 
non-pregnant offspring  
  The results showed significant changes in expression of key genes involved 
in fasting glucose and fatty acid metabolism, between generations and F0 diets. 
Increased  expression  of  PFK-2/F-2,6-BPase  is  associated  with  a  high 
glycolytic  flux  in  the  fed  state
[128].  Under  the  physiological  state  of  fasting, 
increased levels of glucagon decrease glycolysis and increased gluconeogenesis, 
by  down-regulating  the  PFK-2  and  up-regulating  the  F-2,6-BPase  activities. 
Transgenic mice over-expressing PEPCK were found to be hyperglycaemic, with 
higher  insulin  concentrations  and  alterations  in  liver  glycogen  content
[260].  
Furthermore, primary mouse hepatocytes, which over expressed GR, were found 
to have increased PEPCK mRNA expression and a type II diabetes phenotype
[261]. Samuel Peter Hoile   
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 The differences in mRNA expression seen in the F1 PR and F3 groups of 
both protein lineages would suggest that these animals have increased levels of 
gluconeogenesis. If this was the case, then an increased fasting plasma glucose 
concentration would be expected to be present in these groups compared to all 
other  groups.  The  pattern  of  expression  of  the  genes  involved  in  glucose 
metabolism  measured  and  the  fasting  plasma  glucose  values  do  not  correlate 
completely. This could be due to the involvement of other proteins in the pathway 
of fasting glucose metabolism, or the protein levels of the measured genes do not 
match  the  expression  levels.  Furthermore,  plasma  glucose  concentration  also 
reflects the rate of glucose uptake.  Thus any changes in mRNA expression of 
gluconeogenic  genes  may  be,  at  least  in  part,  compensated  by  alterations  in 
glucose uptake. 
Increased mRNA expression of CPT-1 is associated with exaggerated fatty 
acid  β-oxidation  and  decreased  oxidation  of  glucose
[262].  Because  CPT-1 
expression was increased, this would be expected to be accompanied by higher 
fasting plasma β-hydroxybutyrate concentration in the F3 generation compared to 
both the F1 and F2 offspring. There is no simple agreement between fasting β-
hydroxybutyrate values and mRNA expression of genes involved in fasting fatty 
acid metabolism.  This could be due to the involvement of other enzymes in the 
pathway of fatty acid oxidation or because the increased gene expression of CPT-1 
has not resulted in increased protein  levels. Although linear regression analysis 
showed no effect of regulation of PEPCK by GR, there was a significant effect of 
GR mRNA expression on mRNA levels of both PPARα and CPT-1. This suggests 
the  expression  levels  of  these  genes  are  in  part  a  result  of  increased  GR 
expression. 
 
4.4.3 The relationship between maternal and offspring phenotype 
  Comparison of the phenotype of dams and offspring allows two questions to 
be addressed.  By comparing non-pregnant and pregnant offspring in the same 
generation,  it  is  possible  of  determine  whether  there  was  a  specific  effect  of 
pregnancy  on  the  dietary  challenge  on  metabolism,  as  a  result  of  fasting.    In Samuel Peter Hoile   
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addition, comparison of the phenotype of the mother and her offspring may answer 
the question does the phenotype of the offspring reflect that of the mother.   
 
4.4.4  The  effect  of  pregnancy  on  fasting  metabolite  and  hormone 
concentration 
  Comparison of litter mates, one of which was mated and the other which 
was non-pregnant, allows the observation of the effect of pregnancy on fasting 
energy  metabolism  and  hormone  concentration.  Pregnancy  led  to  significant 
differences  in  fasting  plasma  glucose  values  in  the  F0  generation  of  the  PS 
lineage  (Figure  4.7).  This  suggests  that  the  pregnancy  leads  to  alterations  in 
fasting glucose. As these differences are not seen in later generations, it appears 
that the nutritional alteration, of high energy, is sufficient to cover up the effects of 
pregnancy on fasting glucose levels. Although the effect of pregnancy was not 
seen  in  the  F0  generation  in  the  PR  lineages,  this  appears  to  be  due  to  the 
variability in the F0 PR pregnant group. Pregnancy led to a significantly higher 
plasma β-hydroxybutyrate level in the F1 PS animals, as shown in Figure 4.7. As 
this effect was not seen in the F0 generation, or in the PR lineage, it suggests an 
interactive effect of the generation and F0 maternal diet protein intake. All day 8.5 
pregnancy groups have an increased plasma corticosterone level compared to 
their  non-pregnant  offspring,  as  shown  in  Figure  4.8.  Fasting  glucagon  levels 
show an identical pattern to glucose, where the effect of pregnancy was seen in 
the F0 PS group only. Similar fasting leptin concentrations were present for all 
groups, regardless of pregnancy, shown in Figure 4.8. These results show that for 
fasting  glucose,  β-hydroxybutyrate,  corticosterone  and  glucagon  concentration, 
the added physiological stress of pregnancy is sufficient to observe the effects of 
the  dietary  alterations.  However  for  fasting  leptin  concentration  the  additional 
stress of pregnancy did not alter the fasting phenotype. 
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Figure 4.7 Plasma glucose concentrations in pregnant and non-pregnant adult 
siblings, females in the F0, F1 and F2 generations.  Values are means with their 
standard  deviations.  Significant  differences  between  diets  and  generation  were 
determined by T-Test. P<0.05. * represents an effect of pregnancy. Samuel Peter Hoile   
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Figure 4.8 Plasma corticosterone, glucagon and leptin concentrations in pregnant 
and non-pregnant adult siblings, females in the F0, F1 and F2 generations. Values 
are  means  with  their  standard  deviations.  Significant  differences  between  diets  and 
generation were determined by T-Test. P<0.05. * represents an effect of pregnancy. Samuel Peter Hoile   
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4.4.5  The relationship between maternal and offspring phenotype 
By comparing data from dams and their offspring, the extent to which the 
offspring  phenotype  is  based  on  that  of  the  dams,  as  suggested  in  the  PAR 
hypothesis, can be investigated. Alterations in the metabolism of the dam during 
pregnancy lead to significant changes in the physiological phenotype of the non-
pregnant female offspring at day 70. Fasting plasma glucose concentrations were 
comparable for the F1 offspring (F0 dams), and F2 PS-PS-PS offspring (F1 PS-PS 
dams), whereas all other groups showed significantly different levels (Figure 4.9). 
Day  8.5  pregnant  dams  showed  a  trend  in  increased  fasting  plasma  glucose 
concentration between the F0 and F1 generation; this was not seen in the F1 and 
F2 generation adult non-pregnant offspring. Unlike their respective mothers, the F3 
PS-PS-PS group did not show a fasting glucose level comparable to that of a non-
pregnant  adult  control 
[253,254,48,173].  This  indicates  that  although  their  mother’s 
metabolism is adapting to the dietary alterations the F3 PS-PS-PS group have not. 
This is due to the protein content of the F0 diet during pregnancy (Figure 4.3). β-
hydroxybutyrate levels in adult non-pregnant offspring showed no agreement with 
fasting levels present in dams during pregnancy. In terms of the PAR hypothesis, 
selected  offspring  groups  match  the  phenotype  of  their  respective  mothers, 
however  this  is  not  seen  in  all  groups,  suggesting  the  PAR  hypothesis  is 
insufficient to explain all differences in phenotype. 
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In summary, fasting plasma glucose values are increased in the F0 and F1 
generation, in dams. Inversely plasma β-hydroxybutyrate values are increased in 
the F2 generation only. In the F2 generation, where the fasting plasma glucose 
values are no longer increased, the corticosterone levels are increased, in the PR 
lineage only. The F2 generation dams show an increased weight gain and energy 
intake, compared to both the F0 and F1 generations. All offspring groups showed 
increased  fasting  plasma  glucose  and  β-hydroxybutyrate  concentrations  (Figure 
4.3), compared to the level seen in a fasting rat that received no dietary alteration, 
except  for  the  F3  PR  group,  which  had  standard  glucose  values.  Fasting 
corticosterone levels were increased in the F2 PR and both F3 groups, suggesting 
an increased level of stress in these animals. All PR offspring showed decreased 
postnatal weight gain, compared to PS groups, in all generations. The postnatal 
Figure 4.9 Plasma glucose concentrations in day 8.5 pregnancy in the F0, F1 and F2 
generations, and their relative offspring, in both the PS and PR lineages. Where blue 
represents pregnant PS, orange represents non-pregnant PS, red represents pregnant PR 
and purple represents non-pregnant PR. Values are means with their standard deviations. 
Significant differences between diets and generation were determined by two-way ANOVA 
with Bonferroni’s post hoc test. P<0.05 Samuel Peter Hoile   
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energy intake, however, was increased in the F2 generation, compared to both the 
F1 and F3 generations. 
Similar  plasma  concentrations  of  glucagon  and  leptin  are  seen  between 
mother  and  offspring.  In  terms  of  corticosterone,  the  offspring  show  a  similar 
pattern of increased fasting corticosterone in the F3 generation, which was also 
seen in their mothers (F2 generation dams). The increased plasma corticosterone 
concentration seen in the F1 PR-PS dams was also present in the F2 PR-PS adult 
offspring (Figure 4.10). Although all values were increased in the dams, possibly 
representing  the  additional  stress  of  pregnancy,  the  pattern  of  fasting 
corticosterone concentration in the adult offspring is similar to that seen in their 
mothers. The results suggest that the role of corticosterone in the fasting response 
in the offspring showed a similar response to that of its mother during pregnancy, 
and not that of the first generation exposed to the dietary alteration in utero. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 Plasma corticosterone concentrations in day 8.5 pregnancies in the F0, 
F1 and F2 generations, and their relevant offspring. Where blue represents pregnant 
PS,  orange  represents  non-pregnant  PS,  red  represents  pregnant  PR  and  purple 
represents non-pregnant PR. Values are means with their standard deviations. Significant 
differences  between  diets  and  generation  were  determined  by  two-way  ANOVA  with 
Bonferroni’s post hoc test. P<0.05 Samuel Peter Hoile   
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There  are  differences  in  fasting  metabolites  and  weight  gain  between  F0 
pregnancy diet protein intake lineages for each generation, providing evidence of a 
transgenerational effect on phenotype. In terms of the core hypothesis, the results 
confirm that increased energy intake induces an altered phenotype in the offspring, 
which varies between generations and with the nutrient composition of the F0 diet. 
As  described  previously,  gene  expression  in  offspring  has  been  shown  to  be 
altered following maternal dietary changes during pregnancy 
[174,45,187]. It is now 
important to determine the expression of genes involved in the pathways of fasting 
glucose and fatty acid metabolism in the non-pregnant adult offspring, in order to 
observe the effects of the added stress of pregnancy in fasted adult female rats, in 
subsequent generations. 
 
According  to  the  PAR  hypothesis
[92,93],  the  metabolism  of  the  developing 
offspring  is  based  on  that  of  its  mothers  during  pregnancy,  as  the  mother’s 
metabolism will be representative of the external environment. The design of the 
study entails that the nutritional exposure of the offspring was comparable to that of 
the  mothers.  In  terms  of  the  PAR  hypothesis,  a  match  in  the  developing 
environment and later life external environment is present; therefore, one would 
expect the metabolism of the offspring to match that of its mother. Although not all 
results shown in this section match the expression levels of the day 8.5 dams, 
there are similarities in the pattern of expression across groups. F1 PR-PS and F2 
PS-PS-PS day 8.5 dams and their respective offspring (F2 PR-PS and F3 PS-PS-
PS) show similar increases in expression of the genes GR, PEPCK, PFK-2 and 
CPT-1. This can be seen in terms of PEPCK (Figure 4.11). In terms of the PAR 
hypothesis, we would expect all gene expression to be similar, this means that the 
PAR hypothesis does not account for all gene expression levels in offspring. 
The primary hypothesis suggests that the fasting phenotype of adult-non pregnant 
offspring is associated with changes in gene expression, from the data shown it is 
clear that this is the true. It is now important to determine the mechanisms behind 
this alteration in mRNA expression between generations. 
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Figure 4.11 Hepatic PEPCK mRNA expression in day 8.5 pregnancy in the F0, F1 
and F2 generations, and their relative offspring.  Where blue represents pregnant 
PS,  orange  represents  non-pregnant  PS,  red  represents  pregnant  PR  and  purple 
represents  non-pregnant  PR.  Values  are  means  with  their  standard  deviations. 
Significant  differences  between  diets  and  generation  were  determined  by  two-way 
ANOVA with Bonferroni’s post hoc test. P<0.05 
.  Samuel Peter Hoile   
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  Chapter 5   
 
The Effect of Altered Dietary Energy 
Content and Protein Content of Maternal 
Diet on DNA Methylation of the PEPCK 
and DNMT3a2 Promoters in Dams and 
Offspring 
 
 
 
 Samuel Peter Hoile   
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5.1 Introduction 
Transition onto a high energy diet led to an altered fasting metabolism in 
pregnancy across three generations. This resulted in altered regulation of fasting 
metabolism  in  offspring,  up  to  the  F3  generation.  The  trajectory  of  the  altered 
phenotype in both dams and offspring was dependent on the protein content of the 
maternal diet during pregnancy. Differences in fasting energy homeostasis were 
associated  with  significant  differences  in  mRNA  of  specific  genes  involved  in 
fasting glucose and fatty acid metabolism, GR, PEPCK, Fru-2,6-BPase, Glc-6-P, 
PPARα  and  CPT-1.  One  potential  mechanism  behind  the  alterations  in  gene 
expression and therefore fasting phenotype is epigenetics. 
 
5.1.1 The role of DNA methylation in altered phenotype 
  As discussed in section 1.4, epigenetic processes have the potential to alter 
expression of genes through the direct or indirect inhibition of transcription. Insulin 
gene  promoter  activity  was  decreased  by  90%,  in  pancreatic  β-cells,  through 
increased methylation of the CRE
[193]. Through Sequenom Mass ARRAY analysis 
an  association  was  found  between  methylation  status  at  birth  and  obesity  in 
childhood
[263].  Neonatal  methylation  of  the  Retinoid  X  Receptor  α  (RXRA)  and 
endothelial nitric oxide synthase (eNos) promoters accounted for over 25% of the 
variance shown in obesity at age 6 (P=0.009 and 0.002, respectively).  
 
The  link  between  epigenetic  marks and  an  altered  phenotype  has  been  shown 
previously,  therefore,  it  could  provide  one  mechanism  for  the  differences  in 
phenotype seen in the animals of this study. 
If DNA methylation is significantly altered in the non-pregnant adult offspring and 
day 8.5 pregnant dams of the study, as a result of altered nutritional intake, it is not 
known if these marks will be transmitted between generations unaltered, or if they 
are established de novo. 
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The methylation status of the PEPCK and DNMT3a2 promoters were measured in 
both day 8.5 dams and non-pregnant adult females. In order to test the association 
between promoter methylation and mRNA expression, DNMT3a2 gene expression 
will  be  measured  in  both  the  day  8.5  dams  and  non-pregnant  adult  offspring 
groups, using RT-PCR. 
 
5.2 Experimental Design 
  All day 8.5 pregnant dams and non-pregnant adult female offspring samples 
were from the transgenerational feeding study (Section 2.2). 
 
5.2.2 Molecular biology procedures 
  Extraction of RNA and RT-PCR methods are described in Sections 2.3.1 to 
2.3.3.  Extraction  of  DNA  bisulphite  treatment  of  DNA,  PCR  conditions  and 
pyrosequencing methods are described in Sections 2.3.4 to 2.3.8. 
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5.3 Results 
5.3.1 Does energy and protein content of the F0 diet during pregnancy alter 
methylation of the PEPCK promoter in adult offspring? 
  There  were  significant  effects  of  generation  on  PEPCK  promoter 
methylation at CpGs -508 and -100bp, significant effects of protein content of the 
F0 maternal diet during pregnancy on methylation at CpGs -248, -129, -100, -90 
and  -81bp  and  a  significant  interactive  effect  of  generation  and  F0  diet  on 
methylation  at  CpG  -100bp  (Figure  5.1).  At  CpG  -508,  in  the  PS  lineage, 
methylation was significantly higher in the F2 and F3 generation, compared to the 
F1 generation (P<0.005). Methylation at CpG -248 was significantly higher in the 
F1 generation of the PS lineage, compared to all other groups, except for the F1 
PR group; there were no significant differences within the PR lineage. Methylation 
of  CpG  -129,  in  the  PS  lineage  was  significantly  higher  in  the  F1  generation, 
compared to both the F2 and F3 generations, in the PR lineage methylation was 
significantly  lower  in  the  F3  generation,  compared  to  both  the  F1  and  F2 
generations.  At  CpG  -100,  methylation  was  significantly  higher  in  the  F1 
generation, regardless of F0 diet, compared to the F2 and F3 generations, in the 
PR  lineage  only,  methylation  in  the  F3  generation  was  higher  than  the  F2 
generation. In the PS lineage, methylation at CpG -90 was significantly higher in 
the F1 generation, compared to both the F2 and F3 generation, in the PR lineage, 
methylation in the F2 generation was significantly higher than both the F1 and F3 
generations. Methylation of CpG -81 was significantly lower in the F3 generation of 
the PS lineage, compared to both the F1 and F2 generations. Table 5.1 shows the 
interactive effects of generation and F0 diet on PEPCK methylation in adult non-
pregnant female offspring. 
 
CpG  
-606 
CpG  
-508 
CpG  
-440 
CpG 
-248 
CpG 
-218 
CpG 
-129 
CpG  
-100 
CpG  
-90 
CpG  
-81 
Generation  NS  0.012  NS  NS  NS  NS  0.076  NS  NS 
F0 diet  NS  NS  NS  0.015  NS  <0.001  <0.001  <0.001  0.004 
Gen * F0 diet  NS  0.057  NS  NS  NS  NS  0.095  0.034  NS 
  Table 5.1 A General Linear Model showing significant interactive effects of generation 
and F0 diet on PEPCK promoter methylation in non-pregnant adult female offspring Samuel Peter Hoile   
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Figure  5.1  PEPCK  promoter  methylation  in  non-pregnant  adult  female  offspring. 
Values are means with their standard deviations, where ‘a’ is significantly different from ‘b’, 
and ‘ab’ is neither significantly different to ‘a’ or ‘b’. Significant differences were by two-way 
ANOVA, with Bonferroni’s post hoc test P<0.005.  
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5.3.2 Does the energy content of diet and F0 pregnancy diet protein content 
alter methylation of the PEPCK promoter in pregnancy? 
  There was a significant effect of generation on PEPCK methylation in day 
8.5 dams. Methylation of CpG -129 was significantly lower in the F1 generation 
compared to the F0 generation, in the PR lineage only (Figure 5.2) There were no 
further  effects  of  generation  on  PEPCK  methylation.  There  were  no  significant 
effects of diet on PEPCK methylation, at any measured CpG, in day 8.5 dams. 
Table  5.2  shows  the  interactive  effects  of  generation  and  F0  diet  on  PEPCK 
methylation in day 8.5 dams. 
 
 
CpG  
-606 
CpG  
-508 
CpG  
-440 
CpG  
-129 
CpG  
-90 
CpG  
-81 
Generation  0.057  NS  NS  0.031  NS  NS 
F0 diet  NS  NS  NS  NS  NS  NS 
Age * F0 diet  NS  NS  NS  NS  NS  NS 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
Table 5.2 A General Linear Model showing significant interactive effects of generation 
and F0 diet on PEPCK promoter methylation in day 8.5 dams Samuel Peter Hoile   
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Figure 5.2 PEPCK promoter methylation in day 8.5 pregnant dams. Values are means with 
their standard deviations, where ‘a’ is significantly different from ‘b’. Significant differences were 
by two-way ANOVA, with Bonferroni’s post hoc test P<0.005.  
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5.3.3 Does the energy content of diet and F0 pregnancy diet protein content 
alter  hepatic  expression  of  DNMT3a2  in  day8.5  pregnant  dams  or  non-
pregnant adult offspring? 
   There was no effect of generation or diet on DNMT3a2 expression in either 
day 8.5 pregnant dams or non-pregnant adult female offspring (Figure 5.3). Table 
5.3  shows  the  interactive  effects  of  generation  and  F0  diet  on  DNMT3a2 
expression. As shown in Table 5.3 there was no significant effects. 
 
  Day 8.5 pregnant  Offspring 
Generation  0.806  0.801 
F0 diet  0.128  0.893 
Generation * F0 diet  0.532  0.270 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table  5.3  A  General  Linear  Model  showing  significant  interactive  effects  of 
generation and F0 diet on DNMT3a mRNA expression in day 8.5 pregnant dams 
and non-pregnant adult female offspring. Samuel Peter Hoile   
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Figure 5.3 DNMT3a2 mRNA expression in day 8.5 pregnant dams and non-pregnant 
adult offspring. Values are means with their standard deviations, where ‘a’ is significantly 
different from ‘b’. Significant differences were by two-way ANOVA, with Bonferroni’s post 
hoc test P<0.005.  
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5.3.4 Does energy and protein content of the F0 diet during pregnancy alter 
methylation of the DNMT3a2 promoter in adult offspring? 
  There was a significant effect of both generation and F0 diet on methylation 
of  the  DNMT3a2  promoter  in  non-pregnant  adult  female  offspring  (P<0.001) 
(Figure 5.4). There was a significant interactive effect of generation and F0 diet on 
methylation at CpGs -56 and -39 (P<0.001). There was no effect of generation or 
F0 diet on methylation at CpGs -207 and -190. Methylation at both CpG -56 and -
39 was significantly higher in the F1 PS group, compared to all other groups. There 
were no significant effects within the PR lineage for the CpGs. Table 5.4 shows the 
interactive effects of generation and diet on methylation of the DNMT3a2 promoter 
in non-pregnant adult-offspring. 
 
 
 
CpG  
-207 
CpG  
-190 
CpG  
-56 
CpG  
-39 
Generation  NS  NS  <0.001  <0.001 
F0 diet  NS  NS  <0.001  <0.001 
Age * F0 diet  NS  NS  <0.001  <0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.4 A General Linear Model showing significant interactive effects of age and 
maternal  diet  on  DNMT3a2  promoter  methylation  in  non-pregnant  adult  female 
offspring Samuel Peter Hoile   
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Figure  5.4  DNMT3a2  promoter  methylation  in  non-pregnant  adult  female 
offspring.  Values  are  means  with  their  standard  deviations.  Significant  differences 
were by two-way ANOVA, with Bonferroni’s post hoc test P<0.005.  
 Samuel Peter Hoile   
178 
 
5.3.5 Does the energy content of diet and F0 pregnancy diet protein content 
alter methylation of the DNMT3a2 promoter in pregnancy? 
  There were no significant effects of energy content of diet or generation on 
DNMT3a2 promoter methylation, at any CpG, in day 8.5 dams (Figure 5.5). There 
was  a  significant  interactive  effect  of  generation  and  F0  diet  on  methylation  at 
CpGs -56 and -39 (Table 5.5). 
   
 
CpG  
-207 
CpG  
-190 
CpG  
-56 
CpG  
-39 
Generation  NS  NS  NS  NS 
F0 diet  NS  NS  NS  NS 
Age * F0 diet  NS  NS  0.022  0.049 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.5 A General Linear Model showing significant interactive effects of age and 
maternal diet on DNMT3a2 promoter methylation in day 8.5 pregnant dams Samuel Peter Hoile   
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Figure 5.5 DNMT3a2 promoter methylation in day 8.5 pregnant dams. Values are 
means with their standard deviations. Significant differences were by two-way ANOVA, 
with Bonferroni’s post hoc test P<0.005.  
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5.4 Discussion 
5.4.1 PEPCK 
5.4.1.1 CpG specific changes in promoter methylation in non-pregnant adult 
female offspring 
  There was an effect of generation on methylation of CpG-100, where the F1 
generation  had  significantly  higher  methylation  than  both  the  F2  and  F3 
generations,  in  both  the  PS  and  PR  lineages.  CpG  -129  showed  an  effect  of 
protein content of the F0 maternal diet during pregnancy, where the PS lineage 
showed a higher methylation in the F1 group compared to both the F2 and F3 
groups, whereas the PR lineage had an higher methylation in both the F1 and F2 
groups,  compared  to  the  F3  group.  According  to  Skinner’s  definition  of  true 
transgenerational  transmission  methylation  differences  present  in  the  F3 
generation  between the two dietary lines must be heritable, in order to be seen 
three  generations  after  the  initial  exposure
[165].  The  importance  of  measuring 
methylation of CpGs in a given promoter individually is confirmed when considering 
this  data,  where  average  promoter  methylation  values  may  omit  interesting 
findings. 
 
5.4.1.2  The  role  of  promoter  methylation  in  regulation  of  PEPCK  gene 
expression in offspring 
  As stated previously high levels of methylation of the promoter regions of 
most  genes  is  associated  with  decreased  expression  of  the  gene 
[196,194,195,197,193,198,187,199,200,201].  Examples  include  methylation  of the  Insulin  gene 
promoter in mouse pancreatic cells
[193] and methylation of the hMLH1 promoter
[194]. 
PEPCK  expression  in  the  non-pregnant  adult  female  offspring  was  significantly 
lower in the F2 PS-PS-PS group, compared to all other groups. In terms of the 
relationship between methylation and expression of the PEPCK gene, there does 
not appear to be a clear association. A higher level of methylation is seen in the F2 
PS group, compared to the F1 PS group at CpG-508. However at this CpG the F3 
PS group also shows a higher level of expression, with no associated decrease in 
methylation.  A  common  pattern  seen  in  the  methylation  status  of  the  PEPCK Samuel Peter Hoile   
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promoter in the PS lineage is a higher level in CpG specific methylation in the F1 
group, compared to both the F2 and F3 groups. This pattern, seen in CpGs -248, -
129, -100 and -90, however, is not directly comparable to the pattern of expression 
seen. Studies by Kuroda and Deng have shown a clear association between levels 
of  promoter  methylation  and  mRNA  expression.  It  may  be  that  under  the 
physiological state of fasting, the effect of the difference in methylation described 
here remains cryptic. Under alternative situations, whereby PEPCK is regulated by 
different mechanisms, changes in PEPCK mRNA expression may be present. This 
could be due to differences in the regulation of the genes studied, where PEPCK is 
expressed  during  periods  when  glucose  is  low,  whereas  the  insulin  gene, 
measured  by  Kuroda,  is  habitually  expressed.  If  genes  are  expressed  under 
different physiological conditions, it would be expected that the form of regulation 
and extent to which DNA methylation plays will be significantly different between 
genes. In order to affect levels of transcription, factors must bind to around the 
transcription  start  site.  According  to  Chakravarty  the  region  -1500  to  +74  base 
pairs,  relative  to  the  transcription factor  start  site  is necessary  and  sufficient  to 
direct transcription
[238]. The most important region, the CRE can be found at -147 to 
-130 bp
[234]. It could be that there are further CpGs, which could be having stronger 
effects  on  levels  of  PEPCK  transcription.  As  shown  in  the  murine  α1-protease 
inhibitor  gene,  an  enhancer  site  around  3,000bp  upstream  of  the  transcription 
factor start site has the potential to alter levels of transcription
[264], it could be that 
regions further away from the transcription start site are having effects. 
Variation  in  CpG  methylation  will  reflect  altered  transcription  factor  binding  and 
therefore altered levels of transcription, however, this is dependent on the specific 
form of regulation and the transcription factors involved. Fasting alone may not be 
sufficient to observe the effects of altered methylation at the PEPCK promoter. The 
results  however,  provide  conclusive  evidence  that  methylation  of  the  PEPCK 
promoter  is  subject  to  significant  variation  following  an  increased  energy  diet 
throughout life over three generations, and reduced protein in the F0 maternal diet 
during pregnancy.    Samuel Peter Hoile   
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  In order to lead to significant differences in the level of gene transcription, 
alterations in methylation of a promoter region, must directly or indirectly lead to 
changes in transcription factor binding.  The potential transcription factor binding 
sites  covering  CG  dinucleotides,  in  the  PEPCK  promoter,  generated  using  Mat 
Inspector software, are shown in Figure 5.6. By comparing the transcription factor 
binding sites to the methylation levels across the groups, it appears that there is 
altered methylation across the groups at the binding sites for C/EBP, KLTFs and 
CRE. The CRE and C/EBP play a significant role in regulation of transcription of 
the PEPCK gene
[238,231,239]. A loss of expression of C/EBP in mice, leads to an 
absence of expression of PEPCK at birth
[231], and activation of the PEPCK gene by 
cAMP,  acting  via  the  cAMP  response  element  leads  to  a  tenfold  increase  in 
PEPCK expression within 20 minutes
[239]. As a result altered methylation of these 
CpGs  is  likely  to  affect  binding  at  these  sites,  and  could  contribute  to  the 
differences in mRNA expression seen. This suggests that as  methylation of the 
CpGs found within these binding sites is altered between generations, binding of 
these regulatory may be affected. This altered form of regulation may explain some 
of  the  differences  in  PEPCK  gene  expression  between  generations.  Functional 
investigation  into  the  role  of  specific  CpGs  in  the  regulation  of  transcription  of 
PEPCK and the binding of specific factors to specific regions of the promoter will 
clarify the specific role of methylation in regulation of transcription of PEPCK. 
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5’AGCTGACATAAAACATTTAGAGCAGGGGTCAGTATGTATATAGAGTGATTATTCTATATC   -620 
 
         -606 
AGGCATTGCCTCCTCGGAATGAAGCTTACAATCACCCCTCCCTCTGCAGTTCATCTTGGG   -560 
 
                 -508 
GTGGCCAGAGGATCCAGCAGACACCTAGTGGGGTAACACACCCCAGCCAACTCGGCTGTT   -500 
 
      -477 
GCAGACTTTGTCTAGAAGTTTCACGTCTCAGAGCTGAATTCCCTTCTCATGACCTTTGGC   -440 
        HSF                 PPAR 
-440 
CGTGGGAGTGACACCTCACAGCTGTGGTGTTTTGACAACCAGCAGCCACTGGCACACAAA   -380 
 
           -347 -342 
ATGTGCAGCCAGCAGCATATGAAGTCCAAGAGGCGTCCCGGCCAGCCCTGTCCTTGACCC   -320 
 
             -271 
CCACCTGACAATTAAGGCAAGAGCCTATAGTTTGCATCAGCAACAGTCACGGTCAAAGTT   -260 
 
       -248         -218 
TAGTCAATCAAACGTTGTGTAAGGACTCAACTATGGCTGACACGGGGGCCTGAGGCCTCC   -200 
      C/EBP 
 
CAACATTCATTAACAACAGCAAGTTCAATCATTATCTCCCCAAAGTTTATTGTGTTAGGT   -140 
            GR 
       HNF1 
           HNF1 
      -129         -100      -90      -81 
CAGTTCCAAACCGTGCTGACCATGGCTATGATCCAAAGGCCGGCCCCTTACGTCAGAGGC   -80 
                CRE 
          KLTFs 
                   -22 
GAGCCTCCAGGTCCAGCTGAGGGGCAGGGCTGTCCTCCCTTCTGTATACTATTTAAAGCG   -20 
 
           +2 
AGGAGGGCTAGCTACCAAGCACGGTTGGCCTTCCCTCTGGGAACACACCCTTGGCCAACA   +40 
                   3’ 
Figure  5.6  Diagram  showing  relevant  transcription  factor  binding  sites  covering  CpG 
dinucleotides, in the PEPCK promoter.  Diagram shows -500bp to +40bp, where 0bp is the 
transcription start site. Red highlighted represents the transcription start site, yellow highlighted 
represents  CpG  dinucleotides,  bold  text  represents  exon  1  and  underlined  represents  a 
transcription factor binding site. Binding sites shown for Heat shock factor (HSF), PPAR, CCAAT 
enhancer-binding  protein  (C/EBP),  Hepatic  nuclear  factor  1  (HNF1),  GR,  Krueppel  like 
transcription factors (KLTFs) and cAMP response element (CRE). Samuel Peter Hoile   
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5.4.1.3 The effect of pregnancy on PEPCK promoter methylation 
  The differences between both generation and dietary groups were reduced 
when the litter mates of the postnatal day 70 non-pregnant adult female offspring 
became pregnant.  
Between  pregnancy  groups  there  was  a  significant  effect  of  generation  on 
methylation of the PEPCK promoter in day 8.5 dams at CpG  -129 only, where 
methylation in the F1 PR group was significantly higher than the F2 PR group. 
There was no effect of the protein content of the F0 maternal diet during pregnancy 
on PEPCK methylation. 
  When comparing pregnancy groups to their non-pregnant litter mates, there 
was a significant effect of the added stress of pregnancy on CpG methylation of the 
PEPCK promoter at CpGs -440, -129, -90 and -81 bp (P<0.05) (Figure 5.7). The 
effect was dependant on generation and protein content of the F0 maternal diet 
during pregnancy in CpGs -440 and -129, and generation only in CpG -90. The 
effect of the protein content of the maternal diet during pregnancy is seen in CpG -
129, where each protein lineage showed different patterns in CpG methylation. 
The  results  show  that  the  additional  stress  of  pregnancy  leads  to  a  significant 
difference  in  methylation  of  the  PEPCK  promoter,  in  a  CpG  specific  manner. 
However, once pregnant, the significant differences seen between non-pregnant 
groups  are  lost.  This  suggests  that  regulation  of  PEPCK  may  be  significantly 
different in the physiological state of pregnancy.  
As discussed in Section 1.2.1.2, the fasting response is significantly altered during 
pregnancy. As the methylation of the promoter of a key gene involved in fasting is 
significantly altered in pregnancy this could provide one potential mechanisms for 
the changes seen. 
To  date  no  studies  have  shown  the  effect  of  pregnancy  on  the  epigenetic 
regulation of transcription of specific gene, therefore it is not known if these effects 
are  replicated  in  other  genes,  or  if  these  mechanisms  are  conserved  between 
species. 
 Samuel Peter Hoile   
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5.4.1.4  The  role  of  promoter  methylation  on  regulation  of  PEPCK 
transcription in day 8.5 pregnant dams 
In the day 8.5 pregnant dams, there is only one change in methylation of the 
PEPCK  promoter.  At  CpG  -129,  the  F0  PR  group  had  significantly  higher 
methylation than the F1 PR group. In terms of PEPCK expression in day 8.5 dams, 
the F1 PR group had an increased expression, compared to both the PS and PR 
F0 dams. As a result the relationship between the F0 and F1 groups, but not the 
F1 and F2 groups, can be explained by methylation of the PEPCK promoter at 
CpG  -129.  As  shown  in  figure  5.6,  this  region  contains  the  CRE,  suggesting 
activation of the PEPCK gene by cAMP may be involved. Again methylation of 
other CpGs may remain cryptic until the animals are under different physiological 
conditions, where actions of alternative transcription factors may provide further 
differences between groups. 
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  Figure 5.7 The effect of pregnancy on PEPCK promoter methylation. Values are means with 
their standard deviations. Significant differences were by T-TEST (P<0.05), where differences are 
shown with a ‘*’. Solid bars represent non-pregnant adult females. Patterns bars represent day 8.5 
pregnant dams. Blue represents the PS lineage and PR represents the PR lineage. 
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5.4.1.5  The  effect  of  altered  maternal  physiology  on  offspring  promoter 
methylation 
  There  are  similarities  between  the  methylation  status  of  the  PEPCK 
promoter  in  day  8.5  pregnant  dams  and  day  70  non-pregnant  adult  female 
offspring,  for  specific CpGs.  The  relationship  between  methylation  levels  in  the 
PEPCK promoter in the dams and their respective offspring can be seen in figures 
5.8 and 5.9 for the PS and PR lineages, respectively. Both dietary lineages show 
no  significant  differences  between  CpG  methylation  for  specific  groups,  at 
numerous CpGs. PEPCK methylation in the offspring is significantly different from 
that  of  the  dams  for  multiple  CpG  across  all  three  pregnancies.  For  the  PS  
lineage, it appears that after multiple pregnancies, the F3 offspring are showing 
more similar methylation levels to that of the dams (F2 dams), compared to the F1 
offspring  (F0  dams).  Alternatively,  in  the  PR  lineage,  the  smallest  difference 
between dam and offspring methylation is seen in the F2 offspring, rather than the 
F3. Specific CpGs, such as CpG -81, show a greater difference between dams and 
offspring, regardless of protein lineage and generation, this can be explained by 
the large effect of pregnancy, at the CpG. These results suggest that the extent to 
which  offspring  methylation  is  based  on  maternal  methylation  levels  varies 
between generations, in a manner dependent on the protein content of the F0 diet 
during pregnancy. 
 
 
 
 
 
 
 
 
 
 
 Samuel Peter Hoile   
188 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 A comparison between maternal methylation and offspring methylation 
of the PEPCK promoter  in the PS lineage.  Values are means with  their standard 
deviations.  Significant  differences  were  by  T-TEST.  Blue  bars  represent  the  dam 
groups, orange bars represent the offspring groups. 
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Figure 5.9 A comparison between maternal methylation and offspring methylation of the 
PEPCK  promoter  in  the  PR  lineage.  Values  are  means  with  their  standard  deviations. 
Significant  differences  were  by  T-TEST.  Red  bars  represent  the  dam  groups,  purple  bars 
represent the offspring groups. 
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5.4.2 DNMT3a2 
  No  significant  differences  were  present  between  dietary  groups  and 
generation, in terms of DNMT3a2 mRNA expression. However, mRNA expression 
levels in non-pregnant adult female offspring are around double the level seen in 
all  day  8.5  dam  groups.  This  result  suggests  that  the  potential  for  de  novo 
methylation, such as that seen in tissue growth, is greater in non-pregnant females, 
compared  to  pregnant  females,  in  the  rat.  Physiologically,  this  suggests  a 
compromised ability for tissue regrowth following injury, perhaps as a consequence 
for the maternal adaptations towards pregnancy. Liver growth during pregnancy, 
gestational hepatomegaly, occurs in order for the mother to meet the increased 
metabolic demands of the liver
[265]. This mechanism, which results from hepatocyte 
hypertrophy, precedes maternal weight gain and is significantly proportional (r
2 = 
0.56) to fetal number. A study by Milano has shown that the pregnancy hormones 
do  not  play  a  role  in  this  phenomenon,  leaving  the  responsible  mechanism 
unknown. The results here suggest that increased DNMT3a2 mRNA expression in 
pregnancy could be a key part in gestational hepatomegaly. 
 
5.4.2.1 Promoter methylation in non-pregnant adult female offspring 
  Methylation of the DNMT3a2 promoter showed a significant effect of both F0 
diet and generation. Methylation of CpGs -56 and -39, in the F1 PS group was 
significantly higher than all other groups, in both the PS and PR lineages. 
 
5.4.2.2 CpG specific alterations in methylation 
  The potential transcription factor binding sites, covering CG dinucleotides in 
the DNMT3a2 promoter are shown in figure 5.10. The only known transcription 
factors to  regulate  DNMT3a2  transcription  are  Sp1,  Sp3  and  Rbl2
[212,211,213].  As 
shown in figure 5.10, none of these transcription factors bind across altered CpGs. 
There is no published data at present, to suggest that altered binding of any of the 
shown  transcription  factors  will  alter  expression  of  DNMT3a2.  As  a  result,  it  is 
unknown if binding of any of the described transcription factors are altered by the 
significant changes in level of methylation. Samuel Peter Hoile   
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Figure 5.10 Diagram showing relevant transcription factor binding sites covering CpG 
dinucleotides, in the DNMT3a2 promoter.  Diagram shows -216bp to +22bp, where 0bp is the 
transcription start site. Yellow highlighted represents CpG dinucleotides, bold text represents 
exon 1 and underlined represents a transcription factor binding site. Binding sites shown for 
neuron-restrictive silencer facot (1 and 9), MAF and AP1 related factors (2), nuclear factor of 
activated T-cells (3), RXR heterodimers binding sites (4), neuron-specific-olfactory factor (5), 
activator protein (6), human and murine ETS1 factors (7), PRD1-BF1 and ROZ homologous 
domain proteins (8) and mouse krueppel like factor (10). 
 
 
               
  5’AGCAAGTTTGAGACCAGCCTGGACTATGTGAGATTTGCCCTCCAAAGGTCAGAGGATAGA  -216 
 
       -207     -190 
CACTGGGCCGAGAGGGAGGTTTCCCCGGAGGCAGGAAGGAAAGCTGAGTAGGCCTTCTTC  -156 
     3 
           4 
         5 
     
         6 
               
          7 
CAGCTTCAGCTGTTTTTATTCACATGGTGAGCTGCTTGGGTTGTTAGAGTAAAGCCA  -99 
           -56      -39 
CTCTCTCCAGACCACTGATGGGCTGAAGGTCCCTGAGTCTCACGGAGCCTTGCTCATTCCG  -38 
           8 
 
            9 
 
             10 
   
GGAGGGGTCAAGATGACTTCTGCCCCCATTTCCCCAGGCTGAGAAGAAAGCCAAGGTGAT +22 
    3’ Samuel Peter Hoile   
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5.4.2.3  The  role  of  promoter  methylation  in  regulation  of  DNMT3a2 
transcription in offspring 
  There  were  no  significant  changes  in  DNMT3a2  gene  expression  across 
generations or dietary lineages, in the non-pregnant adult female offspring. The 
level of methylation between groups in CpGs -207 and -190, matches that of the 
DNMT3a2 expression, such that there is no change across groups. However there 
are  significant  changes  in  methylation  of  CpGs  -56  and  -39,  which  are  not 
represented in expression of the gene. It appears that altered methylation at these 
CpGs does not play a role in transcription of the gene, but methylation of CpGs -
207 and -190 may. Under altered environments, the higher level of methylation 
present in the F1 PS group may lead to an altered level of transcription of the 
gene. If this is the case, then these animals may have an altered capacity for de 
novo methylation, such as that involved in differentiation of stem cells, following 
organ repair, 
 
5.4.2.4 The effect of pregnancy on DNMT3a2 methylation 
  Again,  with  DNMT3a2,  the  effect  of  pregnancy  on  the  regulation  of 
transcription may be seen when comparing non-pregnant adult female offspring to 
their pregnant litter mates. 
Between  groups,  there  were  no  effects  of  generation  or  protein  content  of  the 
maternal diet during pregnancy on methylation of the DNMT3a2 promoter in day 
8.5 pregnant dams. 
When  comparing  pregnant  to  non-pregnant  litter  mates,  pregnancy  lead  to  a 
significant  increase  in  methylation  of  specific  CpGs  at  the  DNMT3a2  promoter 
(Figure 5.11). Methylation of CpG -207 was significantly higher in F2 PS-PS and 
F1 PR pregnant dams, compared to non-pregnant females of the same generation. 
At CpGs -56 and -39, methylation in all groups was significantly increased in the 
pregnant animals compared to the non-pregnant groups. This is in agreement with 
the mRNA expression levels of DNMT3a2, where lower levels are present in the 
day  8.5  dams.  This  suggests  that  through  DNA  methylation  of  the  DNMT3a2 
promoter,  mRNA  expression  is  decreased  during  pregnancy.  Again,  this  could Samuel Peter Hoile   
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represent  an  altered  capacity  for  tissue  repair  and  hepatomegaly  during 
pregnancy, as a consequence of maternal adaptations to pregnancy. 
Similar to the PEPCK promoter, the added stress of pregnancy led to a loss of 
significant differences between groups, in terms of promoter methylation. Again, to 
date, no one has shown this effect of pregnancy on gene specific methylation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11 The effect of pregnancy on DNMT3a2 promoter methylation. Values are means 
with  their  standard  deviations.  Significant  differences  were  by  T-TEST  (P<0.05),  where 
differences are shown with a ‘*’. Solid bars represent non-pregnant adult females. Patterns bars 
represent day 8.5 pregnant dams. Blue represents the PS lineage and PR represents  the PR 
lineage. 
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5.4.2.5  The  role  of  promoter  methylation  in  regulation  of  DNMT3a2 
transcription in day 8.5 pregnant dams 
  There  were  no  significant  changes  in  DNMT3a2  gene  expression  across 
generations or dietary lineages, in the day 8.5 pregnant dams. 
 
5.4.2.6  The  effect  of  altered  maternal  physiology  on  offspring  promoter 
methylation 
  The relationship between methylation levels in the DNMT3a2 promoter in 
the dams and their relevant offspring can be seen in figures 5.12 and 5.13 for the 
PS  and  PR lineages,  respectively.  CpG  methylation  at  -207  and  -190  bp  show 
effects of maternal diet, where F3 offspring in the PS lineage have significantly 
different  levels  of  methylation,  compared  to  their  respective  dams  (F2)  at  both 
CpGs. Whereas in the PR lineage, both F1 and F2 offspring show significantly 
different methylation at CpG -207, compared to their respective dams (F0 and F1). 
At the CpGs closet to the transcription start site, -56 and -39, all groups in both 
lineages show significantly different levels in methylation in offspring, compared to 
dams. This is likely to be due to the fact that these two CpGs are significantly 
altered by pregnancy and we are comparing pregnant dams to their non-pregnant 
offspring.  
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Figure 5.12 A comparison between maternal methylation and offspring methylation of 
the DNMT3a2 promoter in the PS lineage Values are means with their standard deviations. 
Significant differences were by T-TEST. Blue bars represent the dam groups, orange bars 
represent the offspring groups. 
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Figure  5.13  A  comparison  between  maternal  methylation  and  offspring 
methylation of the DNMT3a2 promoter in the PR lineage.  Values are means with 
their standard deviations. Significant differences were by T-TEST. Red bars represent 
the dam groups, purple bars represent the offspring groups. 
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5.4.3 Understanding of PEPCK and DNMT3a2 promoter methylation 
  From  the  data,  it  is  evident  that  for  both  the  PEPCK  and  DNMT3a2 
promoters, methylation levels in the non-pregnant adult female offspring became 
more variable nearer the transcription start site. This is likely to be associated with 
a regulatory mechanism, with altered transcription factor binding being involved. 
This  is  supported  by  specific  binding  sites  of  transcription  factors,  with  known 
regulatory functions at the promoters, seen in figures 5.10 and 5.7. 
Previous  experiments  have  shown  that  parental  famine  exposure  led  to  a 
decreased in CpG methylation of both the IGF-2
[215], and INISIGF promoters
[201] in 
offspring,  compared  to  non-famine  exposed  same-sex  offspring.  An  increase  in 
methylation was seen in the same offspring in the IL-10, LEP, AMCA1, GNASAS 
and MEG3 genes
[201]. These findings are in agreement, as dietary alteration has 
been shown to significantly alter promoter methylation, in a manner which is not 
restricted to one direction of change. Studies by Burdge and Lillycrop have shown 
altered  methylation  of  the  PPARα  and  GR  promoters  in  34  day  old  offspring, 
following  maternal protein  restriction
[198].  Although  the  study  did not  report  CpG 
specific findings, again the results here have shown the effect of maternal protein 
restriction on promoter methylation. No studies to date have investigated the effect 
of dietary modification on PEPCK or DNMT3a2 promoter methylation, therefore it is 
unknown  if  the  specific  findings  here  are  in  agreement  with  published  data. 
Pregnancy and nutritional transition lead to altered methylation of the PEPCK and 
DNMT3a2  promoters,  independently.  The  effect  of  pregnancy  seems  to  be  so 
great, that differences between dietary groups are not seen. However differences 
are  present  in  adult  non-pregnant  offspring.  The  differences  in  promoter 
methylation are related to significant differences in gene expression.  
This  data  provides  initial  evidence  for  methylation  changes  at  the  DNMT3a2 
promoter, as well as increased evidence for methylation of the PEPCK promoter. 
Further  investigation  of  other  forms  of  nutritional  alteration  will  further  increase 
knowledge on the regulation of the genes through methylation. 
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5.4.4 Implications 
If  nutritional  alterations  in  one  generation  lead  to  significant  changes  in 
promoter methylation in subsequent generations, at least up to the F3 generation, 
then  the  external  environment  during  pregnancy  must  be  carefully  considered. 
Nutritional alteration throughout pregnancy or sustained alteration in energy intake, 
leads  to  significant  changes  in  the  epigenome  of  offspring,  which  cannot  be 
detected  through  investigation  of  the  mother,  therefore  following  an  altered 
environment it is vital to follow up in the offspring in later life. 
The increased energy intake throughout life in these animals is representative of 
migration from a low nutritional intake country to a developed country, such as that 
with a typical Western diet. Significant differences have already been shown in the 
expression of genes and phenotype of the mothers and offspring exposed to the 
high energy diet. Now, altered methylation has been shown, in particular in the 
non-pregnant  adult  female  offspring.  This  provides  a  level  of  concern  when 
considering the impact of a permanent and sometimes severe nutritional change, it 
appeared that the fasting phenotype began to normalize over the course of the 
three generations; however changes in DNA methylation may be more persistent. 
Perhaps a less severe, staggered move onto a new diet may be more beneficial? 
 
5.4.5 Future work 
  Data here has provided a further mechanism into the significant alteration in 
phenotype  seen  in  both  the  pregnant  dams  and  non-pregnant  adult  female 
offspring. The data has shown the additional effect of pregnancy on methylation of 
the  two  specific genes.  Altered expression of  genes  was  present  in  the fasting 
animals, and these, to an extent were related to the altered phenotype. Although 
no directional relationships are present here, methylation of the promoter regions 
of genes is involved in their regulation and therefore the observed alterations in 
expression. However the mechanism here is unclear, it will therefore be necessary 
to  investigate  the  role  of  transcription  factor  binding  at  the  promoter  regions 
covered here and the specific role of single CpGs in the promoters. Luciferase 
construct will determine the role of specific CpGs on gene transcription and electro Samuel Peter Hoile   
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mobility  shift  assays  will  show  the  binding  of  specific  and  general  transcription 
factors to the measured CpGs. 
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  Chapter 6   
 
The Effect of Aging on Methylation of the 
PEPCK and DNMT3a2 Promoters 
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6.1 Introduction 
The results presented in Chapter 5 showed that methylation of the PEPCK 
and  DNMT3a2  promoters  are  subject  to  nutritional  alteration.    The  DOHaD 
hypothesis is based on the assumption that alterations in phenotype are a result of 
changes in the epigenome that are stable across the life course. However, it is not 
known if alterations in DNA methylation, as a result of maternal dietary alteration 
are maintained with aging. 
 
6.1.1 Changes in DNA methylation in aging 
  As described by Wotton and Jackson, nutrient restriction in early life leads to 
a  series  of  changes  within  an  organism,  which  aim  to  facilitate  maximum 
survival
[266].  An  example  of  one  of  these  adaptations  is  reduced  energy 
consumption of the organism, via reduced rates of metabolic processes at both the 
organ and cellular level. Adaptations such as these however may constrain net 
deposition of new tissues. Wotton and Jackson hypothesised that the functional 
consequences of restricted nutrition in early life are readily identified as impaired 
growth  and  development.  This  suggests  that  alterations  in  nutrition  during 
development  significantly  alter  the  trajectory  of  growth  and  development,  the 
mechanism behind this alteration in trajectory is unknown. 
As described in section 1.4.1.2, studies have shown that the epigenome is 
subject to variation throughout the life course
[205,206,208]. According to Bjornsson, 
29% of a male and female Icelandic cohort showed a significant change in blood 
cell  DNA  methylation  of  over  10%,  across  an  11  year  period
[205].  Cancer  is 
associated with a global decrease in methylation and an increase in methylation of 
specific genes
[209]. Therefore the epigenome is subject to specific alterations during 
the  life  course.  Due  to  the  decrease  in  activity  of  DNMT1  with  cellular 
senescence
[192],  one  potential  mechanism  for  the  decreased  stability  of  the 
genome is the decreased maintenance of methylation marks during cell division.  
  Feeding a protein restriction diet leads to significant changes in the aging 
process. In a study by Youngman, feeding a 5% or 10% protein diet throughout life 
inhibited the oxidative damage of proteins seen in the 20% dietary protein control Samuel Peter Hoile   
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group
[267]. The inhibitory effects of protein restriction on the aging process were 
again seen in a study by Lee
[268]. In mice, a high-density oligonucleotide array, 
which measured expression of 6,347 genes in skeletal muscle, showed that protein 
or calorie restriction, completely or partially prevented changes in gene expression 
associated  with  aging.  The  protein  restriction  led  to  a  metabolic  shift,  toward 
increased protein turnover in the animals. Changes in gene expression have been 
shown to be related to alterations in the epigenome, in particular DNA methylation. 
It is not known if the changes in gene expression and decreased protein oxidation 
seen in aging, following protein restriction are associated with significant alterations 
in DNA methylation. 
 
Investigation  of  CpG  specific  methylation  of  the  PEPCK  and  DNMT3a2 
promoters throughout the life course will show if methylation of the promoters is 
subject to alteration during periods of development only, or whether such plasticity 
extends into adulthood. The following question will be addressed in this chapter 
 
-Are  changes  in PEPCK  and  DNMT3a2  mRNA  expression  and promoter 
methylation, induced by maternal diet maintained across the life course? 
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6.2 Experimental Design 
  The  postnatal  day  28,  105,  275  and  475  offspring  were  from  the  study 
described  in  Section  6.2.1.  All  day  8.5  dam  and  non-pregnant  adult  female 
offspring  samples  are  from  the  study  previously  described,  and  RT-PCR  was 
carried out as described (Section 2.2 and Section 2.3.5, respectively). 
 
6.2.1 Animal model 
The experimental design can be seen in Figure 6.1. Experimental diets were 
supplied by TestDiet, Indiana, USA. The full composition of diets can be seen in 
Tables 2.2, 2.3 and 2.4, for macronutrients, vitamins and minerals, respectively. 
Adult females were mated and fed either a protein sufficient diet (PS) containing 
180 g/kg casein (w/w) or an isoenergetic protein restricted diet (PR) containing 90 
g/kg casein (w/w), throughout pregnancy. All dams were placed on the AIN-76A, 
lactation  diet.  After  28  days,  offspring  were  weaned  onto  the  AIN-93M, 
maintenance diet, and placed in group cages, with five rats being placed in each 
cage. At postnatal days 28, 105, 275 and 475, six rats from each dietary group 
were culled, and tissues were collected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Diagram showing the experimental design of the life course study. Where 
the protein sufficient diet is shown by PS, the protein restricted diet by PR, the lactation 
diet by L and the maintenance diet by M. Dams were fed either the PS or PR diet during 
pregnancy, during lactation all dams were fed the AIN76A diet. At weaning offspring were 
moved onto the AIN93-M, maintenance diet. 
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6.2.2 Tissue collection 
  After being culled, livers were collected from each rat. Liver weights were 
measured, and livers were snap frozen in liquid nitrogen upon collection. All tissue 
was stored at -80
oC long term.  
 
6.2.3 Molecular biology procedures 
Extraction of DNA and RNA, reverse transcription, bisulphite treatment of 
DNA, PCR conditions and pyrosequencing methods are described in Section 2.3. 
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6.3 Results 
6.3.1 Does mRNA expression of PEPCK or DNMT3a2 alter with age? 
  There was a significant effect of age on mRNA expression of PEPCK and 
DNMT3a2  (p<0.0001  and  p=0.001,  respectively)  (Figure  6.2).  PEPCK  mRNA 
expression was significantly increased at postnatal day 275, in both the control and 
protein restricted groups, compared to the day 105 groups.  
DNMT3a2 mRNA expression was significantly increased in the control lineage day 
275 group, compared to all other time points, in control offspring, and the day 28 
and day 475 protein restriction lineage group. There were no significant differences 
in DNMT3a2 expression within the PR animals. There were no significant effects of 
diet on mRNA expression of PEPCK or DNMT3a2. 
The results of the analysis of variance are shown in Table 6.1 
  PEPCK  DNMT3a2 
Age   <0.0001  0.001 
Maternal diet  NS  NS 
Age * Maternal diet  NS  NS 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
Table 6.1 A General Linear Model showing significant interactive effects of age and 
maternal diet on PEPCK and DNMT3a2 mRNA expression Samuel Peter Hoile   
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Figure 6.2 PEPCK and DNMT3a2 mRNA expression in offspring of dams fed either a 
PS or PR diet during pregnancy. Values are means with their standard deviations, where 
‘a’ is significantly different from ‘b’, and ‘ab’ is neither significantly different from ‘a’ or ‘b’. 
Significant differences between groups were by one-way ANOVA, with Bonferroni’s post hoc 
test. Significant differences between PS and PR groups were determined using an unpaired 
t-test. P<0.05 Samuel Peter Hoile   
208 
 
6.3.2 Does methylation of the PEPCK promoter alter with age? 
  There  was  a  significant  effect  of  age  on  PEPCK  methylation  (p<0.001) 
(Figure 6.3). There was an effect of age of offspring on DNA methylation at CpGs -
508, -440, -90 and -81 (P<0.05). In the PS and PR groups, methylation of CpG -
508  was  significantly  higher  in  the  D475  offspring,  compared  to  D28  offspring. 
Methylation  of  CpG  -440  was  significantly  increased  in  the  PR  day  28  group 
compared to the day 28 and day 225 PR group, significantly decreased in the PR 
225 group, compared to the PR day 105 group and significantly increased in day 
475 PR group, compared to the  PR 28 group. In the protein restricted lineage, 
methylation of CpG -129 was significantly increased at day 475 compared to day 
28. CpG -90 methylation was significantly lower at 475, compared to day 105, in 
the PR lineage. At CpG -81, in both the PS and PR lineages, methylation was 
significantly higher at day 105, compared to all other measured time points. The 
results of the analysis of variance are shown in Table 6.2. 
 
6.3.2.1 Are changes in PEPCK promoter methylation across the life course 
altered by maternal diet during pregnancy? 
  There was a significant effect of age and maternal diet on PEPCK promoter 
methylation  (p<0.001)  (Figure  6.3).  At  CpG  -440,  methylation  was  significantly 
higher at day 105, following maternal protein restriction. In the protein restriction 
lineage, methylation of CpG -90 was significantly lower at day 475, compared to 
the control offspring. 
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Figure 6.3 PEPCK promoter methylation in offspring of dams fed either a PS or PR diet 
during pregnancy. Values are means with their standard deviations, where ‘a’ is significantly 
different from ‘b’, and ‘ab’ is neither significantly different from ‘a’ or ‘b’. Significant differences 
between  ages  were  by  one-way  ANOVA,  with  Bonferroni’s  post  hoc  test  P<0.006.  Significant 
differences  between  PS  and  PR  groups  are  shown  by  an  ‘*’  and    were  determined  using  an 
unpaired t-test. P<0.05 Samuel Peter Hoile   
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CpG  
-606 
CpG  
-508 
CpG  
-440 
CpG  
-129 
CpG  
-90 
CpG  
-81 
Age  
 
NS  <0.001  0.037  NS  <0.001  <0.001 
Maternal diet  NS  NS  <0.001  NS  0.002  NS 
Age * Maternal diet  NS  NS  <0.001  NS  <0.001  NS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.2 A General Linear Model showing significant interactive effects of age and 
maternal diet on PEPCK promoter methylation Samuel Peter Hoile   
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6.3.3 Does methylation of the DNMT3a2 promoter alter with age? 
There was a significant effect of age on methylation at every CpG of the 
DNMT3a2 promoter (Figure 6.4). At CpG -207, in the PS groups only, methylation 
was significantly higher at day 105 and 475, compared to the day 28 (P<0.005). At 
CpG -190, in the PS groups, methylation was significantly lower in the D28 group, 
compared to the D275 and D475 groups. In the PR lineage, methylation of CpG -
190 was significantly increased at day 475, compared to day 105. At CpGs -56 and 
-39, in both the PS and PR groups, methylation was significantly lower at day 28, 
compared to all other groups. The results of the analysis of variance are shown in Table 
6.3. 
 
6.3.3.1 Are changes in DNMT3a2 promoter methylation across the life course 
altered by maternal diet during pregnancy? 
There  was  no  effect  of  maternal  diet  on  methylation  at  any  CpG  of  the 
dndmt3a2 promoter (Figure 6.4).  
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Figure 6.4 DNMT3a2 promoter methylation in offspring of dams fed either a PS or PR 
diet  during  pregnancy.  Values  are  means  with  their  standard  deviations,  where  ‘a’  is 
significantly  different  from  ‘b’,  and  ‘ab’  is  neither  significantly  different  from  ‘a’  or  ‘b’. 
Significant differences between ages were by one-way ANOVA, with Bonferroni’s post hoc 
test. Significant differences between PS and PR groups were determined using an unpaired t-
test. P<0.05 Samuel Peter Hoile   
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CpG  
-207 
CpG  
-190 
CpG  
-56 
CpG  
-39 
Age   0.001  <0.001  <0.001  <0.001 
Maternal diet  NS  NS  NS  NS 
Age * Maternal diet  NS  NS  NS  NS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.3 A General Linear Model showing significant interactive effects of age and 
maternal diet on DNMT3a2 promoter methylation Samuel Peter Hoile   
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6.4 Discussion 
6.4.1 mRNA expression and aging 
  Although PEPCK expression has been shown to be increased at birth
[229], 
no  studies  to  date  have  shown  variation  in  fasting  PEPCK  mRNA  expression 
throughout life. In this chapter it has been shown that PEPCK mRNA expression 
was significantly altered by aging. At postnatal day 225, PEPCK mRNA expression 
was significantly higher compared to day 105 offspring, regardless of the protein 
content of the maternal diet during pregnancy. Physiologically, this suggests that 
gluconeogenic capacity of the offspring is optimal at day 225 in these rats. This 
means  that  during  periods  of  fasting  the  ability  of  these  animals  to  provide 
sufficient  glucose  for  key  organs  is  maximal.  Compared  to  the  day  105  group, 
where PEPCK expression was lowest, this means a decreased requirement for β-
oxidation of fatty acids, to provide ketone bodies. As a result the production of free 
radicals, and therefore free radical damage, as a result of peroxide production, will 
be lower. 
DNMT3a2 mRNA expression was significantly increased in the postnatal day 225 
offspring,  compared  to  all  other  measured  ages,  in  the  PS  lineage  only.  This 
suggests that the capacity for de novo methylation is significantly increased at this 
age. Physiologically there is no clear reason for this increased capacity, as this age 
is not associated with any obvious changes. Differences in DNMT activity, but not 
mRNA expression, have been shown to vary with aging
[192]. In WI-38 human fetal 
lung  fibroblasts,  maintenance  methyltransferase  activity  of  DNMT1  activity 
decreased by 19.9% from postnatal day 18 to postnatal day 56, whereas de novo 
methyltransferase activity of DNMT3b activity increased by 317.5%. These results 
suggest  the  trajectory  of  alteration  in  activity  of  DNA  methyltransferases  is 
significantly  different  for  the  individual  DNMTs.  As  mRNA  expression  was  not 
measured in this study and DNMT3a activity was not measured in the study, it is 
unknown if these results are expected.  
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6.4.2 Promoter methylation in aging 
  In  male  rats,  methylation  of  both  the  PEPCK  and  DNMT3a2  promoters 
changes  significantly  across  the  life  course,  in  a  CpG  specific  manner.  In  the 
PEPCK  promoter  methylation  of  CpG  -508,  -440,  -129,  -90  and  -81  were 
significantly altered by aging. At CpG -508, methylation was significantly increased 
at postnatal day 475 compared to day 28, irrespective of maternal protein intake. 
Methylation of CpG -440 was significantly higher in the PR lineage at days 105 and 
475, compared to day 28. In the PR lineage, methylation of CpG -440 and -129 
were significantly higher and CpG -90 significantly lower, compared to day 28. At 
postnatal day 105, methylation of CpG -81 was significantly higher than all other 
time  points.  Although  the  significant  differences  in  DNA  methylation  are  not 
associated  with  changes  in  PEPCK  mRNA  expression,  the  results  show  that 
methylation of the PEPCK promoter varies with aging in a manner dependant on 
the protein content of the maternal diet during pregnancy. 
In  the  DNMT3a2  promoter,  there  was  a  significant  effect  of  age  on  CpG 
methylation. All four measured CpGs showed a similar pattern in change with age; 
where methylation in the weanlings (postnatal day 28) was significantly lower than 
all other groups. Again, the methylation status of DNMT3a2 throughout life was not 
clearly associated with mRNA expression. This could also represent a potential for 
altered expression of DNMT3a2, under different physiological conditions. 
 
Previous studies into variation of DNA methylation with time have shown 
significant changes in global methylation with age
[205] and CpG specific changes in 
methylation following altered maternal behaviour
[206]. The data here is not only in 
agreement with that found previously, but extends upon current knowledge. The 
data  here  shows  an  extensive  and  specific  coverage  of  two  distinct  promoter 
regions,  of  genes  with  significantly  different  expression  profiles  during  the  life 
course.  The  data  clearly  shows  the  effect  of  nutritional  alteration  during 
development extends far beyond adulthood to an age comparable to old age in 
humans. 
Despite DNMT3a2 accounting for 50% of all detected  DNMT3a expression, the 
promoter is primarily active during fetal development, with low levels present in Samuel Peter Hoile   
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adult tissue. Whereas the PEPCK promoter is active throughout all postnatal life, 
therefore  differences  in  variation  of  methylation  throughout  the  life  course  are 
expected. Protein restriction of the maternal diet during pregnancy led to significant 
alterations in the trajectory of variation in the PEPCK promoter only, leading to 
methylation levels significantly different between the PS and PR lineages at two 
time points, in two CpGs. The PEPCK promoter undergoes demethylation during 
fetal development
[229], the time during which the nutritional alteration was present. 
As  fetal  development  has  been  show  to  provide  a  window  for  alterations  in 
epigenetic  regulation  of  gene  expression,  differences  in  PEPCK  methylation, 
between PS and PR lineages are not unexpected. In comparison to the PEPCK 
promoter, methylation of the DNMT3a2 promoter remains high throughout the life 
course,  representing  its  decreased  expression.  Syzf  hypothesised  that  the 
epigenome is a dynamic equilibrium between methylation and demethylation
[190]. 
This  is  bought  about  by  active  addition  and  removal  of  methyl  groups  from 
promoter  regions  of  specific  genes.  The  results  here  do  show  a  significant 
alteration in the level of methylation at specific points of the promoter, however 
they  are  not  in  complete  agreement  with  Szyf’s  hypothesis.  Methylation  of  the 
PEPCK and DNMT3a2 promoters appear to follow a specific trajectory of change 
throughout  life,  rather  than  a  balance  between  methylation  and  demethylation. 
Further experiments investigating changes in methylation of the promoters across 
a few hours, under an altered state may confirm this. It is logical that variability is 
more prevalent in genes that have altered levels of expression over  minutes or 
hours. Perhaps genes that are expressed at lower levels, if at all, as a result of 
DNA methylation are less susceptible to variation over time? Therefore this could 
represent the fewer changes shown in DNMT3a2, compared to PEPCK. 
DNMT1 activity has been shown to decrease with cellular senescence
[192]. 
The  data  here  is  in  agreement  with  this  finding  for  two  CpGs  of  the  PEPCK 
promoter, CpGs -90 and -81, where methylation is significantly lower in the D475 
group,  suggesting  decreased  DNMT1  activity  could  account  for  this  finding. 
However  this  effect  is  not  seen  in  the  other  CpGs  measured  in  the  PEPCK 
promoter,  or  any  CpGs  in  the  DNMT3a2  promoter.  These  promoter  regions Samuel Peter Hoile   
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represent just two genes from the whole genome, as a result it is impossible to 
deduce if decreased DNMT1 activity is present here, or if it is having a significant 
effect on methylation levels. 
   
6.4.3 Methylation and expression 
  There  are  no  clear  relationships  between  promoter  methylation  of  both 
PEPCK and DNMT3a2 and fasting mRNA expression. This does not however rule 
out  the  role  of  DNA  methylation  in  regulation  of  the  genes.  The  significant 
differences in methylation of the promoters with aging may remain cryptic until the 
correct stressor and form of regulation is present. Altered methylation at a specific 
CpG site, where a specific transcription factor binds may only have an effect on 
transcription of the gene when the specific form of regulation is present. 
 
6.4.4 Does protein restriction alter trajectory of variation? 
  Previous  studies  have  shown  that  protein  restriction  throughout  life  can 
prevent or inhibit the effects of aging
[268,267]. Protein restriction of the maternal diet 
during pregnancy significantly altered the trajectory of change in methylation of the 
PEPCK promoter across the life course, at specific CpGs. Methylation of CpG -440 
is significantly increased at day 105 in protein restricted offspring, compared to 
control offspring. At CpG -90, methylation was significantly decreased in the PR 
lineage at day 475, compared to the control offspring. Although these differences in 
methylation  were  not  associated  with  change  in  PEPCK  expression,  due  to 
potential transcription factor binding at these CpGs, effects may be present under 
different physiological conditions, where different forms of regulation of the gene 
are taking place. 
 
Variation  in  methylation  of  CpG  -207  of  the  DNMT3a2  promoter  and  mRNA 
expression of DNMT3a2 was significantly altered with age in the PS groups. This 
variation  was  lost  when  maternal protein  restriction  was  applied,  suggesting  an 
inhibition of the effect of aging in the protein restricted offspring. 
 Samuel Peter Hoile   
218 
 
6.4.5 Implications 
  Aging is associated with significant variation in both mRNA expression and 
promoter DNA methylation of specific genes. These variations are dependent on 
the protein content of the maternal diet during pregnancy. These results suggest 
that the epigenome is a not fixed during development, but can be altered during 
postnatal  life,  including  late  stages  of  adult  life.  As  a  result  the  effect  of 
environmental stimuli in altering disease risk, through changes in the epigenome 
may be great. Interestingly protein restriction of the diet, which has been shown to 
lead  to  a  detrimental  phenotype  when  fed  to  dams  during  pregnancy  and/or 
lactation,  may  have  beneficial  effects  in  terms  of  aging,  when  considering 
detrimental effects of aging, such as increased cancer risk. 
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Chapter 7 
 
The Effect of Timing of Nutritional 
Exposure on the Epigenetic Regulation of 
Phosphoenolpyruvate Carboxykinase 
and DNA Methyltransferase 3a2 
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7.1 Introduction 
DNA methylation is regarded generally as a stable epigenetic mark which is 
induced during development and then persists throughout the life course
[184,269].  
Furthermore,  epigenetic  plasticity  is  considered  to  be  closely  linked  to 
developmental  plasticity  and  cell  differentiation
[270,271],  and  thus  after  early 
development,  DNA  methylation  is  essentially  resistant  to  environmental  signals.  
However, data in the previous chapter and a number of studies have challenged 
this view by showing tissue-specific variation in DNA methylation throughout the 
life course and in juvenile and adult tissues
[241]. 
 
7.1.1 Evidence for persistence of plasticity in DNA methylation throughout 
the life course 
There  are  physiological  observations  of  plasticity  in  DNA  methylation 
throughout the life course. Differentiation of Th1 and Th2 cells involved opposite 
changes in methylation of the promoter of the IFNγ gene promoter. Th1 and Th2 
cells  act  to  orchestrate  the  protective  immune  response,  thorough  cytokine 
production
[272]. In Th2 cells the IFNγ promoter is hypermethylated, whereas in Th1 
cells the promoter is hypomethylated
[272]. The mechanism, which is present in both 
human  and  mouse,  is  also  seen  in  natural  killer  cells  in  the  mouse
[272]. 
Hypermethylation  of  the  IFNγ  promoter  in  Th2  cells  leads  to  chromatin 
condensation and exclusion of CREB proteins from the IFNγ promoter
[273]. In the 
presence of the methylation inhibitor 5’-azacytidine, Th2 cells increase production 
of IFNγ, through CREB binding
[273]. The study demonstrates that DNA methylation 
is highly plastic in the immune system and that this plasticity is critical for function. 
The  role  of  DNA  methylation  in  the  onset  of  cancer  has  been  shown 
experimentally
[274,275,276]. Hypermethylation of tumour suppressor genes, leading to 
their  inactivation  has  been  shown  in  APC,  BRCA1,  E-cadherin,  LKB1  and 
MLHI
[275]. Altered epigenetic regulation of tumour genes affects over half of tumour 
suppressor genes that cause cancers when mutated in the germ line
[275]. In ovarian 
cancer  patients,  BRCA1  promoter  hypermethylation  was  shown  to  be  an 
alternative to mutation in causing the inactivation of the BRCA1 tumour suppressor Samuel Peter Hoile   
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gene
[274]. Out of 81 sporadic cases of ovarian cancer, the BRCA1 promoter was 
hypermethylated  in  15%.  Out  of  the  cases,  BRCA1  hypermethylation  was  only 
seen in patients without a family history of breast/ovarian cancer
[274]. These results 
suggest  that  global  DNA  methylation  associated  with  aging  is  accompanied  by 
tissue specific gene hypermethylation, such as tumour suppressor genes. 
Together  these  studies  show  that  the  period  of  plasticity  of  DNA  methylation 
extends throughout the life course.  One implication of these findings is that it may 
be  possible  to  correct  changes  in  promoter  methylation  induced  during 
development by interventions in later life. 
 
As shown in section 1.4, supplementation of a protein restricted diet with folic acid, 
in  the  rat,  prevented  at  least  some  of  the  phenotypic  and  epigenetic  changes 
induced by the PR diet alone.  These findings, together with the effect of folic acid 
supplementation on H19 in men, suggest that dietary interventions with this vitamin 
may reverse the effects of poor maternal nutrition on DNA methylation. To date, 
the only study that has investigated post-natal nutritional alteration is by Burdge et 
al
[25]. Juvenile pubertal offspring (postnatal day 28) of dams fed a protein restricted 
diet during pregnancy were fed with either 1mg/kg or 5mg/kg folic acid for 28 days. 
The effects of the maternal protein restriction however, were not simply reversed, 
an  increased  weight  gain,  lower  plasma  β-hydroxybutyrate  concentration  and 
increased hepatic and triglyceride concentrations were shown, in the 5mg/kg folic 
acid offspring, compared to the 1mg/kg offspring
[25]. Changes were also present in 
the  epigenome,  where  PPARα  and  GR  promoter  methylation  was  increased  in 
liver, in the folic acid supplemented offspring group
[25]. This implies that the timing 
of nutritional exposure may be an important factor which determines its effect on 
DNA methylation.  
To date there have not been any studies which have compared the effects of the 
same amount of dietary folic acid given during development or in later life on DNA 
methylation.          
Although  it  is  known  that  folic  acid  supplementation  can  induce  significant 
alterations in the epigenome and phenotype, in the protein restricted and IUGR rat Samuel Peter Hoile   
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models and in humans, it is not known whether providing the same amount of folic 
acid  at  different  stages  of  the  life  course  induces  the  same  changes  in  DNA 
methylation.  
The purpose of this chapter is to investigate these unanswered questions and to 
test the hypothesis that 
 
-Timing of nutritional alteration is an important factor in determining the direction 
and magnitude in alterations in phenotype via changes in DNA methylation. 
 
In  order  to  test  the  hypothesis,  PEPCK  and  DNMT3a2  gene  expression  and 
methylation will be measured in adult offspring, following folic acid supplementation 
of either the maternal or post-weaning diet. 
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7.2 Experimental design 
7.2.1 Animal model 
All  animal procedures  were  conducted  in  accordance  with  the  UK  Home 
Office Animals (Scientific Procedure) Act (1986). The experimental design can be 
seen  in  Figure  7.1.  Experiments  diets  were  supplied  by  SDS,  Essex,  England 
(Prenatal study FA and FS and AIN-76A) and PMI Nutrition International, Indiana, 
USA (Postnatal study FA and FS and AIN-93G). The full composition of all diets 
can  be  found  in  the  Tables  7.1,  7.2  and  7.3,  for  macronutrients,  vitamins  and 
minerals, respectively. The energy content of the diets can be seen in Figure 7.2.  
Before  arrival  F0  females  were  fed  the  standard  breeding  colony  diet  (2018S 
Teklad Global 18% Protein Rodent Diet, Harlan, Bicester, UK.) Upon arrival, adult 
female virgin Wistar rats (F0) were fed the standard animal house diet (Rat and 
Mouse No.1 Maintenance diet, SDS, Essex, UK) during the 14 day acclimatisation 
period. For the short duration of mating, females were fed the standard animal 
house diet; this was to ensure all breeding males were not exposed to the altered 
nutrition of the experiment. 
For the prenatal supplementation study, six dams were randomly placed on 
either the folic acid adequate (FA) or folic acid supplemented (FS) diet throughout 
pregnancy. Pregnancy was determined by presence of the copulatory plug. Within 
24 hours of birth litters were standardised to eight pups, in order to ensure even 
nutrition for pups. All dams were placed on the AIN-76A, lactation diet. After 28 
days,  offspring  were  weaned  onto  the  high  fat  (HF)  diet,  and  placed  in  group 
cages, with five rats being placed in each cage. At postnatal day 90 offspring were 
culled, and tissues were collected. The experimental design can be seen in Figure 
7.1. 
For the juvenile-pubertal supplementation study, six dams were placed on 
the folic acid adequate (FA) diet throughout pregnancy. Pregnancy was determined 
by  presence  of  the  copulatory  plug.  Within  24  hours  of  birth  litters  were 
standardised to eight pups, in order to ensure even nutrition for pups. All dams 
were placed on the AIN-93G, lactation diet. After 28 days, offspring were weaned 
onto either the FA or folic acid supplemented (FS) diet, and placed in group cages, Samuel Peter Hoile   
224 
 
with five rats being placed in each cage. At postnatal day 56, all offspring were 
moved onto a high fat diet (HF) for 28 days. At postnatal day 84 offspring were 
culled, and tissues were collected. The experimental design can be seen in Figure 
7.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  7.1  Diagram  showing  the  experimental  design  of  both  the  prenatal  and  juvenile-
pubertal supplementation studies. Where the folic acid adequate diet is shown by FA, folic acid 
supplemented diet by FS, the lactation diets by AIN76A and AIN93G and the high fat diet by HF. 
In the prenatal study, dams were fed either the FA or FS diet during pregnancy, during lactation all 
dams were fed the AIN76A diet. At  weaning offspring were moved onto the high fat diet and 
continued on this diet until adulthood. In the postnatal supplementation study, all dams were fed 
the FA diet during pregnancy and the AIN93G diet during lactation. During the Juvenile-pubertal 
period, offspring were fed either the FA or FS diet. After 28 days, all offspring were moved on to 
the high fat diet. They continued on this diet until adulthood. Samuel Peter Hoile   
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Prenatal 
study 
 
Juvenile-
Pubertal 
study 
AIN-
93G 
AIN-
76A 
High 
fat 
Animal 
House 
diet 
Breeding 
colony 
diet 
(2018S) 
g/kg 
  FA  FS  FA  FS   
Casein  180  180  170  170  200  200  168  129  188 
Cornstarch  425  425  448  448  397  150  318  450  450 
Sucrose  213  213  236  236  100  500  206  40.5  50 
Choline  2  2  2  2  2.5  2  2  1.1  1.1 
Methionine  5  5  5  5  5.2  3  5  2.2  4.3 
Cellulose 
(Crude Fiber) 
50  50  43  43  50  50  43  43.2  38 
Soybean oil  100  100  4  4  70  50  20  27.1  60 
Lard  0  0  36  36  0  0  180  0  0 
Total 
metabolizable 
energy, MJ/kg 
17.3  17.3  15.9  15.9  16.4  15.5  19.3  10.74  13.7 
Table 7.1 Table showing the composition of the diets fed to animals during the study. All 
nutrients are given as g/kg. Total metabolizable energy is given in MJ/kg. Diets were supplied by 
SDS, Essex, England (Prenatal study PS and PSF and AIN-76A) and PMI Nutrition International, 
Indiana, USA (Postnatal study PS and PSF and AIN-93G). The animal house diet was supplied by 
SDS, Essex, England. The 2018S diet was supplied by Harlan, Bicester, England. Samuel Peter Hoile   
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  Prenatal 
study 
 
Juvenile-
Pubertal 
study 
AIN-
93G 
AIN-
76A 
High 
fat 
Animal 
House 
diet 
Breeding 
colony  diet 
(2018S) 
g/kg 
  FA  FS  FA  FS   
Vitamin A   6.4  6.4  0.013  0.013  1.2  6.4  0.013  2.5  9.21 
Folic acid  1  5  1  5  2  2  1  0.79  8.4* 
Choline 
Chloride 
        1.25      1.08  1.12 
Inositol          -      2.30  1.45 
ʒ-
carotene 
        -      0.16  2.5 
Table 7.2 Table showing the relevant vitamin content of the diets fed to animals during the 
study. All values are given as mg/kg. Diets were supplied by SDS, Essex, England (Prenatal 
study PS and PSF and AIN-76A) and PMI Nutrition International, Indiana, USA (Postnatal study 
PS and PSF and AIN-93G). The animal house diet was supplied by SDS, Essex, England. The 
2018S diet was supplied by Harlan, Bicester, England.* As dietary folate. Samuel Peter Hoile   
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  Prenatal 
study 
 
Juvenile-
Pubertal 
study 
AIN-
93G 
AIN-
76A 
High 
fat 
Animal 
House 
diet 
Breeding 
colony 
diet 
(2018S) 
g/kg 
  FA  FS  FA  FS           
Calcium 
g/kg 
11.3  11.3  5  5  5  11.3  5  7.3  10 
Sodium 
g/kg 
    1  1  1    1  2.5  2.3 
Chloride 
g/kg 
    2  2  1.6    2  3.8  4 
Sodium Chloride 
g/kg 
1.7  1.7        1.7       
Iron 
mg/kg 
100  100  350  350  41  100  350  159.3  225 
Zinc 
mg/kg 
36.2  36.2  34.0  34.0  35  36.2  34.0  35.8  77 
Table 7.3 Table showing the relevant mineral content of the diets fed to animals during the 
study.  All  minerals  are  given  as  either  g/kg  or  mg/kg.  Diets  were  supplied  by  SDS,  Essex, 
England (Prenatal study PS and PSF and AIN-76A) and PMI Nutrition International, Indiana, USA 
(Postnatal study PS and PSF and AIN-93G). The animal house diet was supplied by SDS, Essex, 
England. The 2018S diet was supplied by Harlan, Bicester, England. Samuel Peter Hoile   
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7.2.2 Tissue collection 
  After being culled livers were collected from each rat. Liver weights were 
measured, and livers were snap frozen in liquid nitrogen upon collection. All tissue 
was stored at -80
oC long term.  
 
7.2.3 Molecular biology procedures 
Extraction  of  RNA  and  DNA,  bisulphite  treatment  of  DNA,  PCR  conditions  and 
pyrosequencing methods are described in section 2.3. 
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7.3 Results 
7.3.1 Does timing and route of exposure of folic acid supplementation lead to 
significant differences in PEPCK expression? 
Supplementation of the prenatal diet during pregnancy with folic acid, did not lead 
to significant differences in hepatic PEPCK expression in either sex (Figures 7.2). 
There  was  a  significant  effect  of folic  acid supplementation  during  the  juvenile-
pubertal  period  on  PEPCK  expression,  in  males  only,  where  supplementation 
increased expression (Figure 7.2). Folic acid supplementation during the juvenile-
pubertal  period,  did  not  lead  to  significant  alterations  in  PEPCK  expression  in 
females (Figure 7.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  7.2  Hepatic  PEPCK  mRNA  expression  in  male  and  female  offspring  from  the 
prenatal and juvenile-pubertal folic acid supplementation studies.  Values are means with 
their  standard  deviations,  where  ‘a’  is  significantly  different  from  ‘b’.  Significant  differences 
between FA and FS groups were determined using an unpaired t-test. P<0.05 Samuel Peter Hoile   
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7.3.2 Does timing and route of exposure of folic acid supplementation lead to 
significant differences in PEPCK methylation? 
  There  was  a  significant  effect  of  folic  acid  supplementation  during  the 
juvenile-pubertal  period  on  PEPCK  methylation,  in  females  only  (Figures  7.3). 
Methylation  of  the  PEPCK  promoter  in  female  offspring  of  the  juvenile-pubertal 
supplementation study was increased at CpGs -508, -440 and -81 in the FS group, 
compared to the FA group. Methylation was decreased at CpGs -606, -129 and -
81, in the FS group, compared to the FA group. No differences in methylation of 
the PEPCK promoter were present in the male offspring, following supplementation 
of the prenatal diet with folic acid (Figures 7.3). Folic acid supplementation of the 
prenatal diet led to a significant change in DNA methylation in males only, where 
methylation of CpG -440 was increased in the FS group, compared to the FA group 
(Figure  7.3).  Table  7.4  shows  the  interactive  effects  of  sex  and  folic  acid 
supplementation in both the prenatal and juvenile-pubertal supplementation groups 
on PEPCK mRNA expression and promoter methylation. 
Prenatal 
Supplementation 
PEPCK 
Expression 
CpG  
-606 
CpG  
-508 
CpG  
-440 
CpG  
-129 
CpG  
-90 
CpG  
-81 
Folic acid supplementation  NS  NS  NS  0.02  NS  NS  NS 
Sex  NS  NS  NS  NS  NS  NS  NS 
Folic acid supplementation*Sex  NS  NS  NS  NS  NS  NS  0.014 
 
Postnatal 
Supplementation 
PEPCK 
Expression 
CpG  
-606 
CpG  
-508 
CpG  
-440 
CpG  
-129 
CpG  
-90 
CpG  
-81 
Folic acid 
supplementation 
0.007  <0.001  <0.001  0.002  0.007  0.036  0.005 
Sex  0.007  <0.001  0.025  NS  NS  NS  NS 
Folic acid 
supplementation*Sex 
NS  0.002  0.003  0.003  NS  NS  <0.001 
 
 
 
 
Table  7.4  A  General  Linear  Model  showing  significant  interactive  effects  of  folic  acid 
supplementation and sex on PEPCK expression and promoter methylation. Samuel Peter Hoile   
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Male Female
Prenatal    Juvenile-Pubertal                Prenatal     Juvenile-Pubertal
CpG -606
CpG -508
CpG -440
CpG -129
CpG -90
CpG -81
Figure  7.3  PEPCK  promoter  methylation  in  the  prenatal  and  juvenile-pubertal  folic  acid 
supplemented  offspring.  Values  are  means  with  their  standard  deviations,  where  ‘a’  is 
significantly different from ‘b’. Significant differences between FA and FS groups were determined 
using an unpaired t-test. P<0.05 Samuel Peter Hoile   
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7.3.3 Does timing and route of exposure of folic acid supplementation lead to 
significant differences in DNMT3a2 expression? 
  Supplementation of folic acid during the juvenile-pubertal period leads to a 
significant  decrease  in  hepatic  DNMT3a2  in  males  (Figure  7.14).  The  same 
supplementation did not lead to significant changes in expression in females. 
Prenatal supplementation of folic acid did not lead to changes in hepatic DNMT3a2 
expression, in either sex (Figure 7.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  7.4  Hepatic  DNMT3a2  mRNA  expression  in  male  and  female  offspring  from  the 
prenatal and juvenile-pubertal folic acid supplementation studies.  Values are means with 
their  standard  deviations,  where  ‘a’  is  significantly  different  from  ‘b’.  Significant  differences 
between FA and FS groups were determined using an unpaired t-test. P<0.05 Samuel Peter Hoile   
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7.3.4 Does timing and route of exposure of folic acid supplementation lead to 
significant differences in DNMT3a2 methylation? 
  In female offspring of the prenatal supplementation study, folic acid led to a 
significant increase in methylation of CpGs -190, -56 and -39 (Figures 7.5). There 
was no change in methylation of CpG -207 (Figure 7.5). There were no differences 
in methylation of the DNMT3a2 promoter following supplementation with folic acid 
during  the  juvenile-pubertal  period  (Figure  7.5).  No  differences  in  DNMT3a2 
promoter  methylation  were  present  in  male  offspring,  following  folic  acid 
supplementation at any time point (Figure 7.5). 
Table 7.5 shows the interactive effects of sex and folic acid supplementation in 
both  the  prenatal  and  juvenile-pubertal  supplementation  groups  on  DNMT3a2 
mRNA expression and promoter methylation. 
Prenatal 
Supplementation 
DNMT3a2 
Expression 
CpG  
-207 
CpG  
-190 
CpG  
-56 
CpG  
-39 
Folic acid 
supplementation 
NS  NS  NS  NS  NS 
Sex  0.038  NS  NS  <0.001  <0.001 
Folic acid 
supplementation*Sex 
NS  NS  NS  NS  NS 
 
Postnatal 
Supplementation 
DNMT3a2 
Expression 
CpG  
-207 
CpG  
-190 
CpG  
-56 
CpG  
-39 
Folic acid 
supplementation 
<0.001  NS  0.003  <0.001  <0.001 
Sex  NS  0.038  <0.001  <0.001  <0.001 
Folic acid 
supplementation*Sex 
NS  NS  <0.001  <0.001  <0.001 
 
 
 
   
 
Table  7.5  A  General  Linear  Model  showing  significant  interactive  effects  of  folic  acid 
supplementation and sex on DNMT3a2 expression and promoter methylation. Samuel Peter Hoile   
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Figure 7.5 DNMT3a2 promoter methylation in the prenatal and juvenile-pubertal folic acid 
supplemented  offspring.  Values  are  means  with  their  standard  deviations,  where  ‘a’  is 
significantly different from ‘b’. Significant differences between FA and FS groups were determined 
using an unpaired t-test. P<0.05 
Male Female
Prenatal    Juvenile-Pubertal                Prenatal     Juvenile-Pubertal
CpG -207
CpG -190
CpG -56
CpG -39Samuel Peter Hoile   
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7.4 Discussion 
  Both the in utero environment and pre-pubescent period provide windows 
of developmental plasticity
[277]. These results show that, in terms of regulation of 
PEPCK  and  DNMT3a2  genes,  folic  acid  supplementation  during  the  juvenile-
pubertal  period  led  to  more  significant  changes  in  PEPCK  and  DNMT3a2 
expression  and  promoter  methylation,  compared  to  prenatal  supplementation. 
Although  other  genes  may  show  different  findings,  in  terms  of  the  differences 
between  timing  of  supplementation,  the  findings  here  suggest  a  different  effect 
when supplementation is provided during the juvenile-pubertal period. 
  In  females,  changes  in  methylation  in  the  PEPCK  promoter,  following 
juvenile-pubertal folic acid supplementation, were directionally opposite at specific 
CpG  sites,  suggesting  the  changes  to  the  epigenome  are  CpG  specific. 
Supplementation led to an increase in methylation of CpGs -508, -440 and -81 and 
a decrease in methylation of CpGs -606, -129 and -90. In females, no changes in 
methylation  were  present  following  prenatal  folic  acid  supplementation. 
Supplementation of the prenatal diet during pregnancy in males led to an increase 
in  methylation  of  CpG  -440  in  the  PEPCK  promoter,  no  other  changes  in 
methylation  were  present.  The  results  suggest  that  folic  acid  only  leads  to 
differences  in  mRNA  expression  and  promoter  methylation  of  PEPCK  and 
DNMT3a2 when provided during the juvenile-pubertal postnatal diet. 
 
7.4.1 The physiological consequences of folic acid supplementation 
  PEPCK mRNA was significantly increased in the folic acid supplemented 
group of the juvenile-pubertal study. As these animals were under the physiological 
state  of  fasting,  this  suggests  a  greater  capacity  for  gluconeogenesis  and  a 
decreased requirement for β-oxidation of fatty acids and creation of free radicals, in 
the form of peroxide, as a waste product. Unfortunately fasting plasma glucose 
concentrations were not available to confirm this. 
Major differences in PEPCK promoter methylation were only present in the female 
offspring, supplemented with folic acid during the juvenile-pubertal period. As well Samuel Peter Hoile   
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as suggesting timing of exposure as a key determinant in the magnitude of effects 
seen, it also suggests a role of sex in altered phenotype. 
Although the changes in CpG methylation were not in the same direction across 
the  PEPCK  promoter,  the  findings  do  suggest  an  altered  capacity  for 
gluconeogenesis under different physiological condition. As stated previously, the 
result of alterations in promoter methylation may remain cryptic unless the correct 
environment is present. 
mRNA expression of DNMT3a2 is higher in males in the FA group of the juvenile-
pubertal study, compared to the FS male and female groups. This may suggest 
that females require a lower level of DNMT3a2, compared to males, representing a 
lower  demand  for  metabolic  plasticity.  The  results  suggest  that  folic  acid 
supplementation of the male diet during the juvenile-pubertal period leads to gene 
expression levels similar to that seen in the females. Although it must be stated, 
that due to the wide range in responses when measuring the mRNA expression of 
the DNMT3a2 gene, differences between the FA and FS groups of the prenatal 
study  could  not  be  distinguished.  This  could  be  due  to  the  lower  levels  of 
expression of the DNMT3a2 gene, where greater variance between samples would 
be present. 
Physiologically,  the  significant  differences  in  the  juvenile-pubertal  study  female 
offspring, in terms of DNMT3a2 methylation, could represent a significantly altered 
level of expression of the gene, under different forms of transcriptional regulation. 
Perhaps the role of DNMT3a2 in tissue growth and repair, in later life, such as in 
pregnancy, may be significantly altered by altered activating and repressing factors 
binding to the altered CpGs.  
 
7.4.2 The route of delivery of folic acid supplementation 
  The  possible  explanations  as  to  why  folic  acid  supplementation  led  to 
different alterations when provided at the two different time points are; the method 
of  delivery,  the  level  of  exposure  and  the  developmental  stage  at  which 
supplementation  was  provided.    First,  the  effect  seen  by  postnatal  folic  acid 
supplementation  may  be  due  to  the  total  available  amount  of  folic  acid  to  the Samuel Peter Hoile   
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offspring. When considering the juvenile-pubertal supplementation animals, they 
received the folic acid supplementation as part of the diet. However, in the prenatal 
supplementation study, the folic acid is fed to the dams and must first cross the 
placental  barrier,  before  the  fetal  circulation  is  exposed.  Transfer  of  folic  acid 
across  the  placenta  is  via  the  Folate  Receptor-a  (FRa)  and  Reduced  Folate 
Transporter 1 (RFC1)
[278]. Data from Sweiry et al suggests that the rate of transfer 
of folic acid from the prenatal circulation to the fetal circulation is around 40%
[279]. 
The  magnitude  of  effect  of  folic  acid  supplementation  may  be  smaller  in  the 
prenatal supplementation groups as the amount of folic acid is decreased when 
crossing the placenta. Alterations in DNA methylation, as a result of increased folic 
acid intake, are dependent on the level of folic acid. When supplementing the diet 
of adult rats with 0, 4.5 or 18 µmol folate/kg feed, it was found that global DNA 
methylation  was  increased  with  supplementation,  where  the highest  increase  in 
methylation was found in the highest supplementation group
[280]. Although, it must 
be mentioned that the differences seen were very small, with the difference shown 
being less than 2%, in terms of global methylation levels. This agrees with the data 
presented  here,  where  the  greatest  difference  in  methylation  was  seen  in  the 
juvenile-pubertal supplemented offspring, which were exposed to higher levels of 
folic acid, through the more efficient route of delivery. 
 
7.4.3  The  role  of  sex  in  differences  in  PEPCK  and  DNMT3a2  promoter 
methylation 
  Females  who  received  folic  acid  supplementation  during  the  juvenile-
pubertal  period  showed  differences  in  promoter  methylation.  Similar  differences 
were not present in the males who received the same diets. This is an important 
and  novel  finding,  which  could  be  explained  by  involvement  of  sex  hormones, 
differences in establishment of the epigenome, or the role of the sex chromosomes 
in establishing methylation marks. Data from the Överkalix data set showed clear 
differences in transmission of altered phenotype through specific sex lines, where 
differences in males were dependent on the slow growth period of their paternal 
grandfather and differences in females were dependent on the slow growth period Samuel Peter Hoile   
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of  their  maternal  grandmother
[163].  In  the  present  study  the  prenatal  folic  acid 
supplementation  was  provided  only  to  the  mother,  perhaps  this  explains  why 
differences were only seen in female offspring? It would be of interest to see the 
effect  of  folic  acid  supplementation  in  males  on  the  gene  regulation  of  their 
offspring. 
 
7.4.4 The link between expression and methylation of PEPCK and DNMT3a2 
in the offspring groups 
  Postnatal folic acid supplementation during the juvenile-pubertal period 
led  to  an  increase  in  PEPCK  mRNA  expression  and  decrease  in  DNMT3a2 
expression in male offspring. Epigenetics underpins phenotype, however, changes 
in expression were not related to changes in methylation of the gene promoters, 
this suggests that in the physiological state of fasting, the mRNA expression of 
PEPCK and DNMT3a2 is not affected by altered binding at these specific CpGs, or 
that the changes in methylation shown here are not sufficient to lead to altered 
binding  at  the  CpG.  Other  forms  of  epigenetic  regulation,  such  as  histone 
modifications may  be  affecting  mRNA expression  of these  genes.  Although  the 
relevance of specific CpGs in these genes are unknown, further experiments will 
investigate this. 
Differences in promoter methylation and mRNA expression were not seen between 
groups following prenatal folic acid supplementation, therefore the genome must 
be subject to changes in methylation following the establishment of the epigenome 
during development. As a result, the juvenile-pubertal period may allow a window 
of  intervention,  following  detrimental  adaptations  made  by  offspring  during  fetal 
development.  Szyf  hypothesises  that  the  epigenome  is  a  dynamic  equilibrium 
between methylation and demethylation
[190]. The hypothesis states that; behaviour, 
chemical, nutritional and physical modifications can lead to alterations in signaling 
pathways, which then led to altered activity of DNMTs and DNA methyltransferases 
(DNMTases). The result is an alteration in DNA methylation levels. The hypothesis 
originated following the discovery that post mitotic neurons, cells which are fully 
differentiated and have no mitotic activity, contain DNMTs
[281]. Syzf interprets this Samuel Peter Hoile   
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as the cells having varying levels of methylation over time, to explain the presence 
of  the  DNA  methylating  enzymes,  stating  that  the  epigenome  is  an  interface 
between the dynamic environment and inherited static genome
[190]. 
PEPCK promoter methylation is subject to demethylation during development
[229]. 
Postnatal folic acid supplementation can lead to alterations in PEPCK promoter 
methylation after the methylation status has been determined during development. 
Potentially, alterations in PEPCK promoter methylation caused by altered exposure 
during development could be reversed during early postnatal life. 
 
7.4.5 Advances in current understanding 
Previous experiments into folic acid supplementation show greatest effects 
of  folic  acid  supplementation,  when  combined  with  prenatal  protein  restriction, 
during pregnancy
[198,51]. Here results show only one change in DNA methylation 
caused at a single CpG in the PEPCK promoter, in  one sex, following prenatal 
supplementation. It appears that the effects of folic acid supplementation may be 
dependent on the protein content of the prenatal diet, during pregnancy. Although 
the  differences  between  sexes  shown  here  cannot  be  explained,  they  are 
consistent with existing literature. Following altered developmental environments, 
such as the Dutch hunger winter in humans and the PR and IUGR model in rats, 
sex-specific  differences  in  specific  phenotypic  characteristics  have  been 
shown
[60,48,23]. 
Women are advised to take folic acid supplements before pregnancy and 
during the first trimester of pregnancy, in order to decrease the risk of Neural tube 
defects  (NTDs)
[282,283].  However,  the  long-lasting  effects  of  folic  acid 
supplementation on the epigenome of offspring in later life must be investigated. 
Although the risk of NTDs in offspring is clearly reduced following supplementation, 
it must be investigated if this comes at a cost. Data here has shown that prenatal 
folic acid supplementation has led to persistent alterations in DNA methylation it is 
not clear if these changes are detrimental to long term health. In the UK, it is not 
mandatory to fortify foods, such as bread, with folic acid. If however, this became 
the  case  it  would  be  essential  to  consider  the  long  term  health  effects  of  this Samuel Peter Hoile   
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fortification, and to determine which level would be most beneficial. It is clear that 
the epigenome is subject to alterations during the juvenile-pubertal period. As a 
result it is therefore important to consider which other environmental factors, be 
they nutritional supplementation, in the form of vitamin supplements for teenagers, 
or other, may influence phenotype long term. 
Folic  acid  supplementation  during  the  juvenile-pubertal  period  led  to  significant 
changes in promoter methylation of both PEPCK and  DNMT3a2, which differed 
between sexes. These results were not related to changes in expression of the 
genes.  Under  different  conditions,  such  as  different  periods  of  stress,  these 
changes may lead to significantly different levels in mRNA expression. 
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Chapter 8 
 
The Effect of Dietary Fatty Acid Intake 
During Pregnancy and Lactation on the 
Epigenetic Regulation of 
Phosphoenolpyruvate Carboxykinase 
and Fads2 
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8.1 Introduction 
 
8.1.2 Maternal high fat feeding 
  As described in section 1.1.3.3, alterations in the fat content of the maternal 
diet  have  been  shown  to  lead  to  significant  differences  in  the  phenotype  of 
offspring
[64,65,66,67,68,69,71,72]. For example, in humans energy balance, metabolism 
and behaviour were significantly altered in offspring, following a maternal high fat 
diet
[70]. In rats, feeding dams a high fat diet during pregnancy and lactation led to a 
significant increase in fasting  glucose concentration 30 minutes after a meal
[67]. 
Although the effect of maternal fat intake on offspring phenotype has been well 
documented, the underlying mechanism is unknown. Alterations in maternal fatty 
acid intake significantly alter the phenotype of offspring, it is not known if significant 
differences in regulation of PEPCK transcription also result. 
 
8.1.3 Δ 6 desaturase 
  The  discussed  studies  show  clear  effects  of  altered  fatty  acid  intake  on 
offspring phenotype. It is clear that these effects are dependent on the type and 
amount  of  fat  as  well  as  the  window  of  exposure.  n-3  and  n-6  PUFA  have 
beneficial roles in terms of tissue function and cell membrane fluidity
[147].  
In  humans  and  rats,  long-chain  polyunsaturated  fatty  acids  are  produced  from 
essential fatty acids, through the fatty acid desaturation/elongation pathway. The 
fatty  acid  desaturation/elongation  pathway  was  described  in  Section  1.2.5.  As 
discussed, the rate-limiting step in the production of 20:4n-6 and 22:6n-3 is the 
desaturation of 18:2n-6 and 18:3n-3 by ʔ6 desaturase
[284]. Feeding mice a 10% fat 
diet has been shown to lead to a significant decrease in expression and activity of 
fads2,  the  gene  which  codes  for  ʔ6  desaturase,  decreased  by  50%  and  70%, 
compared to mice fed triolein
[285]. 
A candidate gene study by Lattika et al has showed that polymorphisms in the 
Fads2 gene accounted for 28.5% of the variance in serum phospholipid levels of 
20:4n-6
[286]. Samuel Peter Hoile   
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It is known that fads2 is significantly altered by alterations in fat intake; however 
understanding of the role of promoter methylation in understanding of the gene is 
currently  limited  to  one  study,  in  mouse.  In  C57BL/6  mice  heterozygous  for 
disruption of cystathione β-synthase (Cbs
+/-), feeding of a hyperhomocysternemia 
inducing diet led to a decrease in expression of the fads2 gene and a lower activity 
of  ʔ6  desaturase.  Following  analysis  of  a  194bp  CpG  rich  region  of  the  fads2 
promoter,  through  bisulfite  conversion,  PCR  and  pyrosequencing,  it  was  shown 
that  methylation  at  8  out  of  11  measured  sites  was  significantly  increased, 
compared to control mice
[287]. Despite a low homology between the mouse and rat 
fads2 promoters the study shows plasticity in the methylation of specific CpGs. 
 
Significant  alterations  in  phenotype,  as  a  result  of  high  fat  feeding  during 
pregnancy  have  been  shown  in  terms  of  fasting  energy  metabolism  and 
desaturation and elongation of fatty acids. It is not known if the effect of maternal 
high fat feeding is generalised to a subset of genes or if the effect is more specific. 
Therefore mRNA expression and promoter methylation of the fads2 and PEPCK 
genes  will  be  investigated,  following  feeding  of  high  fat  diets  to  dams  during 
pregnancy and lactation. In order to show the effect of altered fads2 regulation, 
liver and plasma phospholipid composition will also be determined. 
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8.2 Experimental design 
All animal procedures and sample collection were undertaken by Dr Christopher 
Kelsall, University of Southampton. 
 
8.2.1 Animal model 
  All  animal procedures  were  conducted  in  accordance  with  the  UK  Home 
Office Animals (Scientific Procedure) Act (1986). The experimental design can be 
seen in Figure 8.1. Experiments diets were supplied by SDS, Essex, England. The 
full composition of all diets can be found in the Tables 8.1, 8.2, for macronutrients, 
and fatty acid composition, respectively. Virgin female Wistar rats weighing 200-
250g were fed diets based on the AIN93G formulation containing 7% or 21% (w/w) 
total fat derived from either safflower oil (SAO) or 20:5n-3 and 22:6n-3 (fish oil, FO) 
from 14 days before conception and throughout pregnancy and lactation (n = 6 / 
diet). Diet compositions can be found in Table 8.1. All diets contained the same 
amount of vitamin E to provide sufficient anti-oxidant capacity at the highest level 
of FO intake. Female rats were mated with randomly assigned males, day 0 of 
pregnancy being defined by plug detection. Litters were culled to 8 pups (equal 
numbers of males and females) within 24 hours of spontaneous birth. Offspring (n 
= 6 males or females per dietary group) were weaned at 28 days onto AIN93-M 
diet containing 4% (w/w) soybean oil and maintained on this diet until day 77 when 
they were fasted for twelve hours and then killed by CO2 asphyxiation.  
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Figure  8.1  Diagram  showing  the  experimental  design  of  the  maternal  fatty  acid  study. 
Where the safflower oil diet is shown by SAO and the 20:5n-3 and 22:6n-3 rich fish oil diet is 
shown by FO. The AIN93M maintenance diet is shown by M. Dams were fed with the relevant fat 
diet from 14 days prior to conception, throughout pregnancy and lactation. At weaning pups were 
transferred to the AIN93, maintenance diet. At postnatal day 77, male and female offspring were 
culled for samples collection. Samuel Peter Hoile   
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  7% (w/w) 
Fat 
21% (w/w) 
Fat 
AIN-93M 
g/kg 
  SAO  FO  SAO  FO   
Casein  20.0  20.0  20.0  20.0  14.0 
Cornstarch  39.7  39.7  25.7  25.7  46.6 
Sucrose  10.0  10.0  10.0  10.0  10.0 
Maltodextrin  13.2  13.2  13.2  13.2  15.5 
Cellulose  5.0  5.0  5.0  5.0  5.0 
AIN-93G 
Mineral mix 
3.5  3.5  3.5  3.5  3.5 
AIN-93G 
Vitamin mix 
1.0  1.0  1.0  1.0  1.0 
Choline  0.25  0.25  0.25  0.25  0.25 
Total 
metabolizable 
energy, 
MJ/kg 
1.6  1.6  1.9  1.9  1.6 
Table 8.1 Table showing the composition of the diets fed to animals during the study. All 
nutrients are given as g/kg. Total metabolizable energy is given in MJ/kg. Diets were supplied 
by SDS, Essex, England. Samuel Peter Hoile   
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  7% (w/w) 
Fat 
21% (w/w) 
Fat 
AIN-93M 
g/kg 
  SAO  FO  SAO  FO   
Total saturated 
fatty acids 
70  213  209  640  110 
Total 
monounsaturated 
fatty acids 
124  202  373  606  165 
18:2n-6  505  14  1515  42  376 
18:3n-6  N  3  N  8  2 
20:3n-6  N  2  N  6  N 
20:4n-6  N  10  N  29  N 
22:4n-6  N  1  N  4  N 
22:5n-6  N  2  N  6  N 
Total n-6 PUFA  505  29  1515  88  378 
18:3n-3  1  8  2  23  48 
20:5n-3  N  142  N  427  N 
22:5n-3  N  19  N  58  N 
22:6n-3  N  83  N  248  N 
Total n-3 PUFA  1  252  2  755  48 
18:2n-6 : 18:3n-3  739  2  739  2  8 
Table 8.2 Table showing the fatty acid composition of the diets fed to animals during 
the study. All fatty acids are given as g/kg. Where N represents not detected. Samuel Peter Hoile   
248 
 
8.2.2 Tissue collection 
  After being culled livers were collected from each rat and were snap frozen 
in liquid nitrogen upon collection. All tissue was stored at -80
oC long term.  Blood 
was  collected  by  cardiac  puncture  into  tubes  containing  lithium  heparin,  and 
plasma separated from cells by centrifugation. Plasma was stored at -80
oC. 
 
8.2.3 Molecular biology procedures 
Extraction of RNA and DNA, bisulphite treatment of DNA, PCR conditions 
and pyrosequencing methods are described in section 2.3. 
 
8.2.4 Analysis of phospholipid composition 
  Fatty acid composition of liver and plasma phospholipid was determined by 
gas  chromatography,  as  described  in  Burdge  2000
[250].  These  analyses  were 
carried  out  by  Nicola  Irvine.  Briefly,  liver (approximately  100mg) was  powdered 
under liquid nitrogen and total lipids extracted with chloroform and methanol
[251].  
Plasma (0.8ml) was extracted with chloroform and methanol
[251].  PC was isolated 
from total lipid extracts by solid phase extraction using 100mg aminopropyl silica 
cartridges
[250] and converted to fatty acid methyl esters (FAMEs) by incubation with 
methanol  containing  2%(v/v)  sulphuric  acid
[250].    FAMEs  were  recovered  by 
extraction with hexane.  The proportions of individual fatty acids were measured by 
gas chromatography using BPX70 fused silica capillary column (30m x 0.25mm x 
0.25μm) on an Agilent 6890 gas chromatograph equipped with flame ionisation 
detection.  FAMEs were identified by their retention times relative to standards and 
quantified using Chemstation software.  
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8.3 Results 
8.3.1  Does  type  and  amount  of  maternal  dietary  fat  alter  fasting  glucose 
concentration in male and female offspring? 
  There were no significant effects of type and amount of maternal dietary fat 
on fasting glucose concentration in offspring (Figure 8.2) Fasting plasma glucose 
concentration  in  female  offspring  of  dams  fed  a  fish  oil  during  pregnancy  and 
lactation were significantly lower than the levels shown in the male offspring.  
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Figure 8.2 Fasting plasma glucose values in male and female offspring. Values 
are means with their standard deviation. * represents a significant difference between 
genders, determined by Student’s T-test. Significant differences between groups was 
by one-way ANOVA with Bonferroni’s post hoc test. P<0.05. 
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8.3.2  Does  type  and  amount  of  maternal  dietary  fat  alter  hepatic  PEPCK 
mRNA expression in male and female offspring? 
  There was a significant effect of type of maternal dietary fat on offspring 
hepatic PEPCK mRNA expression in males only (Figure 8.3). 
In male offspring there was a significant effect of amount of dietary fat in the SAO 
group, where expression was significantly increased in the 21% group, compared 
to the 7% group.  
In female offspring there was no effect of type of maternal dietary fat. 
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Figure 8.3 Hepatic PEPCK mRNA expression in male and female offspring. Values 
are means with their standard deviations, where ‘a’ is significantly different from ‘b’ and 
‘ab’ is neither significantly different form ‘a’ or ‘b’. # represents an effect of amount of 
maternal dietary fat between 7 and 21% fat. Significant differences between diets was 
by one-way ANOVA with Bonferroni’s post hoc test. P<0.05. 
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8.3.3  Does  type  and  amount  of  maternal  dietary  fat  alter  liver  PEPCK 
promoter methylation in male and female offspring? 
  There were no significant differences between groups in methylation of the 
PEPCK  promoter.  CpG  -81,  in  male  offspring,  appears  to  show  significant 
differences between groups, where the 21% FO group has no detectable level of 
methylation (Figure 8.4). However the minimum threshold of the pyrosequencer is 
7%, this means no statistical analysis can be performed on results below this level.  
There were no significant effects of type or amount of maternal dietary fat on liver 
promoter methylation in female offspring (Figure 8.5). 
Table 8.4 shows the interactive effects of type and amount of maternal dietary fat 
on CpG specific methylation of the PEPCK promoter. 
 
MALES 
CpG  
-606 
CpG  
-508 
CpG  
-440 
CpG  
-129 
CpG  
-90 
CpG  
-81 
% Fat  0.526  0.169  0.509  0.701  0.053  0.195 
Fat type  0.859  0.622  0.609  0.916  0.331  0.404 
Interaction  0.899  0.481  0.642  0.903  0.186  0.374 
 
FEMALES 
CpG  
-606 
CpG  
-508 
CpG  
-440 
CpG  
-129 
CpG  
-90 
CpG  
-81 
% Fat  0.569  0.438  0.817  0.738  0.371  0.316 
Fat type  0.390  0.266  0.185  0.991  0.224  0.579 
Interaction  0.254  0.513  0.874  0.306  0.845  0.900 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8.4 A General Linear Model showing significant interactive effects of type and 
amount of maternal dietary fat on PEPCK promoter methylation in male and female 
offspring. Samuel Peter Hoile   
254 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.4 PEPCK promoter methylation in male offspring. Values are means 
with  their  standard  deviations,  where  ‘#’  represents  an  effect  of  % maternal  fat. 
Significant differences were by one-way ANOVA, with Bonferroni’s post hoc test 
P<0.005. 
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Figure 8.5 PEPCK promoter methylation in female offspring. Values are means 
with  their  standard  deviations.  Significant  differences  were  by  one-way  ANOVA, 
with Bonferroni’s post hoc test P<0.005. 
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8.3.4  Does  type  and amount  of  maternal  dietary  fat alter  plasma and liver 
phospholipid composition in male and female offspring? 
  There was a significant effect of maternal fat type and amount on the fatty 
acid  composition  of  liver  and  plasma  phosphatidylcholine  (PC),  in  a  manner 
contingent  on  sex.  As  shown  in  table  8.5,  there  were  no  differences  in  the 
proportions of 18:2n-6, 18:3n-3 and 18:3n-6 in liver PC. There were relatively small 
differences between maternal dietary groups and sexes in the proportions of 20:3n-
6, 20:5n-3 and 22:5n-3, in liver PC composition. The principal effects of maternal 
dietary fat content were on the proportions of 20:4n-6 and 22:6n-3 (Figure 8.6). 
There  were  significant  single  factor  effects  of  sex  (P<0.0001),  amount  of  fat 
(P=0.001) and sex*fat type (P<0.0001) on the proportion of 20:4n-6 in liver PC. 
There  was  no  difference  between  maternal  dietary  groups  in  the  proportion  of 
20:4n-6 in male or female offspring of dams fed diets containing 7% fat, in both 
liver and plasma PC (Figure 8.6) In male offspring, there was an effect of amount 
of fat for 20:4n-6 content of PC, in liver, in the FO group. In all cases, the 21% 
groups had a lower 20:4n-6 PC content. In males there was an effect of type of fat 
on PC 22:6n-3 content, in liver only, where the 21% SAO group had a decreased 
amount, compared to the 7% group. In females, there was an effect of amount of 
fat in liver and plasma PC 20:4n-6 content in all groups, except for SAO plasma, 
where the 21% maternal fat diet led to a decreased 20:4n-6 content. In females, 
there was an effect of amount of fat in liver and plasma PC 22:6n-3 content in both 
the  SAO  and  FO  groups,  where  the  21%  maternal fat  diet  led  to  a  decreased 
22:6n-3 content 
There was a significant effect of sex in PC 22:6n-3 composition in liver for both 7% 
and 21% SAO groups.  
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Figure 8.6 20:4n-6 and 22:6n-3 composition of liver and plasma PC in male 
and female offspring. Values are means with their standard deviations. Where ‘a’ 
is significantly different from ‘b’, and ‘ab’ is neither significantly different from ‘a’ or 
‘b’. # represents a significant effect of sex. Significant differences were by one-way 
ANOVA, with Bonferroni’s post hoc test P<0.005.  
 Samuel Peter Hoile   
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  18:2n-6  18:3n-3  20:3n-6  18:3n-3  20:5n-3  22:5n-3 
  Male 7% fat offspring 
SAO  12.1 ± 1.8  0.3 ± 0.2  0.5 ± 0.2
a  0.2 ± 0.2  0.2 ± 0.1
a  0.9 ± 0.3 
FO  13.3 ± 1.4  0.2 ± 0.1  0.8 ± 0.3
 a  0.1 ± 0.1  0.5 ± 0.3
 a  0.9 ± 0.1 
  Male 21% fat offspring 
SAO  12.2 ± 1.6  0.1 ± 0.1  0.4 ± 0.1
 a  0.1 ± 0.1  0.1 ± 0.1
 a  0.8 ± 0.2 
FO  11.4 ± 0.6  0.2 ± 0.1  1.0 ± 0.4
 b  0.1 ± 0.1  1.4 ± 0.4
 b  1.1 ± 0.4 
  Female 7% fat offspring 
SAO  10.2 ± 1.3  0.3 ± 0.1  0.4 ± 0.1  0.1 ± 0.1  0.2 ± 0.2
 a  1.0 ± 0.2 
FO  9.7 ± 1.1  0.2 ± 0.5  0.4 ± 0.1  0.1 ± 0.1  0.5 ± 0.3
 a  0.9 ± 0.1 
  Female 21% fat offspring 
SAO  10.5 ± 3.2  0.2 ± 0.1  0.5 ± 0.3  0.1 ± 0.1  0.3 ± 0.1
 a  0.9 ± 0.4 
FO  12.5 ± 1.9  0.2 ± 0.1  0.5 ± 0.2  0.3 ± 0.4  1.1 ± 0.6
 b  0.8 ± 0.2 
  GLM (p) 
Sex  0.003  NS  NS  NS  NS  NS 
% fat  NS  NS  0.003  NS  <0.0001  NS 
Type of fat  NS  NS  <0.0001  NS  <0.0001  NS 
Sex*% Fat  NS  NS  0.029  NS  NS  NS 
% fat*type of fat  NS  NS  0.001  NS  NS  NS 
Sex*% fat*type 
 of fat 
NS  NS  NS  NS  <0.0001  NS 
 
 
 
 
 
 
Table  8.5  Liver  phosphatidylcholine  fatty  acid  composition  in  male  and  female 
offspring,  where  ‘a’  is  significantly  different  from  ‘b’.  Significant  differences  were 
determined by one-way ANOVA (p<0.005). General linear model results are also shown. 
 Samuel Peter Hoile   
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8.3.5 Does type and amount of maternal dietary fat alter hepatic fads2 mRNA 
expression in male and female offspring? 
  There was a significant effect of amount of maternal dietary fatty acid on 
hepatic fads2 mRNA expression in all  groups in the  male and female offspring 
(Figure 8.7). There was no effect of type of fat on hepatic fads mRNA expression in 
either sex. 
Hepatic  mRNA  expression  of  the  fads2  gene  predicted  9%  and  26%  of 
20:4n-6 and 22:6n-3 content of liver PC in males, respectively. In females, fads2 
predicted 41% and 15% of 20:4n-6 and 22:6n-3 content of liver PC, respectively. 
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Figure 8.7 Hepatic fads2 mRNA expression in male and female offspring. Values 
are means with their standard deviations. * represents an effect of amount of maternal 
dietary fat between 7 and 21% fat. Significant differences between diets was by one-
way ANOVA with Bonferroni’s post hoc test. P<0.05. 
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8.3.6 Does type and amount of maternal dietary fat alter liver fads2 promoter 
methylation in male and female offspring? 
  There were significant effects of type of maternal dietary fat on CpG specific 
methylation of the fads2 promoter, in liver, in male and female offspring (Figures 
8.8  and  8.9).  There  were  effects  of  amount  and  type  of  fat  in  females,  in 
methylation of CpG -394. 
In males, methylation of CpG -623 in males was significantly lower in the 7% SAO 
group, compared to the  7% FO group. In males, methylation of CpG  -394 was 
significantly higher in the 21% FO group, compared to the 21% SAO group. In 
males  methylation  of  CpG  -84  was  significantly  higher  in  the  7%  SAO  group, 
compared  to  the  21%  SAO  group.  Methylation  of  CpG  -76  in  males  was 
significantly higher in the 7% FO group, compared to the 7% SAO group.  
In females, methylation of CpGs -394 was significantly increased in the 21% fat 
groups,  where  the  21%  FO  group  was  significantly  higher  than  the  21%  SAO 
group.  Methylation  of  CpG  -84  was  significantly  lower  in  the  7%  SAO  group, 
compared  to  the  7%  FO  groups.  Methylation  of  CpG  -76  was  significantly 
increased in the 7% and 21% FO groups, compared to the 7% and 21% SAO 
groups. Methylation of CpG -65 was significantly increased in the 7% FO group, 
compared to both SAO groups. 
Table 8.6 shows the interactive effects of type and amount of maternal dietary fat 
on CpG specific methylation of the fads2 promoter. 
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MALES 
CpG  
-722 
CpG  
-711 
CpG  
-678 
CpG  
-623 
CpG  
-608 
CpG  
-585 
CpG  
-394 
CpG  
-84 
CpG  
-76 
CpG  
-65 
CpG  
-31 
% Fat  0.32  0.09  0.001  0.24  0.63  0.94  0.32  0.001  0.01  0.25  0.22 
Fat type  0.02  0.21  0.06  0.001  0.70  0.61  0.002  0.01  0.01  0.09  0.06 
Interaction  0.65  0.08  0.63  0.14  0.50  0.13  0.26  0.21  0.48  0.12  0.54 
 
FEMALES 
CpG  
-722 
CpG  
-711 
CpG  
-678 
CpG  
-623 
CpG  
-608 
CpG  
-585 
CpG  
-394 
CpG  
-84 
CpG  
-76 
CpG  
-65 
CpG  
-31 
% Fat  0.33  0.08  0.96  0.96  0.47  0.56  0.04  0.05  0.07  0.68  0.15 
Fat type  0.73  0.24  0.32  <0.01  0.81  0.02  <0.01  <0.01  <0.01  <0.01  <0.01 
Interaction  0.67  0.24  0.08  0.46  0.86  0.20  0.19  0.13  0.24  0.05  0.92 
 
 
 
 
Linear regression analysis was used to show the correlation between promoter 
methylation and mRNA expression. In males, methylation of CpGs -394, -84 and -
76 predicted 6%, 12% and 16% of fads2 expression, respectively. In females the 
effect was greater where CpGs -394, -84 and -76 predicted 55%, 16% and 28% of 
fads2  expression,  respectively.  In  both  sexes  methylation  of  CpG   -394  was 
negatively associated with fads2 mRNA expression and CpGs  -84 and -76 were 
positively associated with mRNA expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8.6 A General Linear Model showing significant interactive effects of type and 
amount  of  maternal  dietary  fat  on  fads2  promoter  methylation  in  male  and  female 
offspring. Samuel Peter Hoile   
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Figure 8.8 fads2 promoter methylation in male offspring.  Values are means with their 
standard deviations. Where ‘*’ represents a significance of P<0.05 and ‘**’ a significance of 
P<0.0005. ‘#’ represents significantly different from all other dietary groups, with the same 
maternal % dietary fat. Significant differences were by one-way ANOVA, with Bonferroni’s 
post hoc test P<0.005. Samuel Peter Hoile   
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Figure  8.9  Fads2  promoter  methylation  in  female  offspring.  Values  are  means  with  their 
standard  deviations.  Where  ‘*’  represents  a  significance  of  P<0.05  and  ‘**’  a  significance  of 
P<0.0005.  ‘#’  represents  significantly  different  from  all  other  dietary  groups,  with  the  same 
maternal % dietary fat. Significant differences were by one-way ANOVA, with Bonferroni’s post 
hoc test P<0.005. Samuel Peter Hoile   
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8.4 Discussion 
8.4.1 Regulation of offspring fasting glucose metabolism 
  Differences in hepatic PEPCK mRNA expression do not directly correlate to 
fasting plasma glucose values in either sex. As PEPCK represents one step in the 
pathway  of  fasting  glucose  homeostasis,  differences  in  fasting  glucose  may  be 
reflected in mRNA expression of other genes in the pathway. 
  There were no significant differences in the methylation levels of PEPCK 
promoter, in either sex. No differences were present in the methylation of CpGs in 
male or female offspring.  
These findings  in male  and female offspring  suggest  that  altered  expression of 
PEPCK is not through epigenetic regulation of DNA methylation. Altered forms of 
regulation, such as hormonal, may be responsible for differences seen. 
Male  FO  offspring  showed  a  significantly  higher  fasting  plasma  glucose  level, 
compared  to  female  FO  offspring.  This  suggests  either  an  increased  level  of 
gluconeogenesis or a decreased uptake of glucose from tissue. Although levels are 
within the expected range for the species
[254,259], the experiment does not allow us 
to differentiate between the two explanations. As a result it appears that feeding an 
FO diet to mothers during pregnancy and lactation leads to male offspring which 
have  a  greater potential  for providing  glucose  during fasting,  compared  to  their 
female siblings. Potentially this could result in a selective survival of male offspring 
over females, in periods of severe fasting. 
The  21%  fat  male  offspring  show  significantly  higher  levels  of  fasting  PEPCK 
expression.  These  results  suggest  that  although  altered  fat  intake  during 
pregnancy  does not  result  in  altered fasting  glucose  levels,  effects  are  seen  in 
terms of PEPCK transcription, suggesting the effect of altered fat is not limited to a 
subset of genes. Through an increase in the level of PEPCK mRNA expression, 
the 21% male offspring show a greater capacity for gluconeogenesis, although it 
appears this is not present at this point in these animals, perhaps as a result of 
altered regulation of further genes in the gluconeogenic pathway. 
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8.4.2 Regulation of offspring liver and plasma PC composition 
  The  significant  differences  in  liver  and  plasma  PC  composition  between 
groups were mainly evident in 20:4n-6 and 22:6n-3. Hepatic mRNA expression of 
the fads2 gene predicted 9% and 26% of 20:4n-6 and 22:6n-3 content of liver PC 
in males, respectively. In females, fads2 predicted 41% and 15% of 20:4n-6 and 
22:6n-3 content of liver PC, respectively. 
Amount  and  type  of  maternal  dietary  fat  led  to  significant  differences  in  CpG 
specific methylation of the fads2 promoter. Methylation of CpGs -394, -84 and -76 
are associated with expression of the fads2 gene. In males, methylation of CpGs -
394, -84 and -76 predicted 6%, 12% and 16% of fads2 expression, respectively. In 
females the effect was greater where CpGs -394, -84 and -76 predicted 55%, 16% 
and 28% of fads2 expression, respectively. In both sexes methylation of CpG -394 
was  negatively  associated  with  fads2  mRNA  expression,  suggesting  physical 
blocking  of  transcriptional  machinery  or  recruitment  of  methyl  CpG  binding 
proteins.  CpGs  -84  and  -76,  however,  were  positively  associated  with  mRNA 
expression, suggesting blocking of a repressor element to the promoter, following 
methylation.  
Polymorphisms in the fads2 gene were shown to account for 28.5% of the variation 
in serum phospholipid 20:4n-6 concentration in humans
[286]. The results showed 
here,  show  that  regulation  of  the  fads2  mRNA  expression,  via  altered  DNA 
methylation is as important as polymorphisms in overall regulation of phospholipid 
20:4n-6 and 22:6n-3 composition. In mice, increased methylation of 8 out of 11 
measured CpGs was associated with a decreased expression of the promoter
[287]. 
Although the results here, show methylation of three of the CpGs measured in rat 
are  associated  with  expression  of  the  fads2  gene,  and  not  all  negatively 
associated, the findings are in agreement, in that methylation of the fads2 gene is 
an important factor in regulation of gene expression. 
  Altered plasma membrane PC composition, in terms of PUFA, will lead to 
significant differences in the fluidity of the lipid bilayer
[147]. As a result, proteins in 
the  membrane  may  be  unable  to  change  configuration  following  activation  by 
specific  substrate,  this  will  prevent  the  cell  from  responding  to  external  stimuli. Samuel Peter Hoile   
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Female  rats  and  humans  have  a  higher  level  of  22:6n-3  in  liver  and  plasma 
phospholipids, compared to males. Females also have an increased capacity for 
synthesis  of  22:6n-3  in  pregnancy,  to  meet  the  demands  of  the  developing 
offspring
[288].  Variation  in  the  regulation  of  fads2  transcription  induced  during 
development is therefore an important factor in the future capacity to maintain liver 
and plasma 20:4n-6 and 22:6n-3 content in offspring. 
Fads2  mRNA  expression  was  significantly  decreased  in  the  21%  groups, 
regardless of the type of fat and sex of offspring. As a result, 20:4n-6 and 22:6n-3 
PC content of liver was significantly lower in both male and female 21% groups 
Studies have shown the DHA content of phospholipid bilayer in cell membranes is 
significantly associated with both retinal and brain function
[154,155]. As offspring are 
responsible  for  their  own  synthesis  of  long-chain  PUFA,  from  essential  dietary 
precursors, the efficiency of this pathway is vital for optimum function. 
In these animals, increasing the fat content of the maternal diet, regardless of the 
form of fat significantly decreased the DHA content of lipid membranes. As a result, 
the ability of hepatocytes to respond to external signals may be compromised. 
Although more protected from fluctuations in phospholipid content, neurons in the 
brain of offspring may also show significant changes in DHA content and therefore 
function, as a result of the altered fads2 expression. If this is occurring, the high fat 
offspring may be less responsive to external stimuli. 
Although arachidonnic acid (ARA) is used as a precursor for both pro and anti-
inflammatory molecules, such as prostaglandins, the overall effect of an increase in 
arachidonnic  acid  is  anti-inflammatory
[289].  As  well  as  DHA,  ARA  maintains 
hippocampal cell membrane fluidity, where the combined membrane content of the 
two  fats  is  around  20%
[290].  In  the  brain  ARA  also  aids  growth  and  repair  of 
neurons
[291]. Therefore, if brain tissue is similar to liver and plasma, in terms of the 
increased  20:4n-6  content  in  the  7%  offspring,  these  animals  may  have  an 
increased  capacity  for  neuron  repair,  a  decreased  inflammation  and  a  greater 
capacity to respond to external stimuli, compared to the 21% groups. 
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8.4.3 Future work 
  Maternal  fat  intake  may  have  adverse  effects  on  the  capacity  of  female 
offspring to synthesise long-chain PUFA during pregnancy and thus reduced ability 
to  provide  adequate  amounts  of  fatty  acids  to  their  offspring.  The  results  have 
shown that methylation of the fads2 promoter is significantly altered by maternal fat 
intake,  and  that  this  has  significant  effects  on  both  gene  expression  and  the 
phenotype  of  the  offspring.  This  shows  that  PEPCK  is  not  the  only  gene,  with 
metabolic  function,  that  is  significant  altered  by  maternal  nutrition  at  the  gene 
expression and promoter methylation level. 
  In terms of the DOHaD hypothesis, the results show that feeding a high fat 
diet has led to a detrimental change in the phenotype of the offspring, in terms of 
phospholipid composition. However, in order to test if the change in phenotype 
matches the PAR hypothesis, the offspring would need to also be fed a high fat 
diet, such as Bruce et al
[95]. 
  Maternal high fat feeding led to significant changes in mRNA expression of 
PEPCK, in the 21% SAO male offspring, which were not associated with changes 
in  promoter  methylation.  This  shows  that  the  role  of  methylation  in  altered 
expression of the PEPCK gene, following altered maternal nutrition, is dependent 
on the form of altered nutrition. When a protein restricted diet was used, there was 
a  relationship  between  PEPCK  promoter  methylation  and  mRNA  expression. 
However when high fat feeding was used, methylation did not play a role in mRNA 
expression of PEPCK. This is a novel finding. 
  Altered methylation of the PEPCK and fads2 promoters has been shown to 
be an important factor in determining mRNA expression of the genes, following 
certain forms of nutritional alteration. Investigation of transcription factor binding to 
the  promoters,  over  CpGs  which  have  been  shown  to  be  related  to  mRNA 
expression  will  increase  understanding  of  regulation  of  the  PEPCK  and  fads2 
genes. 
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Chapter 9 
 
Validation of the Effect of Altered 
Methylation of Specific CpG 
Dinucleotides on the Function of the 
PEPCK, DNMT3a2 and Fads2 Promoters 
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9.1 Introduction 
  Significant differences in promoter methylation of CpGs -56 and -39 of the 
DNMT3a2 promoter, CpGs -248, -100, -90 and -81 of the PEPCK and CpG -394 of 
the fads2 promoter in offspring of dams fed an altered diet during pregnancy, have 
been shown in previous chapters. These differences were significantly related to 
variations in mRNA expression. As stated in Section 1.4.1.2, methylation of single 
CpG sites in specific promoters is sufficient to affect transcription. For example, 
methylation of a single CpG site in the CRE in human glycoprotein hormone α-
subunit, both in vitro and in vivo, results in a loss of transcriptional activity, through 
altered transcription factor binding
[202]. This relationship is also seen in Epstein-
Barr virus, through methylation of the CBF2 binding site
[203] and the XAF1 gene in 
human  gastric  and  colon  cancers
[204].  Increased  pup  licking  and  grooming  and 
arched backed nursing by dams significantly altered binding of the transcription 
factor  NGFI-A  to  the  glucocorticoid  promoter,  in  the  hippocampus  of  offspring, 
through altered methylation
[206]. 
In order to investigate whether CpGs that showed altered methylation in the 
PEPCK, DNMT3a2 and fads2 promoters in the offspring, which were induced by 
altered maternal diets, are involved in the transcriptional regulation of these genes, 
the binding of nuclear extract to sequences of the promoter regions of the genes, 
containing the CpG sites, was investigated. 
   
The positive association between mRNA expression and total protein levels 
have  been  shown  experimentally  in  terms  of  multiple  genes
[45,292,50,293,294].  The 
purpose of experiments described in this chapter is to determine if this relationship 
is present in genes measured in this thesis. Although the DNMT3a2 gene has been 
extensively studied in this thesis, the relationship between mRNA expression and 
protein  levels  of  PEPCK  in  non-pregnant  adult  female  offspring  and  fads2  in 
offspring of dams fed diets containing FO or SAO during pregnancy, were studied. 
This is because antibodies against these proteins were available for measurement 
of protein levels. 
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 PEPCK was selected to investigate the relationship between protein levels and 
mRNA expression as it has been extensively studied in the experiments described 
in this thesis and appropriate antibodies for western blot detection of protein were 
available. 
   
The following experiments aim to answer the following gaps in the knowledge 
-Are significant differences in mRNA expression of PEPCK, in non-pregnant 
adult offspring associated with similar changes in liver protein levels? 
-Are transcription factors binding to regions around CpGs -248, -100, -90 and 
-81 of the PEPCK promoter, CpGs -56 and -39 of the DNMT3a2 promoter 
and CpG -394 of the fads2 promoter? 
-Is  the  binding  of  these  transcription  factors  significantly  affected  by 
methylation of the CpG sites? 
-Does mutation of specific CpG -394 of the fads2 promoter significantly alter 
levels of gene transcription? 
 
9.2 Experimental Design 
Protein extract was prepared from the livers of non-pregnant adult female 
offspring  from  the  study  described  in  section  2.2,  for  determination  of  PEPCK 
protein levels. Protein extract was prepared from the female offspring of the study 
described in section 8.2, for determination of fads2 protein levels. 
 
9.2.2 Molecular biology procedures 
  Analysis  of  protein  levels  by  Western  blotting  is  described  in  section 
2.3.11.4. Briefly, tissue was lysed in order to release all protein from within cells. 
20μg of protein per sample was run on a western blot gel, comprised of both a 
lower  resolving  gel  and  upper  stacking  gel.  Gels  were  transferred  onto  PVDF 
membranes and transferred at 200mA for 60 minutes, The PVDF membrane was 
blocked with PBS with 0.1% Tween-20 containing 5% Marvel, at 4
oC overnight, 
washed  and  incubated  for  1  hour  at  room  temperature,  shaking,  with  blocking 
solution  containing  the  appropriate  amount  of  primary  antibody.  Following Samuel Peter Hoile   
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incubation with primary antibody, membranes were washed again and incubated in 
blocking buffer containing the appropriate amount of secondary antibody. Protein 
levels  were  detected  incubating  the  membrane  West  DURA  Chemiluminescent 
substrate Super-Signal (Pierce, Fisher, Leicsershire, UK), for 5 minutes. Chemi-
ultrasensitivity was measured using a VersaDoc. 
 
Transcription  factor  binding  to  the  promoter  sequences  within  the  PEPCK, 
DNMT3a2 and fads2 promoters were shown using electro-mobility shift assays, as 
described in section 2.3.11.3. Briefly, components of the binding reaction, such as 
nuclear  extract  and  labelled  or  unlabelled  oligonucleotides  were  run  on  an 
acrylamide  gel.  The  gel  was  then  transferred  for  one  hour  at  200mA  and 
crosslinked.  The  membrane  was  then  incubated  in  blocking  buffer,  conjugate 
buffer/blocking solution, wash buffer and substrate working solution. Following the 
incubations, the bands were visualised using a VersaDoc (Bio-Rad Laboratories, 
Hertfordshire, UK). 
 
Analysis of the role of specific CpGs in transcriptional regulation is described in 
section  2.3.9.  Briefly,  the  promoter region  of fad2  was  amplified using  a  proof-
reading  PCR  reaction,  ligated  into  a  pGl3  vector  and  transfected  into  rat 
hepatocyte,  CC-1  cells.  Quick-change  mutagenesis  of  CpG  -394,  of  the  ligated 
fasd2  promoter-pGl3  complex  was  used  to  create  the  cytosine  to  adenosine 
mutation of the fas2 promoter. 
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9.3 Results 
9.3.1  Does  mRNA  expression  of  PEPCK  in  PS  lineage  F1  and  F2  non-
pregnant adult female offspring correlate with PEPCK protein levels? 
  PEPCK protein levels were measured using western blotting in F1 and F2 
PS  non-pregnant  adult  female  offspring  (n=3/group)  (Figure  9.1).  Using 
densitometry values, measured on the VersaDoc Quantity One software, the total 
levels  of  protein  were  determined.  F1  and  F2  female  offspring  PEPCK  mRNA 
expression and total protein levels can be seen in Figure 9.2. 
Although not significant (p=0.16),when considering the densitometry values there 
appears to be a similarity between RT-PCR and protein levels of PEPCK, between 
the F1 and F2 offspring. Linear regression analysis of protein densitometry values 
and  mRNA  values  shows  a  trend  towards  a  positive  correlation  (p=0.0965, 
r
2=0.656). 
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Figure  9.1  Western  Blot  gel  of  F1  and  F2  PEPCK  non-pregnant  adult  using  Abcam 
primary antibody ab28455 (Rabbit polyclonal anti-PEPCK)  and secondary antibody ab9705 
(Goat anti-rabbit horse-radish peroxidase conjugate). The Abcam ab41746 molecular weight 
marker was used to determine the size of the PEPCK band. 
66 kDa 
97.4 kDa 
PEPCK 69 kDa 
   1        2        3         4        5         6 
 F1      F2 
Figure 9.2 PEPCK mRNA and protein levels in F1 and F2 non-pregnant adult offspring.  
Although not significant, the decreased PEPCK mRNA expression between the F1 and F2 
generations can be seen in the associated protein levels. n = 9/group for RT-PCR analysis, 
n=3/group for protein analysis. Samuel Peter Hoile   
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9.3.2 Does mRNA expression of fads2 in offspring of dams fed altered fat 
diets during pregnancy correlate with fads2 protein levels? 
  Although attempts were made to investigate the protein level of fads2 in 
offspring of dams fed diets containing 7% and 21% SAO and FO during pregnancy 
and lactation, the experiments proved unsuccessful. 
Despite using a range of concentrations of both primary and secondary antibody, 
no bands correlating to detection of fads2 protein could be seen on the western 
blotting gel (Figure 9.3). The range of concentrations can be seen in table 9.1. As 
the primary antibody used was the only one available against the fads2 protein in 
rat, no further progress could be made. 
 
 
 
 
 
 
 
 
 
 
 
 
Lane  Dilution of primary Ab  Dilution of secondary Ab 
1  1/200  1/40000 
2  1/200  1/50000 
3  1/500  1/40000 
4  1/500  1/50000 
5  1/1000  1/40000 
6  1/1000  1/50000 
7  1/200  1/5000 
Table 9.1 Antibody dilutions used in optimisation of fads2 western blot 
Figure 9.3 Western Blot gel fads2 optimisation using goat polyclonal primary anti-fads2, 
sc-109272  (SantaCruz)  and  secondary  antibody,  ab97100    (rabbit  anti-goat,  horse  radish 
peroxidase conjugate) 
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9.3.3 Does nuclear extract of CC-1 cells bind the region containing CpG -248 
of the PEPCK promoter? 
  Methylation of CpG -248 was significantly altered between offspring groups. 
A MatInspector, putative transcription factor binding search showed that the CpG-
248 is within a binding site for C/EBP (shown in Figure 5.6), a known regulator of 
PEPCK transcription
[295]. As a result the binding of nuclear extract to the region 
containing CpG -248 was investigated. 
Binding of nuclear extract is occurring at the region covering CpG -248 of 
the PEPCK promoter (lanes 1 and 2 of Figure 9.4). The absence of a band present 
when an excess of unlabelled probe was added (lane 3 of Figure 9.4) suggests 
that the unlabelled probe is competing out the labelled probe and the binding is 
specific. As the addition of a non-specific probe (oligonucleotide for fads2 -394, 
shown in table 2.13) does not compete out binding of the labelled probe, this again 
suggests that the binding is specific (lane 5 of Figure 9.4). 
 
9.3.3.1  Is  nuclear  extract  binding  to  the  PEPCK  promoter  affected  by 
methylation of CpG -248? 
Presence of a band suggests that methylation of CpG -248 does not prevent 
binding of nuclear extract to the this region of the PEPCK promoter The absence of 
a band present when an excess of unlabelled probe was added (lane 8 of Figure 
9.4) suggests that the unlabelled probe is competing out the labelled probe and the 
binding is specific. As the addition of a non-specific probe does not compete out 
binding of the labelled probe, this again suggests that the binding is specific (lane 9 
of Figure 9.4). 
 
9.3.3.2 Is the C/EBP binding at CpG -248 of the PEPCK promoter? 
  The  addition  of  an  antibody  against  C/EBP  β  (Abcam  ab32358),  to  the 
nuclear extract and labelled probe, was used to confirm binding of C/EBP to the 
PEPCK promoter at CpG -248.  
Decreased electromobility of the bands in lanes 5 and 10, compared to lanes 2 and 
7, suggests that the transcription factor C/EBP β is binding to CpG -238 of the Samuel Peter Hoile   
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PEPCK promoter (lanes 5 and 10 of Figure 9.4). As the band is present in both 
lanes 5 and 10, this suggests that methylation of the CpG does not alter binding 
(lanes 5 and 10 of Figure 9.4). 
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Figure  9.4  Electromobility  Shift  Assay  gel  picture  of  PEPCK  CpG  -248  with 
unmethylated and methylated oligonucleotides. Lane 1 shows the unmethylated labelled 
probe only, lane 2 shows the unmethylated labelled probe with nuclear extract, lane 3 shows 
the unmethylated labelled probe with nuclear extract and an excess of unlabelled probe, lane 
4 shows unmethylated labelled probe with nuclear extract and an excess of unlabelled non-
specific probe, lane 5 shows unmethylated labelled probe with nuclear extract and antibody 
against  C/EBP.  Lane  6  shows  the  methylated  labelled  probe  only,  lane  7  shows  the 
methylated labelled probe with nuclear extract, lane 8 shows the methylated labelled probe 
with nuclear extract and an excess of unlabelled methylated probe, lane 9 shows methylated 
labelled probe with nuclear extract and an excess of unlabelled non-specific probe, lane 10 
shows methylated labelled probe with nuclear extract and antibody against C/EBP Samuel Peter Hoile   
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9.3.4 Does nuclear extract of CC-1 cells bind the region containing CpGs -
100, -90 and -81 of the PEPCK promoter? 
  Methylation of CpGs -100, -90 and -81 was significantly altered between 
offspring  groups.  A  MatInspector,  putative  transcription  factor  binding  search 
showed that the CRE is situated over CpGs -100, -90 and --81 (shown in Figure 
5.6), a known regulatory region of PEPCK transcription
[295]. As a result the binding 
of  nuclear  extract  to  the  region  containing  CpGs  -100,  -90  and  -81  was 
investigated. 
The absence of bands presence in lanes 2, 3, and 4 suggest no nuclear 
extract is binding to the region covering CpGs -100, -90 and -81 of the PEPCK 
promoter (Figure 9.5). Lane 1 shows presence of labelled probe only. Lanes 2, 3 
and 4 show three amounts of nuclear extract (1μg, 4μg and 5μg, respectively) with 
labelled probe. Lane 5 shows labelled probe with nuclear extract with an excess of 
unlabelled probe.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.5 Electromobility Shift Assay gel picture of PEPCK CpGs -100, -90 and -81 with 
unmethylated oligonucleotides. Lane 1 shows the unmethylated labelled probe only, lane 2 
shows  the  unmethylated  labelled  probe  with  1  μg  of  nuclear  extract,  lane  3  shows  the 
unmethylated labelled probe with 4 μg nuclear extract, lane 4 shows the unmethylated labelled 
probe with 5 μg nuclear extract and lane 5 shows unmethylated probe with 4 μg nuclear extract 
and an excess of unlabelled probe. 
1           2          3             4         5 Samuel Peter Hoile   
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9.3.5 Does nuclear extract of CC-1 cells bind the region containing CpG -56 
of the DNMT3a2 promoter? 
Methylation of CpG -56 was significantly altered between offspring groups. 
As a result binding of nuclear extract to this region was investigated.  
The absence of bands presence in lanes 2, 3, and 4 suggest no nuclear 
extract is binding to the region covering CpG -56 of the DNMT3a2 promoter (Figure 
9.6). Lane 1 shows presence of labelled probe only. Lanes 2, 3 and 4 show three 
amounts of nuclear extract (1μg, 4μg and 5μg, respectively) with labelled probe. 
Lane  5  shows  labelled  probe  with  nuclear extract  with  an  excess  of  unlabelled 
probe. 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  9.6  Electromobility  Shift  Assay  gel  picture  of  DNMT3a2  CpG  -56  with 
unmethylated oligonucleotides. Lane 1 shows the unmethylated labelled probe only, lane 2 
shows  the  unmethylated  labelled  probe  with  1  μg  of  nuclear  extract,  lane  3  shows  the 
unmethylated  labelled  probe  with  4  μg  nuclear  extract,  lane  4  shows  the  unmethylated 
labelled probe with 5 μg nuclear extract and lane 5 shows unmethylated probe with 4 μg 
nuclear extract and an excess of unlabelled probe. 
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9.3.6 Does nuclear extract of CC-1 cells bind the region containing CpG -39 
of the DNMT3a2 promoter? 
  Methylation of CpG -39 was significantly altered between offspring groups. 
A MatInspector, putative transcription factor binding search showed that the CpG -
39 is within a binding site for the early growth response factor (EGR), E-twenty six-
1  (ETS-1) and signal transducer and activator of transcription 5 (STAT5). As a 
result  the  binding  of  nuclear  extract  to  the  region  containing  CpG  -39  was 
investigated. 
Binding of nuclear extract is occurring at the region covering CpG -39 of the 
DNMT3a2 promoter (lanes 1 and 2 of Figure 9.7). The absence of a band present 
when an excess of unlabelled probe was added (lane 3 of Figure 9.7) suggests 
that the unlabelled probe is competing out the labelled probe and the binding is 
specific. Although a band is present in lane 3, it is not present at the same level as 
the band  in  lane 2,  suggesting  by  competing  out binding  of  the  factor with  the 
unlabelled  probe,  a  weaker  form  of  binding,  by  an  alternative  factor  may  be 
occurring. As the addition of a non-specific probe (oligonucleotide for fads2 -394, 
shown in table 2.13) does not compete out binding of the labelled probe, this again 
suggests that the binding is specific (lane 5 of Figure 9.7). 
 
9.3.6.1  Are  EGR,  ETS-1  or  STAT5  binding  at  CpG  -39  of  the  DNMT3a2 
promoter? 
   The binding of transcription factors was assessed by adding an excess of 
unlabelled oligonucleotides containing the consensus sequences for early growth 
response factor (EGR), E-twenty six-1 (ETS-1) and signal transducer and activator 
of transcription 5 (STAT5) to 4 μg of nuclear extract and labelled probe. In order to 
confirm  that  the  specific  transcription  factors  are  binding  to  the  region  of  the 
DNMT3a2 promoter, the addition of the unlabelled probe containing the binding 
sequences  of  the  factors,  must  compete  out  the  binding  of  the  extract  to  the 
labelled probe. Two independent sources were used to obtain the biding regions 
for  EGR,  ETS-1  and  STAT5,  MatInspector  (odd  lanes)  and  Santa  Cruz 
Biotechnologies (even lanes). Samuel Peter Hoile   
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The presence of bands in lanes 5 and 6 suggests the EGR factor does not 
bind  to  the  area  covering  CpG  -39.  The  presence  of  bands  in  lanes  7  and  8 
suggests  the  ETS-1  factor  does  not  bind  to  the  area  covering  CpG  -39.  The 
presence of bands in lanes 9 and 10 suggests the STAT5 factor does not bind to 
the area covering CpG -39.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  9.7  Electromobility  Shift  Assay  gel  picture  of  DNMT3a2  CpG  -39  with 
unmethylated  oligonucleotides  and  consensus  sequence  oligonucleotides  for  EGR, 
ETS-1 and STAT5. Lane 1 shows the unmethylated labelled probe only, lane 2 shows the 
unmethylated  labelled probe  with 4 μg of nuclear extract, lane  3 shows the  unmethylated 
labelled probe with 4 μg nuclear extract and an excess of unlabelled probe, lane 4 shows 
unmethylated labelled probe with nuclear extract and an excess of unlabelled non-specific 
probe, lanes 5 and 6 contain the unmethylated labelled probe with 4 μg nuclear extract and an 
excess  of  unlabelled  consensus  sequences  of  EGR  (MatInspector  sequence  in  lane  5, 
SantaCruz sequence in lane 6), lanes 7 and 8 contain the unmethylated labelled probe with 4 
μg nuclear extract and an excess of unlabelled consensus sequences of ETS-1 (MatInspector 
sequence  in  lane  7,  SantaCruz  sequence  in  lane  8)  and  lanes  9  and  10  contain  the 
unmethylated labelled probe with 4 μg nuclear extract and an excess of unlabelled consensus 
sequences of STAT5 (MatInspector sequence in lane 9, SantaCruz sequence in lane 10). 
      1         2       3        4       5        6       7        8        9        10 
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9.3.7 Does nuclear extract of CC-1 cells bind the region containing CpG -394 
of the fads2 promoter? 
Methylation of CpG -394 was significantly altered between male and female 
offspring  groups.  A  MatInspector,  putative  transcription  factor  binding  search 
showed that the CpG-394 is within a binding site for oestrogen receptor (ER). The 
role  of  oestrogen  in  regulation  of  fatty  acid  metabolism  has  been  suggested 
previously
[296]. As a result the binding of nuclear extract to the region containing 
CpG -394 was investigated. 
Binding of nuclear extract is occurring at the region covering CpG -394 of 
the fads2 promoter (lanes 1 and 2 of Figure 9.8). The absence of a band present 
when an excess of unlabelled probe was added (lane 3 of Figure 9.8) suggests 
that the unlabelled probe is competing out the labelled probe and the binding is 
specific. As the addition of a non-specific probe (oligonucleotide for PEPCK -248, 
shown in table 2.13) does not compete out binding of the labelled probe, this again 
suggests that the binding is specific (lane 5 of Figure 9.8). 
   
9.3.7.1  Is  nuclear  extract  binding  to  the  fads2  promoter  affected  by 
methylation of CpG -394? 
  Presence of a band suggests that methylation of CpG -394 does not 
prevent  binding  of  nuclear extract  to  the  this region  of the fads2  promoter  The 
absence of a band present when an excess of unlabelled probe was added (lane 8 
of Figure 9.8) suggests that the unlabelled probe is competing out the labelled 
probe and the binding is specific. As the addition of a non-specific probe does not 
compete out binding of the labelled probe, this again suggests that the binding is 
specific  (lane  9  of  Figure  9.8).  Using  densitometry,  the  intensity  of  binding  of 
nuclear extract was measured on the VersaDoc Quantity One software (figure 9.9). 
 
9.3.7.2 Is the ER binding at CpG -394 of the fads2 promoter? 
  The  addition  of  an  antibody  against  the  oestrogen  receptor  (Abcam 
ab16660) to the nuclear extract and labelled probe was used to investigate binding 
of  the ER to  the fads2  promoter at  CpG  -394. As  shown  by  the  absence  of a Samuel Peter Hoile   
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SuperShift band in lanes 5 and 10, it cannot be confirmed that the ER transcription 
factor  is  binding  around  CpG  -394,  whether  it  is  unmethylated  (lane  5)  or 
methylated (lane 10) (Figure 9.8) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
Figure 9.8 Electromobility Shift Assay gel picture of Fads2 CpG -394 with unmethylated 
and methylated oligonucleotides. Lane 1 shows the unmethylated labelled probe only, lane 
2 shows the unmethylated labelled probe with nuclear extract, lane 3 shows the unmethylated 
labelled  probe  with  nuclear  extract  and  an  excess  of  unlabelled  probe,  lane  4  shows 
unmethylated labelled probe with nuclear extract and an excess of unlabelled non-specific 
probe, lane 5 shows unmethylated labelled probe with nuclear extract and antibody against 
ER. Lane 6 shows the methylated labelled probe only, lane 7 shows the methylated labelled 
probe with nuclear extract, lane 8 shows the methylated labelled probe with nuclear extract 
and an excess of unlabelled methylated probe, lane 9 shows methylated labelled probe with 
nuclear extract and an excess of unlabelled non-specific probe, lane 10 shows methylated 
labelled probe with nuclear extract and antibody against ER. 
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Figure  9.9  Band  intensity  of  fads2  EMSA  showing  the  difference  in  binding  of  nuclear 
extract to both unmethylated and methylated probes. Methylation of the labelled probes led to 
a decreased binding intensity at CpG -394 of the fads2 promoter. Samuel Peter Hoile   
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9.3.8  Does  mutagenesis  of  CpG  -394  of  the  fads2  promoter  alter 
transcriptional activity of fads2? 
  In women, increased exposure to oestrogen is associated with an increased 
level of the products of linoleic acid metabolism
[297] and putative transcription factor 
binding analysis suggests binding of the oestrogen receptor around CpG -394. As 
a result, the role of CpG -394, in the basal level of fads2 transcription and the 
response to oestrogen, was investigated.  Cloning and mutagenesis was used to 
determine the effect of mutation of the cytosine of CpG  -394 dinucleotide to an 
adenosine residue. 
As shown in Figure 9.10, mutation of CpG -394 had no effect on basal levels of 
fads2 transcription (shown in the 0pM 17α-ethinylestradiol bars). In the presence of 
oestrogen, in the form of 17α-ethinylestradiol, mutagenesis of CpG -394, from a 
cytosine  to  an  adenosine,  inhibited  oestrogen  induced  activation  of  fads2 
transcription (P<0.05). 
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Figure 9.10 Luciferase activity of the fads2 promoter in the presence of 0pM, 70pM and 
700pM 17α-ethinylestradiol. Blue bars show the wild-type promoter and red bars show the -
394 cytosine to adenosine mutant promoter. Samuel Peter Hoile   
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9.3.9 Cloning and mutagenesis of DNMT3a2 and PEPCK promoters 
  Although  attempts  were  made  to  clone  and  mutate  the  CpGs  in  the 
DNMT3a2 and PEPCK promoter with known roles in expression of the genes, the 
experiments were unsuccessful. 
In terms of PEPCK, the promoter region was successfully amplified and cloned in 
pGEM-T,  but  could  not  be  successfully  cloned  into  the  pGl3  vector.  The  cut 
plasmid DNA shows presence of the pGl3 vector only, without the presence of the 
PEPCK promoter (Figure 9.11 (A)). Presence of the PEPCK promoter into pGEM-T 
was confirmed by sequencing. It is most likely that this is due to the restriction 
enzymes used for the ligation of the PEPCK PCR product to the digested pGl3 
vector.  
In terms of DNMT3a2, the promoter region was successfully cloned into the pGl3 
vector, however on multiple attempts, sequencing confirmed that the mutagenesis 
of CpGs -56 and -39 were unsuccessful. The reason for this was unclear. The 
successful cloning of DNMT3a2 in pGl3 is shown in Figure 9.11 (B), where the 
digest with NcoI leads to 2 bands and a digest with ApoI leads to multiple bands. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A                                 B 
        Uncut   Cut                     Uncut  NcoI  ApoI 
Figure 9.11 1% Agarose gels showing the progress of PEPCK and DNMT3a2 cloning 
where  A  shows  the  absence  of  the  PEPCK  promoter  in  pGl3  clones  and  B  shows  the 
restriction map of DNMT3a2 cloned in pGl3, where enzymes NcoI and ApoI were used. Samuel Peter Hoile   
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9.4 Discussion 
  Data in this chapter has shown similarities in the pattern of hepatic PEPCK 
mRNA expression and total protein levels, between the F1 and F2 non-pregnant 
female offspring, specific binding of the CRE to CpG -248 of the PEPCK promoter, 
specific binding of nuclear extract to CpG -394 of the fads2 promoter and CpG -39 
of  the  dnmt3a2  promoter.  The  role  of  CpG  -394  in  fads2  transcription,  in  the 
presence of oestrogen was also shown. 
 
9.4.1  The  relationship  between  mRNA  expression  and  protein  levels  of 
PEPCK 
  The positive correlation between mRNA expression and protein levels has 
been  shown  experimentally
[45,292,50,293,294].  In  mIR-29b,  acute  myeloid  leukaemia 
cells a decreased expression of DNMT3a, DNMT3b and DNMT1 was associated 
with a decreased level of protein of all three genes
[293]. As shown by Feng et al, 
expression of DNMT3a mRNA was related to total protein levels, in mouse CNS 
cells
[292].  In  rat,  expression  of  GR  mRNA  was  significantly  increased  in  day  20 
embryo kidney tissue, following maternal low-protein feeding during pregnancy
[45]. 
A similar increase in GR protein levels was seen in the sample group. In another 
study  that  used  maternal  protein  restriction  to  lead  to  an  alteration  in  offspring 
phenotype,  protein  kinase  C  and  p11Oβ-associated  p85α  mRNA  expression  in 
abdominal fat were significantly reduced (p<0.05)
[50].  The mRNA expression levels 
were associated with decreased protein levels. 
Although the results shown in this chapter show data for PEPCK mRNA and 
protein levels, a positive relationship is present, which is in agreement with the 
published  literature
[298].    In  mice,  injection  of  retinol  binding  protein-4  (RBP4) 
resulted  in  a  41%  increase  in  hepatic  PEPCK  expression,  compared  to  control 
mice (P<0.05). This difference was associated with a 94% in liver protein levels of 
PEPCK
[298]. 
It  has  been  experimentally  proven  that  levels  of  DNMT3a  protein  are 
positively associated with mRNA level
[293]; therefore it may be assumed that final 
DNMT3a protein levels are in agreement with measured mRNA expression levels. Samuel Peter Hoile   
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Due to post-transcriptional regulation of protein synthesis, these results cannot be 
extrapolated  to  suggest  that  all  measured  genes  correlate  with  protein  levels. 
However, patterns in mRNA expression of differences between genes, in the same 
metabolic pathway, such as that shown in Figure 3.13, suggest protein levels may 
be related to measured mRNA levels for at least a subset of genes. 
In terms of implications for the animals, the higher level of PEPCK protein, in liver 
of F1 PS non-pregnant female offspring, compared to the F2 PS group, suggests a 
greater capacity for provision of glucose during fasting. As both F1 and F2 groups 
had  high  fasting  glucose  values,  compared  to  an  adult  female  Wistar  rat  that 
received no dietary alteration in their life, or the life of the dam suggests that the 
increase in PEPCK may account for this increase in the F1 generation. As a result, 
different mechanism may be behind the increased fasting plasma glucose values 
between generations. 
 
9.4.2 The relationship between promoter methylation and gene expression 
  Previous studies have shown a relationship between  methylation of gene 
promoters  and  mRNA  expression,  through  altered  transcription  factor 
binding
[299,300]. Using a synthetic oligonucleotide, containing a sequence found in 
the  adenovirus  major  late  promoter,  it  was  shown  that  methylation  affects 
transcription factor binding
[300].  Using  a  gel  retardation  assay,  it  was  found  that 
replacement of a single cytosine residue, with 5-methylcytosine inhibited binding of 
MCTF  52  base  pairs  upstream  from  the  transcription  factor  start  site.  This 
relationship however, is not seen in all cases. Methylation of a specific cytosine 
within synthetic octamers containing Sp1 binding sites did not prevent binding of 
the factor from HeLa cell nuclear extracts
[301]. In this study binding of Sp1 showed 
no significant differences when the octamers were unmethylated or methylated.  
The  data  described  in  this  chapter  shows  that  at  CpG  -248  of  the  PEPCK 
promoter, C/EBPβ binding can occur and that methylation of the CpG does not 
prevent  binding.  Previous  studies  have  shown  a  role  of  C/EBP  in  regulation of 
PEPCK  transcription
[134,302].  A  study  by  O’Brien,  has  shown  binding  of  C/EBP 
specifically regulates PEPCK around -248 base pairs, in regulation by insulin, via Samuel Peter Hoile   
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binding to the insulin response element and cAMP, through the CRE, in mice
[302]. 
Using C/EBPα -/- and C/EBPβ -/- mice, it was shown that both forms of C/EBP are 
involved in regulation of PEPCK
[134]. 
According to Faber et al, methylation off CpG s -90 and -81, inhibit binding of CRE, 
in the human glycoprotein hormone α subunit
[299]. In the studies described in this 
chapter, EMSAs suggest that no nuclear factor is binding across CpGs -100, -90 
and -81 of the rat PEPCK promoter. These experiments were conducted using rat 
hepatocyte CC-1 cell nuclear extract. In different cell types, the nucleus will contain 
other factors, which may bind to the region. However, these factors will not be 
responsible for regulation of gene transcription in liver. 
These results confirm that in rat hepatocytes, C/EBPβ binds across CpG -248 and 
that methylation of the cytosine residue does not alter binding. In terms of the data 
in this thesis, it suggests that regardless of methylation at the site, regulation via 
C/EBPβ is not altered. This suggests that differences in mRNA expression, which 
are  related  to  CpG  -248  methylation,  are  not  due  to  altered  C/EBPβ  binding.  
Studies  into  the  PEPCK  promoter  have  shown  binding  of  two  specific  factors 
(CREB/ATF and pep A) to the hypersensitive, HS A site of the PEPCK promoter 
4,800  base  pairs  upstream  of  the  promoter,  which  contains  a  CRE  site
[303]. 
Therefore, regulation at this site or others may be significantly altered by increased 
or decreased methylation. 
No studies to date have shown altered binding of transcription factors  to 
specific CpGs in the dnm3a2 or fads2 promoters. Therefore, it is unknown if the 
results described in this chapter are in agreement with published findings. EMSAs 
using synthetic oligonucleotides based on regions around CpGs -56 and -39 of the 
DNMT3a2 promoter, showed presence of binding at CpG -39 only. As the band 
present  was  still  present  after  addition  of  an  unlabelled  probe  the  binding  of  a 
transcription factor found in rat hepatocytes, which binds at CpG -39 could not be 
confirmed as EGR, ETS-1 or STAT5. As a result, in these animals, it is a different 
transcription factor, present in the nucleus of CC-1 cells, which may play a role in 
regulation of transcription, binding at CpG -39. As the putative transcription factor 
binding analysis did not highlight any further regulatory factors of interest and the Samuel Peter Hoile   
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known regulatory factors do not bind at this region, the identity of this factor is 
unknown. 
Binding of a transcription factor found within the nucleus of CC-1 cells, was 
confirmed at the region around CpG -394 of the fads2 promoter. This binding is 
specific and the intensity is decreased by methylation of the CpG. Methylation of 
CpG -394 did not completely prevent all binding of the factor to the region; this 
suggests that the CpG -394 may be present in the binding site of the factor, but not 
in the core site. As homology between the core site of transcription factor binding 
and the promoter is required for binding, whereas a complete match between the 
entire binding sequence and promoter sequence will lead to a stronger intensity of 
binding. The oestrogen receptor is expected to bind across this CpG, as shown in 
figure 9.12 this could be the case. If the addition of the methyl groups to the CpG is 
weakening the binding of ER to the site, this may explain the decreased intensity of 
binding in the presence of the methylated oligonucleotide. 
 
 
 
 
 
 
 
The addition of an anti-ER antibody to the EMSA reaction set-up did not lead to a 
shift in the binding of the factor to the synthetic oligonucleotide. Therefore it cannot 
be confirmed that it is the oestrogen receptor that is binding to the region around 
CpG -394. However, this does not rule out that the oestrogen receptor is binding 
here, as the antibody must bind to the factor in a manner that does not prevent the 
factor from binding to the oligonucleotide. The results suggest that regulation of 
mRNA expression, through changes in methylation of CpG -394 is likely to be an 
effect of altered transcription factor binding at CpG -394. As no studies have shown 
data into binding at the fads2 promoter and the role of promoter methylation, it is 
not known if this data is in agreement with the literature. 
                  CpG -394 
5’ – TCTTATCTCTTCACTGATAATTTCGACCTTGTGGAAA – 3’ 
                      ER 
Figure 9.12 Binding of the oestrogen receptor (ER) to the region around CpG -394 of 
the fads2 promoter where the binding site is underlined and core region is in bold. Predicted 
binding site obtained from MatInspector search. Samuel Peter Hoile   
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9.4.3 Mutagenesis of fads2 and transcriptional activity 
  Site-directed mutagenesis has shown that the cytosine at position -394 of 
the fads2 promoter is required for increased transcriptional activity in the presence 
of oestrogen, in the form of 17α-ethinylestradiol. Mutagenesis of the cytosine had 
no  impact  on  basal  levels  of  fads2  transcription  (0pM  17α-ethinylestradiol), 
suggesting the presence of oestrogen leads to an increase in the level of fads2 
transcription, through the  binding  of  a  regulatory  transcription factor  around  the 
cytosine of CpG -394. 
Studies have shown a clear effect of oestrogen on ability to synthesise long chain 
PUFA.  In  women,  increased  exposure  to  oestrogen  was  associated  with  an 
increased level of the products of linolenic acid metabolism, dihomo-γ-linolenic acid 
and  ARA,  potentially  through  increased  ʔ5  and  ʔ6  expression
[297].  Burdge  and 
Wotton have shown that 28 year old women have a 200 times greater ability to 
synthesise  DHA  from  alpha-linoleic  acid,  compared  to  same  age  males,  where 
undetectable  levels  were  recorded
[304].  The  study  used 
13C  alpha-linoleic  acid 
consumption and measured  the fatty acid content of PC. It was suggested that 
pregnant and lactating  women (women of reproductive age) have an  increased 
synthesis of the long chain PUFA, to provide optimum DHA for the development of 
the offspring’s central nervous system. The administration of 17α-ethinylestradiol to 
male to female transsexuals has shown that oestrogen can increase a male’s DHA 
synthesis
[296].  Plasma  cholesteryl  ester  DHA  composition  increased  more  than 
40%, following administration of 17α-ethinylestradiol. The study also investigated 
the administration of 17α-ethinylestradiol, in the form of the oral contraceptive pill, 
to women on DHA status. Women who were taking the pill had a 10% increase in 
proportion of DHA, compared to those who were not
[296]. In a separate study which 
again took into consideration the effect of 17α-ethinylestradiol, in the form of the 
contraceptive pill in women, plasma PC DHA content tended to be increased in 
those  using  the  pill,  compared  to  those  who  did  not
[304].  These  studies  have 
identified a potential mechanism for the increased synthesis of long chain PUFA in 
the  presence  of  oestrogen,  through  the  increased  expression  of  the  fads1  and 
fads2 genes. Findings in this chapter are in agreement with the literature, into the Samuel Peter Hoile   
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increased  capacity  of  long  chain  PUFA  synthesis  in  females  and  extend  the 
knowledge  of  the  underlying  mechanism,  by  providing  clear  evidence  of  the 
oestrogen  on  fads2  transcription  and  by  showing  the  binding  of  a  specific 
transcription  factor  to  the  region.  In  the  context  of  the  observation  studies  by 
Burdge  and  Wotton,  the  data  presented  here  suggests  that  females,  or  those 
receiving  oestrogen  supplements,  may  have  hypomethylation  of  the  oestrogen 
receptor binding site of the fads2 promoter, which will lead to an increased level of 
fads2 mRNA expression and increased ʔ6 protein levels. 
Other  studies  have  shown  an  effect  on  transcription,  following  single  site 
mutagenesis.  In  the  BRCA1  COOH  terminus,  which  acts  as  a  transcriptional 
activation domain, site-directed mutagenesis was used to characterise five known 
germ  lines
[305].  In  dog,  mouse  and  rat,  5  different  sites  of  mutagenesis  were 
associated with an increased level of transcription in four cases and a decreased 
level  of  transcription  in  one  case.  Although  no  known  studies  to  date  have 
investigated the effect of site-directed mutagenesis of the fads2 promoter, naturally 
occurring polymorphisms have been shown to affect levels of transcription of the 
gene
[286].  In  humans,  there  are  two  common  polymorphism  of  the  fads2  gene, 
which  increase  promoter  activity  and  facilitate  transcription  factor  binding, 
rs3834458 and rs968567. The activity of rs968567, a C or T base at position -299, 
was determined, through the use of a luciferase reporter gene assay and EMSA. 
The allele dependent DNA binding was shown, in terms of two complexes to the 
region containing the single nucleotide polymorphism. One of these proteins was 
identified  as  a  member  of  the  ETS  family  of  transcription  factors,  ELK1.The 
promoter region, up to -1014 base pairs, was cloned into HepG2 and HeLa cells 
and the effect of both SNPs was determined
[286]. It was found that in both cell types 
promoter activity was increased when the major T allele was present at -942 and 
the  T  minor  allele  was  present  at  -299  base  pairs.  The  greatest  increase  in 
promoter activity was caused by the C to T mutation at -299 base pairs (rs968567). 
Further experimentation by the group has shown that the polymorphism accounts 
for 28.5% of variance in serum phospholipid composition, in humans
[286]. Samuel Peter Hoile   
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The study by Lattka, along with data in this chapter shows that single bases in the 
fads2 promoter are sufficient to significantly alter transcription of the gene, in both 
humans and in the rat. The data provided in this chapter extends this knowledge by 
showing the importance of the -394 site, on fads2 transcription. 
 
9.4.4 Regulation of long-chain PUFA synthesis by oestrogen  
  The  composition  of  both  liver  and  plasma  PC  content  was  significantly 
reduced by the amount of fat in the maternal diet, where an increase in maternal 
fat led to a decrease in incorporation of ARA and DHA in PC. 
Previous  studies  into  altered  fat  intake  of  during  pregnancy  have  focused  on 
increase saturated fat intake
[64,65,66,67,68,69,70,71,72], there has been little investigation 
into the role of type and amount of dietary fat on offspring development. A study by 
Childs et al has shown that feeding of high and low fat soybean oil, high fat linseed 
oil, high fat salmon oil and high fat sunflower oil diets to dams during gestation, in 
the rat, led to significant differences in n-6 content of liver and plasma PC of fetal 
offspring
[306].  The  study  found  significant  differences  in  linolenic  acid  content  of 
plasma PC and liver PC and PE between the high and low fat soybean oil groups, 
where levels were increased in the high fat group. There were no effects of amount 
of fat, in the soybean groups in terms of liver or plasma PC ARA content. Although 
this study has looked at the effect of different types of fat in offspring, the data is 
from fetal tissue, where the supply of long chain PUFA would be from the dams. As 
a result the findings are not directly comparable to adult offspring. 
A maternal high fat diet significantly altered the capacity of offspring to synthesise 
long chain PUFA. This was reflected in reduced content of ARA and DHA in liver 
and plasma PC in males and females. A reduced cell membrane content of long 
chain PUFA, particularly DHA, is associated with decreased cognitive function and 
retinal response
[154,155]. As such the ability of hepatocytes to respond to external 
stimuli may be reduced. As shown in figure 9.13, the proposed mechanism for the 
decreased ARA and DHA liver and plasma PC content is as follows. 
Feeding  a  maternal  high  fat  diet  during  pregnancy  and  lactation  led  to 
hypermethylation of CpG -394 of the fads2 promoter, in liver. As a result binding of Samuel Peter Hoile   
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the oestrogen receptor was weakened, and therefore transcriptional activity was 
reduced. Due to decreased fads2 mRNA production and ʔ6 desaturase protein, 
the synthesis of ARA and DHA, through the desaturation, elongation pathway was 
reduced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To  date,  this  is  the  first  study  to  show  the  role  of  promoter  methylation  and 
transcription factor binding to the fads2 promoter, so the extent to which these 
results can be confirmed by the current literature is unclear. 
 
Figure  9.13  Increased  maternal  fat  intake  leads  to  decreased  20:4n-6  and  22:6n-3 
content  of  liver  and  plasma  phospholipid  through  reduced  ER  binding  to  the  fads2 
promoter Samuel Peter Hoile   
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The findings in this chapter have provided a potential mechanism for the altered 
phenotype, in terms of liver and plasma PC composition, seen in male and female 
offspring of dams fed an altered fat diet. 
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Chapter 10 
 
Discussion 
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10.1 Discussion 
  The  ability  of  an  organism  to  respond  to  changes  in  its  environment  is 
crucial for Darwinian fitness and evolution
[92,33,307,308,309]. An altered developmental 
environment in utero has the potential to lead to an altered offspring development, 
which  confers  altered  disease  risk  in  later  life
[82,14,86,87,310,311,167,41,312,21].  In  both 
human and animal models, it has been shown that these altered phenotypes are 
transmitted between generations, even when the initial stimulus does not persist 
beyond the F0 generation 
[166]. In humans, nutritional transition is associated with 
an altered risk of disease
[180].  
These observations raise questions about the mechanism by which nutrition during 
development  induces  changes  in  phenotype  and  how  such  effects  may  be 
transmitted  between  generations.  Recent  studies  in  human  and  animal  models 
have  demonstrated  that  epigenetic  processes  are  involved  centrally  in  the 
induction  of  altered  phenotypes
[196,197,198,187,199,200,201,215].  The  experiments 
described  in  this  thesis  were  designed  to  investigate  three  important  areas  of 
uncertainty within the field of the early life origins of disease; if and how induced 
epigenetic marks are transmitted between generations; the degree of specificity 
with which nutritional exposures in early life alter epigenetic marks; and the stability 
of induced changes in the epigenome. 
 
10.2 Are epigenetic marks transmitted between generations? 
The  mechanism  behind  altered  phenotype,  as  a  result  of  long-term 
nutritional  transition  has  not  been  widely  studied  and  is  limited  to  two  human 
observation and two studies in drosophila. In humans, there was a causal link in 
China between migration onto a complex carbohydrate and increased fat content 
diet, such as that present in the Western world, and risk of obesity
[180]. However, 
due to the timing, follow ups in further generations, to test adjustment to the new 
diet have not been obtained. In India, an increase in obesity in mothers during the 
20
th century, who showed levels of glucose intolerance during pregnancy, lead to a 
dramatic increase in the presence of low birth weight and thin at birth offspring
[313]. 
During  adult  life,  these  offspring  tended  to  be  insulin  resistant  and  had  an Samuel Peter Hoile   
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increased risk of developing type II diabetes. Studies in Drosophila have shown 
that  constant  exposure  to  altered  nutrition  leads  to  persistent  changes  in  gene 
expression
[181,182]. These alterations, which led to increased adaptation to medium 
in subsequent generations, provided primary data on adaptation to altered nutrition 
across generations. 
Animal models have shown that an altered environment during pregnancy 
can lead to the development of an altered phenotype, which is evident up to the F2 
generation. In a study by Benyshek, protein restriction of the maternal diet during 
pregnancy and lactation led to a significant decrease in fasting glucose level in 
male offspring, up to the F3 generation
[174]. However the value in the F3 generation 
was significantly lower than in the F2 generation and the F3 offspring also showed 
a  significantly  higher  plasma  insulin  level.  These  results  show  that  the  altered 
phenotype is not transmitted unchanged between generations, where the effect of 
a single period of an altered environment is diminished between generations. This 
pattern was also seen in a study by Drake, where exposure of dexamethasone 
during pregnancy in rats, led to an altered phenotype in the offspring, including low 
birth  weight,  adult  hypertension  and  increased  hepatic  PEPCK  activity
[167].  The 
dexamethasone-programmed  phenotype  was  also  seen  in  F2  generation  male 
offspring, when no altered exposure was present during pregnancy. However, no 
effects  were  seen  in  the  F3  offspring,  suggesting  the  consequence  of 
dexamethasone treatment is only seen up until the F2 generation. In humans, it 
was  shown  by  Giusti  et  al,  that  exposure  to  diethylstilbestrol  led  to  two-fold 
increase in breast cancer risk in woman
[170]. In one case, the granddaughter of a 
diethylstilbestrol  exposed  woman  developed  ovarian  cancer.  This  suggests  that 
initial exposure led to a specific alteration which predisposed the granddaughter to 
development of an alternative form of cancer. Although this is limited to one known 
case, so must be viewed with caution. 
The findings presented here suggest that in rodents, nutritional transition to 
a high energy diet leads to significant alterations in both the maternal metabolism 
and offspring phenotype across four generations.  Transition onto a high energy 
diet was associated with significant differences in offspring growth, levels of gene Samuel Peter Hoile   
300 
 
transcription and promoter methylation. When accompanied by protein restriction 
during  the  F0  pregnancy,  there  were  significant  changes  in  the  trajectory  of 
alteration  in  weight  gain,  hepatic  gene  expression  and  promoter  methylation. 
These  differences  were  dependent  on  generation,  such  that  differences  were 
present  in  the  F3  generation,  which  were  not  seen  in  the  F1  or  F2  generation 
offspring. 
As suggested by Badyaev, parental effects on development are essential for 
the  transfer  of  developmental  resources  needed  to  reconstruct,  maintain  and 
modify genetically inherited components of the phenotype
[314]. Exposure to the high 
energy diet led to alterations in maternal metabolism in the F0 generation. This 
therefore  implies  an  altered  developmental  environment,  and  transfer  of 
information, provided from the mother. As a result of the high energy diet during 
the F0 pregnancy and the maternal affects, F1 offspring had a significantly altered 
metabolic phenotype. The ability of the F1 dams to interact with the environment 
and successfully represent and convey information from the external nutrition was 
altered, this means the F2 developing fetuses were exposed to altered maternal 
signals. Rather than transmission of an altered phenotype, gene expression levels 
and epigenotype between generations, it is hypothesised that information which 
acts as a signal to change, is transmitted between generations, rather than specific 
methylation  marks,  which  convey  an  altered  gene  regulation  and  therefore 
phenotype.  One  possible  explanation  is  that  interactions  between  the  maternal 
metabolism and the environment drive the adjustment of the offspring phenotype, 
through  the  establishment  of  de  novo  methylation  marks  in  each  generation. 
(Figure 10.1). 
It this hypothesis is correct, then the loss of an altered phenotype across 
generations and the presence of a different phenotype generations after an initial 
exposure,  can  be  explained as follows.  The  initial alteration  led  to  a  significant 
alteration  in  the  metabolism  of  the  mother,  leading  to  transmission  of  altered 
signals  during  in  utero  development  of  the  F1  offspring.  As  a  result  an  altered 
phenotype was present in the F1 generation. This has multiple impacts, as the 
altered phenotype may portray an altered disease risk in the F1 generation in later Samuel Peter Hoile   
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life  and  an  altered  metabolism  of  the  F1  generation  will  lead  to  significant 
differences in the ability of F1 dams to transmit information across the placenta. As 
a  result  the  development  of  the  F2  generation  will  be  altered.  If  the  altered 
environment, experienced by the F0 dams, during pregnancy, was transient, it is 
hypothesised  that  the  readjustment  of  the  offspring  generation  to  the  original 
environment will occur within one or two generations. This will depend on the ability 
of the altered maternal metabolism and physiology in the F1 generation, to convey 
the appropriate information regarding the external environment, to the developing 
F2 generation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Natural selection is a mulit-generation process, which requires opportunistic 
mutations and altered phenotypes, which confer an increased Darwinian fitness. 
As an potential mechanism for adjustment to a novel environment, the hypothesis 
suggested  here  is  in  agreement  with  previous  concepts  in  the  field.  In  the 
Figure 10.1 An interpretation of the adjustment towards a novel environment, through 
altered  interactions  between  maternal  phenotype  and  the  environment  where  the 
environment is shown in orange, the F0 generation is shown in blue, the F1 generation is 
shown in red, the F2 generation is shown in green, the F3 generation is shown in purple and 
interactions  are  shown  by  double-headed  arrows.  Indirect  maternal  effects  are  shown  by 
dashed arrows. Samuel Peter Hoile   
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alternative  adaptation  hypothesis,  West-Eberhard  suggests  that  novel  traits 
originate as stable phenotypes prior to reproductive isolation and speciation
[176]. 
One example of this is shown by Slijper, in a two-legged  goat
[315]. The animal, 
which was born with a congenital defect, could not walk on all fours, and therefore 
learnt to walk on two legs. Upon dissection, it was found that the bones of the hind 
leg and leg muscle had undergone dramatic changes. This example shows how 
the goat has the capacity for two-legged walking, which is utilised only under the 
conditions  that  require  it.  The  findings  in  this  study  are  in  agreement  with  the 
alternative adaptation hypothesis, in that the metabolism of the rat was able to 
adjust to the high energy content of the diet, in the apparent absence of genome 
mutation.  Again,  in  support  of  the  hypothesis  stated  in  this  thesis,  epigenetic 
opportunity  appeared  to  be  one  mechanism  behind  the  alteration  in 
metabolism
[178]. In our study, it is suggested that protein restriction of the F0 diet 
during pregnancy, altered the information transmitted from the maternal circulation, 
to the developing fetus and therefore epigenetic opportunity for adjustment, across 
generations was altered. It is therefore suggested that de novo epigenetic marks 
are  established  in  each  generation,  in  order  to  achieve  these  short  time  scale 
alterations in phenotype. In terms of humans, this may suggest that the increased 
prevalence in cardio-metabolic diseases worldwide may be a consequence of a 
shift in nutrition, onto a higher fat and complex carbohydrate diet, leading to altered 
epigenetic  marks  and  an  altered  phenotype,  which  conveys  a  risk  towards  the 
disease. 
 
10.3 Gene specific effects of altered nutrition 
  Candidate gene studies have shown that one form of nutritional alteration or 
exposure to specific chemicals during pregnancy leads to effects across multiple 
genes
[316,317,318,175].  Vinclozin  exposure,  during  embryonic  gonadal  sex 
determination led to an epigenetic reprogramming of the male germ line that is 
associated  with  transgenerational  adult-onset  disease  states
[316].  mRNA 
expression  of  196  genes  was  altered  in  the  F1-F3  generations,  where  most 
showed  a  decreased  expression  or  silencing,  following  exposure.  The  effect  of Samuel Peter Hoile   
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vinclozin exposure during embryonic gonadal sex determination was again shown 
in a study by Skinner, where in the F3 generation a multitude of genes were altered 
in the hippocampus and the amygdala. Where effects were sex specific and related 
to specific behaviour effects in each sex 
[175]. 
  Lillycrop et al have shown that protein restriction of the maternal diet during 
pregnancy,  in  the  rat,  led  to  an  altered  expression  of  genes  in  the  liver 
transcriptome in male offspring, where the majority were increased 
[318]. Folic acid 
supplementation  of  the  protein  restricted  diet  also  led  to  an  altered  mRNA 
expression  of  genes.  Interestingly,  of  all  of  the  genes  changed,  only  a  small 
amount were conserved between the protein restricted and protein restricted plus 
folic acid diets. In our study, we found that dietary challenge during F0 pregnancy 
induced altered gene expression in all three generations, but relatively few genes 
showed transmission of altered expression between generations
[317]. Differences in 
the transcriptome between the PS and PR lineages were present for 1,684 genes 
in the F1 generation, 1,680 genes in the F2 generation and 2,062 genes in the F3 
generation.  Although  differences  in  the  same  113  genes  were  seen  in  each 
generation, 63 of these were directionally opposite. KEGG analysis showed that 
only the Adherens Junctions pathway was altered in all three generations. These 
studies suggest that an altered environment during embryonic development leads 
to an altered expression of multiple genes, that these genes are specific to the 
nature of the nutrient and that subsequent generations do not necessarily show 
alterations in the same number or pathways of genes altered. 
  Data  here  is  in  agreement  with  these  findings,  showing  that  specific 
nutrients induce differential effects on gene regulation. Offspring of dams fed  a 
protein  restricted  diet  had  a  significantly  higher  mRNA  expression  of  GR, 
compared to the PS offspring, but no differences were seen in other genes, such 
as  PPARα  and  DNMT3a2.  Again,  following  high  fat  feeding  of  dams  during 
pregnancy, offspring showed an increased hepatic expression of PEPCK, but a 
decreased mRNA expression of fads2. This suggests that the mechanisms which 
cause  altered  regulation  of  transcription  are  specific  to  and  within  metabolic 
pathways. Samuel Peter Hoile   
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This implies that nutritional alteration in the mother has the potential to alter 
multiple pathways in different ways. As a result, the mechanism by which altered 
nutrition leads to an altered expression of genes is highly specific to the specific 
nature of the altered nutrition, such that addition of folic acid to a protein restricted 
diet can dramatically alter the trajectory of change. When considering the beneficial 
aspects of supplementation and fortification of foods, it is important to consider 
effects  on  a  large  number  of  pathways,  which  may  show  different  effects  in 
subsequent generations. 
 
10.4 Nutrient specific effects on gene regulation 
  It has been shown that different nutrients induce differential effects on gene 
regulation; however no study to date has compared different natures of nutrition on 
regulation of the same gene. In terms of PEPCK, it has been shown, in unrelated 
studies that both a PR diet and exposure to glucocorticoids leads to an increase in 
mRNA expression. It is not known if different natures of nutritional alteration during 
pregnancy lead to the same outcome, in terms of regulation of specific genes. 
In the current study, the role of type of maternal nutritional alteration on the 
epigenetic  regulation and  gene  expression of  PEPCK  was  investigated.  Protein 
restriction of the maternal diet, led to significant difference in PEPCK mRNA across 
the three generations, but no changes between dietary groups in the F1 offspring. 
These differences were associated with significant differences in methylation of the 
PEPCK promoter, which were CpG specific. Alterations in folic acid content of the 
diet had no effect on PEPCK mRNA expression when provided in the prenatal diet; 
however postnatal supplementation led to a significant increase in PEPCK mRNA 
expression in males and significant alterations in promoter methylation in females.  
It  was  also  shown  that  females  have  a  greater  level  of  PEPCK  expression, 
compared  to  males,  suggesting  an  increased  capacity  for  provision  of  glucose 
during  fasting.  Altered  fatty  acid  composition  of  the  maternal  diet  had  modest 
effects on PEPCK mRNA expression and no effects on methylation, in either sex. 
These findings suggest that alterations in the methylation of the PEPCK promoter 
are dependent on both the nature of nutritional alteration and the timing. Samuel Peter Hoile   
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The  results  shown  here  suggest  that  the  mechanism  behind  the  altered  gene 
expression  is preserved,  regardless  of the nature of  the  nutritional intervention. 
This is represented by the significant alterations in the methylation status of the 
genes altered. It appears that the mechanism is highly specific, in that only specific 
genes are affected by one type of nutritional alteration. Following this finding, the 
contributions of maternal affects, the nature of the nutritional alteration, duration 
and timing of exposure are now understood (Figure 10.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.2 The role of specific factors on offspring phenotype where altered nutrition 
and maternal history can significantly alter maternal metabolism Samuel Peter Hoile   
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10.5 Response to nutrition and implications 
  The  findings  in  this  study  have  contributed  to  the  understanding  of  the 
mechanism behind the altered offspring phenotype as a result of altered nutrition. 
The  current  generally  accepted  view  is that  DNA  methylation provides  a  stable 
heritable mechanism by which modifications in the developmental environment can 
lead to the generation of disease associated phenotypes in later life
[184]. However, 
it is known that the methylation status of the epigenome is subject to change with 
age and that this is associated with prevalence of specific diseases
[192]. Disease 
associated phenotypes are also presenting at younger ages
[5]. These observations 
suggest that DNA methylation marks may not be as stable as initially hypothesised. 
Findings  here  suggest  that  the  level  of  DNA  methylation  of  specific  promoters 
varies with age, in a manner dependent on the maternal diet during pregnancy. 
This suggests that DNA methylation is not stable, in the sense that it is unchanged 
throughout  life;  rather  that  the  epigenome  has  plasticity,  where  promoter 
methylation is sensitive to fluctuations in the external environment. 
Due  to  the  perceived  stability  of  DNA  methylation,  it  is  currently 
hypothesised  that  transgenerational  transmission  of  phenotype  involves  stable 
transmission of specific methylation marks. However, findings by Drake, suggest 
that changes in the epigenome are only evident up to the F2 generation, following 
a transient modification in nutrition or chemical exposure
[167]. My findings suggest 
that de novo methylation is occurring, at least in part, in each generation exposed 
to a high energy diet. It is this plasticity in the epigenome between generations that 
allows adjustment of offspring generations towards the novel environment. 
The  effect  of  altered  nutrition  on  changes  in  offspring  gene  regulation  is 
seen as a fixed mechanism, which does not take into account the nature of the 
nutritional modification. However, findings here suggest that there is specificity to 
the plasticity of the epigenome to the altered environment.  Although the underlying 
mechanism may be conserved, findings here suggest that modified regulation of 
one gene may result from modification in the protein level of the diet, but not when 
the fat content of the diet is altered. This suggests that the unknown mechanism Samuel Peter Hoile   
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linking  nutritional  change  and  modification  of  the  epigenome  is  specific  to  the 
nature of the nutritional alteration. 
  The hypothesised mechanism by which an altered environment leads to a 
modified phenotype in adulthood is as follows
[184,319,164,320,321]. An altered external 
environment, such as modification in nutrition, leads to a change in the parental 
effects, such as transmission of different information across the placenta from the 
maternal circulation. This change in maternal signals and altered developmental 
environment  will  modify  the  de  novo  methylation  of  the  epigenome  of  the 
developing organism. Through altered regulation of gene transcription, this will lead 
to  a  change  in  the  phenotype  in  the  developing  organism.  If  the  established 
phenotype  of  the  developing  organism  conveys  an  altered  ability  to  perceive 
information  from  the  maternal  circulation  or  to  process  information  from  the 
external  environment  during  post-natal  development,  this  may  result  in  further 
changes to the epigenome. Any change in the external environment during adult 
life has the potential to lead to changes in the phenotype of the adult organism, as 
a result of the plasticity of the epigenome. The ability of the epigenome to respond 
to changes in the environment will depend on the phenotype established during 
development  and  previous  adult  life.  The  adjustment  of  the  phenotype  of  the 
organism to the environment across the life course is possible due to the plasticity 
of the epigenome. The establishment of an altered phenotype in the adult organism 
will affect the parental effects on the next generation (Figure 10.3 A). This process 
underlies the changes in maternal and offspring phenotype and epigenome seen in 
the findings present here. 
When  considering  this  hypothesis  in  terms  of  multiple  generations,  extra 
effects must be considered. An altered maternal phenotype in the F0 generation 
will  lead  to  the  transmission  of  altered  information  to  both  the  F1  developing 
offspring  and  F2  germ  line,  so  that  the  phenotype  and  epigenome  of  both  are 
modified. During the F1 pregnancy and F2 in utero development, the ability of the 
F2 offspring to interpret information from the maternal circulation will be somewhat 
dependent  on  the  F2  germ  line  phenotype.  The  adjustment  of  the  offspring 
phenotype is also dependent on the persistence of the novel environment, where Samuel Peter Hoile   
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changes will impact the current and therefore future generations, through changes 
in the epigenome (Figure 10.3 B). 
  In mammals, females invest greatly in the production of the next generation, 
through  maternal  adaptations  to  pregnancy  such  as  altered  metabolism  and 
storage of nutrients
[322,104]. As a result, the role of the mother and altered maternal 
effects has been a focus of investigation here. Studies by Pembrey and Skinner 
have  suggested  an  importance  of  paternal  effects  on  the  generation  of  altered 
phenotypes in offspring
[163],167]. Although the direct contribution of altered paternal 
effects, in offspring development, compared to maternal effects, is not clear, the 
role of the father in the hypothesis suggested here must not be ruled out. 
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A 
B 
Figure 10.3 The mechanism by which an altered environment leads to adjustment of the 
organism to the novel environment through changes to the epigenome in one generation 
(A) and across multiple generations (B). Samuel Peter Hoile   
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10.6 Future work 
  The findings in this thesis have increased the understanding of mechanisms 
underlying  the  generation  of  altered  phenotype  in  offspring,  following  altered 
maternal nutrition; however key questions are now apparent. 
It is known that an altered nutrition has the potential to lead to altered epigenetic 
marks  in  the  offspring;  however  the  intermediate  mechanism  here  still  remains 
unknown. How does a nutritional effect become an epigenetic change? 
Different forms of nutritional alteration do not lead to alterations in the same genes, 
or  within  genes  of  the  same  pathways.  Is  the  mechanism  by  which  nutritional 
alteration becomes an epigenetic change specific to the form of alteration, or is it 
preserved? 
By answering these questions there is potential to inhibit and perhaps even reverse 
the establishment of detrimental alterations at the epigenome level. As a result, 
phenotypes that result in an increased susceptibility to disease may be averted. 
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